Me yasa alamun sun kasance na dogon lokaci?
Kuma duk wani ciwon kirji ya kamata a bi da shi ta wannan hanyar, musamman a shekarunka.
Kuma tare da zazzabi
Kuma ya kamata a duba hawan jini da kuma cholesterol.
Kuma kuna da ciwon kirji a yanzu?
Kuma kuna da wannan ciwon kirji a yanzu?
Kuma a kan wannan, kuna da matsala a numfashi
Kuma za ku iya gaya mani, waɗanne alamun bayyanar cututtuka kuke da su?
Kuma yadda zafin ka ya kasance
Kuma ina yin tari.
Kuma ina da wani ɗan rashin lafiya da kuma tari.
Kuma a yau ina da ciwon kirji sosai.
Kuma yanzu ne lokacin da za ku iya kamuwa da cutar Raynaud?
Kuma yana haifar da ciwon kirji.
Kuma ina ganin ina da zazzabi.
Kuma ina so ku bayyana yanayin ciwon kirji.
Kuma suna da zazzabi.
kuma idan kana da ciwon sukari
Kuma kun san, kamar na ji kamar kirji na ya yi zafi.
Ka sani, ina cikin baƙinciki, Ina cikin zagi, Ina cikin ƙiyayya.
Kuma ka na da ciwon kirji.
Kuma kun ce wannan matsin yana cikin kirjinku.
wani yana da dangin da ke da cututtukan zuciya, cututtukan zuciya, bugun zuciya, hawan cholesterol, hawan jini
Waɗanne alamomi ko matsaloli ne kuka lura da su tare da ciwon tsoka?
Shin akwai wasu mutane a cikin gidanku da ke da irin wannan bayyanar?
Shin kuna da wasu alamun bayyanar cututtuka?
Kuna da numfashi?
Shin har yanzu kuna da ciwon kirji?
Domin yanzu kakar mura ce.
Ba za mu manta da ciwon kirji ba, wanda yake fitowa daga zuciya?
Amma matsalar da ta fi muni ita ce ciwon kirji.
Amma ina da matsala a numfashi.
Amma na san cewa mutane da yawa sun gane ni.
Amma dole ne mu kula da kowane ciwon kirji da gaske.
Amma yanzu kana numfashi sosai, ko ba haka ba?
Na manta da shi saboda ciwon kirji.
Kuna jin kamar wani yana matsawa a kirjinku
Har yanzu kuna jin ƙarancin numfashi
Shin suna fama da cutar da alamun cutar suke kama?
Kuna da wasu matsaloli na yau da kullun kamar hawan jini ko makamancin haka?
Kuna da wata cuta ko wata cuta mai tsanani kamar ciwon sukari?
Kuna da wahalar numfashi tare da ciwon kirji?
Kuna da hawan jini?
Shin, kunã da wani ƙunci a cikin numfashinku?
Shin kun san menene alamun cutar?
Kuna ganin wannan hoton?
Sha ruwa mai yawa a yau
Duk da haka, ina yin gwajin ciwon sukari.
Duk da haka yana da alamun da ya yi kama da ni.
Yaya zafin zafin jikinka yake?
Yaya hawan jini?
Idan zazzabin ya ci gaba da tashi,
idan kuna da zazzabi na digiri dari biyu ko sama da haka
Idan kana ganin alamun ko matsalarka na bukatar ƙarin bincike
Na yi zazzabi jiya.
Ina da zazzabi na ɗan lokaci.
Na yi zazzabi jiya.
Ina da ciwo mai tsanani a nan a cikin kirji.
Ni ma ina da matsalar numfashi.
Zan aiko muku da hoto.
Ina jin ciwon kirji a yau
Ina da ɗan ciwon kai da zazzabi a yau.
Ina tsammanin mura ce.
Ina ganin cewa cutar zazzaɓi ce.
Kamar dai mutum mai nauyi yana zaune a kan kirjinka?
Duk abin ya fara ne da ciwon kai da zazzabi kusan lokaci guda.
Yana tsakiyar kirji na.
Matsawa kamar ciwon kirji ne
Ina jin zafi a cikin kirji
Yana tsakiyar kirjina
Yana tsakiyar kirjina
Cage na yana ciwo a cikin kirji
Ina matukar damuwa da wannan ciwon kirji.
Ina so ku gaya mani lokacin da kuke bayanin wannan ciwon kirji.
kamar hawan jini ko ciwon sukari
Yana tsakiyar kirji na.
Yanzu za ku iya shan taksipirina don zazzabi
"Mary, ka yi kwanaki kana da irin wannan ciwo.
Yanzu kun ce kuna da ciwon kirji.
Wani lokaci ina jin ciwon kirji
To, shin kuna da wasu alamun bayyanar da ke tare da ciwo?
Ko kuwa wani yana zaune a kirjinka?
Zazzabi da tari, ciwon kai da kuma ciwon tsoka, duk sun yi daidai da haka.
Yana tsakiyar kirji na.
A cikin wannan hoton, ku nuna mini inda kuka ji zafi.
Domin kuna da zazzabi
To, kuna tsammanin wasu daga cikin wadannan alamun na iya kasancewa da alaka da ciki?
Shin yaranku suna da wasu daga cikin alamun?
"Ku bayyana mini game da ciwon da ke cikin ƙirjinku".
Jinin yana tashi da dare.
Ina da zazzabin da na yi kwanaki biyu da suka wuce
Ya yi zazzabi sosai a daren jiya.
Wannan Dr. Porter ne a cikin dakin gaggawa na Triage.
To, za ku iya gaya mana kadan game da ciwon kirji?
To, a nan a gaba, a cikin ƙirjina, Ina jin zafi.
To, na yi ciwon kirji mai tsanani na ɗan lokaci.
To, idan na ji wannan ciwon a cikin ƙirjina
Wane irin ciwo ne kuke da shi a cikin kirjinku?
Yaushe ne ciwon kirji ya fara?
A wane yanki na kirjinka kake jin zafi?
Ina kuka ji wannan ciwon kirji?
Kuna jin kunyar kirji
Kun san cewa ina da ciwon sukari da sauran matsaloli.
Ka ce kana da ciwon kirji.
Cutar coronavirus (COVID-19) ta kara yaduwa a cikin EU/EEA da Ingila, daga 1 ga Janairu zuwa 15 ga Maris, 2020
Bayanan da ke tattare da cutar COVID-19 a cikin ƙasashen EU / EEA da Burtaniya sun nuna cewa duk da cewa annobar ta COVID-19 tana da matakai daban-daban a cikin ƙasashe daban-daban, duk da haka tana yaduwa cikin sauri a duk ƙasashe.
Dangane da kwarewar cutar a Italiya, ƙasashe, asibitoci da ɗakunan kulawa na musamman dole ne su haɓaka shirye-shiryen su don babban raƙuman marasa lafiya na COVID-19 waɗanda zasu buƙaci sabis na kiwon lafiya na musamman, musamman kulawa ta musamman.
A ranar 31 ga Disamba, 2020, an bayar da rahoton wani gungu na masu fama da cutar huhu da ba a san dalilin ba a Wuhan, lardin Hubei na kasar Sin.
A ranar 9 ga Janairu, 2020, Cibiyar Kula da Cututtuka da Rigakafin Cutar Sin ta ba da rahoton cewa cutar, wacce ke da sabon nau'in coronavirus, daga yanzu za a kira ta da cutar coronavirus-2 mai saurin numfashi mai tsanani, ko kuma SARS-CoV-2.
Tun daga wannan lokacin, cutar da ke haifar da kamuwa da SARS-CoV-2 an kira shi cutar coronavirus (COVID-19).
Bayanai da ake da su zuwa yanzu sun nuna cewa kusan kashi 80% na waɗanda ke da cutar COVID-19 suna fuskantar cutar a cikin ƙananan cututtukan numfashi tare da ko ba tare da ciwon huhu ba, kuma yawancin waɗannan ƙwayoyin suna warkewa.
A cikin kashi 14 cikin dari na masu cutar, COVID-19 ya zama mafi tsanani wanda ya sa marasa lafiya suka shiga asibiti, yayin da kashi 6 cikin dari na masu cutar da suka kamu da cutar suka shiga kulawa ta musamman.
Yawan mutuwar marasa lafiya da ke kwance a asibiti saboda COVID-19 ya kai kashi 4%.
A cikin wannan binciken, mun kimanta yanayin yaduwar cutar COVID-19 a kowace ƙasa ta EU / EEA da Burtaniya kuma mun kwatanta yanayin da lardin Hubei na China.
Har ila yau, muna kwatanta adadin masu kamuwa da cutar COVID-19 a cikin EU / EEA da Ingila tare da waɗanda ke da cutar a Italiya a tsakanin 31 ga Janairu zuwa 15 ga Maris, 2020.
Masu kamuwa da cutar COVID-19 a ƙasashen EU/EEA da Ingila
Bayan haka, COVID-19 ya bazu zuwa wasu yankuna na duniya, kuma yanayin cutar COVID-19 a sauran sassan duniya yanzu yana bin wannan yanayin a cikin ƙasar.
A ranar 11 ga watan Maris, Sakatare Janar na Hukumar Lafiya ta Duniya (WHO) ya ayyana annobar COVID-19.
A cikin fitowar 5 ga Maris na mujallar Eurosurveillance 2020, Spiteri da abokan aikinsa sun ba da rahoton farkon tabbataccen yanayin cutar ta COVID-19 a Turai bisa ga ma'anar WHO.
A cikin EU/EEA, an ba da rahoton farkon waɗanda suka kamu da cutar a ranar 24 ga Janairu, 2020 a Faransa a tsakanin matafiya da suka dawo daga Wuhan, lardin Hubei na China.
Ya zuwa ranar 15 ga Maris, 2020, an gano mutane da suka kamu da cutar COVID-19 a duk kasashe 30 na Tarayyar Turai/Yankin Tattalin Arzikin Turai da Burtaniya (UK), inda aka samu mutum 39,768 da suka kamu da cutar da kuma mutum 1,727 da suka mutu a tsakanin 31 ga Disamba, 2019, tare da Italiya kadai da mutum 1,7750 da suka kamu da cutar da kuma mutum 1,441 da suka mutu.
Samun adadin masu cutar COVID-19 da kuma bayyanarsu
A Cibiyar Kula da Cututtuka ta Turai (ECDC), ana samun bayanan mutanen da aka tabbatar da cutar COVID-19 a kowace ƙasa a kowace rana daga tushen hukuma kamar Ma'aikatar Lafiya, hukumomin kiwon lafiya na ƙasa da na yanki a waɗannan ƙasashe da WHO kuma ana sabunta su da karfe 8:00 na safe.
An yi amfani da bayanan ne don kimanta yanayin COVID-19 a cikin EU / EEA da Ingila da kuma kwatanta su da Italiya.
A matsayin tushen tantance yaduwar COVID-19 mai aiki, mun lissafa gajerun kwanaki 14 na cutar COVID-19, don haka an yi la'akari da lokacin COVID-19 na yau da kullun, a kowace EU / EEA da Burtaniya, a cikin lokacin Janairu 1 zuwa Maris 15, 2020.
An kuma gwada adadin masu kamuwa da cutar a kowace kasa da aka samu a karfe 8:00 na safiyar ranar 15 ga watan Maris na 2020 da na 31 ga watan Janairu zuwa 15 ga watan Maris na 2020.
Yanayin kamuwa da COVID-19 a ƙasashen EU/EEA da Ingila
Yanayin da aka lura a cikin gajeren kwanaki 14 na COVID-19 a cikin EU / EEA da Burtaniya ya yi daidai da yanayin da aka nuna a lardin Hubei na China (Hoto 1).
Gabaɗaya, a cikin ƙasashen EU / EEA da Burtaniya, tarin COVID-19 ya fara kusan 21 ga Fabrairu, sannan ya fara ƙaruwa cikin sauri kusan 28 ga Fabrairu, 2020 (abubuwan da aka haɗe).
Wannan ya samo asali ne daga saurin karuwar adadin wadanda aka ruwaito daga Italiya, amma duk sauran ƙasashen EU/EEA da Burtaniya sun nuna irin wannan ƙaruwar yanayin a cikin tarin COVID-19 (buƙatar da aka haɗe).
Hoto na 2 ya kwatanta adadin mutanen da suka kamu da COVID-19 a cikin EU/EEA da Ingila da kuma wadanda suka kamu da cutar a Italiya a tsakanin 31 ga Janairu zuwa 15 ga Maris, 2020.
Ya bayyana cewa zuwa karfe 8:00 na safiyar ranar 15 ga watan Maris, wasu kasashe 15 na EU/EEA da Ingila sun bayar da rahoton adadin wadanda suka kamu da cutar, wanda ya yi daidai da na Italiya a makonni 3 da suka gabata ko kasa da haka.
Sakamakonmu ya nuna cewa adadin tabbataccen masu cutar COVID-19 a cikin EU/EEA da Burtaniya suna ƙaruwa cikin sauri.
Hanyoyin da aka lura da su a cikin tarin COVID-19 sun nuna cewa cutar ta yadu a cikin ƙasa iri ɗaya.
Duk da cewa kasashe suna fuskantar matakai daban-daban na barkewar cutar, akwai bambance-bambance game da yadda hukumomin kiwon lafiyar jama'a na kasashe ke amsawa, kuma a cikin ƙasashe daban-daban, ana amfani da ƙa'idodi daban-daban ga mutanen da ke buƙatar yin gwajin tabbatarwa ko ƙarin gwajin COVID-19.
A farkon watan Maris na 2020, likitoci a yankunan da ke da ciwon daji a Italiya sun ba da rahoton yanayin da kusan kashi 10% na marasa lafiya da ke dauke da COVID-19 ke buƙatar kulawa ta musamman, kuma kafofin watsa labarai sun ba da rahoton cewa an riga an cika iyakar ƙarfin asibitoci da sassan kulawa ta musamman a waɗannan yankuna.
A halin yanzu, a cikin ƙasashen EU / EEA, kawai a cikin kashi 6% da 1% na masu haƙuri na COVID-19 suna da bayanai game da asibiti da / ko shiga kulawa ta musamman (ba a nuna bayanan ba).
Koyaya, dole ne a tattara su ta hanyar da ta dace don amfani da su azaman ƙarin bayanan sa ido na yanzu, da kuma mai da hankali kan adadin cututtukan da aka ruwaito da kuma mutuwar.
Wani bincike da aka gudanar a 11-2010 ya nuna bambancin da ke tsakanin samun damar asibitocin kulawa ta musamman da na matsakaici a Turai, wanda ya bambanta daga asibitoci 29.2 a Jamus zuwa 4.2 a Portugal a kowane mutum 100,000.
Wannan yana nufin cewa waɗannan ƙasashe suna da albarkatu da yawa ko ƙasa da Italiya (ƙimar matsakaicin gado 12.5 na kulawa ta musamman a kowace mutane 100,000 a cikin 2010-11).
An gabatar da yanayin samfurin da ya danganci wadatar lafiyar lafiya da magani tare da kimantawa ga kowace EU / EEA memba da Burtaniya dangane da yawan marasa lafiya na COVID-19 da ke da haɗarin > 90% na wucewar ƙarfin asibitocin kulawa ta musamman a cikin na shida na ECDC na saurin kimanta haɗarin COVID-19.
Tunda an riga an gano cututtukan da ke da cutar a wasu yankuna a cikin EU / EEA da Ingila, kuma asibitoci da asibitocin kulawa ta musamman galibi suna ba da sabis ga yawan jama'a na yanki, ya kamata a ba da bayanai game da cututtukan da ke da cutar da kuma asibitocin kulawa ta musamman bisa ga tsarin yanki na yanki don matakin kididdiga na 2 (NUTS-2).
Kwarewar cutar a Italiya da yanayin da ake ciki a wasu ƙasashe sun nuna cewa cutar COVID-19 tana yaduwa cikin sauri a cikin EU / EEA da Burtaniya.
Saboda haka, dole ne kasashe, asibitoci da kuma sassan kulawa ta musamman su shirya kansu don fuskantar yanayin watsawa na SARS-CoV-2 mai ci gaba da yawa kuma su samar da shirye-shirye don karɓar marasa lafiya da ke dauke da COVID-19, musamman a cikin kulawa ta musamman, kamar yadda ya faru a yankunan da ke yankin Italiya.
Kamar yadda aka nuna a cikin sabon kimanta haɗarin ECDC, don jinkirta yaduwar cutar SARS-CoV-2 zuwa hanzari, gaba ɗaya da kuma sauya yanayin daga ƙuntatawa zuwa rage saurin annoba, ya zama dole, saboda idan ba a ɗauki matakan da suka dace ba, saurin karuwar masu kamuwa da cutar da ake tsammani na iya ba wa hukumomin yanke shawara da asibitoci isasshen damar ganowa, karɓa da aiwatar da martani mai dacewa.
Binciken hadarin gaggawa ya kuma lissafa matakan kiwon lafiyar jama'a don rage tasirin cutar ta duniya.
Kasashe suna da ɗan gajeren lokaci don ƙarfafa ƙoƙarin sarrafawa da rage saurin yaduwar SARS-CoV-2, don haka rage matsin lamba akan tsarin kiwon lafiya da kulawa.
Idan ba haka ba, tsarin kiwon lafiya na sauran ƙasashen EU / EEA na iya fuskantar babban ɗumbin marasa lafiya da ke buƙatar kulawa ta musamman a cikin kwanaki ko makonni masu zuwa.
Cutar cutar coronavirus ta 2019 (COVID-19), wacce cutar coronavirus ta 2 (SARS-CoV-2) mai saurin kamuwa da cutar numfashi (SARS) ta haifar, ta yi sanadiyar mutuwar sama da mutane 3,000 da cutar sama da mutane 80,000 a China da sauran sassan duniya, kuma a matsayin haka, ta haifar da bala'in bil'adama.
Hakanan SARS-CoV-2 na iya zama kamar kwayar cutar SARS-CoV, wanda ya haifar da SARS a cikin dubban mutane a 2003, wanda aka watsa ta hanyar batsa kuma yana haifar da bayyanar cututtuka iri ɗaya ta hanyar daidaita tsarin.
Koyaya, COVID-19 ba shi da ƙarfi da kisa kamar SARS, amma yana da saurin yaduwa kuma yana cutar da tsofaffi da maza fiye da matasa da mata.
Dangane da karuwar wallafe-wallafen da suka shafi wannan cutar da ke fitowa, wannan tattaunawar tana ƙoƙari ta samar da cikakken bayani game da wannan batun bincike mai mahimmanci.
Za mu gabatar da bayanai na asali game da cututtukan cututtuka, ilimin halittu, ilimin kwayar cuta, ganewar asali, magani, rigakafi da rigakafin cutar.
Kodayake akwai tambayoyi da yawa da ba a amsa ba, ana fatan wannan binciken zai taimaka wajen fahimtar cutar mai hatsari da kuma kawar da ita.
Bikin bazara a ranar 25 ga Janairu, 2020 ya zama abin tunawa da ba a taɓa gani ba ga duk Sinawa waɗanda aka nemi su zauna a gida saboda barkewar sabuwar cutar kwayar cuta, duk lokacin hutu da makonni da yawa bayan haka.
Kwayar cutar tana da alaƙa da kwayar cutar coronavirus (CoV) wacce ta haifar da barkewar cutar ta SARS a shekara ta 2003, don haka a ranar 11 ga Fabrairu, 2020, Hukumar Lafiya ta Duniya (WHO) ta zaɓi sunan SARS-CoV-2 da sunan cutar da ke da alaƙa, cutar CoV-19 (COVID-19) (cutar coronavirus-19 ko COVID-19).
Cutar ta fara ne a Wuhan na kasar Sin kuma ta bazu cikin sauri a duk fadin kasar da kuma wasu kasashe kusan biyar a duniya.
Ya zuwa ranar 2 ga watan Maris na shekarar 2020, cutar ta haifar da kamuwa da mutane fiye da 80,000, inda adadin wadanda suka samu sauki ya zarce 40,000, kuma sama da mutane 3,000 suka mutu.
Hukumar Lafiya ta Duniya ta COVID-19 ta yi gargadin cewa COVID-19 "magabcin jama'a ne lamba 1", kuma yana iya zama mai ƙarfi fiye da ta'addanci.
Dangane da bayanan PubMed (https://www.ncbi.nlm.nih.gov/pubmed/), a cikin ƙasa da watanni biyu, an buga sama da takardu na kimiyya 200 dangane da COVID-19, waɗanda suka haɗa da batutuwa kamar su ilimin kwayar cuta, cututtukan cututtuka, ilimin halitta, ganewar asali da magani tun lokacin da aka fara rahoton labarin a ranar 7 ga Janairu, 2020, game da gano jerin kwayoyin cuta na kwayar cutar da aka ɗauka daga marasa lafiya da yawa.
Wannan bita na nazari yana nufin taƙaita ci gaban bincike a cikin sababbin fannoni da aka ba da hankali.
A cikin sassan da suka yiwu, za mu yi ƙoƙarin kwatanta COVID-19 da SARS da wani cutar coronavirus da ake kira Middle East Respiratory Syndrome (MERS da aka gano a shekarar 2012).
Za mu tattauna abin da muka koya game da rigakafin cutar da kuma bayyanarta, da kuma wasu muhimman tambayoyi da ke gaba.
Kwayar cuta ta coronaviruses an saba da cewa ba ta cutar da mutum, kuma tana haifar da kusan kashi 15% na mura.
Koyaya, a cikin wannan karni, mun haɗu sau biyu da cututtukan coronavirus masu cutarwa na SARS-CoV da MERS-CoV, waɗanda suka haifar da farkon barkewar cutar a cikin 2003 a China da 2012 a Saudi Arabiya, kuma sun bazu zuwa wasu ƙasashe cikin ɗan gajeren lokaci, suna haifar da mummunan annoba da mutuwa.
Saboda haka, COVID-19 na yanzu shine annoba ta uku ta kwayar cutar coronavirus a tarihin ɗan adam.
Kamar yadda aka nuna a hoto na 1, an fara ba da rahoton tarin cutar huhu da ba a san asalinsa ba a ranar 31 ga Disamba, 2019 daga Wuhan zuwa Hukumar Lafiya ta Kasa ta China.
Kwana bakwai bayan haka, an samu wani sabon kwayar cutar.
A ranar 15 ga Janairu, 2020, an ba da rahoton farkon cutar Footy daga Wuhan.
A halin yanzu, annobar ta bazu cikin sauri zuwa garuruwan da ke makwabtaka, sauran larduna da ƙasashe.
A ranar 20 ga watan Janairu, an bayar da rahoton kamuwa da ma'aikatan kiwon lafiya, wanda ya nuna cewa ana iya samun kwayar cutar daga mutum zuwa mutum.
A ranar 23 ga watan Janairu, an sake sanya Wuhan a cikin keɓewa kuma an dakatar da zirga-zirgar jama'a.
A ranar 24 ga Janairu, binciken farko na asibiti game da cutar ya ba da rahoton cewa daga cikin marasa lafiya 40 da suka kamu da cutar, 21 ne kawai suka sami damar tuntuɓar kasuwar abincin teku ta Wuhan, inda ake ganin asalin cutar ta samo asali ne daga wata dabba da ba a bayyana ba.
A ranar 30 ga Janairu, Hukumar Lafiya ta Duniya ta ayyana barkewar cutar a matsayin gaggawa ta duniya.
A lokacin da ake shirya wannan rahoton, cutar ta bazu a duk fadin kasar Sin da kuma wasu kasashe kusan 50 a duniya.
Saboda yanayin yana canzawa cikin sauri, dole ne a ƙayyade ƙarshen yaduwar cutar da kuma tsananin cutar.
A ranar 11 ga Fabrairu, 2020, wani bincike da aka yi tare da cibiyoyin bincike da yawa kan marasa lafiya 8,866 na COVID-19 da suka hada da marasa lafiya 4,021 da suka kamu da COVID-19 sun ba da wannan bayyanar cutar kamar haka (https://mp.weixin.qq.com/s/UlBi-HX_rHPXa1qHA2bhdA).
Kwayar SARS-CoV-2 ta kamu da mutane a kowane zamani, amma galibi ta kamu da mutanen shekaru 65-30.
Kusan rabin (47.7%) na wadanda suka kamu da cutar sun haura shekaru 50, kadan ne a karkashin shekaru 20 kuma mutane 14 ne kawai suka kamu da cutar a karkashin shekaru 10.
SARS-CoV-2 yana cutar da maza fiye da mata (0.31 cikin 100,000).
COVID-19 ya bazu a cikin gungun a cikin Hubei da kewayenta.
Gano COVID-19 ya ɗauki matsakaicin kwanaki 5 (9-2) daga lokacin farawa.
Matsakaicin lokacin da aka saba (7.2-3.0) shine kwanaki 4.8.
Matsakaicin lokaci daga farkon cutar zuwa mutuwa (kimanin 13.4-4.8) ya kasance kwanaki 9.5.
Matsakaicin maimaitawa (R<sub>0</sub>) ya kasance daidai da 3.77 (tare da kusan tabbaci: 4.05-3.51) kuma R<sub>0</sub> an gyara shi 4.82-2.23.
Yawan wadanda suka kamu da cutar ya karu sosai kafin 23 ga Janairu, 2020, daidai da lokacin da yawan tafiye-tafiye ya karu kafin bikin bazara a China.
Mutuwar da aka tabbatar da ita ta kasance 1.44% (kimanin 95%: 1.86-1.10) da kuma daidaitaccen mutuwar duk marasa lafiya ya kasance 3.06 (kimanin 95%: 4.59-2.02).
Manyan abubuwan haɗari guda uku don COVID-19 sune jinsi (maza), shekaru (shekaru 60 ko sama da haka), da kuma ciwon huhu mai tsanani.
Kwayoyin cuta na coronaviruses wani yanki ne na manyan ƙwayoyin cuta masu rufi waɗanda ke ɗauke da keɓaɓɓen RNA.
An rarraba su zuwa nau'ikan guda huɗu, wato, alpha, beta, gamma da delta, wanda a tsakanin su, alpha da beta coronavirus suna cutar da ɗan adam.
Glycoprotein spike (S) na kwayar cutar SARS-CoV da MERS-CoV suna haɗuwa da masu karɓar ƙwayoyin su da ake kira angiotensin-converting enzyme 2 (ACE2) da dipeptidyl peptidase 4 (DPP4), bi da bi, kuma suna haɗuwa da membrane na tantanin halitta.
Kwayar cutar RNA ta kwayar cutar tana fitowa a cikin cytoplasm; bayan kwayar cutar ta kwayar cutar, RNA ta kwayar cutar tare da suturar glycoproteins da sunadarai na nucleocapsid suna samar da kwayar cutar da ke dauke da virion, wanda daga baya ya haɗu da membrane na plasma, wanda ke haifar da sakin sabon kwayar cutar.
An ba da rahoton jerin kwayoyin SARS-CoV-2 na farko a ranar 10 ga Janairu, 2020.
Binciken ya nuna cewa SARS-CoV-2 wani sabon nau'in kwayar cutar beta ne wanda samfurori 10 da aka samo daga asalin cutar a kasuwar abincin teku ta Hunan a Wuhan, suna da kwatankwacin 99.98.
Kwayar cutar SARS-CoV-2 tana da kamanceceniya da SARS-CoV fiye da MERS-CoV.
Ta hanyar binciken da aka yi ta hanyar amfani da na'urar duba siginar lantarki, an gano kwayoyin SARS-CoV-2 a cikin ƙananan ƙananan ɓangarorin epithelium na hanyoyin numfashi na mutum.
ACE2 na mutum an san shi azaman mai karɓar kwayar cutar SARS-CoV-2 da kuma SARS-CoV.
Koyaya, furotin S na SARS-CoV-2 yana da rauni sosai ga mai karɓar ACE2 na ɗan adam fiye da SARS-CoV, wanda ya dace da gaskiyar cewa SARS-CoV-2 yana haifar da rauni fiye da SARS-CoV.
SARS-CoV-2 kuma yana samar da sabon gajeren furotin wanda aka tsara ta hanyar orf3b da kuma furotin na fitarwa wanda aka tsara ta hanyar orf8.
Kwayar cutar SARS-CoV-2 orf3b tana da tasiri a cikin kwayar cutar kwayar cutar kuma tana hana bayyanar IFNβ (interferon beta); duk da haka, orf8 ba shi da wani abu na biyu ko kuma wani aiki da aka sani.
A ranar 18 ga Fabrairu, 2020, Zhou da abokan aikinsa sun ba da rahoton tsarin cryomicroscopic na mai karɓar ACE2 na ɗan adam tare da ƙuduri na 2.9 ingstrom a cikin hadadden tare da mai ɗaukar amino acid mai suna B0AT1.
Sun gano cewa wannan hadadden, wanda ke da bude da rufe, yana tattara shi a matsayin dimer kuma ACE2-B0AT1 zai iya haɗuwa da sunadarai biyu na S, wanda zai iya zama ma'auni don ganowa da cutar coronavirus.
B0AT1 na iya zama manufa ta magani don gano magungunan da ke magance cutar SARS-CoV-2.
Asalin da kuma mai watsa shiri
An gano cewa SARS-CoV da MERS-CoV sun samo asali ne daga batsa kuma an watsa su ga mutane ta hanyar cat da raƙumi, bi da bi.
Ta hanyar kwatanta SARS-CoV-2 da sauran kwayar cutar, an gano cewa bat ne babban mai watsa shiri na SARS-CoV-2, saboda sabon kwayar cutar ta kasance daidai da kashi 96% na SARS-CoVs guda biyu daga bat, bat-SL-CoVZX45 da bat-SL-CoVZX21.
Koyaya, ko wane mai watsa shiri ne ya taimaka cutar ta wuce iyakokin kwayar cutar kuma ta cutar da mutane, ba a san inda ba kuma hanyar watsawa dole ne a bayyana ta.
Jay da abokan aikinsa sun ba da shawarar cewa macizai sun kasance masu ɗaukar kwayar cutar daga batutuwan zuwa mutane ta hanyar haɗin halittar halittar S.
A cewar wani bincike, masu bincike a Guangzhou na kasar Sin sun ba da shawarar cewa pangolins - dabbobi masu shayarwa masu shayarwa masu dogon zango  waɗanda galibi ana amfani da su a cikin maganin gargajiya na kasar Sin, bisa ga kamanceceniya ta kwayoyin halitta tare da kwayar cutar coronavirus da aka gano a cikin pangolins da kwayar cutar SARS-CoV-2, mai yiwuwa shine mai watsa shiri na SARS-CoV-2.
Koyaya, bambancin 1% tsakanin kwayoyin halittar biyu ya zama babban bambanci; saboda haka, ana tsammanin samar da tabbataccen sakamako don tabbatar da daidaito (Hoto na 3).
Abubuwan da ke tattare da SARS-CoV-2 ba a san su ba.
SARS-CoV da MERS-CoV na iya rayuwa cikin yanayin in-vitro na tsawon awanni 48 a cikin bushewar yanayi, tsawon lokaci zuwa kwanaki 5 a yanayin zafi ƙasa da digiri 20 Celsius da danshi na 50%-40%.
Wataƙila SARS-CoV-2 yana da halaye iri ɗaya.
An bayar da rahoton cewa SARS-CoV-2 yana da saukin kamuwa da abubuwa masu zuwa wadanda zasu iya kashe kwayar cutar yadda ya kamata: hasken ultraviolet da kuma sanya shi a zafin jiki na tsawon mintuna 30 a 56 ° C; ether, 75% ethanol, maganin kashe cuta mai dauke da chlorine, acid mai yaduwa, chloroform da sauran mai narkewa, amma chlorhexidine ba shi da wannan damar.
Gabaɗaya, duk yawan mutane ba su da kariya ga SARS-CoV-2 kuma saboda haka suna da saukin kamuwa da sabon kwayar cutar.
A halin yanzu, ba a ba da cikakken rahoton amsawar rigakafi ga SARS-CoV-2 a cikin kowane binciken.
Don haka, zamu iya komawa ne kawai ga binciken da aka yi a baya akan sauran coronaviruses, musamman SARS-CoV da MERS-CoV (Hoto na 4).
Tsarin kwayar cutar gabaɗaya bayan ya mamaye jikin mai masaukin baki, ana gano shi da farko ta hanyar tsarin rigakafin mai masaukin baki ta hanyar masu karɓar alamun ganewa (PRRs) gami da masu karɓar masu karɓar nau'in -C, masu karɓar masu karɓar mai wucewa (TLR), masu karɓar NOD (NLR), da masu karɓar RIG-I (RLR).
Kwayar cutar tana haifar da ayyuka daban-daban kamar bayyanar abubuwan kumburi, balagawar kwayoyin dendritic da kuma hada nau'in interferons na I (IFNs) wanda ke hana yaduwar kwayar cutar da kuma hanzarta fashocytosis na rigakafin kwayar cutar ta hanyar macrophage.
Koyaya, furotin N na SARS-CoV na iya taimakawa wajen kare kwayar cutar daga amsawar rigakafi.
Nan ba da jimawa ba za a fara aikin amsawar rigakafi don magance cutar.
T lymphocytes sun hada da kwayoyin T na CD4<sup>+ da CD8<sup>+ suna taka muhimmiyar rawa a cikin tsaro.
Kwayoyin T na CD4<sup>+ suna motsa kwayoyin B don tayar da takamaiman kwayoyin cutar, kuma kwayoyin CD8<sup>+ suna kashe kwayoyin cutar kai tsaye.
Kwayoyin T masu taimakawa suna samar da cytokines masu kumburi don taimakawa kwayoyin kare kansu.
Koyaya, COVID zai iya hana ayyukan T-cell ta hanyar haifar da apoptosis.
Tsarin rigakafi na jini ya ƙunshi abubuwan da suka hada da C3a da C5a, kuma kwayoyin cutar suna taka rawa wajen yaƙi da kamuwa da kwayar cutar.
Misali, kwayoyin cutar da aka ware daga wani mai lafiya da ya warke sun hana MERS-CoV.
A wani bangaren kuma, hawan jikin mutum yana haifar da yawan yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar.
Haɗarin kamuwa da SARS-CoV-2, wanda shine fashewar tarin cututtukan, ya fi girma a cikin tsofaffi tare da cututtukan da ke tattare da su da mata masu juna biyu.
Yana da kyau cewa mutanen da ke da kamuwa da cutar a cikin adadi mai yawa ko kuma mutanen da ke da aikin rigakafi na rashin ƙarfi suna da damar kamuwa da cutar fiye da sauran.
Matsakaicin lokacin da cutar SARS-CoV-2 ke rayuwa daga kwanaki 1 zuwa 14, wanda binciken da aka yi na marasa lafiya 425 na farko a Wuhan ya nuna cewa yawanci kwanaki 3 zuwa 7.
Koyaya, binciken da aka yi akan marasa lafiya 1,099 ya nuna matsakaicin lokacin da ake amfani da shi na kwanaki 3 kuma ya bambanta daga 0 zuwa 24 a gaba ɗaya.
Wani sabon bincike da aka ambata a sama, bisa la'akari da yawan mutane 8,866 da suka kamu, ya nuna tsawon lokaci na 4.8 (7.2-3.0) na kwanaki.
Yana da mahimmanci ga hukumomin kiwon lafiya su sanya lokacin keɓewa mai inganci bisa ga mafi kyawun lokacin da aka saba don hana yaduwar kwayar cutar ga wasu ta hanyar masu kamuwa da cutar amma ba tare da alamun cutar ba.
A matsayin tsari na yau da kullun, mutanen da ke da kwayar cutar ko kuma masu kamuwa da cutar dole ne su keɓe kansu na tsawon kwanaki 14.
Shin ya kamata a kara tsawon lokacin killacewa zuwa kwanaki 24?
Sau da yawa zazzabi shine farkon bayyanar COVID-19 wanda zai iya bayyana shi kaɗai ko kuma tare da wasu alamun kamar tari mai bushewa, ƙarancin numfashi, ciwon tsoka, ciwon kai, ciwon wuya, ciwon makogwaro, zubar da ruwa, ciwon kirji, zawo, amai da amai.
Wasu marasa lafiya sun sami ƙarancin numfashi da / ko ragewar iskar oxygen na nama mako guda bayan fara cutar.
A cikin matsanancin yanayin, an lura da alamun cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuk
Dole ne a yi wa marasa lafiya da zazzabi da/ko alamun cututtukan numfashi da zazzabi, ko da kuwa ba su da wani bambanci a cikin hotunan ƙwayar cuta, bincike don saurin gano cutar.
Wani binciken alƙaluma a ƙarshen Disamba 2019 ya nuna kashi 98 cikin ɗari na alamun da aka lura da su a cikin marasa lafiya sun kasance: zazzabi, kashi 76 cikin ɗari na tari mai bushe, kashi 55 cikin ɗari na numfashi mai ƙyama da kashi 3 cikin ɗari na zawo; kashi 8 cikin ɗari na marasa lafiya suna buƙatar taimakon iska.
An kuma bayar da rahoton irin wannan binciken a cikin wasu binciken biyu na baya-bayan nan a kan wani gungu na iyali da kuma wani gungu da aka samu ta hanyar watsawa ta hanyar mutanen da ba su da alamun cutar.
A kwatankwacin haka, binciken alƙaluma a cikin 2012 ya nuna cewa marasa lafiya na MERS-CoV suma suna da zazzabi (98%), tari mai bushe (47%) da kuma ƙarancin numfashi (55%) a matsayin manyan alamun cutar.
Koyaya, kashi 80% suna buƙatar taimakon numfashi, wanda ya fi na marasa lafiya na COVID-19 yawa kuma ya dace da ƙimar mutuwar MERS mafi girma idan aka kwatanta da COVID-19.
An kuma lura da zawo (26%) da ciwon hanci (21%) a cikin marasa lafiya da ke dauke da cutar MERS.
A cikin marasa lafiya da ke dauke da cutar SARS, alamun bayyanar cututtuka sun hada da zazzabi (99% zuwa 100%), tari mai bushe (29% zuwa 75%), numfashi mai wuya (40% zuwa 42%), zawo (20% zuwa 25%) da ciwon makogwaro (13%) kuma kimanin 14% zuwa 20% na marasa lafiya suna buƙatar taimakon numfashi.
Ya zuwa ranar 14 ga Fabrairu, lokacin da adadin mutanen da aka tabbatar da su a duniya ya kai 66,576, yawan mutuwar COVID-19 a duniya ya kai kashi 2 cikin dari.
Don kwatanta, an tabbatar da mutuwar SARS a watan Nuwamba na shekara ta 2002 a kashi 10% na 8,096 marasa lafiya.
Game da MERS, bisa ga binciken alƙaluma a watan Yunin 2012, yawan mutuwar ya kai kashi 37 cikin ɗari na 2,494 marasa lafiya.
Wani binciken da ya gabata ya ba da rahoton cewa <i>R</i><i><sub>0</i></sub> na cutar SARS-CoV-2 ya kasance mai tsayi da 6.47 tare da nesa mai aminci (CI) 7.23-5.71, yayin da <i>R0</i> na cutar SARS-Cov ya kasance 2 zuwa 4 kawai.
An kwatanta SARS-CoV-2 da MERS-CoV da SARA-CoV dangane da bayyanar cututtuka, mutuwa, da <i>R</i><i><sub>0</i></sub> a cikin tebur na 1.
Lambobin da ke sama suna nuna cewa SARS-CoV-2 yana da damar yadawa fiye da MERS-CoV da SARS-CoV, amma yawan mutuwar da ke faruwa a cikin su ya fi ƙasa da na biyun.
Saboda haka, sarrafa cutar SARS-CoV-2 ya fi kalubale fiye da MERS-CoV da SARS-CoV.
Clusters sau da yawa suna farawa daga cikin iyali ko al'umma ko kuma motar mota, kamar jirgin ruwa.
Marasa lafiya galibi sun yi tafiya ko sun zauna a Wuhan ko wasu wuraren da ke dauke da cutar ko kuma sun yi hulɗa da mutane masu cutar ko marasa lafiya a cikin makonni biyu kafin fara cutar.
Koyaya, an ba da rahoton cewa mutane na iya samun kwayar cutar sama da makonni biyu ba tare da nuna alamun cutar ba, kuma yana yiwuwa ga marasa lafiya da suka warke da aka sallame daga asibiti su sami ɓoyayyen kwayar cutar a jiki, wanda ya haifar da gargadi don ƙara tsawon lokacin keɓewa.
A farkon matakin, yawan ƙwayoyin cuta na gari (musamman lymphocytes) a cikin marasa lafiya na al'ada ne ko kuma an rage su.
Misali, an lura da cutar lymphopenia tare da ƙididdigar ƙwayoyin cuta na jini ƙasa da 10<sup>9</sup>×4 a kowace lita, ƙididdigar ƙwayoyin cuta ƙasa da 10<sup>9</sup>×1 a kowace lita, da kuma ƙaruwa a cikin ƙwayar aspartate na aminotransferase da viremia (kallon kwayar cutar a cikin jini) a cikin marasa lafiya 1,099 na COVID-19.
An sami ƙaruwa a cikin ƙwayoyin hanta da ƙwayoyin tsoka da kuma ƙwayar myoglobin a cikin jinin wasu marasa lafiya, kuma an sami karuwar furotin mai amsawa C da kuma ƙwayoyin erythrocyte a cikin jini a cikin yawancin marasa lafiya.
A cikin ƙwayoyin cuta masu rauni, matakan D-dimer, wanda shine sakamakon lalacewar fibrin a cikin jini, ya tashi kuma ƙididdigar lymphocyte yana raguwa.
An gano rashin daidaito a cikin hotunan kirji na mafi yawan marasa lafiya na COVID-19 kuma sun haɗa da inuwa mai siffa ko ƙyallen gilashi a cikin huhu.
Marasa lafiya galibi suna fama da ciwon huhu mara kyau, raunin kumburi mai tsanani da kuma ciwon ciwon numfashi mai tsanani (ARDS).
Lokacin da ciwon ciwon numfashi mai tsanani ya faru, rashin kulawa da kumburi, tarin ruwa da ci gaba da fibrosis, yana haifar da matsala mai tsanani na musayar gas.
Rashin aiki na pneumocytes na nau'in 1 da 2 na ciwon huhu yana rage yawan surfactants kuma sakamakon haka, yana haifar da tsayin daka na farfajiya, wanda hakan yana rage ikon huhu don faɗaɗa kuma yana ƙara haɗarin murkushewar ciwon huhu.
Saboda haka, sakamakon radiography na kirji mafi muni ya dace da mafi munin yanayin cutar.
A ranar 18 ga Fabrairu, 2020, bincike na farko na cutar COVID-19 ya gano alamun: lalatawar ƙwayar huhu, samuwar membrane, lalacewar lymphocytes na tsakanin da kuma ganin ƙwayoyin cuta na Chandestoy a cikin huhu na marasa lafiya da suka mutu; alamun da suka dace da cutar kamuwa da kwayar cuta ta kwayar cuta da ARDS (ciwon ciwon rashin lafiya na numfashi mai tsanani) kuma sun yi kama da alamun SARS da MERS.
Gano kwayar SARS-CoV-2 RNA ta hanyar jujjuyawar polymerase transcriptase chain reaction (RT-PCR) ya zama babban ma'auni don gano COVID-19.
Koyaya, saboda yawan ƙarancin ƙarancin ƙarya wanda zai iya hanzarta barkewar cutar, daga ranar 13 ga Fabrairu, 2020, an fara amfani da bayyanar asibiti a cikin Sin don gano cutar (hanyar ganewar asali wacce ba ta dogara da RT-PCR kawai ba).
Haka kuma yanayin cutar SARS.
Saboda haka, haɗuwa da tarihin cutar, bayyanar asibiti, gwajin dakin gwaje-gwaje da binciken radiology ya zama dole don ingantaccen ganewar asali.
A ranar 14 ga Fabrairu, 2020, ƙungiyar Feng Zhang ta gabatar da yarjejeniyar amfani da fasaha ta SHERLOCK mai tushen CRISPR don gano cutar SARS-CoV-2, wanda a cikinsa za a iya gano ɓangarorin RNA na SARS-CoV-2 na roba a cikin ƙarar <sup>18-</sup> 10 × 20 moles a kowace lita zuwa <sup>18-</sup> 10 × 200 moles a kowace lita (100-10 kwafi a kowace microliter shigarwa) ta hanyar sandar a cikin ƙasa da awa ɗaya ba tare da buƙatar kayan aiki mai rikitarwa ba.
Ana fatan cewa wannan sabuwar fasaha, idan aka tabbatar da ita a cikin samfuran asibiti, za ta iya inganta ƙwarewa da kwanciyar hankali.
Saboda karancin gogewa game da sabon coronavirus, likitoci galibi suna kula da marasa lafiya na COVID-19, yayin da suke ƙoƙarin amfani da hanyoyin da aka yi amfani da su ko aka ba da shawarar su don magance cututtukan coronavirus da suka gabata, gami da SARS-CoV da MERS-CoV da sauran cututtukan kwayar cuta (Jadawalin 2).
Wadannan hanyoyin sun hada da maganin psychotic da kuma yiwuwar maganin maganin maganin antiviral, maganin rigakafi, steroids, plasma na marasa lafiya da suka warke, maganin kasar Sin da kuma tallafi na hankali.
An kuma ba da shawarar yin amfani da plasma na marasa lafiya da suka warke don magance sabbin marasa lafiya.
Kamfanonin harhada magunguna suna gasa don samar da rigakafi da allurar rigakafi kan cutar.
SARS-CoV-2 yana fara kai hari ga huhu kuma mai yiwuwa a wasu ƙananan ƙananan ga sauran kwayoyin masu karɓar ACE2, kamar tsarin narkewa da ƙwayoyin cuta.
Koyaya, rashin ƙarfi da rashin ƙarfi na numfashi shine babban barazanar ga marasa lafiya kuma babban dalilin mutuwa.
Don haka, hanyoyin taimakawa numfashi suna da mahimmanci don sauƙaƙe alamun cutar da ceton rayukan marasa lafiya, gami da maganin oxygen na yau da kullun, sake zagayowar oxygen mai tsawo, iska mai iska mai iska da iska mai iska mai iska, gwargwadon tsananin cutar.
Marasa lafiya da ke fama da cututtukan numfashi mai tsanani ya kamata a sanya su a ƙarƙashin maganin oxygenation na membranes na ECMO, wanda shine ingantaccen fasahar biochardiotic wanda aka yi amfani dashi a baya don magance rashin ƙarfin zuciya ko numfashi mai saurin mutuwa.
Bugu da kari, kiyaye daidaiton electrolyte, rigakafi da maganin cututtukan na biyu da kuma girgizar cuta, da kuma kare ayyukan kwayoyin halitta ma suna da mahimmanci dangane da marasa lafiya da ke dauke da cutar SARS-CoV-2.
An tabbatar da cewa annobar cytokine a cikin marasa lafiya da ke dauke da cutar SARS da MERS ta haifar da hawan jiki.
Cytokine Storm wani nau'in halayen kumburi ne na tsarin da ke nuna sakin jerin cytokines ciki har da TNFα, IL-1β, IL-2, IL-6, IFNα, IFNβ, IFNγ da MCP-1.
Wadannan cytokines suna haifar da kwayoyin tsarin rigakafi don samar da yaduwar 'yanci wanda shine babban dalilin ARDS da rashin aiki na daban.
Rashin karfin tsarin garkuwar jiki yana da mahimmanci wajen maganin cutar cytokine, musamman a cikin marasa lafiya masu tsanani.
An yi amfani da maganin corticosteroids da tosilezomab, wanda shine kwayar cutar monoclonal anti-IL6, don maganin cutar cytokine.
Sauran hanyoyin magance hana rigakafi na guguwar cytokine sun hada da: daidaita martani na rigakafi a ƙarƙashin umarnin T-cell; hana aikin IFN-γ, IL-1 da TNF; hana JAK; blinatumib; mai hana siginar cytokine 4; da masu hana HDAC.
Ana amfani da steroids a matsayin magungunan hana rigakafi a cikin maganin SARS don rage lalacewar kumburi.
Koyaya, steroids a cikin babban allurai ba su da amfani wajen warkar da mummunan rauni na jijiyoyin jini a cikin marasa lafiya na COVID-19 da SARS.
Maimakon haka, suna iya haifar da mummunan sakamako masu illa, musamman osteoporosis wanda ya haifar da cutar anemia wanda ke tasiri sosai a cikin bayyanar cutar.
Koyaya, an ba da shawarar yin amfani da ƙananan zuwa matsakaitan allurai na maganin corticosteroids don kula da marasa lafiya masu cutar COVID-19 tare da taka tsantsan a cikin gajeren lokaci.
A lokacin rubuta wannan labarin, ba a tabbatar da ko wani maganin antiviral yana da tasiri ba.
Koyaya, allurar intravenous na Remdesivir, wanda shine analog na nucleotide, ya kasance mai tasiri a cikin wani mara lafiya na Amurka wanda ke da COVID-19.
Remdesivir wani sabon maganin rigakafi ne wanda Gilead ta kirkira, wanda aka kirkira ne don magance cututtukan da suka samo asali daga kwayar cutar Ebola da Marburg.
Daga baya, an gano cewa Remdesivir na iya samun tasirin hanawa akan wasu ƙwayoyin cuta masu amfani da RNA guda ɗaya, gami da MERS da SARS.
A cewar Gilead, an tura wannan sinadarin zuwa China don gwadawa a cikin gwaji biyu na asibiti akan ƙwayoyin cuta masu cutar SARS-CoV-2, kuma sakamakon ya kasance daidai da tsammanin.
Bugu da kari, baricetinib, interferon alfa, lupinavir/ritonavir, da ribavirin sun kuma kasance a matsayin magungunan da za a iya amfani da su wajen kula da marasa lafiya da ke fama da cututtukan numfashi.
Cutar zawo, tashin zuciya, amai, raunin hanta da sauran halayen da ba su dace ba na iya faruwa bayan maganin hade da lupinavir/ritonavir.
Ya kamata a bincika hulɗar da ke tsakanin wannan magani da sauran magungunan da mai haƙuri ke amfani da su.
Plasma daga marasa lafiya da suka warke da kuma samar da rigakafi
Tattara jinin marasa lafiya da suka warke daga cutar mai saurin kamuwa da cuta, don kula da sauran marasa lafiya da ke fama da cutar ko kare masu lafiya daga kamuwa da cutar mai saurin kamuwa da cuta, yana da babban tarihi.
A zahiri, marasa lafiya da suka warke galibi suna da matakan antibodies masu yawa a cikin jinin su don magance kwayar cutar.
Kwayoyin rigakafi sune immunoglobulin (Ig) da kwayoyin B ke samarwa don yaƙar ƙwayoyin cuta da sauran ƙwayoyin cuta na waje waɗanda ke gano ƙwayoyin ƙwayoyin cuta na musamman a cikin ƙwayoyin cuta kuma kai tsaye suna hana su.
A kan wannan, an tattara filasmar daga rukunin marasa lafiya da suka warke daga COVID-19 kuma an yi wa marasa lafiya 10 da ke cikin mawuyacin hali allurar.
Alamun su sun inganta cikin awanni 24 kuma an lura da rage kumburi, rage nauyin kwayar cutar da kuma inganta yanayin iskar oxygen a cikin jinin su.
Koyaya, shawarar da aka yi don amfani da wannan hanyar a kan sikelin da yawa kafin a gabatar da takamaiman hanyoyin magani ya buƙaci ƙarin tabbaci da bayyanawa game da shi.
Bugu da ƙari, ban da tasirin maganin, ya kamata a yi la'akari da rashin dacewar maganin plasma.
Misali, ƙwayoyin cuta na iya tayar da martani na rigakafi kuma su haifar da cutar cytokine wanda zai iya haifar da guba mai saurin mutuwa.
Yawan kwayoyin cutar a cikin jini yawanci yana da ƙarancin kuma ana buƙatar ƙarin jini don magance mutanen da ke da mummunan cuta.
Yana da wahala a haɓaka da samar da takamaiman ƙwayoyin cuta a cikin saurin lokaci don magance annobar duniya.
Saboda haka, ware kwayoyin B daga marasa lafiya da suka warke da gano lambobin kwayoyin da ke yin kwafin kwayar cutar mai tasiri ko kuma yin bincike don kwayar cutar mai tasiri akan sunadarai masu tasiri na kwayar cutar ya fi mahimmanci da amfani.
Ta wannan hanyar, ana iya sauƙaƙe samar da ƙwayoyin cuta.
An yi amfani da maganin gargajiya na kasar Sin na dubban shekaru don magance cututtuka da yawa.
Koyaya, tasirinsa ya dogara ne da haɗuwa da abubuwa da yawa a cikin ƙira wanda ya dogara da ganewar asali bisa ka'idodin maganin gargajiya na kasar Sin.
Yawancin abubuwan da ke aiki ba a san su ba ko kuma ba a bayyana su ba saboda yana da wahala a cire da kuma tabbatar da waɗannan abubuwan ko kuma abubuwan da suka dace.
A halin yanzu, saboda rashin ingantaccen magani na musamman don COVID-19, ana ɗaukar TCM (Magungunan gargajiya na kasar Sin) a matsayin ɗayan manyan hanyoyin maye gurbin marasa lafiya tare da ƙananan alamun ko marasa lafiya waɗanda suka warke daga mawuyacin yanayi.
Misali, an lura cewa Shu Feng Jie Du da Lian Hua Qing Wen sun kasance masu tasiri wajen maganin COVID-19.
An lura da mafi girman adadin maganin COVID-19 a lardunan China da yawa inda aka yi amfani da maganin gargajiya na kasar Sin don kashi 87% na marasa lafiya, gami da: Gansu (63.7%), Ningxia (50%) da Hunan (50%), yayin da lardin Hubei inda aka yi amfani da maganin gargajiya na kasar Sin don kusan 30% na marasa lafiya na COVID-19 yana da mafi ƙarancin adadin murmurewa (13%).
Koyaya, wannan kwatancen yana da matukar wahala, saboda yawancin sauran abubuwan tasiri kamar yawan marasa lafiya da tsananin cutar dole ne a yi la'akari da su yayin kimantawa.
A ranar 18 ga Fabrairu, 2020, Boli Zhang da abokan aikinsa sun buga wani bincike inda suka kwatanta maganin maganin yammaci (WM) shi kaɗai da maganin hada magungunan yammaci da na gargajiya na kasar Sin.
Sun gano cewa lokacin da ake buƙata don dawo da zafin jiki zuwa mafi kyawun yanayin, kawar da alamun cututtuka da kuma shiga asibiti a cikin rukunin Magungunan Yammacin Turai + Magungunan gargajiya na Sin ya yi ƙasa da na Yammacin Turai kawai.
Abin sha'awa, yanayin cutar tare da bayyanar cututtuka (daga m zuwa mai tsanani) ya kasance mafi ƙarancin ƙarancin WM + TCM (magungunan gargajiya na kasar Sin + na yamma) fiye da na yammacin magani kawai (7.4% vs. 46.2%), kuma yawan mutuwa a cikin yammacin magani + na gargajiya ya kasance ƙasa da na yammacin magani kawai (8.8% vs. 39%).
Koyaya, ya kamata a kimanta inganci da amincin maganin gargajiya na kasar Sin na Kamaken ta hanyar gwaji mai kulawa a manyan sikelin da kuma a cikin cibiyoyi da yawa.
Ƙoƙarin gano hanyar aiki da kuma gano abubuwan da ke da tasiri na hanyoyin maganin gargajiya na kasar Sin, ko kuma haɗuwa da su, idan ya yiwu, yana da ban sha'awa da kuma ban sha'awa.
Masu cutar da ake zargi ko kuma waɗanda aka tabbatar da cewa suna da cutar COVID-19 galibi suna fuskantar mummunan mummunan cutar, har ma da mutuwa, kuma waɗanda ke keɓewa suna fuskantar gajiya, kadaici da fushi.
Bugu da ƙari, alamun kamuwa da cuta, gami da zazzabi, rashin isashshen iskar oxygen da tari, da kuma cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut
A farkon barkewar cutar SARS, an ba da rahoton yanayin yanayin rashin lafiyar psychosis, gami da ciwon baƙin ciki na yau da kullun, damuwa, tashin hankali, tashin hankali na motsi, alamun rashin lafiyar psychosis, rikicewar tunani, har ma da son kashe kansa.
Binciken tuntuɓar da keɓewa na tilas, a matsayin wani ɓangare na martani na lafiyar jama'a game da barkewar COVID-19, na iya haifar da damuwa da jin laifi a cikin waɗanda ke da cutar dangane da tasirin cutar, keɓewa da kuma matsalar zamantakewa ga dangi da abokai.
Don haka, ya kamata a samar da kulawar lafiyar hankali ga marasa lafiya na COVID-19, waɗanda ake zargi da waɗanda suka kasance tare da su, da kuma jama'a waɗanda ke buƙatar waɗannan sabis ɗin.
Tallafin ilimin halayyar dan adam ya kamata ya hada da kafa kungiyoyin kiwon lafiya na hankali da ke da kwarewa da dama, ingantaccen bayani tare da cikakken labarai game da barkewar SARS-CoV-2 da shirye-shiryen magani tare da amfani da na'urorin lantarki da aikace-aikacen magana don hana kusanci da wasu.
Ingantattun alluran rigakafi suna da mahimmanci don yanke layin watsawa daga wuraren ajiyar dabbobi da ƙwayoyin cuta na ɗan adam zuwa ga masu karɓar bakuncin, kuma galibi suna dacewa da maganin antiviral a cikin sarrafa annobar ƙwayoyin cuta masu tasowa.
An yi ƙoƙari don haɓaka allurar rigakafin tushen S don samar da ƙwayoyin cuta masu aiki na dogon lokaci da kuma ƙarfin hanawa da / ko rigakafin kariya ga SARS-CoV.
An gwada rigakafin rayuwa a kan dabbobi don SARS.
Koyaya, kafin a fara binciken asibiti, yakamata a tantance ingancin in-vivo na waɗannan masu neman allurar rigakafin a cikin ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙ
Wannan na iya kasancewa saboda SARS ya ƙare shekaru 17 da suka gabata kuma ba a sake samun wani sabon hali ba tun daga lokacin.
A gefe guda, ana samun ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan
An haɓaka dabarun allurar rigakafi ta amfani da kwayar cutar da ba ta aiki ba, plasma na DNA, masu ɗaukar hoto na kwayar cuta, nanoparticles, kwayar cutar kwayar cuta da ƙananan ƙwayoyin cuta na ƙwayoyin cuta don MERS kuma an gwada su a wasu lokuta akan samfuran dabbobi.
Gina rigakafin SARS-CoV-2 mai lafiya da tasiri ga mutanen da ba su da kariya, abu ne mai matukar muhimmanci da kuma gaggawa don sarrafa yanayin cutar da ke ƙaruwa.
Koyaya, saboda dogon lokacin da ake buƙata don tsarawa da samar da allurar rigakafi (a matsakaita watanni 18) da kuma sauye-sauyen kwayar cutar coronavirus, magance wannan matsalar yana da ƙalubale.
A matsayin cutar da ke fitowa, COVID-19 kwanan nan ya fara nuna ƙarin lokacin asibiti a cikin dubban marasa lafiya.
A mafi yawan lokuta, marasa lafiya suna samun sauƙi a hankali kuma ba tare da wani rikitarwa ba.
Koyaya, kamar SARS da MERS, COVID-19 yana da alaƙa da rashin jin daɗi da mutuwa a cikin ƙwayoyin cuta masu rauni.
Saboda haka, ƙirar samfurin rigakafin cutar yana da mahimmanci ga ƙungiyoyin kiwon lafiya masu kulawa don fifita sabis ɗin su, musamman a cikin yankuna masu iyakance albarkatu.
Dangane da binciken asibiti da aka yi zuwa yanzu, waɗannan abubuwan na iya shafar ko kuma suna da alaƙa da ganewar asali na marasa lafiya na COVID-19 (Table 3):
Shekaru: Shekaru shine babban mahimmin abu don tsinkayar cutar SARS, kuma haka yake da COVID-19.
COVID-19 yafi faruwa a cikin shekaru 65-30, inda kashi 47.7% na mutane masu tsayi sama da shekaru 50 suka kamu da cutar a cikin binciken da ya hada da marasa lafiya 8866 da aka bayyana a sama.
Marasa lafiya da ke buƙatar kulawa ta musamman sun fi fama da cututtukan juyayi da rikice-rikice na yanayi kuma suna da shekaru da yawa fiye da marasa lafiya da ba su buƙatar kulawa ta musamman (da matsakaicin shekaru 66 da 51), yana ba da shawarar cewa za a iya ɗaukar shekaru a matsayin mai faɗakarwa game da sakamakon COVID-19.
Jima'i: Kamar yadda aka ambata a sama, SARS-CoV-2 ya kamu da maza fiye da mata (0.31 cikin 100,000 idan aka kwatanta da 0.27 cikin 100,000).
Cutar da ke tattare da cutar: Marasa lafiya da ke da cutar COVID-19 da ke buƙatar kulawa ta musamman suna iya samun rauni mai tsanani ko kuma arrhythmia na zuciya.
Matsalolin zuciya kuma sune manyan sanadin mutuwar masu cutar SARS.
An bayar da rahoton cewa SARS-CoV-2 na iya haɗuwa da kwayar cutar ACE2-positive, wanda zai iya haifar da raunin hanta a cikin marasa lafiya na COVID-19.
Ya kamata a lura cewa shekaru da cututtukan yanayi suna da alaƙa mai ƙarfi kuma suna iya haɗuwa da juna.
Binciken Lab na rashin daidaito: Matsakaicin furotin mai amsawa C a cikin jini yana nuna tsananin kumburi ko lalacewar nama kuma an ba da shawarar a matsayin mai yuwuwar gano cutar, amsawa ga magani da kuma kyakkyawan ci gaba.
An ba da shawarar cewa akwai alaƙa tsakanin matakan CRP da tsananin cutar da kuma cutar COVID-19.
Bugu da ƙari, ƙaruwar lactate dehydrogenase (LDH), aspartate aminotransferase (AST), alanine aminotransferase (ALT), da creatine kinase (CK) na iya tasiri a cikin hasashen sakamako.
Wadannan enzymes suna bayyana sosai a cikin wasu kwayoyin, musamman a cikin zuciya da hanta, kuma ana sakin su yayin lalacewar nama.
Saboda haka, ana ɗaukarsu a matsayin alamun gargajiya don gano cututtukan zuciya ko hanta.
Babban alamun asibiti: Za a yi la'akari da radiography na kirji da ci gaban lokaci na alamun asibiti, tare da sauran abubuwan da suka dace, don hango sakamakon COVID-19.
Amfani da steroids: Kamar yadda aka bayyana a sama, steroids sune masu hana rigakafi, wanda galibi ana amfani dasu azaman magani na ƙarin don rage lalacewar kumburi a cikin cututtukan cututtukan cututtukan cututtuka.
Tun da aka yi amfani da magungunan corticosteroids a cikin marasa lafiya masu cutar SARS, yawancin waɗanda suka tsira daga cutar anemia sun sha wahala tare da rashin ƙarfi na dogon lokaci da ƙarancin ingancin rayuwa.
Don haka, idan ya cancanta, ya kamata a yi amfani da steroids a ƙananan allurai a cikin gajeren lokaci ga marasa lafiya na COVID-19.
Damuwar hankali: Kamar yadda aka bayyana a sama, saboda barkewar COVID-19, marasa lafiya da yawa sun sami damuwa sosai saboda galibi an tilasta musu bin tsawan keɓewa, sun sami shakku da shakku game da abin da ke faruwa, kuma sun ga mutuwar danginsu ko abokai na kusa.
Ba da shawara ta ilimin halayyar dan adam da tallafi na dogon lokaci ya zama dole don taimakawa waɗannan marasa lafiya su kawar da damuwa da dawowa cikin rayuwar yau da kullun.
Dangane da binciken alƙaluma da aka yi zuwa yanzu, COVID-19 yana da halaye daban-daban na annoba idan aka kwatanta da SARS.
SARS-CoV-2 na iya yin kwafi sosai a cikin ƙananan numfashi, kamar sauran coronaviruses na sanyi, a cikin ƙananan numfashi, kuma yana iya bayyana a farkon lokacin kamuwa da cuta tare da ƙananan alamomi ko babu alamomi.
Saboda haka, marasa lafiya masu kamuwa da cutar a farkon ko kuma a lokaci na yau da kullun na iya samar da adadin kwayar cutar a cikin ayyukan yau da kullun, wanda ke haifar da matsala mai yawa don sarrafa annobar.
Koyaya, binciken ya nuna cewa watsa SARS-CoV yana faruwa ne lokacin da marasa lafiya ke cikin mawuyacin yanayi, don haka yawancin watsawa ba a farkon lokaci ba.
Saboda haka, barkewar COVID-19 ta yanzu ta fi haɗari kuma ta fi wahalar sarrafawa fiye da barkewar cutar SARS.
An yi ƙoƙari sosai a cikin China, gami da ƙarin sarrafawa na shiga da fita zuwa Wuhan da biranen da ke kewaye da shi da kuma keɓewar kusan yawan jama'a cikin fatan yanke jerin watsa SARS-CoV-2.
Kodayake waɗannan matakan sun yi tasiri sosai ga tattalin arziƙi da sauran ɓangarorin ƙasar, amma adadin sabbin masu cutar yana raguwa, wanda ke nuna jinkirin annobar.
Mafi kyawun hasashen shine cewa barkewar cutar zata ƙare a watan Maris, kuma matakin bincike na ci gaba zai ɗauki watanni 3 zuwa 4.
Koyaya, wasu masana ba su da kyakkyawan fata.
Paul Hunter da abokan aikinsa sun yi hasashen cewa annobar COVID-19, wacce ta fi SARS kamuwa da cuta, ba za ta kare ba a shekarar 2020.
Ira Langini da abokan aikinsa sun tsara samfurin da zai iya hango sakamakon barkewar cutar, suna ba da shawarar cewa cutar SARS-CoV-2 na iya cutar da kashi biyu bisa uku na yawan mutanen duniya.
Wata ƙungiyar Kanada ta ba da rahoton cewa an gano SARS-CoV-2 a cikin jerin samfuran swabs na hanci da makogwaro a cikin marasa lafiya da suka warke waɗanda aka sallame su daga asibiti makonni 2 da suka gabata.
Koyaya, ana ganin kyakkyawan hangen nesa a China dangane da raguwar sabbin kamuwa da cuta, wanda ke nufin yiwuwar nasarar dabarun yanzu.
Tun da farko an yi hasashen cewa Ebola za ta iya cutar da mutane miliyan daya tare da kashe mutane miliyan daya da rabi.
Koyaya, ta hanyar tsauraran takunkumi da keɓewa, cutar ta sami iko a ƙarshe.
Kamar SARS-CoV, SARS-CoV-2 na iya zama mai rauni a hankali kuma daga ƙarshe ya ɓace ko kuma ya canza zuwa kwayar cuta mai ƙarancin ƙwayoyin cuta wanda ke rayuwa tare da mutane.
An kwatanta cutar ta COVID-19 da SARS da MERS a ƙasa (Hoto 5).
SARS-CoV-2 yana da damar watsawa ta hanyar tari ko tari kuma mai yiwuwa ana yada shi ta hanyar hulɗa kai tsaye da abubuwan da ke dauke da kwayar cutar.
An kuma gano kwayar cutar a cikin kayan da aka shayar, wanda ke kara yiwuwar sabon yaduwar cutar daga kwayar cutar ta mugun jini.
Wani binciken da aka yi kwanan nan a kan marasa lafiya 138 ya ba da rahoton cewa kashi 41% na mutane sun kamu da cutar ta hanyar kamuwa da cuta a asibiti, gami da marasa lafiya 17 da ke da wasu cututtuka da kuma 40 daga ma'aikatan kiwon lafiya.
Don haka, don kare mutane, musamman ma ma'aikatan kiwon lafiya, ma'aikatan kiwon lafiya, dangin, abokan aiki, har ma da masu ziyarar marasa lafiya ko mutane masu kamuwa da cutar, dole ne a yi taka tsantsan.
Layin farko na kariya wanda za'a iya amfani dashi don rage haɗarin kamuwa da cutar shine sanya abin rufe fuska; amfani da nau'ikan masks na tiyata da na numfashi na N95 (seri na 1860s) yana taimakawa wajen sarrafa yaduwar ƙwayoyin cuta.
Masks na tiyata suna hana isar da ruwan numfashi daga cikin iska daga masu cutar da ke iya cutar da wasu ko kuma ya hana waɗannan ɗigon haɗi zuwa saman kayan sannan kuma ya watsa zuwa wasu.
Koyaya, kawai abin rufe fuska na N95 (lambar jerin 1860s) na iya kare ku daga numfashin ƙwayoyin cuta masu girman nanometers 10 zuwa 80, wanda kawai 5% na ƙwayoyin cuta ke iya shiga; SARS-CoV-2 kamar SARS-CoV a girman, tare da girman duka kusan 85 nanometers.
Tunda ƙwayoyin cuta na iya haɗuwa da juna ko da daga tsakanin masks na tiyata guda biyar, masu ba da sabis na kiwon lafiya waɗanda ke hulɗa kai tsaye da marasa lafiya ya kamata su yi amfani da N95 masks (lambar jerin 1860s) kuma su guji sanya masks na tiyata.
Baya ga abin rufe fuska, ma'aikatan kiwon lafiya dole ne su sanya rigar keɓewa mai rufewa don rage haɗarin haɗuwa da kwayar cutar.
Hakanan za'a iya daukar kwayar cutar ta hanyar ido.
A ranar 22 ga Janairu, 2020, likita ya kamu da cutar SARS-CoV-2 yayin da yake sanye da abin rufe fuska na N95, wanda wataƙila ta hanyar idanunsa masu kumburi.
Saboda haka, masu ba da sabis na kiwon lafiya masu kulawa dole ne su yi amfani da tabarau ko tabarau masu haske lokacin kula da marasa lafiya.
Don kiyaye lafiyar jama'a a yankunan da ke da cutar ko kuma wanda ke da yiwuwar cutar, ana ba da shawarar sosai cewa mutane su wanke hannayensu da sabulu mai tsabta fiye da yadda aka saba, su keɓe kansu, su zauna a gida, kuma su rage hulɗa da mutanen da ke da cutar.
Matsakaicin nesa da ya kamata mutane su kasance daga masu fama da cutar ya zama kafa uku.
Wadannan matakan suna daukarsu a matsayin ingantattun hanyoyin ragewa da kuma hana yaduwar cutar.
Kodayake SARS-CoV-2 an san shi a matsayin sabon kamuwa da cutar ga duniyar ɗan adam, babban kamaninsa da SARS-CoV wanda aka ruwaito a ranar 7 ga Janairu, 2020 ya zama babban gargadi ga China, yana mai da hankali kan barkewar cutar SARS a 2003.
Koyaya, ba a yi ƙoƙari don kwantar da hankalin jama'a ba har zuwa 19 ga Janairu, 2020, ranar da Shugaban Cibiyar Kula da Cututtuka ta Wuhan ya ba da sanarwar cewa sabon kwayar cutar tana da iyakantaccen yaduwar yaduwa da kuma tasirin watsawa daga mutum zuwa mutum, kuma ana iya hanawa da kuma hana cutar.
Wannan sakon ya sa ba a dauki gargadin jama'a da muhimmanci ba, musamman a yayin da kasar ke shirin bikin Sabuwar Shekara, kuma an rasa wata muhimmiyar dama ta hana yaduwar cutar a Wuhan.
Kungiyoyin kula da cutar a China na iya koyon wannan darasi mai wahala kuma suyi mahimman ci gaba don matakan gaba.
Misali, waɗannan ƙungiyoyi suna buƙatar (1) yin taka tsantsan yayin sanar da jama'a saboda duk wani bayani da suka gabatar zai iya ɗaukar hankalin jama'a kuma ya canza ra'ayinsu da yanke shawara; (2) zama mafi mai hankali da amsawa ga bayanan da ba daidai ba daga asibitoci, maimakon jiran rahotanni na hukuma daga likitoci ko jami'ai; (3) aiki da ƙarfi don hana yiwuwar barkewar cutar a farkon matakan maimakon kiran jama'a su kwantar da hankali; (4) samar da ingantaccen bayani mai ma'ana a cikin jama'a don haɓaka wayar da kan jama'a game da cutar ta annoba, tare da ci gaba da gwadawa da inganta tsarin amsawa na al'umma a kan lokaci.
Cutar COVID-19, wacce sabon kwayar cutar SARS-CoV-2 ta haifar, ta fara ne a ƙarshen Disamba 2019.
A cikin ƙasa da watanni biyu, cutar ta bazu ko'ina cikin China kuma a lokacin rubuta wannan labarin, ta bazu zuwa kusan ƙasashe 50 a duniya.
Saboda kwayar cutar ta yi kama da SARS-CoV, kuma alamun COVID-19 da SARS sun yi kama, barkewar COVID-19 a farkon ya haifar da tunanin cewa SARS ya dawo.
Koyaya, akwai wasu bambance-bambance masu mahimmanci tsakanin COVID-19 da SARS waɗanda ke da mahimmanci don hana annobar da kula da marasa lafiya.
COVID-19 ya fi shafar tsofaffi da maza fiye da matasa da mata, kuma yana da tsananin cutar da kuma yawan mutuwar da ya fi girma a cikin matasa.
Yawan mutuwar SARS ya fi na COVID-19 girma (10.91 vs. 1.44%).
Marasa lafiya na COVID-19 suna yada cutar ko da ba su da alamun cutar, yayin da masu cutar SARS galibi suna yada cutar lokacin da cutar ta yi tsanani, saboda haka ya fi wahalar hana yaduwar COVID-19 fiye da SARS.
Wannan ya bayyana wani ɓangare dalilin da yasa SARS-CoV-2 ke yaduwa cikin sauri da kuma a kan sikelin da ya fi na SARS-CoV.
A wasu marasa lafiya na COVID-19, gwajin RNA na yau da kullun don gano cutar SARS-CoV-2 na iya haifar da sakamako mara kyau.
A wani bangare kuma, marasa lafiya da suka warke za su iya sake kamuwa da kwayar cutar.
Wadannan binciken sun kara hadarin yaduwar kwayar cutar sosai.
Ganin wannan saurin ci gaba a binciken COVID-19, har yanzu akwai wasu mahimman batutuwa da ba a warware su ba, gami da:
Daga ina ne cutar SARS-CoV-2 ta samo asali?
Kodayake an sami daidaiton kwayoyin halitta kashi 96% tsakanin kwayar cutar SARS-CoV-2 da kuma wasu kwayar cutar SARS-CoVs biyu na bat, har yanzu ba za mu iya yanke shawarar cewa SARS-CoV-2 ya samo asali ne daga bat.
Wane dabba ne ya kasance matsakaici wajen watsa kwayar cutar daga mahaifarta, watau batsa zuwa mutum?
Ba tare da sanin amsoshin tambayoyi 1 da 2 ba, ba za mu iya dakatar da hanyar watsawa yadda ya kamata ba kuma za a iya sake barkewar cutar a kowane lokaci.
Kodayake ƙirar ƙwayoyin halitta da kimantawar ƙwayoyin sun nuna cewa SARS-CoV-2 yana haɗuwa da mai karɓar ACE2, ta yaya ainihin ƙwayar cutar ke shiga cikin ƙwayoyin iska kuma tana ba da damar haifar da canje-canje na pathological?
Shin kwayar cutar tana iya haɗuwa da ƙwayoyin bayyana ACE2 a wasu gabobin jiki?
Har sai an amsa wadannan tambayoyin a fili, ba za mu iya samun ingantacciyar hanyar gano cutar da kuma ingantacciyar hanyar magance ta ba.
Yaya tsawon lokacin da annobar za ta ci gaba?
Ta yaya kwayar cutar ke canzawa a cikin kwayoyin halittar mutum yayin yaduwa tsakanin mutane?
Shin zai zama annoba ta duniya, kamar SARS, ko kuma za a sake samun cutar mura?
Samun amsar wannan tambayar da sauran tambayoyi da yawa yana da mahimmanci amma yana iya ɗaukar lokaci.
Koyaya, ba tare da la'akari da kuɗin da ake buƙata ba, kawai zaɓin da muke da shi shine dakatar da annobar da wuri-wuri da kuma dawo da rayuwa cikin al'ada.
Tushen dabbobi na kwayar cutar coronavirus ta mutum
Shekaru dubbai, canji da daidaitawa sun taimaka wajen juyin halitta na coronavirus (CoVs) da kuma masu masaukin su, gami da mutane.
Kafin 2003, an san cewa kwayar cutar korona ta mutum (HCoV) biyu tana haifar da cututtuka masu saurin gaske, kamar su cutar zazzabin cizon sauro.
An nuna barkewar cutar SARS da cutar MERS a kan wasu tsabar kudi, wanda ke nuna yadda cutar ta cutar coronavirus ta mutum ke iya cutarwa da kuma hadari.
Bayyanar SARS-CoV-2 a tsakiyar China a ƙarshen 2019, ya sake sanya coronavirus a cikin hankali kuma ya ba mu mamaki tare da iyawar watsawa mai tsawo, amma ba shi da cutarwa idan aka kwatanta da ɗan'uwansa SARS-CoV.
Cutar kwayar cutar ta kwayar cutar ta mutum tana da asalin dabba (zoonosis), kuma sanin asalin kwayar cutar ta mutum zai iya taimaka mana sosai.
Yawancin kwayar cutar ta mutum ta samo asali ne daga batsa, wadanda ba su da cutar.
An kuma san wasu kwayar cutar ta HCoVs a matsayin majiyar matsakaiciyar tanki.
Gano dabbobi masu masaukin baki yana taimakawa kai tsaye wajen hana kamuwa da cutar a cikin mutane.
Binciken hulɗar mai watsa labaran coronavirus a cikin dabbobi na iya ba da mahimman bayanai game da cutar a cikin mutane.
A cikin wannan bita, muna ba da cikakken bayani game da bayanan da ke akwai game da kwayar cutar HCoVs guda bakwai, tare da mai da hankali kan tarihin gano su da kuma asalin dabbobi da watsawa tsakanin jinsuna.
Mafi mahimmanci, muna kwatanta da kuma magance nau'ikan kwayar cutar ta mutum daban-daban daga yanayin juyin halitta na kwayar cutar da kuma tsarin kwayar halitta.
Ana tattauna cutar ta COVID-19 ta yanzu a wannan mahallin.
Bugu da ƙari, yanayin da ake buƙata don nasarar motsawa tsakanin masu masaukin baki da kuma bayyanar cututtukan cutar da ke faruwa a cikin cutar ta zama abin lura.
Kwayoyin cuta na corona (CoVs) na cikin dangin Coronaviridae, wanda ya ƙunshi rukuni na ƙwayoyin cuta masu rufin RNA guda ɗaya masu kyau.
Wadannan ƙwayoyin cuta, waɗanda ke da mafi girman kwayar halitta 26 zuwa 32 kilobytes a tsakanin ƙwayoyin cuta na RNA, an sanya musu suna "CoVs (coronavirus) " ko kuma ƙwayoyin cuta masu ɗauke da kambi, saboda yanayin halittarsu kamar kambi.
A tsarin, kwayar cutar ta coronavirus tana da kwayar halitta guda daya wacce take da tsari iri daya.
Kimanin kashi biyu bisa uku na kwayoyin halitta sun haɗu (ORF1a da ORF1b) wanda aka fassara a matsayin kwafin polyprotein pp1a da pp1ab.
Ana sarrafa polyproteins don samar da sunadarai 16 marasa tsari waɗanda aka sanya sunayensu nsp1 zuwa 16.
Kwayar da ke cikin kwayar halitta ta ƙunshi ORFs don gina sunadarai, ciki har da spike (S), kwayar cutar (E), membrane (M), da nucleoprotein (N).
Wasu sunadarai na musamman na layi suna yin kwafin nau'ikan coronavirus daban-daban.
Dangane da bambance-bambance a cikin jerin sunadarai, ana rarraba COVID-19 zuwa nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'
Shaidar phylogenetic ta nuna cewa batsa da beraye suna aiki a matsayin tushen asalin yawancin alpha da beta coronaviruses, yayin da tsuntsaye sune manyan masu ajiyar gamma da Delta coronaviruses.
Shekaru dubbai, coronaviruses suna ci gaba da ƙetare shingen tsakanin jinsuna, kuma wasu sun bayyana a matsayin mahimman cututtukan ɗan adam.
Ya zuwa yanzu, an gano nau'ikan kwayar cutar coronavirus guda bakwai.
Daga cikinsu, HCoV-229E da HCoV-NL63 sune Alpha-CoVs.
Sauran beta-CoV guda biyar sun hada da HCoV-OC43, HCoV-HKU1, SARS-CoV), MERS-CoV, da SARS-CoV-2.
HCoV-229E, HCoV-OC43, HCoV-HKU1 da HCoV-NL63 galibi suna haifar da ƙananan alamomi kamar su rashin ƙarfi da / ko zawo.
A gefe guda, SARS-CoV, MERS-CoV da SARS-CoV-2 da aka gano kwanan nan suna da cututtuka masu yawa, suna haifar da kamuwa da cuta mai tsanani na ƙananan hanyoyin numfashi a cikin yawancin marasa lafiya kuma suna haifar da haɗarin kamuwa da cutar rashin ƙarfi na numfashi (ARDS) da bayyanar cututtuka na waje.
An gano kwayar cutar HCoV-229E ta farko, B814, daga hanci na marasa lafiya da suka kamu da cutar ta narkewa a tsakiyar shekarun 1960.
Tun daga wannan lokacin, an sami ƙarin bayani ta hanyar gudanar da bincike mai zurfi kan HCoV-229E da HCoV-OC43, waɗanda duka biyu ke haifar da alamun iyakance kai.
A zahiri, har zuwa lokacin barkewar cutar SARS, an yarda da cewa kamuwa da kwayar cutar ta HCoVs ba ta da lahani.
Yaduwar SARS a 2003 na daya daga cikin mafi munin yanayi na zamani, inda sama da mutane 8,000 suka kamu da cutar kuma yawan mutuwar ya kai kusan 10%.
Shekaru goma bayan haka, barkewar cutar MERS ta Gabas ta Tsakiya ta haifar da ci gaba a cikin yankin Larabawa, kuma wasu lokuta da ba a saba gani ba sun bazu zuwa sauran sassan duniya.
Sabon kwayar cutar coronavirus ta mutum 2019 (2019-nCoV), wanda daga baya aka sake masa suna SARS-CoV-2, shine wanda ya haifar da annobar cutar coronavirus ta 2019 (COVID-19), wanda ya kashe mutane 3,120 kuma ya kamu da mutane sama da 91,000 zuwa 3 ga Maris, 2020.
An yi gargadi kuma dole ne duniya ta shirya don cutar SARS-CoV-2 mai yaduwa.
Dukkan nau'ikan kwayar cutar ta mutum guda bakwai sun samo asali ne daga dabbobi daga batsa, beraye da dabbobi masu gida.
Shaida mai yawa ta tabbatar da cewa asalin juyin halitta na dukkan kwayar cutar ta mutum shine batsa, inda ƙwayoyin cuta ke daidaitawa sosai amma ba su da cutarwa kuma suna da bambancin kwayoyin halitta.
Cutar COVID-19 ta haifar da manyan kalubale na likita, kimiyya, zamantakewa da ɗabi'a ga China da duniya.
Binciken asalin dabbobi na HCoVs yana ba da tsari don fahimtar tarihin halitta, ƙarfin motsawa da abubuwan da ke iyakance bambancin bambancin.
Hakanan yana iya sauƙaƙe ko jagorantar bincike game da dabbobi masu ajiya, matsakaici, da masu haɓaka SARS-CoV-2 kuma ana iya amfani da su don hana irin waɗannan abubuwan a nan gaba.
A cikin wannan bita na nazarin, muna ba da cikakken bayani game da asalin dabbobi, watsawa tsakanin jinsuna, da kuma aikin cututtukan HCoVs.
Musamman, muna nunawa da kuma tattauna yanayin da ya saba cewa kwayar cutar mahaifa ta HCoVs ba ta da cutar a cikin rukunin masu masaukin su, amma ta zama mai cutar bayan yaduwar tsakanin nau'ikan zuwa sabon mai masaukin.
Muna kuma nazarin yanayin juyin halittar kwayar cutar ta HCoV, inda yawanci haɓakar watsawa ke tare da raguwar aikin cutar.
Sakamakon ci gaba da barkewar cutar SARS-CoV-2 an kuma tattauna a cikin wannan mahallin.
An san kwayar cutar coronavirus ta dabbobi tun daga ƙarshen shekarun 1930.
Kafin gano asalin HCoV-229E nau'in B814, daga hancin marasa lafiya da suka kamu da cutar, an sami nau'ikan coronavirus daban-daban daga dabbobi daban-daban, ciki har da turke, beraye, shanu, aladu, kuliyoyi da karnuka.
A cikin shekarun da suka gabata, an gano kwayar cutar coronavirus guda bakwai.
Takaitaccen tarihin gano kwayar cutar ta HCoV a cikin jerin lokaci (Table 1) na iya zama mai fa'ida da bayani.
An fara samun kwayar HCoV-229E a shekarar 1966 daga hanyoyin numfashi na marasa lafiya da ke fama da kamuwa da cutar ta sama, sannan kuma ya daidaita don girma a cikin layin kwayar numfashi na WI-38.
Marasa lafiya da ke dauke da HCoV-229E sun nuna alamun bayyanar cututtuka kamar na yau da kullun, gami da ciwon kai, tari, rashin lafiya da kumburi, tare da zazzabi da tari a cikin kashi 10 zuwa 20%.
Daga baya, a cikin 1967, HCoV-OC43 ya rabu daga kwayar halitta da kuma jerin abubuwan da suka biyo baya a cikin kwakwalwar yara.
An gano cewa halayen asibiti na kamuwa da cutar HCoV-OC43 sun yi kama da wadanda HCoV-229E ya haifar, wanda a alamance ya yi kama da sauran cututtukan cututtukan numfashi, gami da kwayar cutar mura ta A da rhinoviruses.
HCoV-229E da HCoV-OC43 duk sun yadu a duniya kuma galibi ana yaduwa a lokacin hunturu da kuma a cikin yanayin yanayi.
Gabaɗaya, lokacin ɓoyewar waɗannan ƙwayoyin cuta guda biyu bai kai mako ɗaya ba, kuma ana iya gano cutar a cikin kusan makonni 2.
Bisa ga binciken ɗan adam a kan masu sa kai, mutanen da ke da lafiya waɗanda suka kamu da HCoV-229E sun sami saurin raguwa.
Wasu marasa lafiya da ke da rauni a tsarin garkuwar jiki ne kawai suka kamu da cutar ta numfashi mai tsanani.
SARS, wanda kuma aka fi sani da "atypical pneumonia", shine farkon kwayar cutar coronavirus ta mutum da aka rubuta a tarihin rayuwar ɗan adam, kuma an gano asalin cutar SARS-CoV, wanda shine na uku na kwayar cutar coronavirus ta mutum.
An gano farkon cutar SARS a ƙarshen 2002 a lardin Guangdong na kasar Sin.
Cutar SARS ta haifar da kamuwa da cutar 8,096 tare da mutuwar 774 kuma ta bazu a kasashe da nahiyoyi da yawa.
Baya ga abubuwan da suka faru na yaduwar yaduwar, an kiyasta cewa kowane abu na iya haifar da kusan kashi biyu na kamuwa da cuta na biyu, tare da tsawon kwanaki 4 zuwa 7 da kuma ƙimar kwayar cutar da ke bayyana a rana ta goma.
Marasa lafiya da suka kamu da SARS-CoV sun fara da alamun bayyanar cututtuka kamar ciwon tsoka, ciwon kai, zazzabi, rauni da rawar jiki sannan kuma sun sami wahalar numfashi, tari da kuma matsalar numfashi a ƙarshen lokaci.
Lymphopenia, ƙididdigar ƙididdigar gwajin aikin hanta da kuma ƙimar keratin kinase sun kasance cikin sakamakon SARS na yau da kullun.
A cikin marasa lafiya da ke dauke da cutar SARS, an kuma lura da lalacewar alveolar, haɓakar ƙwayoyin epithelial da kuma ƙaruwa na macrophages.
Kimanin kashi 20 zuwa 30% na marasa lafiya suna buƙatar kulawa mai mahimmanci da iska mai iska.
Baya ga tsarin numfashi na ƙasa, wasu gabobin jiki da yawa, gami da tsarin narkewa, hanta da kuma al'aura na iya kamuwa da cutar a cikin waɗannan cututtukan na gaggawa, wanda yawanci yakan zo tare da guguwar cytokine kuma yana iya zama mai kisa, musamman a cikin marasa lafiya masu rauni.
An fara gano kwayar cutar ne a lokacin da aka yi wa wani dangin wani mai cutar da ke tafiya daga Guangzhou zuwa Hong Kong.
Tun daga wannan lokacin, an yi ƙoƙari sosai don bincika kwayar cutar ta HCoV.
An gano HCoV-NL63 daga jariri mai wata bakwai a Netherlands a ƙarshen 2004.
An fara lura da cewa yana da yawa a cikin yara ƙanana, tsofaffi, da marasa lafiya waɗanda ke da rauni na rigakafi ko cututtukan numfashi.
Rashin kumburi, kumburi, zazzabi da kuma ciwon huhu a cikin cutar da HCoV-NL63 ke haifarwa sun zama ruwan dare.
Wani bincike na kai tsaye ya bayyana ware irin wannan kwayar cutar daga samfurin hanci na jariri mai wata takwas da ke da cutar kirji a Netherlands.
Kodayake an gano wannan lamarin a cikin Netherlands, amma a zahiri ya bazu a duk duniya.
An kiyasta cewa HCoV-NL63 shine ke haifar da kusan kashi 4.7% na cututtukan numfashi, kuma ya kai kololuwa a farkon bazara, bazara da hunturu.
HCoV-NL63 kuma yana da alaƙa da larynx na larynx, wanda aka fi sani da kumburi na larynx.
A wannan shekarar, HCoV-HKU1 ya rabu da wani mutum mai shekaru 71 da ke kwance a asibiti a Hong Kong saboda ciwon kirji da kuma ciwon hanci.
Baya ga cututtukan cututtukan zuciya da na hanci da na hanci da na ciki, an kuma ba da rahoton alaƙar HCoV-HKU1 da ƙaruwar cututtukan hanci da na ciki.
HCoV-HKU1 kamar HCoV-NL63, HCoV-229E da HCoV-OC43 an gano su a duk duniya a matsayin masu haifar da rashin lafiya na numfashi.
Duk waɗannan ƙwayoyin cuta guda huɗu na kwayar cutar ta mutum sun dace da mutane kuma gabaɗaya ba su da wataƙila ta canza don haifar da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan
Gabaɗaya, lokacin da waɗannan HCoVs suka sami damar watsawa cikin tasiri da ci gaba a cikin mutane, cutar su ko cutar su ta ragu.
An fara gano kwayar cutar MERS-CoV a cikin 2012 a Saudi Arabia, daga huhu na wani mutum mai shekaru 60 da haihuwa wanda ke da ciwon kirji mai tsanani da rashin kumburi.
Kodayake yawancin lab da aka tabbatar da su sun samo asali ne daga Gabas ta Tsakiya, an kuma lura da wasu kasashe na Turai da Tunisia da ke shigo da su da kuma wasu cututtukan na biyu na kusanci.
Wani barkewar cutar na biyu ya faru a Koriya ta Kudu a shekarar 2015 inda aka tabbatar da mutane 186.
Bayyanar asibiti na MERS yana kama da cutar SARS, wanda aka gano da ci gaba da ciwon nono.
Ba kamar SARS ba, yawancin marasa lafiya da ke dauke da cutar MERS suna da rashin isasshen kuraje, wanda ke da banbanci ga MERS a cikin cututtukan da ke haifar da kwayar cutar ta mutum.
Fiye da kashi 30 cikin dari na marasa lafiya suna da alamun cututtukan ciki kamar zawo da amai.
Ya zuwa 14 ga Fabrairu, 2020, an bayar da rahoton sama da lamura 2,500 da aka tabbatar a dakin gwaje-gwaje tare da yawan mutuwar mutane 34.4%, wanda ya sanya MERS-CoV daya daga cikin cututtukan da suka fi cutar da aka sani ga mutane.
A tsakiyar zuwa ƙarshen Disamba 2019, an gano tarin marasa lafiya da ke fama da cutar sankara a Wuhan, lardin Hubei, China, waɗanda yanzu an gano cewa suna da alaƙa da kamuwa da cutar SARS-CoV-2.
Hukumar Lafiya ta Duniya ta bayyana barkewar cutar SARS-CoV-2 ta hanyar kamuwa da cututtukan numfashi a matsayin gaggawa ta damuwa ga lafiyar jama'a a duniya, kuma ta sanya sunan cutar COVID-19.
Ya zuwa ranar 3 ga Maris, 2020, an tabbatar da mutane 90,00053, a duk duniya, kuma yawan mutuwar ya kai kusan kashi 3.4%.
Ya kamata a lura cewa, yawan mutuwar a Hubei, China ya kai kashi 4.2%, yayin da yake a waje da kasar ya kai kashi 1.2%.
SARS-CoV-2 kamar SARS-CoV da SARS-CoV suna haifar da kamuwa da cuta mai saurin numfashi wanda ke bayyana a cikin zazzabi, tari da kuma numfashi mai wuya.
An kuma lura da zawo a wasu marasa lafiya.
Ciki da cinya na ɗaya daga cikin mafi munin alamun kuma yana iya zama cikin sauri zuwa ciwon numfashi mai tsanani.
Kodayake SARS-CoV da SARS-CoV-2 suna da kamanceceniya sosai saboda kusan kashi 82 cikin ɗari na dogon tsarin nucleotide, suna cikin tarin bishiyoyi biyu daban-daban.
SARS-CoV-2 a bayyane yake yana da ƙarancin kwayar cuta idan aka kwatanta da SARS-CoV da MERS-CoV amma yana da damar watsawa.
An samu rahotanni na mutane marasa alamun cutar SARS-CoV-2 kuma hakan na iya taimakawa wajen hanzarta yaduwar cutar a duniya.
Kwatantawa da gano bambance-bambance tsakanin SARS-CoV-2 da sauran kwayar cutar HCoVs guda shida sun nuna wasu kamance da bambance-bambance masu ban sha'awa.
Na farko, lokacin ɓoyewa da lokacin cutar HCoVs suna da kama sosai.
A wannan yanayin, SARS-CoV-2 yana nuna yanayin gaba ɗaya na sauran kwayar cutar ta COVID.
Na biyu, tsananin bayyanar COVID-19 ya kasance tsakanin SARS-CoV da kuma kwayar cutar coronavirus guda huɗu na mutum (gami da HCoV-229E, HCoV-OC43, HCoV-HKU1 da HCoV-NL63).
A gefe guda, kamuwa da cutar SARS-CoV-2 tana nuna halaye da aka fi gani a lokacin kamuwa da cutar ta HCoVs, gami da bayyanar cututtuka marasa kyau, marasa nauyi ko ma rashin bayyanar cututtuka.
A gefe guda, ƙananan ƙananan ƙananan lokuta na COVID-19 mai tsanani ana iya ɗaukar su azaman alamun kamuwa da cutar SARS-CoV, kodayake ƙananan ƙananan.
Na uku, watsa SARS-CoV-2 ya ci gaba da nuna wasu alamu masu ban sha'awa waɗanda ke nuna duka SARS-CoV da kuma kwayar cutar ta mutum.
A gefe guda, SARS-CoV-2 yana da yiwuwar watsawa aƙalla kamar sauran kwayar cutar ta mutum tare da yaduwar jama'a.
A gefe guda, dole ne a gano ko yiwuwar watsa SARS-CoV-2 daga mutum zuwa mutum bayan kamuwa, kamar yadda ya faru da SARS-CoV da MERS-CoV.
A ƙarshe, ana iya gano SARS-CoV-2 kamar sauran kwayar cutar ta mutum a cikin samfurori na kwayar halitta.
Har yanzu ba a san ko SARS-CoV-2 na iya taka muhimmiyar rawa kamar SARS-CoV ba, aƙalla a wasu yanayi.
Hakanan yana da ban sha'awa don ganin ko SARS-CoV-2 yana nuna yanayi na yanayi kamar yadda yake a cikin cututtukan coronavirus na mutum.
Koyaya, halayen SARS-CoV-2 gami da iyawar watsawa, cutar, da ci gaba da yaduwa bayan wucewa daga mutum zai yi tasiri ga ƙarshen barkewar COVID-19.
Dukkanin kwayar cutar ta HCoVs huɗu sun dace da mutane tare da yaduwar jama'a wanda ke haifar da bayyanar cututtuka masu sauƙi.
A wani bangare kuma, yana iya zama daidai a ce mutane sun daidaita da kyau ga waɗannan ƙwayoyin cuta guda huɗu.
A takaice, dukansu na iya zama masu tsira daga tsoffin cututtukan cutar ta HCoVs.
An cire kwayar cutar ta HCoVs da ke haifar da cututtuka masu tsanani a cikin mutane da kuma mutane da ke fama da cututtukan HCoVs masu tsanani daga binciken.
Don wannan, dole ne kwayar cutar ta HCoVs ta ninka a cikin mutane yadda ya kamata don ba da damar tattara canje-canje na daidaitawa wanda ke hana abubuwan da ke iyakance mai masaukin.
A wannan yanayin, yayin da yaduwar SARS-CoV-2 ke ci gaba da karuwa kuma yawancin mutane suna kamuwa da cutar, cutar tana da damar da ta fi dacewa da mutane.
Idan cutar ta daidaita sosai, zai yi wuya a hana yaduwar ta ta hanyar keɓewa ko wasu hanyoyin sarrafa kamuwa da cuta.
A cikin shekaru da yawa, kwayar cutar coronavirus guda huɗu ta yadu a cikin yawan jama'a, suna haifar da sake fashewa a cikin mutanen da ke da tsarin rigakafi na yau da kullun.
Wadannan ƙwayoyin cuta ba sa buƙatar wani tanki na dabba.
A gefe guda, ƙwayoyin cuta masu saurin kamuwa da cuta SARS-CoV da MERS-CoV ba su dace da mutane da kyau ba kuma ba za a iya samun sauyin su a cikin mutane ba.
Dole ne su kiyaye kansu a cikin wuraren ajiyar dabbobi kuma su haifa, yawanci ta hanyar daya ko fiye da matsakaici da masu watsa shirye-shirye, suna neman damar watsawa zuwa ga mutane masu mahimmanci.
SARS-CoV-2 yana da halaye masu kama da SARS-SARS-CoV/MERS-CoV da kuma kwayar cutar coronavirus guda huɗu na mutum.
Kamar dai yadda yake tare da yaduwar yaduwar kwayar cutar HCoVs, aƙalla a yanzu, tana da yaduwar yaduwa.
Koyaya, yana da ƙarin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cut.
Ko zai iya daidaitawa da mutane kuma ya iya motsawa tsakanin mutane ba tare da buƙatar mai riƙewa ko mai watsa shiri na dabba ba, zai bayyana a nan gaba.
Kafin tattauna asalin dabbobi na HCoVs, ya fi kyau muyi magana game da ma'anoni da halaye na masu ba da izini na juyin halitta, na halitta, na adanawa, na matsakaici da masu rarrabawa na HCoVs.
Dabba ana ɗaukarsa mai watsa shiri ne na juyin halitta na kwayar cutar ta mutum idan ya kasance yana da tushen wani dangi na kusa wanda yake da babban daidaituwa a matakin jerin nucleotides.
Kwayar cutar ta asali yawanci tana da kyau tare da mai masaukin baki kuma ba ta da cutar.
Hakanan, mai masaukin ajiyar zai adana kwayar cutar ta HCoV a kai a kai kuma na dogon lokaci.
A duka biyun, masu watsawa suna kamuwa da cutar ta halitta kuma suna aiki a matsayin masu karɓar bakuncin kwayar cutar ta HCoV ko kuma kwayar cutar mahaifa.
A gefe guda, idan kwayar cutar ta mutum ta kamu da wani mai watsa shiri na tsaka-tsaki, kwanan nan, kafin ko kusan a daidai lokacin da aka gabatar da ita ga mutane, ba ta dace da sabon mai watsa shiri da kyau kuma galibi cutar ce.
Mai watsa shiri na iya zama tushen dabba don kamuwa da cutar ga ɗan adam kuma ya zama mai watsa shiri mai haɓaka wanda ke ba da damar kwayar cutar ta ɗan lokaci ta ninka sannan ta watsa zuwa ga ɗan adam don haɓaka girman kamuwa da cuta a cikin ɗan adam.
Idan kwayar cutar ta mutum ba ta iya ci gaba da yaduwa a cikin mai watsawa na tsaka-tsaki ba, za ta ƙare a matsayin kamuwa da cuta ta hanyar hanawa.
Akasin haka, kwayar cutar ta mutum na iya daidaitawa da mai watsa shiri na matsakaici har ma da haifar da cutar ta asali na dogon lokaci.
A wannan yanayin, mai watsa shiri na tsakiya ya zama mai watsa shiri na al'ada.
A sake nazarin bayanan annoba, an gano cewa mutumin da ke da alamar SARS yana da tarihin hulɗa da dabbobi da aka farauta.
Binciken da aka yi na ci gaba da yaduwar cutar ya nuna cewa yaduwar kwayar cutar ta SARS-CoV G a cikin dillalan dabbobi ya fi na jama'a.
An gano masara mai rufe fuska (Paguma larvata) da wani kare mai suna raccoon a kasuwannin dabbobi masu rai a karon farko a matsayin masu dauke da kwayar cutar SARS-CoV mai kama da SARS-CoV.
Wannan ya tabbatar da cewa ba a sake samun rahoton cutar SARS ba bayan an kashe dukkan masu cutar a kasuwa.
Koyaya, an ba da rahoton cewa civets na masks a cikin daji ko gonaki waɗanda ba su haɗu da kasuwannin dabbobi masu rai ba galibi ba su da cutar SARS-CoV, a wasu kalmomin, ana iya yanke shawarar cewa civets na masks na iya zama kawai a matsayin mai watsa shiri na matsakaici na kwayar cutar, maimakon mai riƙe da SARS-CoV na halitta.
Abin lura, saboda kashi 80% na dabbobi daban-daban a kasuwannin Guangzhou suna da rigakafin SARS-CoV, ba za a iya yin watsi da yiwuwar cewa nau'ikan ƙananan dabbobi masu shayarwa suna aiki a matsayin masu watsa shirye-shiryen SARS-CoV masu rarrabawa ba.
Dukkanin waɗannan sun zama masu karɓar bakuncin SARS-CoV na ƙarshe.
Binciken gano wani mai watsa shiri na dabba na SARS-CoV ya haifar da gano wani kwayar cutar bat coronavirus mai matukar kama da shi wanda aka sanya wa suna HKU3 (SARSr-Rh-BatCoV HKU3), wanda ke cikin ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun
Sakamakon gwajin antibody na SARS-CoV da kuma jerin kwayoyin SARSr-Rh-BatCoV HKU3 sun kasance masu kyau a cikin waɗannan bat.
Wannan da sauran kwayar cutar bat coronavirus suna da kashi 88-92% na daidaiton jerin nucleotides tare da SARS-CoV.
Wadannan binciken sun kafa sabon ra'ayi, wanda ke nufin cewa batutuwan suna daukar bakuncin cututtukan mutum masu tasowa.
An kuma gano wasu cututtukan SARS-like coronaviruses (SL-CoVs) a cikin batsa, amma babu wani daga cikinsu da za a iya ware shi a matsayin kwayar cutar mai rai, sai dai WIV1.
An gano enzyme na 2 mai canza angiotensin na mutum (ACE2) a matsayin mai karɓar SARS-CoV.
An gano cewa WIV1 da aka samo daga samfurin bat-inhibitor, yana amfani da bat ACE2, man shanu, da mutum a matsayin mai karɓar ƙwayoyin cuta don shigar da kwayar.
Abin sha'awa, maganin alurar riga kafi na marasa lafiya masu murmurewa tare da SARS ya iya kawar da WIV1.
Ya zuwa yanzu, WIV1 ya nuna mafi kusanci ga kakannin SARS-CoV a cikin batsa, tare da kashi 95% na daidaiton jerin nucleotide.
Duk da yawan kamance tsakanin kwayar cutar biyu, an yarda cewa WIV1 ba shine matsakaiciyar kwayar cutar mahaifa ba ga SARS-CoV kuma batsa ba shine farkon mai riƙe da SARS-CoV ba.
Binciken ilimin halittu ya rarraba MERS-CoV a cikin rukuni guda na CoV-HKU4 na bat da CoV-HKU5 na bat.
CoV-HKU4 na Bat da MERS-CoV duk suna amfani da mai karɓar bakuncin mai kama da juna, mai suna dipeptidyl peptidase 4 (DPP4), don shigar da kwayar cutar.
Tsarin RNA polymerase-dependent RNA don MERS-CoV ya fi kusa da nau'ikan beta-bat coronavirus da aka gano a Turai da Afirka.
Ya zuwa yanzu, ba a gano wani MERS-CoV mai rai a cikin damisa ba.
MERS-CoV da kuma dangin sa na kusa na bat CoV-HKU25 suna da kashi 87% na daidaiton jerin nucleotides.
Saboda haka, batsa bazai zama mai watsa shiri na farko na MERS-CoV ba.
A gefe guda, binciken da aka yi a Gabas ta Tsakiya ya nuna cewa raƙuman dromedary sun kasance masu inganci ga maganin rigakafin MERS-CoV, kamar raƙuman da ke da asalin Gabas ta Tsakiya waɗanda ke cikin ƙasashen Afirka da yawa.
An samo kwayar cutar MERS-CoV mai rai mai kama da wanda aka samo a cikin mutane daga samfurin hanci na raƙuman dutse, wanda ke nuna cewa raƙuman suna aiki a matsayin mai masaukin gidan ajiyar MERS-CoV na gaske.
Ya kamata a lura cewa a cikin batutuwa da aka gwada tare da MERS-CoV, an lura da ƙananan alamun bayyanar cututtuka tare da kwayar cutar mai tsanani.
Ya kamata a lura cewa raƙuman da ke dauke da cutar ba kawai suna yada kwayar cutar ta hanyar numfashi ba har ma ta hanyar motsi-baki, wanda shine babban hanyar watsa kwayar cutar a cikin bat.
Koyaya, har yanzu akwai tambayoyi, saboda yawancin waɗanda ke kamuwa da cutar MERS ba su taɓa hulɗa da raƙuma ba kafin bayyanar cututtuka, saboda haka ana iya yanke shawarar cewa cutar ta bazu daga mutum zuwa mutum ko ta hanyar hanyoyin da ba a san su ba da kuma nau'in dabbobi waɗanda ke ɗaukar MERS-CoV.
SARS-CoV-2 yana nuna kwayar cutar nucleotide a kashi 96.2% tare da bat coronavirus RaTG13 wanda aka ware daga bat Rhinolophus affinis.
Kamar SARS-CoV da MERS-CoV, bambancin jerin tsakanin SARS-CoV-2 da RaTG13 ya fi yadda za a iya la'akari da alaƙar iyaye.
A takaice, batsa bazai zama farkon mai masaukin SARS-CoV-2 ba sai dai idan an sami kusan irin wannan bat coronavirus a nan gaba.
Wataƙila, masu watsa kwayar cutar SARS-CoV-2 na dabbobi sun kasance tsakanin nau'ikan namun daji waɗanda aka yi wa sallama da kashe su a kasuwar cin abincin teku ta Hunan, wanda yawancin shari'o'in COVID-19 na farko suka danganta da su kuma yana nuna yiwuwar watsawa daga dabba zuwa mutum.
Sabbin karatu da yawa bisa jerin abubuwan da suka faru sun nuna cewa wani rukuni na ƙananan dabbobi masu shayarwa da ke cikin haɗari da ake kira pangolin (Manis javanica) na iya zama asalin asalin SARS-CoV-2 mai alaƙa da beta-CoV.
Wadannan sababbin kwayoyin halittar pangolin coronavirus suna da kashi 85-92 cikin dari na daidaiton jerin nucleotides tare da SARS-CoV-2.
Koyaya, suna da alaƙa da RaTG13 tare da kusan kashi 90 cikin ɗari na kamanceceniya a cikin jerin nucleotides.
Suna zama nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'in nau'ikan nau'ikan nau
Akasin haka, SARS-CoV-2 da RaTG13 RBDs suna da bambancin bambanci, kodayake suna da ƙarin daidaito na genomically homologous.
Wani binciken da aka yi a baya a kan pangolins na marasa lafiya ya kuma ba da rahoton gano kwayar cutar daga samfuran huhu, wanda aka gano yana da alaƙa da SARS-CoV-2.
An yi amfani da hanyoyin tattarawa daban-daban da kuma zaɓin hannu don ƙirƙirar jerin kwayoyin halitta na ɗan lokaci wanda ya ɗauki kusan kashi 86.3% na tsawon tsarin kwayar cutar.
Ba za a iya yin watsi da yiwuwar pangolin a matsayin mai watsa shiri na SARS-CoV-2 na dabbobi ba.
Koyaya, a halin yanzu babu wata hujja game da asalin kai tsaye na pangolin don SARS-CoV-2 saboda bambancin jerin tsakanin SARS-CoV-2 da SARS-CoV-2 mai alaƙa da beta-CoVs.
Bugu da ƙari, tazarar tsakanin SARS-CoV-2 da RaTG13 ta fi tazarar tsakanin SARS-CoV-2 da SARS-CoV-2 beta-coronavirus a cikin pangolin.
Dole ne a gano hanyar juyin halitta na SARS-CoV-2 a cikin batsa, pangolins da sauran dabbobi masu shayarwa.
Yayinda aka sami mafi girman daidaiton daidaituwa a cikin RBDs tsakanin SARS-CoV-2 da pangolin, beta-coronavirus masu alaƙa da SARS-CoV-2, SARS-CoV-2 da RaTG13 suna da mafi girman daidaiton daidaituwa a cikin jerin kwayoyin halitta.
An yi imanin cewa babban daidaito tsakanin RBDs na SARS-CoV-2 da SARS-CoV-2 a cikin pangolin ya samo asali ne ta hanyar juyin halitta tare da daidaitaccen zaɓi.
An ba da shawarar musayar don amfanin nootropic tsakanin SARS-CoV-2 da RaTG13 a cikin nau'in dabbobi na uku.
Ana inganta nootropic a matsayin mai nasara a cikin juyin halitta tsakanin beta-CoVs.
Bincike game da asalin SARS-CoV-2 wanda ba na dabba ba har yanzu yana gudana kuma ba za a iya bayyana shi da tabbaci ba.
Baya ga kwayar cutar ta HCoVs mai saurin kamuwa da cuta, an kuma yi nazarin asalin dabbobi HCoV-229E, HCoV-OC43, HCoV-NL63, da HCoV-HKU1.
Shaidar phylogenetic ta nuna cewa HCoV-NL63 da HCoV-229E dukansu na iya samo asali ne daga bat coronavirus, yayin da aka gano kwayar cutar HCoV-OC43 da HCoV-HKU1 a cikin beraye.
An ba da rahoton cewa kwayar cutar bat coronavirus mai suna ARCoV.2 (Appalachian Ridge CoV) da aka gano a cikin batirin Arewacin Amurka mai launin fata yana da alaƙa da HCoV-NL63.
A gefe guda, HCoV-229E ya danganci kwayar halitta da wani kwayar cutar bat-CoV mai suna Hipposideros/GhanaKwam/19/2008, wanda aka gano a Ghana, yayin da ake tsammanin raƙuma ne ke daukar bakuncin matsakaiciyar cutar.
Don ƙarin haske, an taƙaita ilimin yanzu game da asalin dabbobi na ƙwayoyin cuta na mutum a cikin Hoto na 1 da Table 2.
Nazarin ilimin halittu ya ba da shaidar abubuwan da suka faru na watsa kwayar cutar ta kwayar cutar ta mutum a cikin tarihi.
Lokacin da aka gano kwayar cutar HCoV-OC43 a tsakanin jinsuna don yaduwa daga dabbobi zuwa mutane a cikin 1890, an yi rikodin cutar kamuwa da cuta ta numfashi.
Tarihin watsawa tsakanin nau'in HCoV-229E ba shi da tabbas.
An gano alpha-CoVs na bat da ke da kusanci da SARS-CoV-2.
Daga cikinsu akwai Alpha alpaca coronavirus.
Shaida mai yawa na goyon bayan mahimmancin kai tsaye na kwayar cutar daga bat zuwa mutum.
Da farko, mutane na iya tuntuɓar batsa maimakon alpacas saboda kasancewar su a cikin yanayin yanayin muhalli na yau da kullun.
Madadin haka, mutane suna da kusanci da alpacas.
Na biyu, alpha-CoVs na bat-da-hCoV-229E sun bambanta kuma ba su da cutar a cikin bat, yayin da alpha-CoV Alpaca ya haifar da barkewar cutar numfashi a cikin dabbobi.
A ƙarshe, babu wani alpaca coronavirus da aka gano a cikin namun daji.
Saboda haka, ba za a iya yin watsi da yiwuwar alpacas su ɗauki HCoV-229E alpha coronavirus daga mutane ba.
A zahiri, batutuwa sune tushen kai tsaye na ƙwayoyin cuta masu cutar mutum, gami da cutar ta Harri, cutar Ebola, cutar Nipah, da cutar Hendra.
Saboda haka ba abin mamaki bane cewa batsa na iya watsa HCoV-229E kai tsaye ga mutane.
A gefe guda, kodayake alpha-bat coronavirus yana aiki a matsayin mai riƙe da kwayar HCoV-229E, alpacas da raƙuman dutse na iya zama masu watsa shirye-shirye na matsakaici waɗanda ke watsa ƙwayoyin cuta ga mutane, kamar yadda ya faru da MERS-CoV.
MERS-CoV misali ne mai kyau na watsawa tsakanin jinsuna daga batutuwan zuwa raƙuman dutse da kuma daga raƙuman dutse zuwa mutane.
A farkon gano MERS-CoV, an gano cewa batutuwan ne suka haifar da ciwon, kuma binciken da aka samu daga baya ya tabbatar da hakan.
A bayyane yake cewa batsa shine tushen wadataccen nau'in kwayar cutar don musayar jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin jinsin.
Tsawon rayuwa, ƙauyuka masu yawa, hulɗar zamantakewa da ƙarfi na iya tashi, duk suna ba da kyakkyawan yanayi ga batutuwa a matsayin "mai watsa kwayar cuta".
A gefe guda, MERS-CoV ya kasance a cikin raƙuma shekaru da yawa.
Kwayar cutar ta daidaita sosai tare da waɗannan raƙuman, wanda ya canza daga mai watsa shiri na tsaka-tsaki zuwa mai riƙe da ɗakunan ajiya na yau da kullun.
MERS-CoV yana haifar da rashin lafiya mai sauƙi kuma ƙimar canji a cikin waɗannan dabbobin ba ta da yawa.
Yaduwar cutar zuwa ga mutane ba zato ba tsammani ne, kuma mutane ne ke daukar bakuncin MERS-CoV saboda ba za a iya ci gaba da watsa shi tsakanin mutane ba.
Idan aka kwatanta da rawar raƙuma a watsa MERS-CoV, rawar pangolins - idan har suna taka rawa - a watsa SARS-CoV-2 ya bambanta.
Musamman, beta-CoVs na pangolin suna da cututtukan cututtuka a cikin pangolins.
Suna iya zama masu masaukin SARS-CoV-2 alpha coronaviruses, kamar yadda algae suke a cikin SARS-CoV.
Za a tabbatar ko a ƙi yiwuwar watsa SARS-CoV-2 tsakanin jinsuna daga dabbobi zuwa mutane a cikin nazarin gaba.
Na farko, batutuwan na iya zama masu riƙe da wani kwayar cutar da ke da alaƙa da SARS-CoV-2 wanda kusan yayi kama da SARS-CoV-2.
Mutane na iya samun alaƙar muhalli tare da batsa ta hanyar aiki a cikin ma'aikata ko ma'adinai.
Na biyu, pangolins na iya zama ɗaya daga cikin masu watsa shirye-shiryen watsa shirye-shiryen watsa shirye-shiryen watsa shirye-shiryen watsa shirye-shiryen watsa shirye-shiryen watsa shirye-shiryen watsa shirye-shiryen watsa shirye-shiryen watsa shirye-shiryen watsa shirye-shiryen watsa shirye-shiryen watsa shirye-shiryen watsa shirye-shiryen watsa shirye-shiryen watsa shirye-shiryen watsa shirye-shiryen watsa shirye-shiryen watsa shirye-shiryen watsa shirye-shiryen watsa shirye-shiryen watsa shirye-shiryen watsa shirye-shiryen watsa shirye-shiryen watsa shirye-shiryen watsa shirye-shiryen watsa shirye-shiryen watsa shirye-shiryen watsa shirye-shiryen watsa shirye-shiryen watsa shirye-shiryen watsa shirye-shiryen watsa shirye-shiryen watsa shirye-shiryen watsa shirye-shiryen watsa shirye-shiryen watsa shirye-shiryen watsa shirye-shiryen watsa shirye-shiryen watsa shirye-shiryen watsa shirye-shiryen watsa shirye-shiryen watsa shirye-shiryen watsa shirye-shiryen watsa shirye-shiryen watsa shirye-shiryen watsa shirye-shiryen watsa shirye-shiryen watsa shirye-shiryen watsa shirye-shiryen watsa shirye-shiryen.
Mutane suna kamuwa da cutar ta hanyar yanka da cin naman da aka yi musu.
Yawancin dabbobi masu shayarwa, ciki har da dabbobin gida da na gida, na iya kamuwa da cutar SARS-CoV-2.
Ana buƙatar bincike kan dabbobi da namun daji don bincika ƙwayoyin cuta.
Na uku, nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in
Binciken asalin dabba na SARS-CoV-2 har yanzu yana gudana.
Baya ga nau'ikan nau'ikan dabbobi daban-daban, akwai manyan abubuwan da ke haifar da kwayar cutar guda uku waɗanda ke sauƙaƙa ƙetare shingen tsakanin nau'ikan kwayar cutar ta coronavirus.
Da farko, suna da ƙananan ƙwayoyin halitta a cikin kwafin RNA.
"Dangane da matakin daidaitawar kwayar cutar ta RNA guda ɗaya, dangane da matakin daidaitawar kwayar cutar ta COVID zuwa sabbin runduna, ƙididdigar ƙimar canji don kwayar cutar ta COVID bisa ƙimar maye gurbin matsakaici na kusan 10  4 sauye-sauye a kowace shekara a wurin 2, ana iya ɗauka ""matsakaici"" zuwa ""mai girma"".
Kwayar cutar coronavirus tana da wani exoribonuclease wanda ba za a iya karantawa ba, kuma cire shi zai haifar da sauye-sauye da rauni mai yawa ko ma lalacewa.
Abin sha'awa, an san cewa analog na nucleotide wanda ake kira Remdesivir yana hana kwayar cutar ta hanyar hana wannan exoribonuclease da RNA polymerase mai alaƙa da RNA.
Remdesivir yana daya daga cikin magungunan da suka fi dacewa don magance SARS-CoV-2 wanda dole ne a gwada shi a asibiti.
Koyaya, ƙimar canjin kwayar cutar ta COVID kusan sau miliyan fiye da na masu masaukin su.
Bugu da ƙari, yawan canjin canji yawanci yana da girma lokacin da coronavirus bai dace da mai masaukin ba.
Idan aka kwatanta da yawan canjin SARS-CoV, yawan canjin SARS-CoV-2 ya yi ƙasa sosai, wanda ke nuna babban matakin dacewa da ɗan adam.
Wataƙila ya riga ya daidaita zuwa wani mai masaukin da ya yi kama da ɗan adam.
Ba kamar SARS-CoV-2 ba, wannan gaskiya ne ga MERS-CoV, wanda ya dace da raƙuman raƙuman ruwa.
A ka'ida, ba zai yiwu ba cewa kwayar halitta ta iya hana allurar rigakafi da maganin rigakafin SARS-CoV-2 cikin sauri.
Na biyu, babban kwayar RNA a cikin kwayar cuta na COVID yana ba da ƙarin sassauci a cikin gyaran kwayar halitta don sauye-sauye ko ƙwayoyin cuta, wanda hakan ke haifar da ƙaruwa a cikin yiwuwar juyin halitta tsakanin jinsuna, wanda ke taimakawa wajen fitowar sabon kwayar cuta lokacin da yanayi ya dace.
Wannan yana da goyan bayan ɗakunan karatu na musamman da keɓaɓɓu da kuma ayyukan sunadarai waɗanda aka tsara zuwa ƙarshen 3′ na genomic.
Na uku, kwayar cuta ta canza alamu a bazuwar kuma sau da yawa yayin kwafin RNA ta hanyar tsarin ""zabin kwafi"".
A cikin mai masaukin baki, wanda ke aiki a matsayin alamar haɗuwa, sauya zaren yana faruwa sau da yawa yayin fassarar RNA na COVID.
RNAs masu dogon daidaituwa da tsawo na gaba da kuma na gaba na iya haɗuwa don samar da sabbin ƙwayoyin cuta.
An gano shaidar halitta ta hanyar kwayoyin halitta, a cikin HCoV-HKU1 da HCoV-OC43 da kuma a cikin kwayar cutar ta dabbobi kamar SL-CoV na bat da CoV-HKU9 na bat.
Hadin kai tsakanin mai watsawa da kwayar cutar dangane da watsawa
Baya ga abubuwan da aka ambata na uku na kwayar cutar, hulɗar kwayar cutar tare da mai karɓar mai watsa shiri wani mahimmin abu ne wanda ke tasiri ga watsawar tsakanin jinsuna.
A nan ne aka ɗauki kwayar cutar SARS-CoV a matsayin misali na mai watsawa kuma ya nuna hujja na zaɓin mai kyau a lokacin watsawar tsakanin nau'ikan.
Bisa ga nazarin kwatancen tsakanin keɓaɓɓun SARS-CoV na ɗan adam da na al'ada, an gano cewa SARS-CoV yana daidaitawa da sauri zuwa ga masu masaukin baki daban-daban, musamman ta hanyar canji a cikin RBD da furotin S.
A yadda aka saba, RBD a cikin S-protein na kwayar cutar ta COVID tana hulɗa da mai karɓar kwayar halitta kuma ana zaɓar ta ta hanyar amsawar kwayar cutar mai masaukin baki.
RBD a cikin SARS-CoV yana cikin amino acid 318 zuwa 510 a kan S1 wanda ke haifar da haɗuwa da ACE2 na ɗan adam da kuma masu karɓar ƙwayoyin cuta don shigar da kwayar cutar.
Yanayin haɗin mai karɓar SARS-CoV yana iya gano masu karɓar ACE2 na dabbobi daban-daban ciki har da bat, zebra, beraye da raccoon, wanda ke ba da damar watsa kwayar cutar tsakanin jinsuna.
A zahiri, an lura da ragowar amino acid 6 kawai waɗanda RBDs ɗin su ya bambanta tsakanin ƙwayoyin cuta da aka ware daga mutane da kuma ƙwayoyin cuta, kuma 4 daga cikinsu suna cikin tsarin haɗin mai karɓar mai karɓar ACE2.
SARS-CoV Zubada yana da sauye-sauye biyu K479N da S487T a cikin RBD wanda zai iya haifar da ƙaruwa na hulɗar furotin mai magana da ƙwayoyin cuta tare da masu karɓar ACE2 na ɗan adam.
A takaice dai, wadannan amino acid guda biyu na iya taka muhimmiyar rawa wajen daidaita kwayar cutar zuwa ga mutane.
Ya kamata a lura cewa mai karɓar ƙwayar SARS-CoV-2 daidai yake da SARS-CoV.
Bambanci na kashi 30 tsakanin SARS-CoV-2 da SARS-CoV a cikin S1 na furotin S yana nuna cewa sha'awar haɗuwa da furotin S ɗin ta zuwa ACE2 na ɗan adam, mai yiwuwa ya canza.
A zahiri, binciken cryo-EM ya nuna kusan sau 10-20 na dangantaka tsakanin wannan haɗin da haɗin tsakanin furotin ACE2 da furotin S na SARS-CoV.
Hakanan zai zama mai ban sha'awa don tantance ko waɗanne masu karɓar na'urar karɓar na'urar cuta ne masu mahimmanci don watsawa idan aka kwatanta da babban canjin canji a cikin SARS-CoV-2.
Abin sha'awa, HCoV-NL63 yana haɗuwa da enzyme mai canza angiotensin 2 (ACE2), amma tare da wani ɓangare daban na S.
Akwai sauran masu karɓar kwayar cutar ta mutum da yawa ciki har da aminopeptidase N don HCoV-229E da 9-O-acetyl sialic acid don HCoV-OC43.
Wannan na iya zama dalilin nasarar da wadannan coronaviruses suka samu a cikin mutane bayan yaduwar jinsuna tsakanin dabbobi.
Baya ga masu karɓar ƙwayoyin cuta, sakamakon watsawar tsakanin nau'ikan kwayar cutar ta HCoVs yana shafar sauran dogaro da mai masaukin baki da abubuwan iyakancewa.
Bambancin waɗannan sunadarai masu masaukin baki tsakanin mutane da masu riƙe da ɗakunan ajiya na COVID-19 na mutum kamar batsa, raƙuman daji da beraye na iya zama cikas ga watsawa tsakanin nau'ikan.
Don samun nasarar watsawa tsakanin jinsuna, kwayar cutar ta mutum dole ne ta ɗauki abubuwan dogara da mai masaukin baki kuma ta hana abubuwan da ke iyakance mai masaukin baki.
A wannan yanayin, dole ne a gano kuma a bayyana abubuwan da ke haifar da kwayoyin halittar wannan muhimmin yanayin hulɗar kwayar cutar-mai masaukin baki.
Binciken da ba shi da son kai a cikin dukkanin kwayoyin halitta na dogara ga mai masaukin baki da abubuwan da ke iyakance SARS-CoV-2, ta amfani da fasahar CRISPR mai ci gaba na iya zama mai tasiri.
Yunƙurin sabbin kwayar cutar ta HCoVs: komawar zuwa sifili
Bambancin bat-CoVs yana ba da dama ga fitowar sabbin kwayar cutar ta mutum.
A kan wannan, bat-CoVs suna aiki a matsayin tushen asalin kwayar cutar ta mutum.
Bugu da kari, saurin canzawa da kuma kwayar halitta na halitta suna haifar da juyin halittar kwayar cutar ta HCoV kuma suna aiki a matsayin matakai biyu masu mahimmanci a cikin wannan tsari.
Misali, samun ko rasa sabbin kwayoyin da ke yin kwafin furotin na iya inganta tsarin kwayar cutar sosai.
Daga cikin sunadarai na SARS-CoV, ORF8 ya zama mai mahimmanci wajen daidaitawa ga mutane, saboda an ware ƙwayoyin cutar bat da ke da alaƙa da SARS-CoV, amma an gano cewa sun haɗa sunadarai na ORF8 da ke ɓoye.
An gano wani fasalin cire kwayar cutar SARS-CoVs mai kwayar cutar 29-nucleotide a cikin jinsunan da aka ware a farkon barkewar cutar a cikin mutane.
Wannan cirewar ya raba ORF8 zuwa ORF8a da ORF8b kuma wani nau'in bambancin bambanci ne wanda ke sauƙaƙa sauyawa tsakanin masu masaukin baki.
Bugu da ƙari, SARS-CoV na iya samun tarihin ƙwayoyin cuta tsakanin asalin alpha da gamma na coronavirus, wanda ya haifar da gano ƙananan ƙananan ƙwayoyin cuta a cikin RNA polymerase.
An kuma gano wuraren da ke cikin kwayar halitta a cikin nsp9, babban ɓangaren nsp10 da ɓangarorin nsp14.
Hakazalika, an gano cewa a cikin annobar MERS-CoV, an lura da wasu lamura na kwayar halitta tsakanin jinsuna daban-daban da suka faru a kan raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman.
Baya ga SARS-CoV da MERS-CoV, an kuma lura da abubuwan da ke faruwa a cikin wasu kwayar cutar ta mutum, inda kwayar cutar ta mutum ta haɗu da kwayar cutar ta dabbobi a cikin ƙwayoyin halittar su.
Ya kamata a kuma yi gargadin cewa zabin wucin gadi na iya haifar da canje-canje da ba a so a cikin kwayoyin halittar kwayar cutar, wanda wataƙila sakamakon sakin ƙwayoyin cuta daga matsin lamba, misali ta tsarin garkuwar jiki na mai masaukin.
Misali na wannan tasirin shine lalacewar tsawon ORF4 a cikin HCoV-229E prototype string wanda ke faruwa saboda cire nucleotides biyu.
Kodayake ana iya ganin ingantaccen ORF4 a cikin ƙwayoyin cuta na bat da raƙumi da ke da alaƙa da HCoV-229E, Alpha-Coronaviruses na alpaca suna da ƙirar nucleotide wanda ke haifar da canjin canjin tsarin karatun.
Kwanan nan, juyin halittar sabbin kwayar cutar ta HCoVs ya ci gaba da matsin lamba a kan masu masaukin ajiyar su.
Lokacin da batutuwan suka kamu da cutar ta COVID-19, an gano marasa alamun ko kuma marasa alamun, wanda ke nuna daidaituwa tsakanin COVID da batutuwan.
Wannan ya nuna cewa batutuwan sun dace da kwayar cutar ta COVID-19 ta fuskar jiki da ta jiki.
Misali, rashin kunnawa a farkon amsawar kumburi a cikin batsa, yana rage tasirin cututtukan da aka kunna ta hanyar coronaviruses.
Bugu da ƙari, aikin kwayar halitta mai kisa a cikin batsa yana da damuwa saboda ƙaruwa a cikin samar da mai hana kwayar halitta mai kisa NKG2/CD94 da kuma ƙananan ƙididdigar ƙwayoyin ƙwayoyin cuta masu haɗuwa da ƙwayoyin cuta na farko.
Bugu da ƙari, babban matakin abubuwan da ke dauke da oxygen (ROS) wanda ke haifar da aikin metabolism mai tsawo na bat, a lokaci guda, na iya haifar da hana kwafin kwayar cutar ta COVID-19 kuma yana tasiri ta hanyar exoribonuclease a kan samfurin da aka karɓa, wanda ke haifar da matsin lamba don samar da nau'ikan kwayar cutar da ke da babban sakamako mai illa lokacin da aka shigar da su cikin sabon mai masaukin baki.
Hakanan nau'ikan COVID masu ƙarancin cututtukan cututtukan cuta suna haɓaka ta hanyar nucleosynthesis, wanda ke haifar da samun sabbin sunadarai ko halayen sunadarai don daidaitawar mai masaukin baki.
Saboda haka, ba daidaituwa bane cewa sabbin kwayar cutar HCoVs guda uku sun bayyana a cikin shekaru ashirin da suka gabata.
Kwayoyin cuta na coronaviruses ba su da cutar ko kuma suna haifar da ƙananan cututtuka a cikin rundunar rundunarsu, kamar su bat da raƙuma.
Suna yin kwafi sosai ba tare da haifar da amsa mai ƙarfi daga mai masaukin ba.
A nan akwai wasu abubuwan ban mamaki game da dalilin da yasa ake ganin masu dauke da cutar marasa alamun cutar da kuma abin da ke haifar da mummunan kamuwa da cutar a cikin mutane.
Alamun da suka fi tsanani, yawanci saboda yawan amsawar tsarin garkuwar jiki da kuma guguwar cytokine, inda mafi ƙarfin amsawar garkuwar jiki, lalacewar huhu zai zama mafi tsanani.
A gefe guda, a cikin masu dauke da cutar ba tare da wata alama ba, amsawar rigakafi ta rabu da kwayar cutar ta coronavirus.
Wannan dabarar don ware amsawar rigakafi na iya samun tasiri mai kyau a maganin SARS-CoV-2.
Amsar interferon a cikin batsa tana da ƙarfi sosai.
Saboda haka, amfani da interferon nau'in I ya kamata ya zama mai amfani aƙalla a farkon kamuwa da cutar SARS-CoV-2 a cikin mutane.
Bugu da ƙari, kunnawar NLRP3 na inflammasome a cikin batsa ba shi da kyau.
A cikin wannan ma'anar, hana kumburi NLRP3 tare da MCC950 na iya zama da amfani wajen magance COVID-19.
Yunƙurin SARS-CoV-2 ya bi irin wannan tsari na gaba ɗaya wanda ya haifar da SARS-CoV da MERS-CoV.
Kodayake beta-CoVs suna da kusan kashi 95% na nucleotide na SARS-CoV, akwai wani bat coronavirus wanda yake da kashi 96% na nucleotide na SARS-CoV-2.
Duk da yake an gano cewa albasa da sauran dabbobin da ke kasuwa suna daukar nauyin kwayar cutar SARS-CoV, ba a gano farkon mai daukar nauyin SARS-CoV-2 ba.
An gano beta-pangolin coronaviruses masu kamanceceniya da SARS-CoV-2, wanda ke nuna cewa mai yiwuwa pangolins sun yi aiki a matsayin daya daga cikin masu watsa shirye-shirye ko kuma beta-pangolin coronaviruses na iya kasancewa a cikin sassan kwayoyin da suka haifar da sigar SARS-CoV-2 ta ƙarshe.
Ko da yake wannan tambaya ta kasance, babu wata shaida da ta nuna cewa SARS-CoV-2 an yi shi da gangan ko kuma ba da gangan ba.
Kwayoyin cutar coronaviruses sun sake zama abin lura saboda barkewar cutar SARS-CoV-2 kwanan nan.
Nazarin kwayar cutar coronavirus a cikin batsa da sauran dabbobi ya canza fahimtarmu game da mahimmancin asalin dabbobi da kuma dabbobi masu ajiyar kwayar cutar ta mutum a cikin yaduwarsu ga mutane.
Shaida mai gamsarwa ta nuna cewa SARS-CoV, MERS-CoV da SARS-CoV-2 sun samo asali ne daga bat kuma an watsa su ga mutane ta hanyar masu watsa shirye-shirye.
Ganin cewa kamuwa da cutar SARS-CoV ta samo asali ne daga hulɗa tsakanin mutane da dabbobi a kasuwa, rufe kasuwannin shuka da kashe dabbobi na iya kawo ƙarshen barkewar cutar SARS.
A cikin wannan ma'anar, saboda gano cewa wasu layin kwayar cutar beta-pangolin suna da kusanci da SARS-CoV-2, dole ne a tattara pangolins daga kasuwannin da ake sayar da su don hana watsawa ta hanyar dabbobi.
Koyaya, ko SARS-CoV-2 yana yaduwa ga mutane ta hanyar pangolins da sauran dabbobi da kuma yadda ake yaduwa, bincike na gaba zai bayyana.
A gefe guda, MERS-CoV ya kasance a cikin raƙuman dutse na dogon lokaci.
Waɗannan raƙuman suna da mahimmanci a matsayin kayan sufuri kuma babban tushen nama, madara, fata da kayayyakin ulu ga mazauna yankin.
Sun yadu a Gabas ta Tsakiya da Afirka.
Saboda haka, ba zai yiwu a kashe dukkan raƙuma don sarrafa MERS ba, kamar yadda ya faru don sarrafa barkewar SARS-CoV da SARS-CoV-2 a cikin dabbobin daji na kasuwar China.
Don dakatar da sake barkewar MERS, ana buƙatar cikakkiyar hanya don haɓaka allurar rigakafi mai tasiri don magance MERS-CoV a cikin raƙuma, tare da la'akari da duk matakan da suka dace don sarrafa kamuwa da cuta.
Saboda ba za mu iya kawar da wadannan ƙwayoyin cuta ba, za a iya samar da sababbin nau'ikan kwayoyin cuta da za su iya haifar da yaduwar cutar.
Akwai nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan.
Musamman, bat-CoVs suna da bambancin bambancin da ke iya yaduwa daga dabba zuwa mutum.
Akwai damar da yawa da za su iya canzawa ko kuma su sami kwayar halitta, wanda zai haifar da fitowar sabbin kwayar cutar corona da ke da damar yaduwa da / ko kisa ga mutane a nan gaba.
Dole ne a manta da al'adun cin namun daji a wasu yankunan kasar Sin don rage yawan hulɗa mara amfani tsakanin mutane da dabbobi.
Dangane da bala'in SARS, MERS da COVID-19, ya kamata a samar da ingantaccen shiri da shirin amsawa.
A zahiri, yawancin ƙwayoyin cuta sun kasance a duniyar nan na dogon lokaci.
Suna zaune a cikin wuraren da suke da shi don samun damar yaduwa.
Kodayake batutuwan suna da halaye da yawa waɗanda ke taimakawa wajen yaduwar ƙwayoyin cuta, amma idan mutane sun sami isasshen horo don nisanta kansu daga waɗannan dabbobin, za a iya rage haɗarin haɗuwa da batutuwan da sauran nau'ikan namun daji.
Kulawa akai-akai a cikin dabbobi masu shayarwa yana da mahimmanci don fahimtar yanayin halittu na coronaviruses da kuma masu masaukin su na halitta, wanda zai zama da amfani wajen hana su kamuwa daga dabbobi zuwa mutane da kuma yaduwar su a nan gaba.
A ƙarshe, hanya mafi inganci don hana yaduwar kwayar cutar daga dabbobi zuwa ga mutane ita ce ta hanyar mutane su guje wa mazaunin da ke da alamun kwayar cutar da ke yaduwa daga dabbobi zuwa ga mutane.
Har yanzu ba a sami wasu abubuwa da yawa a cikin jigon asalin dabba na SARS-CoV-2.
Da farko, idan batutuwan sun watsa kwayar cutar SARS-CoV-2 ga pangolins, zai zama mai ban sha'awa a ga abin da yanayi ke haifar da batutuwan da pangolins na iya raba yanayin yanayin yanayin.
Na biyu, idan dabbobin bats suna taka rawa kai tsaye wajen yaduwa ga mutane, dole ne a gano yadda mutane ke hulɗa da su.
Na uku, idan wani dabba mai shayarwa na uku yana aiki a matsayin mai masaukin baki na gaske, dole ne a gano yadda yake hulɗa da nau'ikan daban-daban ciki har da mutane, batsa da pangolins.
A ƙarshe, saboda yawancin dabbobi masu shayarwa, gami da dabbobi masu gida, na iya kamuwa da cutar SARS-CoV-2, ya kamata a sanya ido da kuma kamuwa da gwaji.
Ko dai a cikin wani bat, pangolin ko wani dabba mai shayarwa, ana sa ran cewa SARS-CoV-2 ko kuma kwayoyin cutar iyayenta, waɗanda suke da kama da juna, za a iya gano su a cikin mahaifarsu ta asali a nan gaba.
Bincike mai gudana a cikin wannan fannin zai bayyana hanyar juyin halitta na SARS-CoV-2 a cikin dabbobi, tare da mahimman bayanai game da rigakafi da sarrafa COVID-19 a cikin mutane.
"Ana buƙatar sabunta ma'aunin ganewar asali na COVID-19 ""mai shakku"" da ""an tabbatar da cutar""".
A ranar 6 ga Fabrairu, 2020, ƙungiyarmu ta buga jagorar gaggawa don ganowa da kula da kamuwa da cutar coronavirus 2019 (2019-nCoV), wanda ke ba da kwarewarmu kuma ya samar da kyakkyawan tunani don yaƙar wannan annoba a duk duniya.
Koyaya, cutar coronavirus 2019 (COVID-19) sabuwar cuta ce, kuma iliminmu da wayewarmu suna ƙaruwa a hankali bisa ga binciken bincike da ke gudana da ƙwarewar asibiti. Saboda haka, dabarun ganewar asali da magani suna ci gaba da sabuntawa.
A cikin wannan wasikar mun amsa ga wani bayani game da jagorarmu kuma mun gabatar da sabbin ka'idojin ganewar asali na wadanda ake zargi da kuma wadanda aka amince da su bisa ga sabon jagorar ganewar asali da kula da COVID-19 (Sashe na 7) da Kwamitin Lafiya na Jamhuriyar Jama'ar Sin ya bayar.
A watan Disamba na 2019, sabon kwayar cutar coronavirus 2019 (2019-nCoV) ya haifar da barkewar annoba wacce yanzu aka sanya mata suna a hukumance a matsayin cutar coronavirus 2019 (COVID-19) kuma an sanya kwayar cutar a matsayin coronavirus na matsanancin cutar numfashi.
A ranar 11 ga Maris, 2020, Hukumar Lafiya ta Duniya ta bayyana COVID-19 a matsayin annoba ta duniya.
Don magance cutar SARS-CoV-2, ƙungiyarmu ta tsara jagorar gaggawa wanda aka buga ta kan layi a cikin Military Medical Research a ranar 6 ga Fabrairu, 2020.
Wannan ya jawo hankali sosai tun bayan wallafawa.
Lura cewa COVID-19 sabuwar cuta ce, bisa ga binciken bincike da kuma gwajin asibiti, iliminmu da wayewarmu suna ƙaruwa a hankali. Saboda haka, dabarun ganewar asali da magani suna ci gaba da sabuntawa.
Misali, an buga hanyoyin gano cutar COVID-19 da kuma maganin da kwamitin lafiya na kasar Sin (http://www.nhc.gov.cn/), tsakanin 16 ga Janairu, 2020 zuwa 3 ga Maris, 2020, a cikin juzu'i bakwai, wanda wasu daga cikin abubuwan da aka tsara sun canza.
Yanzu da umarninmu ya sami ra'ayi daga Zhou da abokan aiki, sun ba da shawara mai sauƙi don ƙididdigewa bisa ga kwarewar asibiti.
Aikin su ya kara sabbin hujjoji ga jagorarmu kuma ya kuma bada muhimmiyar ma'ana game da cutar ta duniya.
Muna godiya da kuma amincewa da irin wannan gagarumin kokarin da suka yi.
Koyaya, bisa ga sabbin hanyoyin ganowa da maganin COVID-19 (na bakwai na gwaji) da kuma binciken kwanan nan, aikin su ma yana buƙatar sabuntawa.
A bisa ga gyara ta bakwai (3 ga Maris 2020), don tabbatar da abin da ake zargi, dole ne a haɗa kowane fasalin tarihin annobar tare da alamun asibiti guda biyu don yin cikakken bincike, ko kuma idan babu tarihin annobar, dole ne ya sami alamun asibiti guda uku.
Tarihin cutar: (1) Tarihin tafiya ko zama a Wuhan da kewaye ko kuma wasu al'ummomin da aka ba da rahoton cutar COVID-19 a cikin kwanaki 14 da suka gabata kafin bayyanar cututtuka a can; (2) Tarihin hulɗa da mutanen da ke dauke da cutar SARS-CoV-2 (tare da gwajin nucleic acid mai kyau); (3) Tarihin hulɗa da marasa lafiya da zazzabi ko cututtukan numfashi daga Wuhan da ke kewaye ko kuma wasu al'ummomin da aka ba da rahoton COVID-19 a cikin kwanaki 14 da suka gabata kafin bayyanar cututtuka; (4) Tarihin hulɗa da tarin tabbatar da cututtukan zazzabi da / ko alamun numfashi (an sami 2 a cikin makonni 2 a cikin ƙananan yankuna kamar gida, aiki, makaranta, da sauransu).
Alamomin asibiti: (1) zazzabi da/ko alamun numfashi. (2) suna da fasalin hoto na kamuwa da COVID-19; (3) yawan ƙwayoyin farin jini, a farkon farawa a cikin nau'ikan ƙididdigar al'ada, raguwa, ko raguwar lymphocytes.
Tabbatar da ganewar asali dole ne ya kasance bisa ga wanda ake zargi da cutar ko kuma yanayin cutar ta hanyar: (1) gwajin PCR na ainihi don SARS-CoV-2 yana da kyau; (2) jerin kwayoyin cutar gabaɗaya wanda ke nuna babban daidaituwa tare da sabon coronavirus; (3) sakamako mai kyau don takamaiman IgM antibody da IgG antibody zuwa SARS-CoV-2 a cikin gwajin serum; ko canza SARS-CoV-2 takamaiman IgG antibody daga mara kyau zuwa mai kyau ko haɓaka titer sau 4 ko fiye a cikin matakin dawowa fiye da haka a cikin mawuyacin lokaci.
Za mu iya ganin cewa an ƙara gwajin PCR na lokaci-lokaci don acid nucleic a cikin tsarin numfashi ko samfurin jini zuwa na biyu (18 ga Janairu 2020) da na uku (22 ga Janairu 2020).
An ƙara gano cutarwar kwayoyin halittar jini a juzu'i na huɗu (27 ga Janairu, 2020) da na biyar (8 ga Fabrairu, 2020); sannan kuma an ƙara hujjojin ƙwayar cuta a juzu'i na bakwai.
Wannan gyare-gyare ya dogara ne akan ci gaba da kokarin da masu bincike ke yi na neman ingantaccen kayan aikin gano kwayar nucleic acid don saurin ganewa, da kuma samfurori na tsarin numfashi ciki har da samfurin jini, wanda ya haifar da ingantaccen ma'auni tare da haɓaka wadatar samfura daban-daban da ƙarin tallafi kan dogaro da sakamakon kwayar cutar.
Bugu da ƙari, akwai ƙarin shaidu da ke gargaɗe mu da mu yi taka tsantsan da marasa lafiya da ke da alamun rashin lafiya ko kuma marasa alamun.
Saboda haka, dole ne a sabunta zane-zanen juzu'i na Zhou da abokan aiki, saboda sun sanya mutum ba tare da alamun asibiti ba a cikin ƙananan haɗari.
Hakanan dole ne a tabbatar da tsarin ƙididdigar a cikin ƙarin ayyuka da nazarin asibiti.
A ƙarshe, muna fatan akwai ƙarin hujjoji kai tsaye kuma muna roƙon masu karatu su ba da ra'ayoyinsu.
Don gano wanda ake zargi da kuma tabbatar da cutar, muna ba da shawarar su bi sabbin jagororin ƙasashensu.
Ƙungiyarmu za ta ci gaba da inganta jagororin don samar da taimako a kan lokaci.
Bangladesh ta ba da rahoton sabbin mutuwar COVID-19, mafi girma a rana guda
Jiya, Bangladesh ta sanar da mutuwar mata biyar a rana guda saboda COVID-19.
Wannan shi ne adadin mafi girma na mutuwar cutar a rana guda.
Jiya, Cibiyar Kula da Cututtuka, Kula da Cututtuka da Bincike ta Bangladesh (IEDCR) ta ba da rahoton kamuwa da mutane 114 da kuma masu warkewa 33 da ke cikin gida.
An samu mutuwar mutane 17 a duka.
A wani rahoto na labarai na kan layi, darektan IEDCR, Dr Mirjad Sabrina Flora, ta ce wadanda suka mutu maza hudu ne da mace daya.
A cewar likita Mirjad, mutum biyu sun haura shekaru 60, biyu suna tsakanin shekaru 51 zuwa 60 kuma mutum daya yana tsakanin shekaru 41 zuwa 50.
Ya kuma ce biyu daga cikin wadanda aka kashe sun fito ne daga Dhaka.
Hukumar Lafiya ta Duniya (WHO) ta ayyana COVID-19 a matsayin annoba ta duniya a ranar 11 ga Maris.
Wani jami'in asibiti ya shaidawa kamfanin dillancin labarai na Anadolu cewa daya daga cikin wadanda aka kashe shi ne Jalal Seifur Rahman, shugaban hukumar yaki da cin hanci da rashawa ta Bangladesh, wanda ke kula da shi a asibitin Maitri na Kuwait.
Ministan Sufuri da Gidajen Babba na Bangladesh, Obid al-Qadir, ya ce a cikin wani sanarwar bidiyo ta yanar gizo a ranar Asabar cewa, sufuri na cikin gida zai kasance a cikin hutu fiye da yadda aka tsara tun farko, wato har zuwa Asabar mai zuwa.
Shirin dakatar da sufuri na cikin gida, wanda ya fara a ranar 26 ga Maris, zai ƙare a ranar Asabar, 4 ga Afrilu.
Har yanzu ana ba da izinin jigilar kayayyakin masarufi - magani, mai da abinci.
An samu mutum na farko da ya kamu da cutar COVID-19 a Bangladesh a ranar 8 ga Maris, wanda ya shafi mutane biyu da suka dawo daga Italiya, wanda matar daya daga cikinsu ta kamu da cutar.
A ranar 19 ga watan Maris, dukkansu uku sun warke.
Cutar SARS-CoV-2 ta zarce miliyan a duniya
A ranar Alhamis, adadin masu cutar SARS-CoV-2 a duniya ya wuce miliyan daya, a cewar bayanan Jami'ar Johns Hopkins.
Akalla mutane 52,000 ne suka mutu sakamakon cutar COVID-19, cutar da coronavirus ke haifarwa.
Wannan muhimmin abu ya faru ne a ranar da Malawi ta sanar da kamuwa da cutar ta farko da kuma Zambia ta bayar da rahoton mutuwar farko da cutar ta yi.
Koriya ta Arewa ta yi ikirarin cewa ita ce daya daga cikin kasashen da ba su kamu da cutar ba a ranar Alhamis.
A jiya, Hukumar Lafiya ta Duniya ta ba da rahoton 105,1635 da aka tabbatar da su, ciki har da 793,332 a cikin awanni ashirin da huɗu kafin karfe 10 na safe (0800 UTC) a ranar 4 ga Afrilu.
A Amurka, an samu sama da mutane 244,000 da suka kamu da cutar coronavirus, wanda ya yi sanadiyar mutuwar mutane akalla 5,900.
Jaridar CBC News ta ruwaito cewa, bisa ga bayanan Jami'ar Johns Hopkins, sama da mutane 1,000 ne suka rasa rayukansu sakamakon cutar a Amurka a ranar Laraba.
A duk duniya, kasashe suna daukar wasu matakai don hana yaduwar kwayar cutar.
A ranar Alhamis, Sarkin Moscow, Sergei Sobyanin, ya tsawaita dokar hana fita zuwa 1.
A matakin kasa, Shugaba Vladimir Putin ya sanar da cewa 'yan Rasha za su samu albashi ba tare da yin aiki ba har zuwa ranar 30 ga Afrilu.
Majalisar Portugal ta kada kuri'ar kara wa'adin gaggawa na kwanaki 15 da kuri'u 215 a kan 10 a kan 1 a kan 1 a kan 1.
Saudiyya ta sanar da dokar hana zirga-zirga a biranen Makka da Madina na tsawon yini, inda a baya dokar hana zirga-zirga ta kasance tsakanin karfe 3 na yamma zuwa karfe 6 na safe.
An shirya Thailand ta aiwatar da dokar hana zirga-zirga tsakanin karfe 10 na dare zuwa karfe 4 na safe.
Gwamnan Ohio, Mike DeWine, ya sanar da cewa jihar ta tsawaita dokar hana fita zuwa ranar farko ga watan.
Shaguna a Ostiraliya sun rage takunkumin sayar da tawul a kowane ma'amala
A ranar Lahadi da Asabar da yamma, manyan shagunan Australiya na Woolworth da Coles sun rage adadin sayen tawul ɗin takarda zuwa biyu da kunshin ɗaya a kowane sayayya a duk shagunan ƙasar.
ALDI ta sanar da iyakance sayan fakiti daya ne kawai a ranar Litinin.
An sanya waɗannan ƙuntatawa a matsayin saƙo a akwatin biyan kuɗi da shafukan Facebook na shaguna.
An bayar da rahoton cewa masu siye suna adana soda saboda tsoron COVID-19 da kuma keɓewar kansu.
A ranar Laraba, Woolworths ya kuma iyakance sayen tawul din wanka don isar da ƙofar gida zuwa kunshin ɗaya a kowane oda.
Waɗannan canje-canjen sun biyo bayan fakitin da suka gabata guda huɗu don kowane iyakancewar ma'amala, waɗanda Woolworths da Coles suka gabatar a ranar 4 da 5 ga Maris, bi da bi.
"Colos Supermarkets a cikin hirarsu da kafofin watsa labarai a ranar 8 ga Maris ta ba da rahoton cewa, duk da ƙuntatawa na fakiti huɗu, ""yawancin shagunan suna samun ƙarin sayarwa a cikin sa'a ɗaya bayan isar da kayayyaki"," suna kiran buƙatar ""marasa misali"", yayin da shagunan sarkar ALDI, a cikin post ɗin Facebook ɗin su a ranar Talata, sun kira siyarwar ""ba a taɓa yin hakan ba"".
"A cewar mai magana da yawun Walworth, tallace-tallace sun tashi da ""tsalle""".
Shagon Costco a Canberra ya iyakance adadin da aka yarda da shi zuwa fakiti biyu a makon da ya gabata.
Don rage wannan karancin, Coles ya ba da umarni ga manyan fakitoci daga masu samarwa kuma ya ƙara yawan isar da kayayyaki, Woolworth ya ba da umarnin ƙarin ɗakunan ajiya, kuma Aldi ya riga ya yi ajiya don tayin musamman na Laraba.
Rachel Zimmerman, Shugabar zartarwa ta kungiyar 'yan kasuwar Australiya, ta ce 'yan kasuwar suna kokarin kara yawan kayayyakin da suke da su, amma takunkumin da hukumomin yankin suka sanya game da lokacin da manyan motoci ke tafiya ya sa hakan ya zama da wahala.
Ya yi tsammanin farashin zai karu, saboda masu samarwa suna kokarin biyan bukatar kuma suna da karancin abubuwan musamman.
A ranar Talata, ALDI (Kayan Shago) ya sanar da cewa wasu shagunan ba za su iya gudanar da siyarwar musamman ta Laraba ba saboda fitowar hannun jari da wuri.
A wani rahoto na News.com.au, masanin harkar sayar da kayayyaki, Dr. Gary Mortimer na Jami'ar Fasaha ta Queensland ya ce shagunan suna cike kayansu a kowane dare.
Ya lura cewa tawul din wanka abu ne mai girma wanda ke ɗaukar adadi kaɗan a cikin sarari mai yawa. Idan aka sayar, babban sarari zai kwashe ɗakunan ajiya kuma ya haifar da rashin jin daɗi.
"Rachel Zimmerman ta shaida wa ABC News cewa, ""Coles da Woolworth sun yi imanin cewa idan akwai isasshen kaya a kan shelves, idan akwai wadataccen kayan aiki kamar tawul da kuma maganin kashe cuta, za a iya rage yawan cinikin"."
Kamfanin da ke kera takunkumin wanka mai sake amfani da shi, wanda ake kira Who Gives a Crap, ya ce sun gama kayayyakinsu a ranar Laraba.
Kamar yadda News.com.au ta ruwaito, Kimberly-Clark, mai kera tawul din wanka Clinix da Solaris Piper, mai kera Sorbent sun jaddada cewa suna aiki awanni 24 a mako don biyan bukatun kasuwa.
Shafin yanar gizo na dukiya mai suna Domain.com ya ruwaito cewa yayin da masu siye ke hutu saboda doguwar hutun ranar ma'aikata kuma ba a yin gwanjo sosai, wasu masu siyar da gidaje suna ba da tawul ɗin wanka kyauta ga mai gabatar da farko a gwanjo na Melbourne.
Mujallar NT News ta ranar Alhamis, jaridar da ake bugawa a Darwin, ta ƙunshi shafi takwas na shafi wanda aka buga don amfani da shi a matsayin tawul ɗin wanka.
A cewar ABC Australia a ranar 3 ga Maris, a farko shaguna ba su da niyyar aiwatar da takunkumin, suna mai cewa ba su da shirin aiwatar da takunkumin sayayya.
Russell Zimmerman ya kara da cewa, "Akwai bukatar wasu kayayyaki kamar masks, disinfectants, dryers, powders da kuma kayan wanke hannu.
Hakazalika, a wajen Ostiraliya, an lura cewa a ranar Lahadi da yamma, babban kantin sayar da kayayyaki na kan layi na Okado na Burtaniya ya iyakance sayen tawul ɗin wanka zuwa fakiti biyu na 12.
Hukumar Lafiya ta Duniya ta sanar da annobar COVID-19
A ranar Laraba, Hukumar Lafiya ta Duniya (WHO) ta ayyana barkewar cutar COVID-19 da SARS-CoV-2 ke haifarwa a matsayin annoba.
"Duk da cewa kalmar nan "tazara" tana nufin yadda cutar ta yadu, kuma ba ta nuna yadda hatsarin yanayin yake ba, WHO ta lura da bukatar gwamnatoci su mayar da hankali kan:
"Dukkanin kasashe na iya juya yanayin wannan annobar.
Tedros Adhanom, shugaban WHO ya yi imanin cewa, "idan kasashe suka dauki mataki kan ganowa, gwaji, magani, warewa, ganowa da kuma karfafa mutane".
" "Muna matukar damuwa da matakan gargadi na yaduwar cutar da kuma rashin kulawa. ""
"A cewar Dr. Tom Friedman, tsohon daraktan Cibiyoyin Kula da Cututtuka da Cututtuka na Amurka, wannan annoba ta kasance ""marasa misali"".
A cikin wata sanarwa da CNN ta fitar a watan Fabrairu, ya ce, "Babu wani kwayar cutar numfashi da aka gano banda mura, daga lokacin bayyanar cututtuka zuwa barkewar cutar a duniya baki daya".
Ghebreyesus ya bayyana irin wannan ra'ayi, yana cewa: "Ba mu taɓa ganin wata annoba ta coronavirus ba a baya.
Ya ci gaba, "Ba mu taɓa ganin wata annoba ba da za a iya sarrafa ta a lokaci guda".
Sabon matsayin cutar a matsayin annoba ya biyo bayan shawarar da Hukumar Lafiya ta Duniya ta yanke a watan Janairu, inda ta ayyana barkewar cutar a matsayin gaggawa ta lafiyar jama'a a duniya.
"Dr. Anthony Fusey, darektan Cibiyar Kula da Cutar Cutar Cutar da Cutar da ke Amurka, ya ce, ""A cikin lokaci, abubuwa suna ta taɓarɓarewa"".
Kamar yadda na Alhamis, Kamfanin dillancin labarai na Associated Press ya ruwaito cewa akwai aƙalla mutane 126,000 da suka kamu da cutar COVID-19 a duniya, wanda ya yi sanadiyar mutuwar mutane sama da 4600.
Cutar cutar coronavirus ta 2020-2019 wata cuta ce mai ci gaba da cutar coronavirus ta 2019 (COVID-19), wadda ke haifar da cutar coronavirus mai saurin kamuwa da cuta ta 2 (SARS-COVID-2).
An gano barkewar cutar a watan Disamba na 2019 a Wuhan na kasar Sin, an ayyana ta a matsayin matsalar gaggawa ta lafiyar jama'a ta kasa a ranar 30 ga Janairu, 2020, kuma an bayyana ta a matsayin annoba ta duniya a ranar 11 ga Maris, 2020.
Ya zuwa ranar 10 ga Afrilu, 2020, an samu rahotanni game da mutane miliyan 1.61 da suka kamu da cutar COVID-19 a kasashe 210 da yankuna, wanda ya yi sanadiyyar mutuwar mutane kusan 97,000.
Kimanin mutane 364,000 ne suka warke.
An kiyasta yawan mutuwar mutane a China ya kai 4%, duk da haka, a duniya, ya bambanta daga 13.4% a Algeria zuwa 0.08% a New Zealand.
Alamun da aka saba da su sun hada da zazzabi, tari da kuma wahalar numfashi.
Haɗuwa da cutar sun haɗa da ciwon huhu da kuma ciwon rashin ƙarfi na numfashi.
Lokaci daga lokacin da aka kamu da kwayar cutar zuwa lokacin bayyanar cututtuka yawanci yakan ɗauki kimanin kwanaki 5, amma yana iya bambanta daga kwana biyu zuwa goma sha huɗu.
Babu takamaiman maganin rigakafi ko maganin rigakafin cutar.
Maganin farko shine ainihin maganin cututtuka da kuma maganin tallafi. Matakan rigakafi da aka ba da shawarar sun haɗa da wanke hannu, rufe baki yayin tari, nisantar mutane, da bincika da keɓe mutanen da ake tsammanin suna da cutar.
Hukumomi a duk duniya sun mayar da martani kan takunkumin tafiye-tafiye, keɓewa, ƙuntatawa na motsi, kula da haɗarin aiki da rufe wuraren aiki.
Cutar ta haifar da mummunan rikice-rikicen zamantakewar tattalin arziki na duniya, jinkiri ko soke abubuwan wasanni, addini, siyasa da al'adu, da kuma karancin albarkatu da aka haifar da tsoratar da sayayya.
Makarantu da jami'o'i a kasashe 193 sun rufe ko dai a kasa ko kuma a gida, wanda ya shafi kusan kashi 99.4 cikin dari na yawan daliban duniya.
An yada bayanai marasa kyau game da kwayar cutar a yanar gizo, kuma an lura da wasu al'amura na tsoratar da baƙi da nuna bambanci ga Sinawa, sauran mutane masu launin fata da kuma asalin Gabas da Kudu maso gabashin Asiya da sauran yankuna waɗanda suka ga yawan kamuwa da cutar.
An rage gurɓataccen iska da fitar da iskar carbon saboda raguwar tafiye-tafiye da kuma hutun masana'antu masu nauyi.
Hukumomin kiwon lafiya na Wuhan, China (babban birnin lardin Hubei), sun ba da rahoton cutar huhu da ba a san dalilin ba a ranar 31 ga Disamba, 2019, kuma an fara bincike a farkon Janairu, 2020.
Yawancin masu cutar sun kasance ne a kasuwar sayar da kayan kifin na Hunan, saboda haka ana ganin cewa kwayar cutar ta samo asali ne daga cutar zeonosis (tauraron da ke tsakanin mutane da dabbobi).
Kwayar cutar da ta haifar da annobar da aka sani da SARS-CoV-2, sabuwar kamuwa da cuta ce da aka gano wacce ke da halaye masu kama da bat coronavirus, pangolin coronavirus da SARS-CoV. Daga baya, an gano cewa mutumin da ya fara nuna alamun cutar ya kamu da cutar a ranar 1 ga Disamba, 2019, kuma mutumin bai yi hulɗa da kasuwar abincin teku ba.
Daga rukunin farko na al'amuran da aka ruwaito a watan Disamba na 2019, kashi biyu bisa uku na masu kamuwa da cutar sun danganci kasuwa.
A ranar 13 ga watan Maris na shekarar 2020, wani rahoto da ba a tabbatar da shi ba daga South China Morning Post ya nuna cewa irin wannan lamarin da aka gano a ranar 17 ga watan Nuwamba na shekarar 2019 a cikin wani mutum mai shekaru 55 a lardin Hubei, na iya zama farkon cutar. A ranar 26 ga watan Fabrairun 2020, WHO ta ba da rahoton cewa, saboda raguwar sabbin cututtuka a China, a Italiya, Iran da Koriya ta Kudu, adadin wadanda suka kamu da cutar ya tashi ba zato ba tsammani, inda sabon adadin wadanda suka kamu a waje da kasar Sin ya zarce na kasar Sin a karon farko.
Ana iya rashin bayar da rahoton muhimman rahotanni a matsayin ƙarin, musamman a lokuta da ke da ƙananan alamun.
Ya zuwa ranar 26 ga watan Fabrairu, an samu karancin cututtuka a cikin matasa, kuma kashi 2.4% na dukkan wadanda suka kamu da cutar a duniya sune shekarunsu 19 zuwa kasa. Patrick Wallans, babban mai ba da shawara kan kimiyyar gwamnatin Burtaniya, ya kiyasta cewa don samun rigakafin gama gari, ya zama dole kashi 60% na yawan mutanen Burtaniya su kamu da cutar.
Lamarin ya shafi al'ummar da aka gwada COVID-19 kuma an tabbatar da gwajin su a matsayin tabbatacce bisa ka'idojin hukuma.
Tun daga ranar 23 ga watan Maris, babu wata kasa da ta yi gwajin sama da kashi 3 cikin 100 na yawan jama'arta, kuma manufofin hukuma na kasashe da dama ciki har da Italiya, Netherlands, Spain da Switzerland sun kasance kan hana yin gwajin ga mutanen da ke da alamun rashin lafiya.
Wani bincike da aka fitar a ranar 16 ga watan Maris ya nuna cewa a kasar Sin, har zuwa ranar 23 ga watan Janairu, kusan kashi 86% na kamuwa da cutar COVID-19 ba a gano su ba, kuma wadannan cututtukan da ba a rubuta su ba ne tushen kamuwa da cutar a kashi 79% na wadanda aka rubuta.
Wani bincike na kididdiga da aka fitar a ranar 30 ga Maris ya kiyasta cewa adadin kamuwa da cuta a Italiya ya fi adadin wadanda aka ruwaito.
Kwanan nan, kimantawa na asali na yawan maimaitawa (R0) don COVID-19 ya kasance 1.4 zuwa 2.4.
Wani bincike da Cibiyar Kula da Cututtuka da Rigakafin Amurka ta fitar ya sanya shi 5.7.
Yawancin mutane da ke da cutar COVID-19 suna samun sauki.
Ga waɗanda ba haka ba, lokacin bayyanar cututtuka zuwa mutuwa ya bambanta tsakanin kwanaki 6 zuwa 41, wanda ya fi kowa kwanaki 14.
Ya zuwa 10 ga Afrilu, 2020, kusan mutuwar 97,000 an danganta su ga COVID-19.
A China, kusan kashi 80% na mutuwar sun faru ne a cikin mutanen da suka haura shekaru 60, kuma kashi 75% suna da cututtukan da suka gabata ciki har da cututtukan zuciya da ciwon sukari. Lamarin mutuwar COVID-19 na yau da kullun ya shafi mutanen da suka mutu waɗanda aka gwada su kuma suka sami sakamako mai kyau na gwajin COVID-19 bisa ga ka'idojin hukuma.
Adadin ainihin mutuwar COVID-19 ya fi haka yawa saboda ba a haɗa da mutanen da suka mutu ba tare da yin gwaji ba, misali a gida ko a wuraren kula da marasa lafiya.
Bayanai na farko daga Italiya sun nuna cewa adadin mutuwar cutar ta cutar ta COVID ya ninka na hukuma sau 5 zuwa 4.
"Mai magana da yawun Cibiyar Kula da Cututtuka da Rigakafin Cutar (CDC) ta Amurka ta amince cewa ""mun san cewa [yawan] ya fi na ainihi"". Rahotanni da aka bayar na ƙididdigar da ba ta dace ba a Amurka sun tabbatar da wannan. Wannan ƙididdigar da ba ta dace ba, galibi tana faruwa a cikin annoba kamar annobar mura ta alade H1N1 (H1N1). An ba da rahoton farkon mutuwar da aka tabbatar a ranar 9 ga Janairu, 2020 a Wuhan. "
Mutuwa ta farko a wajen kasar Sin ta faru ne a ranar 1 ga watan Fabrairu a Philippines, kuma ta farko a wajen Asiya ta faru ne a ranar 14 ga watan Fabrairu a Faransa.
Ya zuwa ranar 28 ga watan Fabrairu, an samu rahoton fiye da mutane goma da suka mutu a kasashen Iran, Koriya ta Kudu da Italiya, a wajen kasar Sin.
Ya zuwa ranar 13 ga watan Maris, an samu rahoton mutuwar mutane a kasashe da yankuna sama da 40, a duk nahiyoyi sai dai Antarctica. Ana amfani da wasu ma'auni don tantance yawan mutuwar.
Wadannan lambobin sun bambanta a yankuna daban-daban da lokuta daban-daban, kuma abubuwan da suka shafi su kamar yawan gwaje-gwajen da aka yi, ingancin tsarin kulawa, zaɓuɓɓukan magani, tsawon lokacin da aka fara cutar, da kuma yanayin alƙaluma kamar shekaru, jinsi, da lafiyar jama'a.
A cewar Jami'ar Johns Hopkins, a ranar 10 ga Afrilu, 2020, yawan mutuwar-zuwa-haɗari a duniya ya kai kashi 6% (9,70,39 daga cikin mutane 161,7204).
Adadin ya bambanta dangane da yankin.
A China, kimantawar yawan mutuwar cutar ta ragu daga 17.3% (mutanen da ke da alamun bayyanar cututtuka na 1 zuwa 10 ga Janairu 2020) zuwa 0.7% (ga mutanen da ke da alamun bayyanar cututtuka bayan 1 ga Fabrairu 2020). Sauran lissafin sun haɗa da: yawan mutuwar cutar (CFR), wanda ke nuna yawan mutanen da aka gano cewa suna mutuwa daga cutar, da kuma yawan mutuwar kamuwa da cuta (IFR), wanda ke nuna yawan mutanen da suka kamu da cutar (wanda aka gano da wanda ba a gano ba) da ke mutuwa daga cutar.
Wannan ƙididdigar ba ta da iyakancewar lokaci kuma tana aiki ne akan takamaiman al'umma daga kamuwa da cuta zuwa warkewa.
Wasu masu bincike na jami'a sun yi kokarin kirga wannan adadi don takamaiman yawan jama'a.
Cibiyar Magunguna ta Jami'ar Oxford ta kiyasta cewa yawan mutuwar cutar a duniya gaba daya ya kasance tsakanin 0.1% zuwa 0.39%.
Kimanin wannan ƙididdigar ta dace da sakamakon gwajin bazuwar COVID-19 a Jamus da nazarin ƙididdiga na nazarin tasirin gwajin akan ƙididdigar CFR.
Hukumar Lafiya ta Duniya ta amince cewa za a iya sarrafa cutar ta duniya.
Ba a san lokacin da cutar za ta kai ba kuma zai iya bambanta dangane da wuri.
Maciej Boni na Penn State University ya yarda: "Yadda ake yada cututtukan cututtuka idan ba a kula da su ba, yawanci suna ci gaba da zama ba tare da canzawa ba bayan wani lokaci kuma suna raguwa bayan an gama masu masaukin baki".
"Amma a yanzu, duk wani tsinkaya mai ma'ana game da lokacin da cutar za ta ƙare kusan ba zai yiwu ba"".
Babban mai ba da shawara kan harkokin kiwon lafiya na gwamnatin China, Zhong Nan Shan ya ce, "Zai yiwu a kawo karshen cutar nan da watan Yuni, idan dukkan kasashe sun hada kai don bin shawarar da Hukumar Lafiya ta Duniya (WHO) ta bayar kan matakan da za a dauka don dakatar da yaduwar cutar".
"A ranar 17 ga Maris, Adam Kucharski na Kwalejin Kiwon Lafiya da Magunguna ta London ya ce SARS-CoV-2 ""yana yaduwa kuma mai yiwuwa zai kasance shekara ɗaya ko biyu"".
"A cewar wani binciken da kwalejin Imperial College ta yi karkashin jagorancin Neil Ferguson, za a bukaci" nisantar jiki da sauran matakan ""har sai an samu allurar rigakafi (kimanin watanni 18 ko sama da haka) """.
William Schaffner na Jami'ar Vanderbilt ya ce, "Ina ganin ba zai yiwu cutar ta kare ba - saboda tana da saurin yaduwa" kuma "na iya zama wata cuta ta yanayi da ke sake fashewa a kowace shekara".
Matsayin cutar da za ta sake yaduwa ya dogara da rigakafin garken da kuma yadda aka canza shi.
Alamun COVID-19 na iya zama marasa mahimmanci kuma mutanen da ke kamuwa da cutar na iya zama marasa alamun.
Alamomin biyu na kowa sune zazzabi (88%) da tari mai bushe (68%).
Alamomin da ba sa yawan faruwa sun hada da gajiya, rashin jin ƙamshi, numfashi mai wuya, ciwon tsoka da na haɗin gwiwa, ciwon makogwaro, ciwon kai, rawar jiki, amai, zubar da jini, zawo ko ciwon cyanosis. Kungiyar Lafiya ta Duniya ta ce kusan mutum daya cikin shida na kamuwa da rashin lafiya mai tsanani kuma yana fuskantar matsalar numfashi.
Cibiyar Kula da Cututtuka da Rigakafin Cutar (CDC) ta Amurka ta tsara alamun gaggawa a matsayin wahalar numfashi, ciwon kirji mai ɗorewa ko jin matsi, rikicewar kwatsam, wahalar farkawa daga bacci da ƙonewa a fuska ko lebe; idan akwai alamun, ana ba da shawarar neman magani na gaggawa. Ci gaban cutar na iya haifar da matsanancin ciwon kirji, ciwon numfashi mai tsanani, ciwon shan inna, tashin hankali, tashin hankali na cututtukan jini, da mutuwa.
Wasu mutane da ke dauke da cutar na iya zama marasa alamun cutar kuma ba su nuna alamun asibiti ba, amma sakamakon gwajin ya tabbatar da kamuwa da su, don haka masu bincike sun ba da shawarar cewa a kula da mutanen da ke da kusanci da waɗannan masu cutar don hana yaduwar kamuwa da cuta.
An kiyasta cewa yawan marasa cutar a kasar Sin ya kai kashi 44 cikin dari.
Lokacin rufi (lokacin shiga cikin kamuwa da cuta da fara bayyanar cututtuka) yawanci yakan bambanta daga kwana ɗaya zuwa goma sha huɗu; a mafi yawan lokuta kwanaki biyar. Wani misali na rashin tabbas shine ƙididdigar kashi na mutanen da ke da COVID-19 waɗanda suka rasa ƙanshin su ya ragu zuwa 30% da farko kuma daga baya zuwa 15%.
Wasu bayanai game da barkewar cutar sun bayyana kwanan nan.
An yi imanin cewa a farkon matakan, yaduwar kwayar cutar ta hanyar kusanci da ƙananan ƙwayoyin cuta waɗanda aka samar yayin tari, tari ko magana, idan aka yi la'akari da kusanci tsakanin mita 1 zuwa 2 (fiti 3 zuwa 6).
Nazarin ya nuna cewa lokacin da aka yi tari ba tare da rufewa ba, saukad da na iya motsawa daga mita 4.5 (mita 15) zuwa mita 8.2 (mita 27).
Wasu sun ba da shawarar cewa za a iya yada kwayar ta hanyar ƙananan ɗigon ruwa, waɗanda ke gudana, misali, yayin magana, kuma suna rataye a cikin iska na dogon lokaci. Rashin numfashi na iya yadawa yayin numfashi da magana, kodayake ba a yada kwayar cutar ta hanyar iska.
Wadannan digo na iya shiga cikin baki ko hanci na mutanen da ke kusa da mu kuma su shiga cikin huhu.
Wasu hanyoyin kiwon lafiya kamar su tubalisation da kuma CPR na iya haifar da watsawa na numfashi a cikin iska kuma hakan na haifar da fitar iska.
Idan ka taba wani abu mai dauke da cutar kamar fata sannan ka shafa idanunka, hanci da baki, cutar na iya yaduwa.
Duk da yake akwai damuwa game da yaduwar kwayar cutar ta hanyar fitsari, ba a la'akari da wannan hadarin da gaske ba.
Gwamnatin China ta yi watsi da yiwuwar yaduwar SARS-CoV-2 ta hanyar baki. Kwayar cutar tana yaduwa sosai a cikin kwanaki uku na farko bayan bayyanar cututtuka, duk da haka, tana iya yaduwa ga wasu kafin bayyanar cututtuka da kuma a cikin matakan ƙarshe na cutar.
Gwajin mutane ya nuna tabbatacce har zuwa kwanaki uku kafin bayyanar cututtuka, wanda ke nuna cewa ana iya samun yaduwar cutar kafin bayyanar cututtuka masu mahimmanci.
Akwai rahotanni kaɗan na lab da aka tabbatar da marasa alamun cutar, amma wasu ƙasashe sun gano watsawar marasa alamun cutar yayin binciken da aka yi kan gano mutanen da suka tuntuɓi.
Cibiyar Kula da Cututtuka ta Turai (ECDC) ta bayyana cewa kodayake ba a bayyana yadda sauƙin yaduwar cutar ta zama cikakke ba, amma mutum ɗaya da ya kamu da cutar na iya kamuwa da mutane biyu zuwa uku. Kwayar cutar tana iya kasancewa a kan fuska daga awanni zuwa kwanaki.
Musamman, an ga cewa kwayar cutar tana iya ganowa sama da kwanaki uku akan filastik (polypropylene) da bakin karfe 304 mai guba, rana ɗaya akan takalma, da sama da awanni huɗu akan jan ƙarfe.
Amma wannan ya dogara da zafi da zafin jiki. An gwada gwajin COVID-19 a cikin dabbobin gida da sauran dabbobi.
Babu wata hujja da ta nuna cewa dabbobi na iya yada kwayar cutar zuwa ga mutane, duk da cewa hukumomin Burtaniya sun ba da shawarar wanke hannu bayan sun tuntubi dabbobi, kamar yadda ake yi idan aka taba wasu wuraren da ke dauke da cutar.
Kwayar cuta mai saurin numfashi ta coronavirus 2 (SARS-CoV-2) sabuwar kwayar cuta ce da aka fara ganowa a cikin mutane uku da ke fama da cutar kirji da kuma na hanci a Wuhan wadanda ke fama da matsalar rashin isashshen iskar oxygen da kuma matsalar numfashi.
Dukkanin halaye na sabon coronavirus suna bayyana a cikin sauran coronaviruses na yanayi. A waje da jikin mutum, ana kashe kwayar cutar da sabulu na yau da kullun, saboda layin kariya yana narkewa a cikin sabulu. SARS-CoV-2 yana da kusanci da SARS-CoV.
An yi imanin cewa cutar ta samo asali ne daga cutar zenozide ko kuma cutar da ke tsakanin mutane da dabbobi.
Binciken kwayoyin halitta ya nuna cewa kwayar cutar ta Corona ta kasance a cikin kwayar halitta tare da Betacoronavirus da kuma Sarbecovirus (kwayar B) tare da nau'ikan asali biyu na bat.
Kwayar cutar tana da kashi 96% na kamanceceniya a cikin dukkanin kwayoyin halitta tare da sauran bat coronavirus (BatCov RaTG13).
A watan Fabrairun 2020, masu bincike na kasar Sin sun gano cewa akwai bambanci guda daya ne kawai a tsakanin kwayar cutar pangolin da ta mutum a wasu sassan jerin kwayoyin halitta.
Idan aka kwatanta dukkanin kwayoyin halittar zamani, akwai kashi 92% na kayan halittar halittar tsakanin pangolin coronavirus da SARS-CoV-2, wanda bai isa ya tabbatar da pangolins a matsayin mai watsa shiri na tsaka-tsaki ba.
Ana iya gano kamuwa da kwayar cutar ta hanyar alamun, kodayake za a tabbatar da tabbataccen ganewar asali ta hanyar maganin polymerase chain reaction (Rrt-PCR) na kwayar cutar ko CT.
Wani bincike da ya kwatanta polymerase chain reaction (PCR) da CT scan (CT) a Wuhan ya nuna cewa CT ya fi PCR ta hankali, kodayake ba ta da ƙwarewa sosai, kuma yawancin fasalulluka na gani sun haɗu da sauran nau'ikan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuk
"Tun daga Maris 2020, Kwalejin Radiology ta Amurka ta ba da shawarar cewa ""Kada a yi amfani da CT don yin bincike ko gwajin layin farko na COVID-19"."
Hukumar Lafiya ta Duniya ta fitar da wasu ka'idojin gwajin RNA don SARS-CoV-2, wanda ya fara a ranar 17 ga Janairu.
Gwajin yana amfani da polymerase chain reaction (rRT-PCR).
Ana iya yin gwajin ne a kan numfashi ko jini.
Sakamakon yawanci ana bayar da shi cikin 'yan sa'o'i zuwa' yan kwanaki.
Ana yin gwajin ne da maganin hana kumburi, kodayake ana iya amfani da maganin hanci. Yawancin dakunan gwaje-gwaje da kamfanoni suna haɓaka gwajin ƙwayar cuta wanda ke gano ƙwayoyin cuta.
Ya zuwa ranar 6 ga Afrilu, 2020, babu ɗayan waɗannan da ya isa ya zama cikakke don amfani da yawa.
A Amurka, Cellex ne ya tsara gwajin kwayar cutar, wanda aka ba da izinin amfani da gaggawa kawai ta hanyar dakunan gwaje-gwaje masu izini.
Bayanan hoto na musamman a cikin hotunan radiology da na kwamfuta (CT) na mutanen da ke da alamun sun haɗa da ƙuƙwalwar gilashi kuma ba a lura da rikicewar motsi ba.
Kungiyar Radiology ta Italiya tana tattara bayanan yanar gizo na binciken hoto na tabbatar da cutar.
Saboda lokaci tare da sauran kamuwa da cuta kamar su adenoviruses, yin hoto ba tare da tabbatar da PCR na ƙarshe ba, yana da iyakancewa don gano COVID-19.
Wani babban bincike a China ya kwatanta sakamakon CT na kirji da PCR kuma ya nuna cewa ko da yake ba a amfani da hoton hoto sosai don kamuwa da cutar, amma yana da saurin kuma ana iya amfani dashi azaman kayan aikin bincike a yankunan da cutar ta barke.
An haɓaka cibiyoyin sadarwa na AI don gano fasalin hoto na kwayar cutar a cikin hotunan radiology da CT.
Dabaru don hana yaduwar cutar sun hada da kiyaye tsabtar mutum gaba daya, wanke hannu, gujewa taɓa idanu, hanci ko baki da hannaye marasa wankewa, da tari ko tari a cikin tawul, da jefa tawul cikin kwandon shara da sauri.
An shawarci wadanda suka riga sun kamu da cutar su sanya abin rufe fuska a wuraren jama'a.
Ana kuma ba da shawarar nisantar jiki don hana yaduwar cutar. Yawancin gwamnatoci sun takaita duk tafiye-tafiye marasa mahimmanci zuwa ƙasashe da yankuna da cutar ta shafa.
Koyaya, a cikin manyan sassan duniya, kwayar cutar ta kai ga yaduwar al'umma.
Wannan yana nufin cewa kwayar cutar tana yaduwa tsakanin al'ummomi kuma wasu membobin al'umma ba su san inda ko kuma abin da suka kamu da cutar ba. Ana ba da shawarar masu ba da sabis na kulawa waɗanda ke kula da wanda ke da cutar su bi ƙa'idodin rigakafi, kiyayewa yayin tuntuɓar, da kuma amfani da abin rufe ido. Binciken bayanan tuntuɓar mai kamuwa da cuta hanya ce mai mahimmanci da hukumomin kiwon lafiya ke amfani da ita don gano tushen kamuwa da cuta da hana ƙarin kamuwa da cuta.
Amfani da bayanan wurin wayar salula ta gwamnatoci don wannan dalili ya haifar da damuwa game da kiyaye sirrin, wanda Amnesty International tare da wasu kungiyoyi sama da 100 suka ba da sanarwar neman a takaita irin wannan sa ido.
An yi amfani da aikace-aikacen wayar hannu da yawa ko kuma an ba da shawarar yin amfani da su da son rai, kuma a ranar 7 ga Afrilu, 2020, sama da ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwar
Masu amfani za su sami saƙo wanda zai tambaye su ko sun yi hulɗa kai tsaye da mutumin da ya gwada tabbatacce na COVID-19. Akwai ra'ayoyi marasa kyau game da yadda za a hana kamuwa da cutar, misali, wanke hanci da hanci tare da wanke baki ba su da tasiri.
Babu allurar rigakafin COVID-19, duk da haka kungiyoyi daban-daban suna aiki don samun sa.
Ana ba da shawarar wanke hannu don hana yaduwar cutar.
Cibiyar Kula da Cututtuka da Rigakafinta ta ba da shawarar cewa mutane su wanke hannayensu da sabulu da ruwa na akalla sakan ashirin, musamman bayan sun je gidan wanka ko kuma idan hannayensu sun kasance masu datti sosai; kafin cin abinci; bayan yin iska, tari ko tari.
A waje da jikin mutum, ana kashe kwayar cutar da sabulu na yau da kullun, saboda sabulu yana lalata murfin kariya.
CDC ta kuma ba da shawarar yin amfani da maganin kashe cutar hannu na barasa tare da aƙalla kashi 60% na barasa idan babu ruwa da sabulu.
Hukumar Lafiya ta Duniya ta shawarci mutane da su guji taɓa idanunsu, hanci, ko bakinsu da hannayen da ba a wanke ba.
Za a iya yin maganin shafawa tare da wasu magunguna (na minti daya na maganin shafawa don fuskokin karfe mai tsayayye), wanda ya hada da 62-71% ethanol, 50-100% isopropanol, 0.1% sodium hypochlorite, 0.5% hydrogen peroxide da 0.2%-7.5% povidone iodine.
Sauran hanyoyin kamar benzalkonium chloride da chloroxidein gluconate ba su da tasiri sosai.
A cewar shawarar CDC, idan mutum yana da shakku ko an tabbatar da cutar a wani wuri kamar ofishi ko cibiyar kula da lafiya, duk wuraren da ake amfani da su kamar ofisoshin, sabis na kiwon lafiya, wuraren watsawa, kayan aikin lantarki na kowa kamar su kwamfutar hannu, nuni mai taɓawa, allon maɓalli, sarrafawa na nesa da na'urorin ATM da marasa lafiya ke amfani da su ya kamata su kasance masu tsabta.
Kungiyoyin kiwon lafiya sun shawarci mutane da su rufe hanci da baki da tawul din su da hannu idan suna tari ko tari kuma su jefar da tawul din nan da nan.
Ana ba da shawarar sanya abin rufe fuska ga mutanen da ke da yiwuwar kamuwa da cutar saboda abin rufe fuska na iya rage girma da nesa na saukowar ruwan numfashi yayin magana, tari da tari.
Hukumar Lafiya ta Duniya ta fitar da jagororin kan lokacin da kuma yadda ake amfani da abin rufe fuska.
A cewar Stephen Griffin, masanin ilimin cutar cutar a Jami'ar Leeds, "Samun abin rufe fuska na iya rage sha'awar mutane su taba fuskarsu, wanda shine babban hanyar watsa cutar, tare da hannayensu a tsaye". Ana kuma ba da shawarar sanya abin rufe fuska ga mutanen da ke kula da wadanda ake zargi da cutar. "
Hukumar Lafiya ta Duniya ta shawarci mutanen da ke da lafiya su yi amfani da abin rufe fuska ne kawai idan suna da babban haɗari, misali, kula da waɗanda ke da COVID-19, kodayake ta tabbatar da cewa amfani da abin rufe fuska na iya taimaka wa mutane kada su taɓa fuskokinsu.
Kasashe da dama sun fara karfafawa jama'a gwiwa kan amfani da abin rufe fuska.
A Amurka, CDC ta ba da shawarar yin amfani da abin rufe fuska na masana'antu wanda ba na likita ba. Musamman China ta ba da shawarar yin amfani da abin rufe fuska na likita sau ɗaya ga mutanen da ke da lafiya, musamman ma a cikin kusanci na mita 1 (ƙafa 3 ko ƙasa da haka) tare da wasu.
Hong Kong ta ba da shawarar yin amfani da abin rufe fuska a cikin sufuri na jama'a ko wuraren da jama'a ke yawan aiki.
Jami'an kiwon lafiya na Thailand suna ƙarfafa mutane su samar da abin rufe fuska a gida da kuma wanke fuskokinsu a kullum.
Jamhuriyar Czechoslovakia ta haramta fita a wuraren jama'a ba tare da sanya abin rufe fuska ba ko rufe hanci da baki.
A ranar 16 ga Maris, Vietnam ta bukaci kowa da kowa ya sanya abin rufe fuska yayin da yake cikin jama'a don kare kansa da sauran mutane.
Gwamnatin Austria ta sanya sanya abin rufe fuska ya zama tilas ga waɗanda ke shiga shagon abinci.
Isra'ila ta bukaci dukkan 'yan kasar su sanya abin rufe fuska a wuraren jama'a.
Taiwan, wacce ta kai karfin samar da masks miliyan goma a rana tun tsakiyar watan Maris, ta sanya sanya abin rufe fuska ga fasinjojin jiragen kasa da na bas na tsakanin birane daga ranar 1 ga Afrilu.
A Panama, ana buƙatar sanya abin rufe fuska yayin fita waje, kuma waɗanda ba za su iya yin abin rufe fuska ba dole ne su yi a gida.
An yi amfani da abin rufe fuska sosai a Japan, Koriya ta Kudu, Malaysia da Singapore.
Nisa nesa (wanda kuma ake kira nesa ta jiki) ya ƙunshi matakan sarrafa kamuwa da cuta da ake yi da nufin rage cutar ta hanyar rage hulɗa tsakanin mutane.
Hanyoyin sun hada da keɓewa; ƙuntatawa kan tafiye-tafiye; da kuma dakatar da makarantu, wuraren aiki, filayen wasanni, gidajen wasan kwaikwayo ko cibiyoyin kasuwanci.
Mutane na iya kiyaye nisantar jama'a ta hanyar zama a gida, rage tafiye tafiye, guje wa wuraren cunkoso, yin amfani da yanayin ba tare da tuntuɓar mutane ba, da kuma kiyaye nesa da wasu.
Yawancin gwamnatoci a halin yanzu sun tilasta ko ba da shawarar nisantar zamantakewa a cikin yankunan keɓewa waɗanda ke fama da cutar.
Matsakaicin yawan jama'a a cikin al'ummomin da hukumomin gwamnati da hukumomin kiwon lafiya suka ba da shawarar a Amurka, an rage su da sauri daga mutane 250 (idan babu wasu cututtukan COVID-19 a yankin) zuwa 50 kuma zuwa 10.
"Tun daga 22 ga Maris, 2020, Jamus ta haramta tarurrukan mutane sama da biyu. Manya da mutanen da ke da cututtukan kiwon lafiya na yau da kullun kamar su ciwon sukari, cututtukan zuciya, cututtukan numfashi, hawan jini da raunin rigakafi suna cikin haɗarin kamuwa da cutar mai tsanani da rikitarwa, kuma CDC ta ba da shawarar su zauna a gida kamar yadda ya kamata a yankunan da ke da yawan jama'a. A ƙarshen Maris, 2020, Hukumar Lafiya ta Duniya da sauran al'ummomin kiwon lafiya sun canza kalmar ""yankewar zamantakewa"" zuwa ""yankewar jiki"" don bayyana manufar ita ce rage hulɗa ta jiki yayin kiyaye sadarwar zamantakewa ta hanyar yanar gizo ko ta nesa. "
Amfani da kalmar "yanke nesa" ya haifar da ra'ayin cewa mutane suyi aiki a cikin zamantakewar zamantakewar zamantakewa, maimakon ƙarfafa su suyi hulɗa da wasu ta hanyar madadin. Wasu hukumomi sun ba da jagororin kiwon lafiya na jima'i a yayin cutar.
Wannan ya hada da shawarar a rage jima'i ga wanda ba shi da alamun cutar.
An shawarci mutanen da ke da cutar COVID-19 da waɗanda ake zargin suna da cutar su keɓe kansu.
Kungiyoyin kiwon lafiya sun gabatar da cikakkun hanyoyin da za a bi don keɓe kai. Yawancin gwamnatoci sun ba da shawarar ko sun ba da shawarar keɓe kai ga duk mutanen da ke zaune a yankunan da ke da cutar.
An ba da umarnin tsauraran tsauraran tsauraran tsauraran tsauraran tsauraran tsauraran tsauraran tsauraran tsauraran tsauraran tsauraran tsauraran tsauraran tsauraran tsauraran tsauraran tsauraran tsauraran tsauraran tsauraran tsauraran tsauraran tsauraran tsauraran tsauraran tsauraran tsauraran tsauraran tsauraran tsauraran tsauraran tsauraran tsauraran tsauraran tsauraran tsauraran tsauraran tsauraran tsauraran tsauraran tsauraran tsauraran tsauraran tsauraran tsauraran tsauraran tsauraran tsauraran tsauraran tsauraran tsauraran tsauraran tsauraran tsauraran tsauraran tsauraran tsauraran tsauraran tsauraran tsauraran tsauraran tsauraran tsauraran tsauraran tsauraran tsauraran tsauraran tsauraran tsauraran tsauraran tsauraran tsauraran tsauraran tsauraran tsauraran.
An shawarci mutanen da suka yi hulɗa da mutumin da ke da cutar COVID-19 da waɗanda suka yi tafiya kwanan nan zuwa ƙasa ko yankin da ke da yaduwar cutar su keɓe kansu har zuwa kwanaki 14 daga lokacin da suka yi hulɗa da su na ƙarshe.
Dabarun sarrafa yaduwar cuta sun haɗa da iyakance ko hanawa da rage yawan yaduwar cuta.
Za a sanya takunkumi a farkon barkewar cutar, da nufin ganowa da ware mutanen da ke dauke da cutar, da kuma gabatar da wasu matakan kula da cutar da kuma allurar rigakafi don dakatar da yaduwar cutar ga wasu mutane.
Lokacin da ba za a iya hana cutar ba, ana yin ƙoƙari don ragewa: matakan da aka ɗauka don rage saurin yaduwar kwayar cutar da rage tasirinsa a kan tsarin kiwon lafiya da al'umma.
Ana iya amfani da haɗuwa da ƙuntatawa da kuma ragewa a lokaci guda.
Dakatar da cutar na buƙatar tsauraran matakai don rage ƙimar maimaitawar cutar ta ƙasa da 1. Wani ɓangare na gudanar da cutar ta duniya shine rage girman cutar, wanda ake kira daidaita yanayin cutar.
Wannan zai rage haɗarin ɗimbin ayyukan kiwon lafiya kuma ya ba da ƙarin lokaci don samar da allurar rigakafi da magani.
Sauran hanyoyin da ba na magani ba da za su iya sarrafa yaduwar cutar sun hada da matakan rigakafin mutum, kamar tsabtace hannu, sanya abin rufe fuska da keɓewa; matakan jama'a da ke nufin nisantar jiki kamar dakatar da makarantu da soke taron jama'a; sa hannu na jama'a don ƙarfafa karɓa da shiga cikin irin waɗannan hanyoyin; da kuma matakan muhalli kamar tsabtace farfajiyar. An aiwatar da manyan matakan da aka yi niyya don shawo kan cutar a China lokacin da cutar ta bayyana, kamar keɓe birane gaba ɗaya da hana tafiye-tafiye.
Sauran ƙasashe ma sun ɗauki matakai daban-daban da nufin rage yaduwar kwayar cutar.
Koriya ta Kudu ta koma ga tantancewar jama'a da keɓewar gidaje, tare da yin gargadin hana yawan mutane da ke dauke da cutar da kuma sauya wuraren da suke.
Singapore ta ba da tallafi ga waɗanda suka kamu da cutar da suka keɓe kansu kuma sun sanya manyan tarar ga waɗanda suka yi watsi da keɓewar.
Taiwan ta kara samar da masks da kuma sanya manyan tarar kan kayan aikin kiwon lafiya. Kwaikwayo da aka yi a kan Burtaniya da Amurka sun nuna cewa rage yawan annoba (rage, ba dakatar da cutar ba) da kuma hana (juyawa cutar) suna da manyan kalubale.
Ingantattun manufofin daidaitawa na iya rage yawan buƙatun kiwon lafiya da kashi biyu bisa uku da mutuwar da rabi, amma har yanzu yana haifar da dubban dubban mutuwar da wucewar ƙarfin tsarin kiwon lafiya.
Za a iya hana cutar, amma dole ne a ci gaba da yin hakan har sai cutar ta yadu tsakanin mutane (ko kuma har sai an samar da allurar rigakafi, duk abin da ya fara faruwa), in ba haka ba cutar za ta sake tashi da yaduwa idan an rage matakan tsauraran matakai.
Shigar da matakan da za a yi na tsawon lokaci don magance cutar ta haifar da tsadar zamantakewa da tattalin arziki.
Babu wani takamaiman maganin rigakafin kwayar cutar COVID-19 da aka amince da shi, amma ana kokarin gwadawa, gami da gwajin maganin da ake da shi.
Samun maganin hana zubar da ciki ba tare da takardar sayan magani ba, shan ruwa da hutawa na iya zama mai tasiri wajen sauƙaƙe alamun.
Dangane da tsananin, magani tare da oxygen, ruwan jini da kuma taimakon numfashi na iya zama dole.
Yin amfani da steroids na iya kara rikitar da cutar.
An bincika wasu magungunan da aka yi amfani da su a baya don magance wasu cututtukan kwayar cuta, don amfani da su a cikin maganin COVID-19.
Hukumar Lafiya ta Duniya ta ce wasu "magunguna na gida da na gargajiya" na iya rage rikitarwa na SARS-COVID-19.
Ƙarfafa iya aiki da aiwatar da kiwon lafiya don magance bukatun marasa lafiya na COVID-19 an bayyana shi a matsayin babban mataki na amsa cutar.
Cibiyar Kula da Cututtuka ta Turai (ECDC) da Ofishin Yankin Yammacin Turai na WHO sun ba da umarni ga asibitoci da ayyukan kiwon lafiya da na farko don sauya albarkatu a matakai daban-daban ciki har da mayar da hankali ga ayyukan dakin gwaje-gwaje zuwa gwajin COVID-19, soke hanyoyin zaɓi idan ya yiwu, warewa da keɓe marasa lafiya masu cutar COVID-19 masu kyau, da haɓaka ƙarfin kulawa ta musamman ta hanyar horar da ma'aikata da haɓaka yawan injunan iska da na gado.
Akwai ra'ayoyi daban-daban game da asalin mutumin da ya fara kamuwa da cutar (wanda ake kira mai cutar Zero).
Lamarin farko da aka sani na sabon coronavirus na iya komawa ranar 1 ga Disamba, 2019 a Wuhan, Hubei da China.
A cikin wata guda, adadin masu kamuwa da cutar coronavirus ya karu a hankali a Hubei.
Yawancin su sun shafi kasuwar cinikin abincin teku ta Hunan inda ake sayar da dabbobi masu rai, kuma akwai ka'idar cewa cutar ta samo asali ne daga waɗannan nau'ikan dabbobi, a wasu kalmomin, asalin dabbobi ne. An gano tarin huhu tare da sanadin da ba a sani ba a ranar 26 ga Disamba, kuma an kula da su a asibitin lardin Hubei na Dokta Zhang Jian, kuma an sanar da Cibiyar Kula da Cututtuka ta Wuhan a ranar 27 ga Disamba.
A ranar 30 ga Disamba, wata ƙungiyar likitoci a Asibitin Wuhan ta gargaɗi abokan aikinta game da wani "Semi-SARS coronavirus".
An tuhumi likitoci takwas da suka hada da Lee Wenliang da yada jita-jita ta hanyar 'yan sanda, kuma wani likita, mai suna Ifen, ya sha fama da tsawa daga manyan jami'an saboda kara yawan matakan gargadi.
Hukumar Lafiya ta Wuhan ta ba da sanarwar jama'a a ranar 31 ga Disamba kuma ta sanar da WHO.
An bayar da rahoton adadi mai yawa na cututtukan huhu da ba a sani ba ga jami'an kiwon lafiya a Wuhan a farkon watan Janairu, wanda ya haifar da fara bincike.A farkon barkewar cutar, adadin masu kamuwa da cutar ya ninka kusan kowace kwana bakwai da rabi.
A farkon da tsakiyar watan Janairun 2020, cutar ta bazu zuwa wasu lardunan China saboda yanayin Sabuwar Shekarar Sin da kuma gaskiyar cewa Wuhan tana ɗaya daga cikin cibiyoyin sufuri da kuma manyan hanyoyin jirgin ƙasa.
A ranar 20 ga watan Janairu, kasar Sin ta bayar da rahoton kusan sabbin mutane 140 da suka kamu da cutar, ciki har da biyu a Beijing da daya a Shenzhen.
Daga baya, bayanan hukuma sun nuna cewa a ranar 20 ga Janairu, 2020, mutane 6,174 ne suka kamu da cutar. A ranar 26 ga Maris, Amurka ta fi China da Italiya yawan wadanda suka kamu da cutar a duniya. A ranar 9 ga Afrilu, 2020, an ba da rahoton sama da mutane miliyan 1.61 a duniya, sama da mutane 97,000 sun mutu, kuma sama da mutane 364,000 sun warke.
Aƙalla an sami rahoton kamuwa da cuta guda ɗaya a cikin ƙasashe da yankuna kusan 200.
Saboda annobar a Turai, kasashe da dama a yankin Schengen sun takaita motsi kyauta kuma sun kafa iko a kan iyakoki.
Amsoshin ƙasa sun haɗa da matakan ƙuntatawa kamar su keɓewa (a ƙarƙashin taken kamar umarnin zama a gida, umarnin mafaka a gida ko cikakken keɓewa) da ƙuntatawa. Ya zuwa ranar 2 ga Afrilu, kusan mutane miliyan 300 a Amurka, ko kuma kusan kashi 90 cikin ɗari na yawan jama'a, suna ƙarƙashin wasu nau'ikan keɓewa na gida, sama da miliyan 50 a Philippines, kusan miliyan 59 a Afirka ta Kudu da miliyan 1.3 a Indiya suna cikin keɓewar gida.
A ranar 26 ga watan Maris, mutane biliyan 1.7 ne a duniya ke karkashin wani nau'i na keɓewa, wanda ya karu zuwa biliyan 2.6 bayan kwana biyu, kusan kashi ɗaya bisa uku na yawan mutanen duniya.
Lamarin farko da aka tabbatar da COVID-19 ya faru ne a ranar 1 ga Disamba, 2019 a Wuhan; rahoton da ba a tabbatar da shi ba ya nuna cewa farkon lamarin ya faru ne a ranar 17 ga Nuwamba.
Dokta Zhang Jixian ya gano tarin marasa lafiya da ke fama da cutar sankarar bargo ba tare da sanadin ba a ranar 26 ga Disamba, kuma asibitin ya kai rahoton ga Cibiyar Kula da Cututtuka ta Jiang Han Wuhan a ranar 27 ga Disamba.
Gwajin farko na kwayoyin halittar da aka yi a kan marasa lafiya a ranar 27 ga Disamba, 2019 ya nuna cewa akwai SARS-like coronavirus.
Hukumar kiwon lafiya ta Wuhan ta fitar da sanarwar jama'a a ranar 31 ga Disamba.
An sanar da WHO a wannan ranar.
"Da aka fitar da sanarwar, 'yan sanda sun gargadi likitocin Wuhan game da ""rashin jita-jita"" game da annobar.
Hukumar Lafiya ta Kasa ta kasar Sin da farko ta ce babu "tabbacin tabbatacce" na kamuwa da cutar daga mutum zuwa mutum.
A karshen watan Janairu, gwamnatin kasar Sin ta kaddamar da wani yunkuri na kawo karshen yaduwar cutar, wanda daga baya Sakatare Janar na Jam'iyyar Kwaminis ta Sin, Xi Jinping, ya bayyana a matsayin "yaƙin mutane" don dakile yaduwar cutar.
"A lokacin da aka bayyana shi a matsayin ""mafi girman keɓewa a tarihin ɗan adam"", an ba da sanarwar belin lafiya a ranar 23 ga Janairu, wanda ya dakatar da shiga da fita daga Wuhan kuma ya bazu zuwa birane 15 na Hubei, wanda ya shafi mutane kusan miliyan 57. "
An haramta amfani da motocin sirri a cikin birni.
An dakatar da bikin Sabuwar Shekarar Sin (Janairu 25) a yankuna da yawa.
Hukumomi sun kuma sanar da gina asibitin wucin gadi, asibitin Huoshenshan, wanda aka kammala cikin kwanaki 10.
An gina asibitin Leishenshan don kula da ƙarin marasa lafiya.
Baya ga sabbin asibitocin da aka gina, kasar Sin ta kuma mayar da wasu cibiyoyi 14 a Wuhan, kamar cibiyoyin taro da filayen wasa, asibitoci na wucin gadi. A ranar 26 ga Janairu, gwamnati ta kara daukar matakan dakile barkewar COVID-19, ciki har da bayar da sanarwar lafiya ga matafiya da kuma tsawaita hutun bikin bazara.
Jami'o'i da makarantu ma sun rufe a duk fadin kasar.
Yankunan Hong Kong da Macau sun dauki matakai da dama, musamman game da makarantu da jami'o'i.
An aiwatar da matakan nesa a yankuna da dama na kasar Sin.
An sanya takunkumin tafiye-tafiye a ciki da wajen lardin Hubei.
An sauya sufuri na jama'a, kuma an rufe gidajen tarihi na ɗan lokaci a duk faɗin China.
An sanya takunkumin hana zirga-zirgar jama'a a birane da dama, kuma an kiyasta cewa mutane miliyan 760 (fiye da rabin yawan jama'a) sun fuskanci wasu nau'ikan takunkumin fita daga gida. Bayan barkewar cutar ta shiga matakin duniya a watan Maris, hukumomin kasar Sin sun dauki tsauraran matakai don hana kamuwa da cutar daga wasu ƙasashe.
Misali, Beijing ta sanya wa dukkan matafiya na kasa da kasa da ke shigowa birnin takunkumin killacewa na kwanaki 14.A ranar 23 ga watan Maris, kasar Sin ta samu mutum daya da ya kamu da cutar a cikin gida, wanda ya kamu da cutar kwanaki biyar da suka gabata ta hanyar matafiyi da ya dawo daga Wutabul zuwa Guangzhou.
A ranar 24 ga Maris, 2020, Firayim Ministan kasar Sin, Li Keqiang, ya ba da rahoton cewa an dakatar da yaduwar cututtukan cutar a cikin gida kuma an sarrafa cutar a kasar Sin.
A wannan ranar ne aka sassauta takunkumin tafiye-tafiye a Hubei sai dai Wuhan, watanni biyu bayan aiwatar da dokar killacewa. Ma'aikatar Harkokin Wajen kasar Sin ta sanar a ranar 26 ga watan Maris, 2020 cewa za a dakatar da shiga kasar ga mazauna kasar da masu biza daga ranar 28 ga watan Maris, kuma ba a bayyana cikakken bayani kan tsawon lokacin da wannan manufofin za su ci gaba ba.
Wadanda ke son shiga kasar Sin dole ne su nemi biza a ofisoshin jakadancin kasar Sin ko ofisoshin jakadancin kasar.
Gwamnatin kasar Sin ta karfafawa masu kasuwanci da masana'antu gwiwa su fara aiki daga ranar 30 ga watan Maris, tare da samar da kudade masu yawa ga kamfanoni. Majalisar Jiha ta ayyana ranar makoki ta jama'a don yin zaman zaman shuru na minti uku a ranar 4 ga Afrilu da karfe 10:00 na yamma, daidai lokacin bikin King Ming, duk da cewa gwamnatin ta bukaci iyalai ta hanyar yanar gizo da su kiyaye nesa don hana sabon barkewar cutar COVID-19.
An tabbatar da cewa COVID-19 ya yadu daga China zuwa Koriya ta Kudu a ranar 20 ga Janairu, 2020.
Hukumar Lafiya da Kiwon Lafiya ta kasar ta bayar da rahoton karuwar adadin wadanda suka kamu da cutar a ranar 20 ga watan Fabrairu, wanda ya samo asali ne daga taron da aka yi a Daegu don sabon motsi na addini da ake kira Shincheonji Church of Christ.
Magoya bayan Shincheonji da suka gana da Dagou daga Wuhan suna da shakku kan asalin cutar.
Ya zuwa 22 ga Fabrairu, daga cikin masu bin Cocin 9,336, alamun cutar sun bayyana a cikin 1,261 ko kusan 13%. Koriya ta Kudu ta sanar da matakin gaggawa a ranar 23 ga Fabrairu, 2020.
A ranar 28 ga watan Fabrairu, an samu fiye da mutane 2,000 da aka tabbatar da cutar a Koriya, wanda ya kai 3150 a ranar 29 ga watan Fabrairu.
An killace dukkan sansanonin sojin Koriya ta Kudu bayan da aka samu rahoton cewa sojoji uku sun kamu da cutar.
An kuma shafar jadawalin jiragen sama na kamfanonin jiragen sama, wanda hakan ya sa suka zama masu sauya sheka. Koriya ta Kudu ta gabatar da shirin da ya fi girma kuma mafi kyau a duniya, wanda ya yi nasara wajen tantance yawan jama'a don cutar da kuma ware mutanen da ke dauke da cutar, da kuma ganowa da kuma keɓe mutanen da suka yi hulɗa da su.
Hanyoyin binciken sun hada da tilastawa masu shigowa da jiragen sama na kasa da kasa su bayar da rahoton alamun cutar ta hanyar aikace-aikacen wayar hannu, gwajin jirgin sama don cutar da za a bayyana sakamakon sa a rana mai zuwa, da kuma kara damar yin gwaji har zuwa mutane 20,000 a kowace rana.
Shirin Koriya ta Kudu ya kasance nasara wajen shawo kan yaduwar cutar duk da cewa ba a killace dukkan biranen ba. Da farko al'ummar Koriya ta Kudu ta kasance mai tsaka-tsaki a cikin martani ga rikicin da Shugaba Moon Jae-in ya yi.
Yawancin 'yan kasar Koriya sun sanya hannu kan takarda don bayyana laifin da ake yi wa Mnu, saboda abin da suka ga rashin kulawa da gwamnati a kula da cutar, yayin da wasu suka yi sa hannu don yabon yadda ta amsa.
Koriya ta Kudu ta samu mafi karancin adadin masu kamuwa da cutar a rana daya a cikin makonni hudu a ranar 23 ga watan Maris.
A ranar 29 ga Maris, an ba da rahoton cewa daga ranar 1 ga Afrilu, duk sabbin da suka shigo ƙasar daga ƙasashen waje za a keɓe su na tsawon makonni biyu.
A ranar 1 ga Afrilu, kafofin watsa labarai sun ruwaito cewa Koriya ta Kudu ta karbi buƙatun daga kasashe 121 don taimakawa wajen gwajin cutar.
Iran ta sanar da farkon wanda aka tabbatar da cutar SARS-CoV-2 a ranar 19 ga Fabrairu a Qom, inda a ranar biyu, a cewar Ma'aikatar Lafiya da Ilimi na Likita, mutane biyu suka mutu.
Matakan farko da gwamnati ta sanar sun hada da soke kide kide da wake-wake da sauran al'amuran al'adu, gasa ta wasanni da sallar Juma'a da kuma dakatar da jami'o'i, cibiyoyin ilimi da makarantu.
Iran ta ware tiriliyan 5 na Riyal don yaki da cutar.
A ranar 26 ga watan Fabrairun 2020, Shugaba Hassan Rouhani ya bayyana cewa babu wani shiri na killace yankunan da ke fama da cutar, sai dai mutane ne kawai za a killace.
An sanar da tsare-tsaren rage tafiye-tafiye na birane a watan Maris, duk da haka, ana ci gaba da samun cunkoso tsakanin biranen kasar kafin Sabuwar Shekarar Iran.
An bude wuraren ibada na Shi'a a birnin Qom har zuwa ranar 16 ga watan Maris, 2020. Iran ta zama cibiyar yaduwar cutar bayan China a watan Fabrairu.
A yayin da ake ikirarin cewa an rufe batun yaduwar cutar a Iran, sama da kasashe goma sun ba da rahoton cutar a Iran har zuwa 28 ga Fabrairu, wanda ke nuna cewa cutar ta iya zama mai tsanani fiye da 388 da gwamnatin Iran ta ruwaito zuwa wannan kwanan wata.
An rufe majalisar dokokin Iran, kuma 23 daga cikin mambobi 290 sun ba da rahoton cewa sun gwada tabbatacce ga kwayar cutar a ranar 3 ga Maris.
A ranar 12 ga watan Maris, mai sa ido kan kare hakkin dan Adam ya bukaci hukumomin gidan yari na Iran da su saki masu kare hakkin dan adam da aka tsare saboda rashin jituwa ta lumana ba tare da wani sharadi ba, tare da sakin dukkan fursunonin da suka cancanci hakan na wucin gadi.
An bayyana cewa a cikin keɓaɓɓun wurare kamar cibiyoyin tsare, waɗanda ba su da ingantaccen kulawar likita, haɗarin yaduwar kwayar cutar ya fi girma.
A ranar 15 ga watan Maris, gwamnatin Iran ta bayar da rahoton mutuwar mutane 100 a rana daya, wanda shine mafi girma a kasar tun bayan barkewar cutar.
An sanar da mutuwar akalla 'yan siyasa 12 da jami'an gwamnati masu aiki ko tsoffin Iran har zuwa ranar 17 ga Maris.
Har zuwa ranar 23 ga watan Maris, Iran tana da sabbin mutane 50 da suka kamu da cutar a kowace awa, da kuma mutum daya da ya mutu sakamakon cutar coronavirus.
A cewar wani jami'in Hukumar Lafiya ta Duniya, yiwuwar kamuwa da cutar a Iran ya ninka sau biyar na wanda aka ruwaito.
An kuma ba da shawarar cewa takunkumin Amurka kan Iran na iya yin tasiri ga ikon ƙasar ta na amsawa ta hanyar da ta dace game da barkewar cutar.
Babban Kwamishinan 'Yancin Dan Adam na Majalisar Dinkin Duniya ya yi kira da a rage matsin lamba na tattalin arziki a kan kasashen da suka fi fama da cutar, ciki har da Iran.
An tabbatar da barkewar cutar a Italiya a ranar 31 ga Janairu, daidai lokacin da aka tabbatar da gwajin gwajin SARS-CoV-2 ga yawon bude ido biyu na kasar Sin a Rome.
Cutar ta yi ta ƙaruwa sosai, wanda ya tilasta wa gwamnatin Italiya ta dakatar da zirga-zirgar jiragen sama da ke shigowa da fita daga China da kuma bayyana dokar ta baci.
An gano wani tarin mutane da ba su da alaƙa da COVID-19 daga baya, wanda ya fara daga 16 da aka tabbatar a Lombardy a ranar 21 ga Fabrairu. A ranar 22 ga Fabrairu, Majalisar Ministocin ta sanar da amincewa da sabuwar doka don shawo kan yaduwar cutar, wanda ya haɗa da keɓe mutane sama da 50,000 a sassa daban-daban 11 na arewacin Italiya.
Firayim Minista Giuseppe Conte ya ce "An hana shiga da fita daga yankunan da cutar ta bulla".
"An riga an bayar da umarni kan dakatar da ayyukan kasuwanci da wasannin motsa jiki a wadannan yankuna. " "A ranar 4 ga watan Maris, bayan mutuwar mutane 100 a Italiya, gwamnati ta ba da umarnin rufe makarantu da jami'o'i a duk fadin kasar. "
An gudanar da dukkan manyan wasannin wasanni, ciki har da wasannin kwallon kafa na Serie A, a rufe har zuwa watan Afrilu, amma a ranar 9 ga Maris, an dakatar da duk wasannin na tsawon wata guda.
A ranar 11 ga Maris, Firayim Minista Kent ya ba da umarnin dakatar da kusan duk ayyukan kasuwanci, ban da manyan kantuna da kantunan magani. A ranar 6 ga Maris, Kwalejin Kula da Magunguna ta Italiya, Anesthesia, Rehabilitation and Intensive Care (SIAARTI), ta ba da shawarwarin ɗabi'a na likita game da hanyoyin haɗin uku da za a iya amfani da su.
A ranar 19 ga watan Maris, Italiya ta zarce China a matsayin mafi yawan mutanen da suka mutu a duniya sakamakon cutar korona, inda ta samu mutuwar mutane 3,405 a rana guda sakamakon annobar.
A ranar 22 ga watan Maris, an bayar da rahoton cewa Rasha ta aika da jiragen sama na soja tara dauke da kayan aikin likita zuwa Italiya.
Ya zuwa ranar 5 ga Afrilu, an sami mutane 128,948 da aka tabbatar, 15,887 sun mutu, kuma 21,815 sun warke a Italiya, tare da mafi yawan waɗannan a yankin Lombardy.
Wani rahoto daga CNN ya nuna cewa haɗuwa da dalilai biyu, ƙarancin yawan jama'ar Italiya da rashin iya gwada duk waɗanda suka kamu da cutar zuwa yau, na iya haifar da ƙimar mutuwa.
Amsar Burtaniya ga cutar da farko ta bayyana a matsayin ɗayan ƙasashe da suka fi fuskantar cutar, kuma har zuwa 18 ga Maris, 2020, gwamnatin Burtaniya ba ta tilasta kowane nau'in nisantar zamantakewa ko matakan keɓewa ga 'yan ƙasa ba.
Sakamakon haka, an soki gwamnati saboda rashin saurin aiki da kuma daukar mataki mai mahimmanci wajen amsa damuwar jama'a. A ranar 16 ga Maris, Firayim Minista Boris Johnson, a cikin jawabinsa, ya hana tafiye-tafiye marasa mahimmanci da kuma hulɗa da jama'a, yana kira ga mutane da su yi aiki daga gida idan ya yiwu, kuma su guji zuwa wurare kamar mashaya, gidajen cin abinci da gidajen sinima.
A ranar 20 ga watan Maris, gwamnati ta sanar da cewa duk wuraren shakatawa kamar mashaya da wuraren motsa jiki dole ne a rufe su da wuri-wuri, tare da yin alƙawarin biyan kashi 80 cikin ɗari na albashin ma'aikatansu har zuwa dala 2,500 a wata don hana karuwar rashin aikin yi a cikin rikicin. A ranar 23 ga watan Maris, Firayim Minista ya sanar da tsauraran matakan nisantar zamantakewar jama'a, hana tarurrukan sama da mutane biyu, da kuma iyakance tafiye-tafiye da ayyukan waje har zuwa lokacin da ya zama dole.
Wadannan ƙuntatawa sun bambanta da matakan da suka gabata, wanda aka aiwatar ta hanyar 'yan sanda da kuma ta hanyar tarawa da kuma tarwatsa al'umma.
An ba da umarnin rufe yawancin kasuwancin, sai dai banbancin kasuwancin da aka ɗauka ""m"" ciki har da manyan kantuna, kantunan magani, bankuna, kantunan kaya, tashoshin mai da gareji. "
A ranar 20 ga watan Janairu, an gano kuma an tabbatar da farkon cutar COVID-19 a jihar Pacific Northwest a Washington a cikin wani mutum wanda ya dawo daga Wuhan a ranar 15 ga Janairu.
An kafa Kungiyar Aiki kan Cutar Korona ta Fadar White House a ranar 29 ga Janairu.
A ranar 31 ga watan Janairu, gwamnatin Trump ta ayyana dokar ta baci ta kiwon lafiyar jama'a kuma ta sanya takunkumi ga matafiya masu shigowa daga China.
A ranar 28 ga Janairu, 2020, Cibiyar Kula da Cututtuka, babbar cibiyar kiwon lafiyar jama'a ta gwamnatin Amurka, ta sanar da cewa sun kirkiro kayan gwajin su.
Duk da haka, Amurka ta fara jinkirin yin gwaji, wanda ya sanya ainihin yaduwar cutar ba ta da tabbas.
Sakamakon kit ɗin gwajin da aka samar da gwamnatin tarayya a watan Fabrairu, da rashin amincewar da gwamnatin tarayya (ta hanyar jami'o'i, kamfanoni da asibitoci) ta bayar game da kit ɗin gwajin da ba su da inganci, da kuma ƙuntatawa ga waɗanda suka cancanci yin gwajin, an yi gwajin da aka yi a farkon Maris (ana buƙatar umarnin likita).
Har zuwa ranar 27 ga watan Fabrairu, Washington Post ta ruwaito cewa an yi kasa da gwaje-gwaje 4,000 a Amurka.
Atlantic ya ruwaito cewa a ranar 13 ga watan Maris, an yi gwaji kasa da 14,000.
A ranar 22 ga watan Maris, kamfanin dillancin labarai na Associated Press ya ruwaito cewa, mutane da dama da ke da alamun cutar da kuma umarnin likita na yin gwaji sun jira daga sa'o'i da dama zuwa kwanaki don yin gwaji. Bayan rahoton farko na mutuwar a Amurka a ranar 29 ga Fabrairu, Gwamnan Jihar Jay Insley ya ayyana dokar ta baci, matakin da sauran jihohi suka bi.
Makarantu a yankin Seattle sun rufe darussan su a ranar 3 ga Maris, kuma a tsakiyar Maris, makarantu a duk faɗin ƙasar sun rufe. A ranar 6 ga Maris, 2020, ƙungiyar masana cututtukan cututtuka a Royal College London sun ba da hasashen tasirin cutar ta coronavirus a Amurka.
A wannan ranar, Shugaba Trump ya sanya hannu kan dokar bayar da tallafi na karawa juna sani da kuma shirye-shirye, wanda ya ba da dala biliyan 8.3 don tallafawa hukumomin tarayya da ke bukatar amsa cutar.
Kamfanoni sun sanya takunkumin tafiye-tafiye ga ma'aikata, sun soke taro, kuma sun karfafa ma'aikata suyi aiki daga gida.
An rufe abubuwan wasanni da kuma wasanni. A ranar 11 ga Maris, Trump ya sanya takunkumin tafiye-tafiye na kwanaki 30 ga yawancin ƙasashen Turai, ban da Burtaniya, wanda ya fara aiki daga ranar 13 ga Maris.
Kashegari, ya kafa takunkumi musamman ga Ingila da Ireland.
A ranar 13 ga watan Maris, ya ayyana dokar ta baci ta kasa, wanda ya sanya kudaden tarayya a cikin aikin mayar da martani ga rikicin.
Tun daga ranar 15 ga watan Maris, yawancin kasuwancin Amurka sun rufe ko rage lokutan aiki don rage yaduwar cutar.
Ya zuwa ranar 17 ga watan Maris, an tabbatar da barkewar cutar a dukkan jihohi 50 da kuma a yankin Columbia. A ranar 23 ga watan Maris, an bayar da rahoton cewa birnin New York yana da mutane 10,700 da suka kamu da cutar, wanda ya fi adadin wadanda suka kamu da cutar a Koriya ta Kudu.
A ranar 25 ga Maris, Wally ya bayyana cewa nisantar zamantakewar jama'a na da tasiri, saboda ƙididdigar saurin ninka yanayin ya ragu daga kwanaki 2 zuwa kwanaki 4.7.
Ya zuwa ranar 28 ga watan Maris, an tabbatar da mutane 32,308 a birnin New York City, kuma mutane 672 sun mutu sakamakon kamuwa da cutar. A ranar 26 ga watan Maris, an ba da rahoton cewa Amurka tana da mafi yawan masu kamuwa da cutar coronavirus fiye da kowace ƙasa a duniya, gami da China da Italiya. Ya zuwa ranar 8 ga Afrilu, an tabbatar da mutane 40,335 a Amurka, kuma mutane 128,41 sun mutu.
A cewar rahotannin kafofin watsa labarai a ranar 30 ga Maris, Shugaba Trump ya yanke shawarar tsawaita ka'idojin nisantar jama'a har zuwa 30 ga Afrilu.
A wannan ranar, USNS Comfort, wani jirgin asibiti mai gado 1,000 ya tashi a New York.
A ranar 3 ga Afrilu, Amurka ta karya rikodin mutuwar 884 na cutar coronavirus a cikin awanni 24.
A ranar 3 ga Afrilu, a jihar New York, an samu sama da mutum 100,000 da suka kamu da cutar. An soki Fadar White House saboda watsi da barazanar da kuma takaita umarnin jami'an kiwon lafiya da masana kimiyya na daidaita sanarwar jama'a da wallafe-wallafen game da cutar tare da ofishin mataimakin shugaban kasa Mike Pence.
An raba ra'ayi game da yadda Trump ya gudanar da rikicin a jam'iyyun biyu.
Wasu jami'an Amurka sun soki dogaro kan shigo da kayayyakin masarufi daga China, ciki har da kayayyakin kiwon lafiya.
An gudanar da nazarin yanayin tafiye-tafiye na iska don tsarawa da kuma hango hasashen yanayin yaduwar kwayar cutar kuma an buga shi a cikin mujallar Travel Medicine a tsakiyar watan Janairun 2020.
A shekarar 2018 daga Kungiyar Sufurin Jiragen Sama ta Duniya, Bangkok, Hong Kong, Tokyo da Taipei sun sami mafi yawan fasinjoji daga Wuhan.
Dubai, Sydney da Melbourne sune wuraren da aka fi so don matafiya daga Wuhan.
Bali ta kasance a saman biranen 20 da aka fi so, dangane da rashin shiri, yayin da biranen Ostiraliya suka fi dacewa, dangane da shiri. Ostiraliya ta sanar da shirin ta na gaggawa na amsawa ga sabon coronavirus (COVID-19) a ranar 7 ga Fabrairu.
Sanarwar ta ce har yanzu ba a gano bayanai da yawa game da COVID-19 ba kuma Ostiraliya za ta ba da shawarar kula da iyakoki da sadarwa a cikin martani ga cutar.
A ranar 21 ga watan Maris, an ayyana dokar ta baci ta kare hakkin dan adam a Australia.
Saboda tsauraran matakan killace zirga-zirgar jama'a a Wuhan da Hubei, kasashe da dama sun shirya fitar da 'yan kasarsu da jami'an diflomasiyya daga yankin, musamman ta hanyar jiragen haya daga kasar da kuma tare da izinin jami'an kasar Sin.
Kanada, Amurka, Argentina, Jamus da Thailand sun kasance cikin kasashen farko da suka fara aiwatar da shirin fitar da 'yan kasarsu.
Pakistan ta ce ba za ta mayar da 'yan kasarta daga China ba.
A ranar 7 ga watan Fabrairu, Brazil ta fitar da 'yan kasar Brazil 34 ko danginsu tare da' yan Poland hudu, da Sin daya da kuma dan Indiya daya.
'Yan kasar Poland, China da Indiya sun sauka daga jirgin a Poland, inda jirgin na Brazil ya tsaya kafin ya ci gaba da tafiya zuwa Brazil.
An killace 'yan Brazil da suka je Wuhan a wani sansanin soji kusa da Brazil.
A wannan ranar, an kwashe 'yan Kanada 215 (176 daga jirgin farko da 39 daga jirgin na biyu da gwamnatin Amurka ta yi hayar su) daga Wuhan kuma an kai su CFB Trenton don keɓewa na tsawon makonni biyu.
A ranar 11 ga watan Fabrairu, wani jirgin sama tare da wasu 'yan Kanada 185 daga Wuhan ya sauka a CFB Trenton.
Hukumomin Austriya sun kai mutane 277 zuwa gidan yarin na tsibirin Kirsimeti, wanda aka canza zuwa wurin keɓewa, a ranar 3 da 4 ga Fabrairu, inda suka zauna na kwanaki 14.
Jirgin saukar jiragen sama na New Zealand ya isa Auckland a ranar 5 ga Fabrairu; fasinjojinsa (ciki har da mutanen daga Australiya da Pacific) an ware su a sansanin jiragen ruwa na Whangaparoa a arewacin Auckland.
A ranar 15 ga watan Fabrairu, Amurka ta sanar da cewa za ta kwashe Amurkawa daga jirgin ruwa mai suna Diamond Princess.
A ranar 21 ga watan Fabrairu, jirgin da ke dauke da fasinjoji 129 na Kanada da aka kwashe daga jirgin ruwa mai suna Diamond Princess ya sauka a Trenton, Ontario.
A farkon watan Maris, gwamnatin Indiya ta dauki matakin kwashe 'yan kasarta daga Iran. A ranar 14 ga watan Maris, jirgin charter na kamfanin jiragen sama na Afirka ta Kudu ya dawo da 'yan kasa 122 zuwa kasar.
An gudanar da gwajin lafiya kafin a tashi, kuma an ci gaba da sanya 'yan Afirka ta Kudu huɗu masu alamun cutar ta COVID-19 a can don rage haɗarin.
Sai dai mutanen Afirka ta Kudu da suka nuna cewa ba su da cutar ne kawai suka koma gida.
Sakamakon gwajin duk 'yan Afirka ta Kudu, gami da ma'aikatan jirgin sama, ma'aikatan otal,' yan sanda da sojoji da ke cikin aikin jin kai, waɗanda aka sanya su a cikin kulawa da keɓewa na kwanaki 14 a filin shakatawa na Ranch don dalilai na kariya, sun kasance marasa kyau.
A ranar 20 ga watan Maris, Amurka ta janye wasu dakarunta daga kasar Iraki saboda annobar.
A ranar 5 ga watan Fabrairu, Ma'aikatar Harkokin Wajen China ta ce kasashe 21 (ciki har da Belarus, Pakistan, Trinidad da Tobago, Masar da Iran) sun aika da taimako ga kasar Sin.
Wasu daliban kasar Sin a jami'o'in Amurka sun hada kai don taimakawa wajen tura kayan agaji zuwa sassan kasar Sin da cutar ta shafa. Wata kungiya a yankin Chicago ta samu nasarar tura kayan rufe fuska 50,000 na N95 zuwa asibitocin lardin Hubei a ranar 30 ga watan Janairu. Kungiyar agaji ta Direct Relief, tare da hadin gwiwar FedEx, ta tura kayan rufe fuska 20,000 tare da sauran kayan kula da kai, ciki har da safofin hannu da sutura, ta hanyar jirgin sama zuwa asibitocin Wuhan Union a ranar 30 ga watan Janairu.
A ranar 5 ga watan Fabrairu, Bill da Melinda Gates sun sanar da bayar da gudummawar dala miliyan 100 ga WHO don tallafawa bincike kan allurar rigakafi da hanyoyin magani da kuma tallafawa "mutane masu hadarin gaske a Afirka da Kudancin Asiya".
Interaksyon ta ruwaito cewa gwamnatin China ta ba da gudummawar abin rufe fuska 200,000 ga Philippines a ranar 6 ga Fabrairu, sannan Sanata Richard Gordon ya aika da abin rufe fuska miliyan 3.16 zuwa Wuhan.
A ranar 19 ga watan Fabrairu, Red Cross ta Singapore ta sanar da cewa za ta tura tallafin dala miliyan 2.26 zuwa China.
Japan ta ba da gudummawar abin rufe fuska miliyan daya ga Wuhan, Turkiyya ta aika da kayan aikin likita, Rasha ta aika da kayayyakin kiwon lafiya sama da tan 13 zuwa Wuhan, Malaysia ta sanar da bayar da gudummawar safar hannu na kiwon lafiya miliyan 18 ga China, Jamus ta aika da kayayyakin kiwon lafiya da dama da suka hada da kayan kwalliya 10,000, sannan Amurka ta aika da kayayyakin kiwon lafiya tan 17.8 zuwa China tare da alkawarin tallafin kudi na dala miliyan 100 ga kasashen da suka kamu da cutar. Bayan da cutar ta fara samun sauki a kasar Sin, kasar ta taimaka wa sauran kasashen da ke fama da cutar.
A watan Maris, China, Cuba da Rasha sun aika da kayan aikin likita da kwararru don taimakawa Italiya wajen magance barkewar cutar coronavirus.
Shahararren dan kasuwa Jack Ma ya aika da kayan gwaji miliyan 1.1, masks miliyan 6 da kuma fakitoci 60,000 na kayan kariya don rarraba ta kungiyar tarayyar Afirka zuwa Addis Ababa, Habasha.
Ya ci gaba da aika da kayan gwajin 5,000, masks 100,000 da na'urorin motsa jiki 5 zuwa Panama.
"Mun kuma ba da gudummawar kayan aikin likita ga Kanada. Netherlands, Spain, Turkey, Georgia da Jamhuriyar Czech sun nuna damuwa game da abin rufe fuska da kayan aikin bincike na kasar Sin. "
Misali, Spain ta yi watsi da amfani da kayan gwajin da aka yi a kasar Sin wanda ya kai kashi 30 cikin dari, yayin da Netherlands ta yi tsokaci kan abin rufe fuska 600,000 da aka yi da kasar Sin.
Belgium ta ki karbar masks 100,000 da ba za a iya amfani da su ba, saboda ana tunanin cewa sun fito ne daga China, amma a zahiri daga Colombia.
A gefe guda, tallafin da China ke bayarwa a wasu sassan Latin Amurka da Afirka ya zama na gaba. Tun daga ranar 2 ga Afrilu, Bankin Duniya ya ƙaddamar da ayyukan tallafi na gaggawa ga ƙasashe masu tasowa.
Hukumar Lafiya ta Duniya (WHO) ta yaba wa kokarin da hukumomin China ke yi na sarrafawa da kuma shawo kan annobar.
"Kungiyar Lafiya ta Duniya ta kwatanta wannan yanayin da barkewar cutar SARS a 2002-2004, lokacin da aka zargi jami'an kasar Sin da ɓoye bayanai, wanda hakan ya yi tasiri ga ƙoƙarin hana yaduwar cutar, kuma a cikin rikicin na yanzu, gwamnatin tarayya ta "yi aiki a kan sanarwar yau da kullun don hana barkewar cutar kafin hutun Sabuwar Shekara ta Hasken rana". "
"A ranar 23 ga Janairu, Wakilin WHO, Guden Galle, ya mayar da martani ga shawarar da hukumomin tsakiya suka yanke na aiwatar da dokar hana zirga-zirga a Wuhan, ya bayyana cewa ""ba shawarar WHO ba ce"" amma ""lambar da ta fi muhimmanci game da jajircewa wajen shawo kan annobar a wani wuri da ta fi ko'ina rauni"" kuma ya kira ta ""wanda ba a taba ganin irinsa ba a tarihin lafiyar jama'a. "A ranar 30 ga Janairu, bayan tabbatar da kamuwa da cutar daga mutum zuwa mutum a wajen kasar Sin da kuma karuwar adadin wadanda suka kamu a wasu kasashe, WHO ta ayyana barkewar cutar a matsayin gaggawa ta lafiyar jama'a a duniya, kuma ta shida tun bayan halin da aka fara a lokacin cutar sankara ta shekarar 2009".
"Tedros Adhanom, Sakatare Janar na WHO ya bayyana cewa PHEIC ya kasance saboda ""hadarin yaduwar duniya, musamman a ƙasashe masu ƙarancin kuɗi da matsakaitan kuɗi da rashin ingantaccen tsarin kiwon lafiya. "
"A cikin martani ga takunkumin tafiye-tafiye, Tedros ya bayyana cewa: ""Babu wani dalili na matakan da ba dole ba wanda ke tsoma baki tare da tafiye-tafiye da kasuwancin duniya"," kuma ya ci gaba da cewa ""WHO ba ta ba da shawarar hana kasuwanci da motsi ba"."
A ranar 5 ga watan Fabrairu, Majalisar Dinkin Duniya ta nemi al'umma ta duniya da ta ba da dala miliyan 675 don taimakawa wajen samar da kudade na shirye-shiryen dabarun a ƙasashe masu ƙarancin kuɗi, tare da nuna buƙatar tallafawa ƙasashe waɗanda "ba su da ingantaccen tsarin gano waɗanda ke da cutar ko ma suna da alamun cutar".
Tedros ya ci gaba da cewa, "Muna da ƙarfi kamar yadda muke da rauni a cikin haɗin kanmu", kuma ya nemi al'umma ta duniya da "ko dai su saka hannun jari a yau ko kuma su ninka kuɗin nan gaba". A ranar 11 ga Fabrairu, WHO a taron manema labarai ta sanar da sunan cutar COVID-19.
A wannan ranar, Tedros ya bayyana cewa Sakatare Janar na Majalisar Dinkin Duniya, Antonio Guterres, ya amince da amfani da "Ingantaccen tsarin Majalisar Dinkin Duniya a cikin martani ga annoba".
"A sakamakon haka, ƙungiyar kula da rikice-rikicen Majalisar Dinkin Duniya ta shiga don daidaita aikin da Majalisar Dinkin Duniya ke yi, kuma za a ba su damar, a cewar WHO, ""mai da hankali kan maganin likita, yayin da sauran hukumomi za su iya aiwatar da ƙwarewarsu a cikin manyan al'amuran zamantakewa, tattalin arziki da tasirin juyin halitta na barkewar cutar. ""
A ranar 14 ga watan Fabrairu, an kaddamar da wata tawagar hadin gwiwa karkashin jagorancin WHO don samar da ƙwararrun masana na duniya da WHO a cikin halin da ake ciki a China don taimakawa cikin gida da kuma kimanta "taurin cutar da yaduwar cutar" ta hanyar gudanar da bita da tarurruka tare da cibiyoyin ƙasa da kuma gudanar da ziyarar filin don kimanta "tasirin ayyukan amsawa a lardin da lardin / lardin, gami da birane da karkara. A ranar 25 ga Fabrairu, WHO ta ba da sanarwar cewa "duniya dole ne ta yi aiki sosai don shirya don yiwuwar cutar ta coronavirus", kuma ta ce duk da cewa har yanzu ba ta da wuri a kira ta cutar. "
"Dangane da karuwar cutar a Iran, WHO ta tura tawagar hadin gwiwa don kimanta lamarin. A ranar 28 ga Fabrairu, jami'an WHO sun ce za a kara kimanta barazanar cutar ta coronavirus a duniya daga ""high"" zuwa ""very high"".
Mike Ryan, Babban Daraktan Shirin Gaggawa na Hukumar Lafiya ta Duniya, ya yi gargadin a cikin wata sanarwa cewa, "Wannan gaskiya ce ga dukkan gwamnatocin duniya: daga barci.
"Kwayar cutar tana kan hanya kuma ya kamata ku kasance a shirye, kuma ku tuna cewa amsa mai kyau na iya taimakawa duniya ta guji ""ƙara".
Ryan ya ci gaba da cewa, bayanan da ake da su yanzu ba su tabbatar da cewa jami'an kiwon lafiya na duniya za su ayyana cutar a matsayin annoba ba, saboda irin wannan sanarwar na nufin cewa, " " lallai ne mu yarda cewa kowane mutum a duniya zai kamu da cutar. "
A ranar 11 ga watan Maris, Hukumar Lafiya ta Duniya ta ayyana yaduwar cutar coronavirus a matsayin annoba ta duniya.
Darakta Janar ya ce WHO "ta damu sosai game da matakan gargadi na barkewar cutar da kuma rashin daukar matakan". WHO ta fuskanci suka saboda rashin kulawar cutar, gami da jinkirin sanar da dokar ta baci ta kiwon lafiyar jama'a da kuma rarraba kwayar cutar a matsayin annoba. "
Wannan martani na siyasa ya hada da rokon shugaban hukumar lafiya ta duniya Tedros Adhanom da ya nemi ya yi murabus, wanda ya samu sa hannu sama da 733,000 tun daga ranar 6 ga watan Afrilu.
A ranar 26 ga Maris, 2020, masana 'yancin dan adam na Majalisar Dinkin Duniya sun jaddada girmama hakkin mutane a lokacin annobar COVID-19.
Kungiyar ta ce ya kamata a samar da matakan ceto ga kowa da kuma cewa gwamnati ce ke da alhakin yin hakan.
Kungiyar ta jaddada cewa rashin samun kudin shiga ko rashin inshorar lafiya ba zai zama hujja ba don nuna bambanci ga wani rukuni na mutane.
Masana sun jaddada cewa kowa yana da hakkin samun lafiya, gami da nakasassu, kananan yara, marasa galihu, 'yan gudun hijira, marasa gida, wadanda ke rayuwa cikin mawuyacin yanayi, wadanda ke tsare da kuma 'yan gudun hijira da sauran mutanen da ke bukatar tallafin gwamnati.
Hukumomin gwamnati na duniya suna kula da tasirin tattalin arziki da zamantakewar rikicin COVID-19.
Kungiyar hadin gwiwar tattalin arziki da ci gaba ta kafa wani wuri don samar da cikakken bayani kan yadda ake gudanar da manufofin a kasashen duniya, da kuma ra'ayoyi da shawarwari.
Daga manufofin ƙarfafa tsarin kiwon lafiya da tattalin arzikin duniya zuwa nazarin tasirin keɓewa da ƙuntatawa na tafiye-tafiye, Digital Hub ya ƙunshi bin tsarin ƙasa (yadda ƙasashe ke amsa rikicin) da nufin taimakawa ƙasashe su koya daga ƙwarewar juna da sauƙaƙe amsawar duniya mai jituwa ga ƙalubalen coronavirus.
Gwamnatin China ta fuskanci suka daga Amurka, Ministan Ministocin Burtaniya Michael Gove da Eduardo Bolsonaro, dan shugaban Brazil Jair Bolsonaro, saboda yadda suka shawo kan annobar da ta barke a lardin Hubei na kasar Sin.
An kori wasu jami'an jam'iyyar kwaminis ta kasar Sin (CPC) daga mukamin su saboda gudanar da kokarin killace mutane a tsakiyar kasar Sin, wanda ke nuna rashin jin dadin yadda hukumomin siyasa ke amsa annobar a yankunan.
Wasu masu sukar sun yi imanin cewa wannan matakin na kare Sakatare Janar na Jam'iyyar Kwaminis ta Sin Xi Jinping ne, saboda fushin jama'a a kansa a cikin annobar coronavirus.
Wasu manyan jami'an kasar Sin, kamar Zhao Lijian, sun yi watsi da sanin farkon barkewar cutar Wuhan, wanda ya haifar da ka'idodin makircin Amurka da Italiya game da China a matsayin ainihin dalilin barkewar COVID-19.
"Gwamnatin Donald Trump a Amurka ta kira coronavirus a matsayin ""kwayar cutar Sin"" ko ""kwayar cutar Wuhan"" kuma ta ce ""yanayin da aka yi ya haifar da barkewar cutar wanda yanzu ya zama annobar duniya"" wanda hakan ya fuskanci sukar wasu masu sukar da ake kira wariyar launin fata da kuma ""karkatar da hankali kan rashin nasarar gwamnatinsa wajen shawo kan cutar". "
"Daily Beast ta samu hanyar sadarwa ta hanyar hanyar sadarwa ta hanyar Majalisar Tsaro ta Kasa, ta amfani da dabarar da ake kira ""Duk abin da ke karkashin China""".
"An bukaci mu yi iyakar kokarinmu wajen isar da wannan sako ga jama'a ta kowace hanya, ciki har da taron manema labarai da hirar talabijin. "Wasu jaridu kamar Politico, Foreign Policy da Bloomberg sun yi ikirarin cewa kokarin da China ke yi na aika da agaji ga kasashen da cutar ta shafa na daga cikin farfagandar da kasar ke yi na yin tasiri a duniya.
"Joseph Borel, jami'in harkokin wajen EU ya yi gargadin cewa ""akwai wani bangare na geopolitics wanda ya hada da kokarin yin tasiri ta hanyar karkatar da hankali da kuma 'siyasa ta karimci"".
Burrell ya kara da cewa, "Kasar Sin tana matukar son nunawa kowa cewa, ba kamar Amurka ba, tana da hadin kai da kuma amintaccen abokin tarayya".
China ta kuma bukaci Amurka da ta dage takunkumin hana ayyukan ta na Syria da Venezuela da Iran domin ta taimaka musu, yayin da ta tura tallafi mai yawa ga kasashen biyu na karshe.
An dakatar da isar da masks 100,000 daga Jack Ma zuwa Cuba saboda takunkumin Amurka a ranar 3 ga Afrilu.
An kuma zargi jami'an Amurka da tura tallafin da wasu kasashen suka bayar zuwa kasarsu.
An kuma bayar da rahoton rikice-rikice game da abin rufe fuska tsakanin wasu ƙasashe, kamar Jamus, Austria da Switzerland; da Jamhuriyar Czech da Italiya.
Bugu da kari, Turkiyya ta kwace daruruwan motocin masu sanyaya iska zuwa Spain.
A farkon watan Maris, gwamnatin Italiya ta soki Tarayyar Turai saboda rashin hadin kai da Italiya da cutar coronavirus ta shafa.
Maurizio Massari, jakadan Italiya a Tarayyar Turai, ya ce China ce kawai ta mayar da martani.
"Tabbas, wannan ba kyakkyawan alama bane na haɗin kan Turai""".
A ranar 22 ga watan Maris, bayan tattaunawa ta waya da Firayim Ministan Italiya Giuseppe Conte, Shugaban Rasha Vladimir Putin ya tura sojojin Rasha zuwa Italiya don aika da kayan aikin soja, kayan aikin kashe cututtuka na musamman da sauran kayan aikin likita.
"Labarin La Stampa na Italiya, yana ambaton wani "mafi girman tushen siyasa", ya ce kashi 80% na taimakon Rasha ga Italiya "ba shi da amfani ko kuma ba shi da amfani".
"Wadannan majiyoyin sun zargi Rasha da yin amfani da yanayin ""yanayin siyasa da diflomasiyya"" ta hanyar yin abin kunya".
Attilio Fontana, shugaban Lombardy da Ministan Harkokin Wajen Italiya Luigi Di Maio, sun yi watsi da rahoton da kafofin watsa labarai suka fitar, suna mai godiya ga kokarin.
Rasha ta aika da jirgin da ke dauke da kayan kiwon lafiya zuwa Amurka.
"Dmitry Peskov, mai magana da yawun Kremlin ya bayyana cewa, ""Lokacin da muka ba da shawara ga abokan aikinmu a Amurka, mun yi zaton cewa lokacin da masu kera kayan aikin likita da kayayyakin kiwon lafiya a Amurka suka dawo, za su iya taimaka mana idan ya zama dole. ""
"An shirya gudanar da atisayen yaki na NATO ""Defender 2020"" a Jamus, Poland da kasashen Baltic, a kan karami, a matsayin babban atisayen yaki tun bayan karshen yakin sanyi".
Sakatare Janar na Kamfen na kawar da makaman nukiliya, Keith Hudson ya soki aikin Defender 2020: "A cikin rikicin lafiyar jama'a na yanzu, ba wai kawai rayukan sojojin Amurka da na kasashen Turai da yawa da ke cikin haɗari ba, har ma da rayukan mazauna ƙasashen da ake gudanar da ayyukan". Gwamnatin Iran ta sami mummunan rauni daga cutar, kuma kusan 'yan majalisa ashirin da huɗu da wasu mutane goma sha biyar na yanzu ko na baya sun kamu da cutar. "
Shugaban Iran Hassan Rouhani ya aika da wasika a bude ga shugabannin duniya a ranar 14 ga watan Maris na shekarar 2020 inda ya nemi taimako, inda ya ce kasarsa na kokarin magance barkewar cutar saboda rashin samun damar shiga kasuwannin duniya sakamakon takunkumin Amurka kan Iran. Wannan annobar ta sa Amurka ta dauki matakan zamantakewa da aka saba da su a wasu kasashe masu arziki, ciki har da kiwon lafiya na duniya, kula da yara na duniya, izinin da ya dace ga iyali da kuma karin kudade ga lafiyar jama'a.
Masu sharhi a fannin siyasa sun yi hasashen cewa cutar ta coronavirus na iya shafar damar sake zaben Donald Trump a zaben shugaban kasa na 2020 da kuma dangantakar Japan da Koriya ta Kudu.
Bayan da Japan ta sanar da cewa za ta killace duk matafiya da ke shigowa daga Koriya ta Kudu na tsawon makonni biyu a wuraren da gwamnati ta tsara, Koriya ta Kudu ta soki Japan da "tabbatar da kai tsaye game da kokarin killacewar".
Tun da farko, mutanen Koriya ta Kudu sun kasance masu ra'ayi biyu game da yadda Shugaba Moon Jae-in ya amsa rikicin.
Yawancin 'yan Koriya sun sanya hannu kan takardu da ke kira ga Moon ya yi murabus, saboda abin da suka ce rashin ingancin gwamnati ne a kan barkewar cutar, ko kuma yabon yadda ta amsa. Cutar ta ba da damar kasashe su kafa dokokin gaggawa don aiwatar da martani mai dacewa.
Wasu masu sharhi sun nuna damuwa cewa hakan na iya haifar da gwamnatoci su riƙe iko sosai.
A Hungary, majalisar dokokin kasar ta kada kuri'ar amincewa da Firayim Minista Viktor Orbán ya yi mulki ba tare da wani lokaci ba, an dakatar da majalisar da kuma zaben, kuma an hukunta wadanda ke yada labaran karya game da cutar da kuma yadda gwamnati ke tafiyar da rikicin.
Yaduwar cutar ta COVID-19 ta faru ne saboda wasu nau'ikan karancin kayan aiki, wanda ya haifar da karuwar amfani da kayan aikin yaki da cutar, tsoratar da sayayya da kuma rikice-rikice a cikin ayyukan masana'antu da kayan aiki.
Hukumar Abinci da Magunguna ta Amurka ta ba da gargadi game da karancin magunguna da kayan aikin likita saboda karuwar bukatar mabukaci da kuma rashin wadatar kayayyaki.
Wasu yankuna kuma sun ga yawan masu sayen kayayyaki, wanda ya haifar da zubar da ɗakunan ajiya daga kayan masarufi kamar abinci, tawul ɗin wanka da kwalaben ruwa, wanda ya haifar da ƙarancin wadata.
Musamman masana'antar fasaha ta yi gargadin jinkirin jigilar kayayyakin lantarki.
A cewar Sakatare Janar na Hukumar Lafiya ta Duniya, Tedros Ahanom, bukatar kayan kariya ta mutum ya ninka sau 100.
Wannan bukatar ta haifar da hauhawar farashin har sau ashirin na farashin yau da kullun kuma ya haifar da jinkiri na watanni hudu zuwa shida a cikin samar da kayayyakin kiwon lafiya.
Har ila yau, ya haifar da karancin kayan kariya na mutum a duniya, kuma Hukumar Lafiya ta Duniya ta yi gargadin cewa zai iya haifar da haɗarin lafiyar ma'aikata.
A Ostiraliya, annobar ta ba da sabon dama ga dillalan Diego don sayar da kayayyakin Australiya a China.
Wannan ya haifar da karancin jarirai a wasu manyan kantuna, kuma sakamakon haka gwamnatin Australia ta hana shi. Duk da yawan adadin COVID-19 a arewacin Italiya da yankin Wuhan da kuma yawan bukatar abinci da ya biyo baya, babu ɗayan yankunan da suka sami mummunan lalacewar abinci.
Matakan China da Italiya kan kamfani da safarar kayayyakin masarufi sun yi nasara, kuma sun hana tsananin karancin abinci da aka zata a Turai da kuma Arewacin Amurka.
Aikin gona a yankunan arewacin Italiya, inda ake samar da kayan gona, bai ragu ba, amma a cewar wakilan yankin, farashin zai iya tashi.
Rashin kayan abinci sun kasance na ɗan lokaci ne kawai, har ma a Wuhan, yayin da manyan jami'an kasar Sin suka buɗe rumbunan naman alade don tabbatar da isasshen abinci ga jama'a.
Irin wannan doka a Italiya ta bukaci masu samar da abinci su ajiye don irin wannan lokacin.
An ji rauni a tattalin arzikin duniya a China: A cewar wani rahoto na kafofin watsa labarai a ranar 16 ga Maris, tattalin arzikin China ya sha wahala sosai a cikin watanni biyu na farko na 2020 saboda matakan gwamnati na hana barkewar cutar, tare da rage tallace-tallace da kashi 20.5%.
Tunda babban yankin China yana daya daga cikin manyan cibiyoyin tattalin arziki da masana'antu, barkewar cutar ta zama babbar barazana ga tattalin arzikin duniya.
Agathe Demarais na Ofishin Bayanan Tattalin Arziki ya yi hasashen cewa kasuwannin za su kasance marasa daidaito har sai an bayyana yanayin sakamakon da zai iya zuwa.
A watan Janairun 2020, wasu manazarta sun kiyasta cewa tasirin tattalin arziki na cutar a kan ci gaban duniya na iya zama mafi girma fiye da barkewar cutar SARS a tsakanin 2002 zuwa 2004.
Wani masani a Jami'ar Washington da ke St. Louis ya kiyasta cewa, za a yi hasara da dala biliyan 300 a sarkar samar da kayayyaki ta duniya, wanda hakan zai ci gaba har tsawon shekaru biyu.
"Kwamfuta ta "fuskanci raguwa sosai" saboda raguwar bukatar China, a cewar rahoton kungiyar OPEC".
Kasuwannin hannayen jari na duniya sun fadi a ranar 24 ga Fabrairu saboda karuwar adadin masu kamuwa da cutar COVID-19 a wajen kasar Sin.
A ranar 27 ga watan Fabrairu, karuwar damuwa game da barkewar cutar coronavirus ta haifar da koma bayan da ba a taba ganin irinsa ba a cikin NASDAQ-100, S&amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;
Dukkanin alamun guda uku sun fadi sama da 10% a karshen mako.
A ranar 28 ga watan Fabrairu, kamfanin kimantawa na GMBH Scope ya tabbatar da kimantawar bashi na kasar Sin amma yana da mummunan hangen nesa.
Hannun jari, sun sake faduwa sosai saboda tsoron cutar coronavirus, mafi girman faduwar da aka samu a ranar 16 ga Maris.
Mutane da yawa suna ganin cewa ana iya samun koma bayan tattalin arziki.
Masanin tattalin arziki, Muhammad al-Arian, ya yaba da matakan gaggawa na bankunan tsakiya da na kasashe.
Babban bankuna sun fi saurin amsawa fiye da rikicin kuɗi na 2008.
Saboda takunkumin tafiye-tafiye da aka sanya, rufe wuraren jama'a kamar wuraren yawon bude ido da kuma shawarar gwamnatoci kan kada su yi tafiya zuwa wasu kasashe, masana'antar yawon bude ido na daga cikin wadanda suka fi fama da cutar.
Sakamakon haka, kamfanonin jiragen sama da dama sun soke zirga-zirga saboda rashin bukatar, ciki har da British Airways, China Eastern Airlines da Qantas, yayin da kamfanin jirgin sama na yankin na Burtaniya Flybe ya yi fatara.
Sakamakon ya kasance a kan masana'antar jirgin ruwa na nishaɗi wanda ba a taɓa gani ba.
An kuma rufe tashoshin jiragen kasa da tashoshin jiragen ruwa da dama.
Cutar ta zo daidai da lokacin rani, babban lokacin tafiye-tafiye da ke da alaƙa da hutun Sabuwar Shekarar Sin.
Gwamnatocin kasa da na yankuna sun soke wasu abubuwan da suka faru kamar bikin Sabuwar Shekara da aka saba yi, kuma kamfanoni masu zaman kansu sun rufe shagunan su da wuraren shakatawa kamar Disneyland Hong Kong da Disneyland Shanghai.
An rufe yawancin abubuwan da ake yi na bikin Sabuwar Shekara da wuraren shakatawa don hana taron jama'a, gami da Forbidden City a Beijing da kuma wuraren shakatawa na gargajiya.
A larduna 24 daga cikin 31 na kasar Sin, hukumomin gunduma da na yanki sun tsawaita hutun sabuwar shekara har zuwa 10 ga Fabrairu, kuma sun umarci yawancin wuraren aiki da kada su bude a wannan ranar.
Wadannan yankuna sun wakilci kashi 80 cikin 100 na kayayyakin cikin gida da kuma kashi 90 cikin 100 na kayayyakin fitarwa.
Hong Kong ta kara yawan maganin cutar zuwa mafi girma kuma ta ayyana dokar ta baci, ta rufe makarantu har zuwa watan Maris, kuma ta soke bukukuwan Sabuwar Shekara. An shafi bangaren sayar da kayayyaki a duk duniya, kuma an rage awoyi ko kuma an yi hutun wucin gadi.
Ziyarar kantin sayar da kayayyaki a Turai da Latin Amurka ya ragu da kashi 40%.
Kasashen Gabas ta Tsakiya da Arewacin Amurka sun ga kashi 50-60 cikin dari na tallace-tallace.
Wannan kuma ya haifar da raguwar sayayya a cikin shaguna a watan Maris idan aka kwatanta da Fabrairu.
Manyan manyan cibiyoyin cin kasuwa na duniya sun ɗauki matakan kari, kamar haɓaka kiyaye ka'idojin kiwon lafiya, shigar da masu binciken zafin jiki don bincika yanayin zafin jiki na masu siye da soke abubuwan da suka faru. A cewar Hukumar Tattalin Arzikin Majalisar Dinkin Duniya don Latin Amurka, koma bayan annobar cutar zai haifar da talauci na kusan mutane miliyan 14 zuwa 22 a Latin Amurka, wanda ya fi adadin da ba tare da cutar ba.
A watan Janairu da Fabrairu na shekarar 2020, a lokacin da annobar ta yi tsanani a birnin Wuhan, mutane kusan miliyan biyar ne suka rasa ayyukansu a kasar Sin.
Yawan ma'aikatan da ke yin aikin hijira na karkara na kasar Sin kusan miliyan 300 sun makale a gidajensu a lardunan da ke bakin teku ko kuma a lardin Hubei. A watan Maris na shekarar 2020, sama da Amurkawa miliyan 10 sun rasa ayyukansu kuma sun nemi taimakon gwamnati.
A cewar kimantawar Bankin Tarayyar St. Louis, barkewar cutar coronavirus na iya shafar ayyuka miliyan 47 a Amurka, tare da kara yawan rashin aikin yi zuwa 32%. Cikakken keɓewa a Indiya ya haifar da rashin aikin yi ga ma'aikatan Indiya miliyan goma (waɗanda ke aiki a kan albashi). Sakamakon binciken da Cibiyar Angus Reed ta gudanar ya nuna cewa kashi 44% na iyalai na Kanada sun sha wahala daga wani nau'in rashin aikin yi. Tun lokacin da aka aiwatar da keɓewar keɓewa a tsakiyar Maris 2020, a Spain, kusan ma'aikata 900,000 sun rasa ayyukansu.
A rabin watan Maris, ma'aikata miliyan 4 na Faransa sun nemi biyan bashin rashin aikin yi na wucin gadi, kuma ma'aikata miliyan 1 na Burtaniya sun nemi bashi na duniya (Universal Credit).Kusan rabin kamfanoni miliyan a Jamus sun aiwatar da shirye-shiryen aiki na ɗan gajeren lokaci na ma'aikata tare da tallafin gwamnati da ake kira Kurzarbet.
Kasashen Faransa da Birtaniya sun amince da shirin biyan diyya na wucin gadi na Jamus.
Bangarorin da ke aiki a fagen zane-zane da al'adun al'adu sun sha wahala sosai daga mummunan yanayin cutar ta pandemic, wanda ya shafi ayyukan ƙungiyoyi da ma'aikata da masu zaman kansu a duk duniya.
Kungiyoyin al'adu da na fasaha sun yi ƙoƙari don tallafawa aikinsu (galibi tare da kudaden gwamnati) don ba da damar al'adun al'adu ga jama'a, kiyaye lafiyar ma'aikatansu da jama'a, da kuma tallafawa masu fasaha a duk lokacin da zai yiwu.
Ya zuwa Maris 2020, a duk duniya, a cikin matakai daban-daban, gidajen tarihi, dakunan karatu, wuraren wasan kwaikwayo da sauran cibiyoyin al'adu tare da nune-nunen su, abubuwan da suka faru da wasan kwaikwayon da aka soke ko aka jinkirta, an rufe su har abada.
A sakamakon haka, an kuma yi ƙoƙari sosai don samar da wasu ayyuka ta hanyar dandamali na dijital. Wani sabon abu kuma mai hanzarta raguwar cutar shine soke abubuwan addini, manyan abubuwan wasanni da sauran abubuwan zamantakewar jama'a kamar bukukuwan kiɗa da kide kide, taron fasaha da nunin kayan kwalliya.
Har ila yau, masana'antar fina-finai ta yi taƙaici. Vatican ta sanar da cewa an soke al'adar Lahadi mai tsarki a Roma, wanda ya kamata a yi a makon da ya gabata a lokacin azumi na Krista.
Yawancin bishops sun ba da shawarar tsofaffin Kiristoci su zauna a gida maimakon halartar ayyukan ranar Lahadi; wasu majami'u sun watsa ayyukan coci ta hanyar rediyo, watsa shirye-shiryen kan layi ko talabijin, yayin da wasu suka ba da shawarar bauta ta mutum.
Yayin da Bishop na Cocin Roman Katolika ya rufe majami'unsu da kananan majami'u kuma an kwashe filin St. Peter daga masu bautar Kirista, sauran hukumomin addini sun soke ayyukansu kuma sun hana taron jama'a a majami'u, masallatai, majami'u, temples da wuraren ibada.
Ma'aikatar Lafiya ta Iran ta sanar da cewa za a soke sallar Juma'a a yankunan da cutar ta bulla, kuma za a ci gaba da rufe wuraren ibada, yayin da Saudiyya ta hana 'yan kasashen waje shiga, ta kuma hana alhazai zuwa wuraren ibada a Makka da Madina ga 'yan kasarta.
Cutar ta haifar da babbar katsewa a cikin wasannin motsa jiki tun bayan yakin duniya na biyu.
An soke ko kuma jinkirta yawancin manyan wasannin wasanni, gami da gasar UEFA Champions League 2019-2020, Premier League 2019-2020, UEFA Euro 2020, kakar NBA da kuma kakar NHL daga 2019 zuwa 2020.
"Cutar ta kuma kawo cikas ga shirye-shiryen gasar Olympics ta bazara ta 2020, wanda da farko aka tsara zai fara ne daga karshen watan Yuli; Kwamitin wasannin Olympics na kasa da kasa ya sanar a ranar 24 ga watan Maris cewa za a yi bikin ne "a wani lokaci banda shekarar 2020 amma ba bayan bazara ta 2021 ba". " An rufe gidajen caca da sauran wuraren wasanni a duk duniya, kuma an jinkirta ko soke wasannin karta kai tsaye. "
Wannan ya haifar da yawancin masu caca zuwa caca ta kan layi, kuma yawancin rukunin caca na kan layi sun ba da rahoton ƙaruwa mai yawa a cikin yawan masu shiga shafin su. Har ila yau, masana'antar nishaɗi ta shafa, kuma ƙungiyoyi da yawa sun dakatar ko soke rangadin wasan kwaikwayo.
Yawancin manyan gidajen sinima, gami da waɗanda ke kan Broadway, sun dakatar da duk wasan kwaikwayon su.
"Wasu masu fasaha sun bincika hanyoyin da za su ci gaba da samarwa da kuma raba aiki ta hanyar Intanet a matsayin madadin wasan kwaikwayon gargajiya na rayuwa, kamar wasan kwaikwayon kai tsaye ko ƙirƙirar ""balaguron Intanet"" na yanar gizo don masu fasaha don yin, rarraba da tallata ayyukansu. "
An yi amfani da abubuwan da ake kira 'coronavirus' a yanar gizo don jan hankali da kuma yin barkwanci a cikin wannan rikici.
Tun bayan barkewar COVID-19, an sami mummunan nuna bambanci, tsattsauran ra'ayi da wariyar launin fata ga mutanen China da na Gabashin Asiya da kuma mutanen ƙasashen Turai masu yawan kamuwa da cutar, Amurka da sauran ƙasashe.
Abubuwa kamar tsoro, shakku da tashin hankali sun faru a kasashe da dama musamman a Turai, Gabashin Asiya, Arewacin Amurka da yankin Asiya.
Rahotanni daga watan Fabrairu (lokacin da mafi yawan lamuran suka kasance a China) sun nuna ra'ayoyin wariyar launin fata na kungiyoyi da dama a duniya waɗanda ke ganin mutanen China sun cancanci cutar da abin da ake da'awa ya zama hukunci.
Wasu kasashen Afirka ma sun ga karuwar adawa da kasar Sin.
Yawancin mazauna Wuhan da Hubei sun ba da rahoton cewa an nuna musu wariya saboda su 'yan asalin yankin ne.
Akwai tallafi na kan layi da na waje daga yankunan da cutar ta shafa a China.
Yayin da cutar ke ci gaba a cikin ƙasashe masu yawan kamuwa da cutar, mutanen Italiya, ƙasar farko a Turai da ta fara fuskantar mummunan yaduwar COVID-19, na iya ci gaba da fuskantar rashin yarda da kuma tsoratar da 'yan kasashen waje daga wasu ƙasashe. 'Yan ƙasa a ƙasashe ciki har da Malaysia, New Zealand, Singapore da Koriya ta Kudu da farko sun sanya hannu kan takardun hana shiga' yan ƙasar Sin zuwa ƙasarsu a ƙoƙarin dakatar da cutar.
A Japan, hashtag #ChineseDontComeToJapan ya yi ta yawo a Twitter.
Mutanen kasar Sin da sauran mutanen Asiya a Burtaniya da Amurka sun ruwaito karuwar cin zarafin wariyar launin fata da kuma hare-hare.
Shugaba Donald Trump ya fuskanci suka saboda sanya sunan coronavirus a matsayin "kwayar cutar Sin", wata kalma da masu sukar ke ganin alama ce ta wariyar launin fata da kuma adawa da Sin.
Masu zanga-zanga a Ukraine sun kai hari kan motocin bas da ke dauke da 'yan kasar Ukraine da na kasashen waje da suka tashi daga birnin Wuhan zuwa Novy Senzary.
Dalibai daga yankunan arewa maso gabashin Indiya da ke da iyaka da China da kuma daliban da ke karatu a manyan biranen Indiya sun sami tsoro da damuwa saboda barkewar cutar coronavirus.
"Dilip Ghosh, shugaban jam'iyyar Bharatiya Janata na jihar Bengal ta Kudu, ya ce Sinawa sun lalata yanayi kuma ""don haka Allah ya yi musu sakayya""".
"Wannan maganar daga baya ya yi Allah wadai da ita kuma ya kira ta ""kuskure"" a ofishin jakadancin kasar Sin da ke Calcutta. A kasar Sin, tsattsauran ra'ayi da wariyar launin fata da ake yi wa 'yan kasar da ba na kasar Sin ba ya kara tsananta bayan annobar, inda aka ce' yan kasashen waje "ƙazanta ne na kasashen waje" ko kuma a ce za a jefa su cikin "kayan shara".
Yawancin jaridu da ke da sassan kuɗi sun cire waɗannan sassan don rufe labaran da suka shafi cutar coronavirus.
Yawancin masu wallafa kimiyya sun ba da takardun kimiyya masu alaƙa da barkewar cutar kyauta ga kowa.
Wasu masana kimiyya sun yanke shawarar raba sakamakon su cikin sauri a kan sabobin da aka riga aka buga kamar bioRxiv.
Cutar mai saurin fitowa: Cutar mai saurin fitowa tare da yiwuwar cutar, yawanci sabo ne a cikin yaduwar cutar ko nau'in watsawa.
Duniya da cuta - bita kan duniya da yaduwar cuta
Jerin annoba da annobar - jerin mutuwar cututtukan da ke haifar da cututtuka
Cinikin namun daji da cututtukan da ke tsakanin mutane da dabbobi, da kuma hadarin kiwon lafiya da ke tattare da cinikin namun daji a cikin namun daji da ba na ƙasarsu ba
Gwajin dakin gwaje-gwaje na cutar coronavirus na numfashi na 2019 (COVID-19) da kuma cutar SARS-CoV-2 mai alaƙa, ya ƙunshi hanyoyi guda biyu, hanyoyin da ke gano kasancewar kwayar cutar da kuma hanyoyin da ke gano kasancewar ƙwayoyin cuta da aka samar don amsawa ga kasancewar kamuwa da cuta.
An tabbatar da kasancewar ƙwayoyin cuta a cikin samfuran ta hanyar RT-PCR, wanda ke gano RNA coronavirus.
Wannan gwaji ne na musamman kuma an tsara shi ne don gano kwayar cutar SARS-CoV-2 RNA kawai.
Ana amfani dashi don tabbatar da sabon kamuwa da cuta ko mai aiki.
Ana iya amfani da gano kwayar cutar (seramology) don ganewar asali da kuma sa ido kan yawan jama'a.
Gwajin kwayar cutar zai nuna yawan wadanda suka kamu da cutar, gami da wadanda alamun cutar suka yi kasa da bukatar a bayar da rahoto ko kuma wadanda ba su da alamun cutar.
Za a iya tantance ainihin yawan mutuwar da kuma matakin rigakafin dabbobi a cikin al'umma ta hanyar amfani da sakamakon gwajin.
Saboda iyakancewar gwaji, har zuwa Maris 2020, babu wata ƙasa da ke da ingantaccen bayanai game da yaduwar kwayar cutar a cikin jama'a.
Ya zuwa ranar 23 ga watan Maris, babu wata kasa da ta gwada sama da kashi 3% na yawan jama'arta, kuma akwai bambance-bambance masu yawa dangane da adadin gwajin da aka yi a ƙasashe daban-daban na duniya.
Hakanan, sauyawa na iya yin tasiri sosai a kan yawan mutuwar da aka ruwaito, wanda wataƙila an yi tsammanin ya wuce kima a wasu ƙasashe.
Ta hanyar amsawar polymerase chain reaction (rRT-PCR), ana iya yin gwajin akan samfuran numfashi da aka samu ta hanyoyi daban-daban, gami da ƙin ƙwayoyin cuta ko ƙwayoyin cuta.
Sakamakon yawanci ana sanar dashi bayan 'yan sa'o'i ko kuma kwanaki biyu.
Gwajin RT-PCR da aka yi tare da ɗaukar samfurin hanci kawai a cikin makon farko na cutar ya kasance mai aminci.
Daga nan, kwayar cutar na iya ɓacewa a cikin makogwaro, kodayake tana ci gaba da ninka a cikin huhu.
Don masu kamuwa da cutar da aka gwada a mako na biyu, ana iya samun samfurori daga hanyoyin numfashi na ƙasa ta hanyar katire na sutura ko fitar da kumburin.
Daya daga cikin samfurori na farko na PCR an shirya shi a watan Janairun 2020 ta Charité a Berlin, wanda ya yi amfani da polymerase chain reaction reverse transcription (rRT-PCR) kuma ya samar da tushe don samar da kayan aiki 250,000 da Hukumar Lafiya ta Duniya (WHO) ta rarraba.
Birtaniya ta samar da gwajin har zuwa 23 ga Janairu, 2020. Kamfanin Kogenebiotech na Koriya ta Kudu ya samar da kayan bincike na SARS-CoV-2 na asibiti, bisa PCR, mai suna PowerChek Coronavirus, a ranar 28 ga Janairu, 2020.
"Gene ""E"" wanda ke cikin dukkan nau'ikan beta na coronavirus da kuma gano RdRp wanda ke cikin SARS-CoV-2 kawai. A China, BGI Group shine farkon kamfanin da ya sami izinin gaggawa daga Hukumar Kula da Kayayyakin Kiwon Lafiya ta China don kayan aikin gano PCR na asali don gano SARS-CoV-2. A Amurka, Cibiyoyin Kula da Cututtuka da Rigakafin Cututtuka (CDC) na Amurka suna ba da izinin gano ainihin lokacin RT-PCR na cutar coronavirus ta 2019 (2019-nCoV) ta hanyar International Reagent Resource a cikin dakunan gwaje-gwaje na kiwon lafiya na jama'a. "
Daya daga cikin gwaje-gwaje guda uku na kwayoyin halitta a cikin tsofaffin kayan aikin gwajin ba su cika ba saboda lahani a cikin mai ganowa, wanda ya haifar da matsala a gwajin a CDC Atlanta; wannan ya haifar da raguwar adadin samfuran da aka kimanta cikin nasara a cikin watan Fabrairun 2020 gaba ɗaya da matsakaicin 100 a kowace rana.
Ba a tabbatar da tabbacin gwajin da ke amfani da abubuwa biyu ba har zuwa 28 ga Fabrairu, 2020, kuma an ba da izinin ci gaba da gwaji ga dakunan gwaje-gwaje na jihohi da na gida daga wannan kwanan wata.
Hukumar Abinci da Magunguna ta amince da gwajin a karkashin izinin amfani da gaggawa. Cibiyoyin gwaje-gwaje na kasuwanci na Amurka sun fara gwajinsa a farkon Maris 2020.
Har zuwa 5 ga Maris, 2020, LabCorp ta sanar da cewa ana samun gwajin COVID-19 bisa RT-PCR a duk faɗin ƙasar.
Quest Diagnostics ya kuma samar da fakitin gwajin COVID-19 a duk fadin kasar daga 9 ga Maris, 2020.
Babu wani takunkumin keɓewa da aka ayyana; dole ne a tattara samfurin da kuma bincika shi bisa ga bukatun CDC.
A Rasha, Cibiyar Nazarin Kiwon Lafiya da Kiwon Lafiya ta Rasha ta tsara kuma ta samar da gwajin COVID-19.
A ranar 11 ga Fabrairu, 2020, Hukumar Kula da Lafiya ta Tarayya ta yi rajistar gwajin. A ranar 12 ga Maris, 2020, Mayo Clinic ta bayar da rahoton cewa ta samar da gwajin don gano cutar COVID-19. A ranar 13 ga Maris, 2020, Roche Diagnostics ta sami amincewar Hukumar Abinci da Magunguna don gwajin da za a iya yi a cikin awanni 3.5 kuma a cikin babban girma, sakamakon haka, na'ura guda ɗaya na iya yin gwajin kusan 4,128 a kowane awa 24.
A ranar 19 ga Maris, 2020, Hukumar Abinci da Magunguna ta ba da izinin amfani da gaggawa (EUA) ga Abbott Laboratories saboda gwajin tsarin Abbott's m2000; Hukumar Abinci da Magunguna ta ba da izini iri ɗaya ga Hologic, LabCorp da Thermo Fisher Scientific.
A ranar 21 ga Maris, 2020, Cepheid ta kuma sami EUA daga Hukumar Abinci da Magunguna don gwajin da zai ɗauki mintuna 45.
Hukumar Abinci da Magunguna ta amince da gwajin da ke amfani da fasahar ƙarfafa isothermal nucleic acid maimakon PCR.
Ganin cewa wannan ba ya buƙatar saitin sake zagayowar zafin jiki, wannan hanyar na iya ba da sakamako mai kyau a cikin minti 5 kawai kuma a cikin minti 13 sakamakon sakamako mara kyau.
A halin yanzu akwai na'urori 18,000 na wadannan na'urori a Amurka, kuma Abbott na shirin samar da gwaje-gwaje 50,000 a rana tare da kara samarwa nan ba da jimawa ba. A yanzu haka, ana gina gwajin gwaji a Taiwan wanda ke amfani da kwayar cutar monoclonal, wanda ke hada kwayar cutar nucleocycline (N) ta musamman da sabbin kwayar cutar corona; ana fatan wannan gwajin zai iya samar da sakamako a cikin mintuna 15 zuwa 20 kamar yadda gwajin hanzari na mura yake.
Har zuwa Maris 2020, binciken bayanan ya kammala cewa "Radiography na kwarangwal na kirji ba shi da ƙima sosai don gano cutar a farkon matakan cutar, yayin da binciken CT na iya kasancewa tun kafin bayyanar cututtuka. "
Abubuwan da aka saba da su na CT sun haɗa da ƙirar gilashin gilashi mai sau biyu tare da rarraba gefe, ba daidai ba, da baya (baya).
Subpleural dominance yana faruwa ne ta hanyar ci gaba da cutar, kamuwa da cuta, da kuma halayen hauka.
Wani bincike a Wuhan, inda cutar ta fara, ya kwatanta PCR da CT tare da bayyana cewa CT ya fi PCR mahimmanci, kodayake ba shi da ƙwarewa sosai, kuma yawancin halayen hotunansa sun haɗu da sauran cututtukan huhu da matsalolin numfashi.
Har zuwa Maris 2020, Hukumar Kula da Radiology ta Amurka ta ba da shawarar cewa "Kada a yi amfani da CT don yin bincike kan cutar a matsayin layin farko na gwajin COVID-19". Har zuwa Maris 2020, CDC ta ba da shawarar yin amfani da PCR don yin bincike.
Wani ɓangare na amsawar garkuwar jiki ga cutar shine samar da ƙwayoyin cuta kamar IgM da IgG.
Ana iya amfani da su don gano cutar a cikin mutane, a tsakanin kwanaki 7 ko fiye bayan bayyanar cututtuka, don ƙayyade rigakafin jiki da kuma don sa ido kan yawan jama'a. Ana iya yin gwaje-gwaje a cikin manyan dakunan gwaje-gwaje (CLT) ko ta hanyar gwajin wurin kulawa (PoCT).
Tsarin sarrafa kansa mai ƙarfi a yawancin dakunan gwaje-gwaje zai iya yin waɗannan kimantawa, amma samun damar su ya dogara da yawan samarwa ga kowane tsarin.
Don CLT, ana amfani da samfurin jini guda ɗaya, duk da haka ana iya amfani da samfuran jerin don bin diddigin amsawar rigakafi.
Don PoCT ana samun samfurin jini ta hanyar huda fata.
Ba kamar hanyoyin PCR ba, ba a buƙatar aiwatar da matakan fitarwa kafin a gwada su. A ranar 26 ga Maris, 2020, Hukumar Abinci da Magunguna ta FDA ta gabatar da kamfanoni 29 waɗanda suka sanar da WHO bisa ga buƙatu kuma sakamakon haka za su iya rarraba gwajin rigakafin su.
Ya zuwa ranar 7 ga Afrilu, 2020, FDA ta amince da gwajin guda ɗaya kawai a ƙarƙashin izinin amfani da gaggawa. A ƙarshen Maris, 2020, Euroimmun Medical Laboratory Diagnostics da Epitope Diagnostics sun sami izinin Turai don kayan gwajin su; waɗannan kayan aikin na iya gano IgG da IgA antibodies akan kwayar cutar a cikin samfuran jini.
Ana iya yin gwajin a cikin 'yan ɗari a kowace awa, saboda haka ya fi saurin yin gwajin PCR na RNA na kwayar cutar.
Antibodies yawanci ana iya gano su har zuwa kwanaki 14 bayan fara kamuwa da cutar. A farkon watan Afrilu, Burtaniya ta sanar da cewa babu wani kayan gwajin antibody da aka saya da ya isa.
"Hong Kong ta kafa wani shiri inda wadanda ake zargi da cutar za su iya zama a gida, ""sashen gaggawa zai ba wa mai haƙuri bututun samfurin"," mai haƙuri zai saka tuff a cikin bututun, ya sake aikawa, kuma ya sami sakamakon gwajin bayan ɗan lokaci. Hukumar Lafiya ta Jama'a (NHS) a Burtaniya ta sanar da cewa tana gwaji kan wani shiri inda ake yin gwajin a gida don kawar da haɗarin kamuwa da cutar yayin tafiya zuwa asibiti ko buƙatar yin maganin rigakafi a cikin motar asibiti. A cibiyoyin sabis na masu ɗaukar COVID-19 don gwajin abubuwan da ake zargi, ƙwararren ma'aikacin kiwon lafiya zai yi samfurin ta hanyar amfani da matakan kariya. "
Cibiyoyin Kula da Motsa Jiragen Sama (Drive-through centers) sun taimaka wa Koriya ta Kudu wajen gudanar da daya daga cikin gaggawa da kuma na yau da kullun a duk duniya. A Jamus, Kungiyar Likitocin Lafiya ta kasa ta sanar a ranar 2 ga watan Maris cewa tana da damar yin gwajin kimanin 12,000 a kowace rana a cikin ambulances, wanda ya kai 10,700 a makon da ya gabata.
Idan likita ya ba da shawarar yin gwajin, inshorar lafiya za ta biya kuɗin.
A cewar shugaban Cibiyar Robert Koch, Jamus na da damar yin gwajin 160,000 a mako.
Har zuwa 19 ga Maris, an fara ba da sabis na gwaji a kan hawa a wasu manyan birane.
Har zuwa 26 ga Maris, 2020, jimlar gwajin da aka yi a Jamus ba a san su ba, saboda sakamakon da aka bayar kawai yana da kyau.
"Binciken farko na dakin gwaje-gwaje ya nuna cewa aƙalla samfura 48,3295 an gwada su har zuwa makon kalanda na 12/2020, tare da gwajin SARS-CoV-2 mai tabbatacce ga mutane 33,491 (6.9%). A Isra'ila, masu bincike a asibitocin Teknion da Rambam sun kirkiro wata hanyar yin gwajin samfurori daga marasa lafiya 64 a lokaci guda, inda ake haɗa dukkan samfurori tare da gwada su, kuma idan sun kasance masu tabbatacce, ana gwada su a hankali. An buɗe wani dakin gwaje-gwaje na gaggawa mai girman murabba'in murabba'in mita 2,000 a Wuhan da ake kira ""Ho-yan"" (Sin: 火眼, ma'ana "hasken wuta") a ranar 5 ga Fabrairu, 2020 ta BGI, wanda zai iya gwada samfurori 100 a rana.
Wanda ya kafa BGI, Wang Jian, shi da kansa ya kula da aikin na kwanaki biyar; a cikin samfurin, an gano cewa idan ba tare da wannan ƙarfin ba, za a sami ƙarin kamuwa da cuta a Hubei da kashi 47% kuma farashin aiwatar da keɓewa zai ninka.
Bayan Wuhan, an kafa Hu-yan a Shenzhen, Tianjin, Beijing da Shanghai, a cikin birane 12 a duk faɗin China.
Ya zuwa 4 ga Maris, 2020, jimlar fitarwa ta yau da kullun ya kai 50,000. An buga zane-zane na buɗewa da na haɗin gwiwa ta hanyar Origami Assays, wanda zai iya gwada samfurori har zuwa 1,122 don COVID-19, tare da gwajin 93 kawai. Ana iya aiwatar da waɗannan ƙirar daidaitaccen a cikin ƙananan dakunan gwaje-gwaje ba tare da buƙatar kayan aikin robotic na ruwa ba.
Har zuwa watan Maris, karancin da kuma isassun adadin maganin, ya kasance daya daga cikin matsalolin samar da gwajin taro a Tarayyar Turai, Burtaniya da Amurka.
Wannan ya sa wasu masu bincike suka fara nazarin hanyoyin shirya samfurin, wanda ya hada da dumama samfuran zuwa 98 ° C (208 ° F) na tsawon minti 5 don sakin kwayoyin RNA don gwaji na gaba. A ranar 31 ga Maris, an sanar da cewa Hadaddiyar Daular Larabawa ta gwada fiye da kowace ƙasa a wannan lokacin a cikin yawan jama'arta, kuma tana kan hanyar cimma matakin gwajin yawan jama'arta.
An yi wannan ne ta hanyar hada damar samar da sabis na hawa da siyan babban dakin gwaje-gwaje na yawan jama'a daga Group 42 da BGI (bisa ga dakin gwaje-gwaje na gano gaggawa na "Ho-Yan" a China).
An gina wannan dakin gwaje-gwaje cikin kwanaki 14, kuma zai iya yin dubun dubatan gwajin RT-PCR a rana, kuma shine na farko a wannan sikelin da aka fara aiki a wajen kasar Sin.
An haɓaka hanyoyin gwaji daban-daban waɗanda ke niyya ga sassa daban-daban na bayanan kwayar cutar coronavirus a China, Faransa, Jamus, Hong Kong, Japan da Amurka.
Hukumar Lafiya ta Duniya ta yi amfani da umarnin Jamus don samar da kayan aiki da za a aika wa ƙasashe masu ƙarancin kuɗi waɗanda ba su da isassun albarkatu don yin kayan aiki.
An fitar da umarnin Jamus a ranar 17 ga Janairu, 2020; yarjejeniyar CDC ta Amurka ba ta kasance ba har zuwa 28 ga Janairu, wanda ya jinkirta gwajin da ke cikin Amurka. China da Amurka suna da matsaloli game da amincin kayan aikin gwaji a farkon barkewar cutar, kuma waɗannan ƙasashe da Ostiraliya ba su iya samar da isassun kayan aikin da za su iya biyan buƙatu da shawarwarin masana kiwon lafiya don yin gwajin ba.
A gefe guda kuma, masana sun ce samun damar yin gwaji a Koriya ta Kudu ya taimaka wajen rage yaduwar sabbin kwayar cutar.
Gwamnatin Koriya ta Kudu ta gina ƙarfin gwaji, galibi a cikin dakin gwaje-gwaje na masu zaman kansu, a cikin 'yan shekaru.
A ranar 16 ga Maris, Hukumar Lafiya ta Duniya ta sanar da cewa ya kamata a hanzarta shirye-shiryen daukar gwaje-gwaje a matsayin hanya mafi kyau don rage saurin ci gaban cutar COVID-19. Babban bukatar gwajin saboda yaduwar cutar ya haifar da ɗaruruwan dubban gwaje-gwaje a cikin dakunan gwaje-gwaje masu zaman kansu na Amurka, kuma samar da kayan samfurin da sinadarai ya yi wahala.
A watan Maris na shekarar 2020, kasar Sin ta bayar da rahoton cewa kayan gwajin da aka samar a kasar suna da matsala kuma basu da inganci.
A Amurka, kayan gwajin da CDC ta yi suna da "rauni"; bayan haka gwamnati ta cire shingen hukuma da ke hana gwajin masu zaman kansu. Spain ta sayi kayan gwajin daga kamfanin Shenzhen Bioeasy Biotechnology Co Ltd na China amma ta gano cewa sakamakon ba daidai ba ne.
Kamfanin ya bayyana cewa sakamakon da bai dace ba na iya zama sakamakon rashin samun samfurin da ya dace ko kuma amfani da kayan gwajin ba daidai ba.
Ma'aikatar Tsaro ta Spain ta sanar da cewa za ta tattara kayan aikin da ke dauke da sakamakon da bai dace ba kuma ta canza su zuwa wani kayan aikin gwaji daban da Shenzhen Bioeasy ta bayar. Kashi 80% na kayan aikin gwajin da Jamhuriyar Czech ta saya daga China sun samar da sakamako mara kyau. Slovakia ta sayi kayan gwajin miliyan 1.2 daga China wanda aka gano ba daidai bane.
Firayim Minista Matović ya ba da shawarar a jefa su cikin Tekun Danube. Aitkara, wani memba na Ma'aikatar Lafiya ta Turkiyya, ya ce kayan gwajin da Turkiyya ta saya daga China suna da "babban kuskuren kuskure" kuma "ba a yi amfani da su ba". Burtaniya ta sayi kayan gwaji miliyan 3.5 daga China amma a farkon Afrilu 2020 an sanar da cewa ba za a iya amfani da su ba. "
Gwajin tare da keɓe waɗanda suka sami sakamako mai kyau da kuma bin diddigin mutanen da suka haɗu da waɗanda ke da cutar SARS-CoV-2 ya haifar da sakamako mai kyau.
Masu bincike a garin Vo na Italiya, inda aka fara samun mutuwar COVID-19 a Italiya, sun gudanar da gwaje-gwaje biyu a kan mazauna 3,400 na garin, a tsakanin kimanin kwanaki goma.
Kimanin rabin mutanen da suka nuna tabbatacce ba su da alamun cutar, kuma an keɓe duk waɗanda aka gano.
Ta hanyar takaita zirga-zirgar birni, sabbin kamuwa da cuta sun ragu sosai.
Cutar cutar coronavirus ta 2020 ta yadu a Singapore a hankali fiye da sauran ƙasashe masu tasowa saboda tsananin bin diddigin tuntuɓar, ƙuntatawa kan tafiye-tafiye na cikin gida, gwaji da keɓewa, amma babu wani takunkumi mai ƙarfi kamar rufe gidajen cin abinci da wuraren sayar da kayayyaki.
An soke yawancin abubuwan da suka faru kuma Singapore ta shawarci 'yan kasarta da su zauna a gida a ranar 28 ga Maris, amma makarantu sun sake buɗewa a ranar 23 ga Maris bayan hutun.
Wasu kasashe kamar Iceland da Koriya ta Kudu sun gudanar da cutar ta hanyar tsauraran tsare-tsaren bin diddigin tuntuɓar, ƙuntatawa kan tafiye-tafiye na cikin gida, gwaji da keɓewa, amma tare da ƙarancin ƙa'idodi.
Wani bincike na kididdiga ya nuna cewa kasashen da suka yi gwajin ganewar asali fiye da yawan mutuwar, sun sami ƙananan mutuwar, mai yiwuwa saboda waɗannan ƙasashe sun fi iya gano yanayin cututtukan da ke da ƙananan alamun ko kuma waɗanda ba su da alamun.
Hukumar Lafiya ta Duniya ta ba da shawarar cewa ƙasashe waɗanda ba su da ƙarfin yin gwaji kuma suna da dakunan gwaje-gwaje tare da ƙarancin ƙwarewa game da COVID-19, su aika da samfuran COVID-19 na farko masu inganci biyar da na farko marasa inganci goma don tabbatarwa zuwa ɗayan dakunan gwaje-gwaje na WHO na 16.
A waje da dakunan gwaje-gwaje 16, akwai guda 7 a Asiya, 5 a Turai, 2 a Asiya, 1 a Arewacin Amurka da 1 a Ostiraliya.
"A cikin tebur a ƙarƙashin shafi ""Gaskiya ta hanyar % na gwaje-gwaje"" ana yin tasiri ta hanyar tsarin gwajin kowace ƙasa. "
A cikin daidaito, ƙasar da ke gwada kawai waɗanda aka shigar da su asibiti, tana da ƙarin tabbatacce cikin kashi XNUMX, idan aka kwatanta da ƙasar da ke gwada dukkan 'yan ƙasa, ba tare da la'akari da bayyanar cututtuka ba.
Wanke hannu (ko wanke hannu), wanda kuma ake kira tsabtace hannu, yana nufin aikin da mutum yake yi don kawar da ƙura, mai, ƙwayoyin cuta, ko sauran abubuwa marasa amfani a hannu.
"Wanke hannu da sabulu akai-akai a cikin ""lokacin da ake bukata"" a cikin yini yana hana yaduwar cututtuka da yawa, misali zawo da annoba, waɗanda ake yadawa ta hanyar hanyar magana ta baki".
Hakanan mutane na iya kamuwa da cututtukan numfashi kamar mura ko kuma maƙarƙashiya idan ba su wanke hannayensu ba kafin su taɓa idanunsu, hanci, ko baki (misali, mucous membranes).
Akwai muhimman lokuta guda biyar a rana don wanke hannu da sabulu don rage yaduwar cututtukan baki: bayan wanka (hawan jini da kuma zubar da jini), bayan wanke kayan wanka na jariri (canjin farji), kafin ciyar da jariri, kafin cin abinci, da kafin da bayan shirya abinci, ko lokacin da kake taɓawa naman alade, kifi, ko naman alade.
Idan babu sabulu da ruwa, to, za ka iya wanke hannayenka da toka. Hukumar Lafiya ta Duniya ta bada shawarar wanke hannu.
Kafin, lokacin da kuma bayan dafa abinci.
Kafin da kuma bayan kula da mai haƙuri.
Bayan an canza wanka ko bayan an wanke yaron da ya je gidan wanka.
Ciki ko tari bayan ka kwashe hanci.
Bayan sun taba dabbobi, sun ciyar da su, kuma sun taba shararsu.
Kula da lafiyar hannu na asibiti yana nufin ayyukan kiwon lafiya da suka shafi hanyoyin kiwon lafiya.
Wanke hannu kafin shan magani ko kuma yin wasu magunguna na iya hana ko rage yaduwar kwayar cutar.
Babban manufar likita na wanke hannu shine tsabtace hannu daga cututtukan cututtuka (kwayoyin cuta, ƙwayoyin cuta ko sauran ƙwayoyin cuta waɗanda zasu iya haifar da cuta) da sunadarai waɗanda zasu iya haifar da rauni ko cuta.
Wannan yana da mahimmanci ga mutanen da ke hulɗa da abinci ko aiki a cikin likitanci, amma yana da mahimmanci ga jama'a.
Wanke hannu yana da fa'idodi da yawa, gami da rage yaduwar mura, kwayar cutar corona da sauran cututtukan da ke yaduwa; da kuma hana cututtukan da ke haifar da zawo; da kuma rage kamuwa da cututtukan numfashi.
Kuma rage yawan mutuwar jarirai a cikin haihuwar gida.
Wani bincike a shekarar 2013 ya nuna cewa ingantaccen wanke hannu na iya haifar da ɗan ci gaba a cikin matsakaicin ci gaban yara a ƙarƙashin shekaru biyar.
A kasashe masu tasowa, ana iya rage yawan mutuwar yara da ke da alaƙa da cututtukan numfashi da zawo ta hanyar sauya halaye masu sauƙi kamar wanke hannu da sabulu.
Wannan mai sauki zai iya rage yawan mutuwar cutar da kashi 50%.
Hanyoyin da ke inganta wanke hannu sun sami damar rage zawo da kusan kashi daya bisa uku, wanda yayi daidai da samar da ruwa mai tsafta a yankunan da ke da karancin kudin shiga.
Kashi 48% na raguwar cututtukan zawo ana iya danganta su da wanke hannu da sabulu. Wanke hannu da sabulu shine mafi inganci kuma mafi arha wajen hana zawo da cututtukan numfashi (ARI), wanda ake yi a matsayin al'ada a gidaje, makarantu da al'ummomi a duniya.
Ciwon huhu, babban ARI, shine sanadin mutuwa na farko a cikin yara 'yan ƙasa da shekara biyar, yana kashe yara miliyan 1.8 a kowace shekara.
Ciwon zawo da kuma na ciki suna haifar da mutuwar kusan yara miliyan 3.5 a kowace shekara.
UNICEF ta ce sauya wanke hannu kafin cin abinci da bayan wanka zuwa al'ada mai dorewa zai iya ceton rayuka fiye da duk wani allurar rigakafi ko kuma aikin likita, rage mutuwar zawo da kusan rabin, da kuma mutuwar cututtukan numfashi da kashi ɗaya cikin huɗu.
Wanke hannu yawanci ana haɗa shi da sauran hanyoyin tsabtace ruwa, maganin kashe cuta da shirye-shiryen tsabtace jiki (WASH).
Wanke hannu yana hana impetigo, wanda ake yadawa ta hanyar taɓawa ta jiki.
Wani karamin illa na wanke hannu shine cewa wanke hannu sau da yawa na iya haifar da lalacewar fata saboda bushewar fata.
Wani bincike a Denmark a shekarar 2012 ya nuna cewa yawan wanke hannu na iya haifar da itching da kuma kumburi da ake kira eczema ko dermatitis, wanda ya zama ruwan dare musamman tsakanin ma'aikatan kiwon lafiya.
Wanke hannaye da yawa kuma ana kiranta da alamun cutar OCD.
Akwai muhimman lokuta guda biyar a rana don wanke hannu da sabulu don rage yaduwar cututtukan baki: bayan wanka (hawan jini da kuma zubar da jini), bayan wanke wanka (canjin farji), kafin ciyar da yaro, kafin cin abinci, da kafin / bayan shirya abinci ko lokacin taɓa naman da ba a cinye ba, kifi ko naman alade.
Sauran lokutan da ya kamata a bi da hanyoyin wanke hannu don hana yaduwar cutar sun hada da kafin da bayan kula da rauni ko rauni, bayan tari, tari, ko yin fensho; bayan taɓawa da ƙazamar dabbobi ko sarrafa dabbobi; da bayan taɓawa da sharar gida.
A kasashe da dama, yawan wanke hannu da sabulu bai kai haka ba.
Wani bincike kan wanke hannu a kasashe 54 a shekarar 2015 ya nuna cewa, a matsakaita, kashi 38.7% na mutane suna wanke hannayensu da sabulu. A shekarar 2014, wani bincike ya nuna cewa Saudiyya ce ke da yawan wanke hannu mafi girma da kashi 97%, Amurka ta kusa da matsakaici da kashi 77% kuma China ce ke da mafi karancin kashi 23%.
"Shirin kula da lafiya mai mahimmanci" wanda Ma'aikatar Ilimi ta Philippines ta kaddamar, misali ne na inganta matakan kiwon lafiya da ilimi ga yara".
Sau biyu a shekara, tare da wanke hannu yau da kullun, wanke hannu yau da kullun tare da fluoride, shine mafi mahimmancin wannan shirin na ƙasa.
An kuma yi nasarar aiwatar da shi a Indonesia.
Ana ƙara cire kwayoyin cuta daga fata ta hanyar ƙara sabulu ko kayan tsaftacewa zuwa ruwa.
Babban aikin sabulu da masu tsabtace shine rage shingen narkewa a cikin ruwa, don haɓaka narkewa.
Ruwa kadai ba shi da tasiri sosai a tsabtace fata, saboda ƙwayoyin mai da furotin, waɗanda sune abubuwan da ke cikin ƙasa, ba sa narkewa cikin ruwa.
Koyaya, tsaftacewar ruwa mai gudana zai taimaka sosai...
Sabulu mai ƙarfi na iya ƙunsar ƙananan ƙwayoyin cuta fiye da na baya saboda sake amfani.
Wasu ƙananan nazarin da suka yi tunanin cewa ana iya watsa ƙwayoyin cuta daga sabulu mai ƙarfi sun kammala cewa ba zai yiwu ba, saboda ana wanke ƙwayoyin cuta da sabulu.
"CDC ta kara da cewa: ""Sauron ruwa yana da kyau tare da yiwuwar amfani ba tare da buƙatar taɓa hannu ba"".
An yi talla sosai game da sabulun antibacterial don inganta lafiyar jama'a.
Ya zuwa yanzu, babu wata hujja da ta nuna cewa amfani da maganin rigakafi ko maganin kashe cututtukan da aka ba da shawarar zai iya haifar da kwayoyin da ke da juriya ga maganin rigakafi a cikin yanayi.
Koyaya, sabulun antibacterial sun haɗa da kayan antibacterial na yau da kullun kamar triclosan, wanda ke da jerin nau'ikan kwayoyin da ke da juriya.
Saboda haka, koda kuwa ba a kashe nau'ikan maganin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafi ba, ba za su iya zama masu tasiri kamar yadda aka riga aka bayyana a kasuwa ba.
Baya ga surfactants da masu kare fata, wannan ingantaccen tsari na iya haɗawa da acid (acid acid, ascorbic acid da lactic acid) a matsayin mai daidaita pH, acid benzoic mai aiki tare da ƙwayoyin cuta, da sauran kayan shafawa na fata (aloe vera, bitamin, mantle, tsire-tsire na shuka). Wani cikakken bincike daga Jami'ar Oregon Faculty of Public Health ya nuna cewa sabulu mai sauƙi yana da tasiri kamar sabulu na farko na maganin ƙwayoyin cuta wanda ya ƙunshi triclosan, a cikin rigakafin cututtuka da kuma kashe ƙwayoyin cuta na hannu.
Ruwa mai zafi, wanda yake da sauki don wanke hannu, ba ya da zafi sosai don kashe kwayoyin cuta.
Kwayoyin cuta suna girma cikin sauri a zafin jiki (37 ° C).
Koyaya, ruwan sabulu mai zafi ya fi ruwan sabulu mai sanyi tasiri wajen kawar da ƙwayoyin cuta na halitta waɗanda ke ɗauke da ƙura da ƙwayoyin cuta.
Koyaya, akasin yarda da sanannen abu, binciken kimiyya ya nuna cewa amfani da ruwan zafi ba shi da tasiri kan rage yawan ƙwayoyin cuta.
Mai tsabtace hannu ko mai tsabtace hannu shine mai tsabtace hannu wanda ba shi da ruwa.
A ƙarshen shekarun 1990 da farkon karni na 21, masu tsabtace hannu na tushen ruwa (wanda aka fi sani da masu tsabtace hannu na barasa, masu tsabtace hannu, ko masu tsabtace hannu) sun zama sananne.
Yawancin lokaci suna da tushen isopropyl ko ethanol tare da mai kafa kamar carburetor (polymer acrylic acid) wanda ke juyawa zuwa gel, ko mai laushi kamar glycerin a cikin ruwa, ko kumfa don sauƙaƙe amfani da giya da rage tasirin busassun giya.
Ƙara hydrogen peroxide mai narkewa yana ƙara aikin rigakafin ƙwayoyin cuta. Maganin tsabtace hannu, wanda ya ƙunshi aƙalla kashi 60 zuwa 95% na giya, yana da tasiri sosai wajen kashe ƙwayoyin cuta.
Magungunan kashe cututtukan ƙwayoyin cuta na barasa suna kashe ƙwayoyin cuta, ƙwayoyin cuta masu tsayayya da magunguna da yawa (MRSA da VRE), masu haifar da cutar tarin fuka da kuma ƙwayoyin cuta da yawa (gami da HIV, herpes, RSV, rhinovirus, vaccine, mura da hepatitis) da fungi.
Maganin maganin rigakafi na 70% na iya kashe kwayoyin cuta a hannu har zuwa kashi 99.97% (rage logarithm na 3.5, kwatankwacin raguwar 35 decibels) a cikin ƙasa da sakan 30 da amfani, kuma kashi 99.99% zuwa 99.999% (rage logarithm na 4-5) na iya kashe kwayoyin cuta a hannu a cikin minti 1. Maganin maganin rigakafin hannu sun fi amfani da kwayoyin cuta, kuma sun fi tasiri akan wasu ƙwayoyin cuta.
Maganin kashe kumburin hannu na barasa ba shi da tasiri sosai a matsayin kari ga neuroviruses (ko Norwalk), wanda shine mafi yawan sanadin cututtukan gastroenteritis.Ya kamata a yi amfani da isasshen maganin kashe kumburin hannu ko kuma a shafa giya a kan fata tare da rigar sosai da rufe hannaye biyu.
An narkar da gaba da baya na hannaye biyu da tsakanin da ƙarshen dukkan yatsun hannu na kimanin dakika 30 don bushewa da ruwa, bene ko sutura.
Hakanan yakamata a wanke yatsun hannu sosai tare da man shafawa a kan sawun hannu. Cibiyar Kula da Cututtuka da Rigakafin Amurka ta ba da shawarar wanke hannu, musamman idan hannaye suna da datti sosai, fiye da kayan shafawa na hannu.
Amfani da waɗannan masu wanke hannu yana ƙaruwa saboda sauƙin amfani da saurin kashe ƙwayoyin cuta; duk da haka, bai kamata a yi amfani da su a matsayin madadin wanke hannu da kyau ba, sai dai idan sabulu da ruwa suna nan.
Amfani da magungunan kashe cututtukan barasa sau da yawa yana sa hannu ya bushe, sai dai idan an kara mai laushi da / ko mai laushi a cikin tsarin su.
Ana iya rage tasirin busassun giya ta hanyar ƙara glycerin da / ko sauran kayan shafawa zuwa fom.
A cikin gwaji na asibiti, kayan aikin tsabtace hannu na barasa waɗanda ke ƙunshe da mai laushi sun haifar da ƙarancin ƙonewa da bushewa idan aka kwatanta da sabulu masu ƙwayoyin cuta.
Allergic contact dermatitis, contact itch syndrome ko kuma rashin jin daɗi ga barasa ko abubuwan da aka kara a cikin kayan aikin giya na hannu ba safai suke faruwa.
Yana da shahara saboda yana haifar da ƙananan dermatitis na tuntuɓar mai saurin shafawa fiye da wanke hannu da ruwa da sabulu.
Duk da ingancinsa, masu amfani da kayan aikin da ba na ruwa ba sa tsabtace hannayenka daga kwayoyin halitta, kawai suna sanya su cikin tsabta.
Wannan shine dalilin da ya sa kayan aikin tsabtace hannu ba su da tasiri kamar sabulu da ruwa don hana yaduwar magungunan cuta, saboda masu cutar suna ci gaba da kasancewa a hannu.
Ingancin maganin shafawa na hannu ba tare da barasa ba ya dogara sosai da abubuwan da ke ciki da kuma tsarin da aka tsara, kuma a tarihi, ya kasance mai tasiri sosai fiye da barasa da kayan maye.
Kwanan nan, abubuwan da ke amfani da benzalkonium chloride sun nuna ci gaba da haɓaka aikin rigakafin ƙwayoyin cuta bayan amfani, sabanin giya, wanda bayan amfani da yawa, mai yiwuwa ya haifar da raguwar inganci saboda yanayin jujjuyawar hanzari.
Mutane da yawa a cikin ƙananan al'ummomi ba za su iya sayen sabulu ba kuma suna amfani da ƙasa da toka.
Ash ko ƙasa na iya zama mafi tasiri fiye da ruwa, amma mai yiwuwa ba shi da tasiri fiye da sabulu.
Wani abin damuwa shi ne gurɓata ƙasa ko toka da ƙwayoyin cuta, wanda zai iya ƙara taimakawa wajen yaduwar cutar maimakon rage ta.
Ash, kamar sabulu, yana da maganin rigakafi, saboda yana samar da maganin alkaline lokacin da ya sadu da ruwa.
Hukumar Lafiya ta Duniya ta ba da shawarar sabulu, toka ko yashi a matsayin madadin sabulu lokacin da babu sabulu.
Tsarin wanke hannu da aka ba da shawarar Cibiyoyin Kula da Cututtuka na Amurka don hana watsa cutar ya ƙunshi waɗannan matakan:
Ka wanke hannunka da ruwan zãfi ko sanyi.
Ana ba da shawarar ruwa mai gudana saboda ana iya samun tafkuna masu sanyi, kodayake zafin ruwan zai iya zama ba shi da bambanci.
Sanya hannayenka da bayan hannayenka, tsakanin yatsunsu da kuma ƙarƙashin ƙusoshi tare da sabulu mai yawa.
Sabulu yana cire ƙwayoyin cuta daga fata, kuma bincike ya nuna cewa mutane suna wanke hannayensu sosai idan suna amfani da sabulu fiye da lokacin da suke amfani da ruwa kawai.
Yi wanka a hannunka na akalla sakan 20.
Yin tausa da hannu yana haifar da tausa wanda ke taimakawa wajen kashe ƙwayoyin cuta, ta hanyar yin tausa na dogon lokaci yana kashe ƙwayoyin cuta da yawa.
Yi wanka a ƙarƙashin tukunyar ruwa.
Ana iya sake gurɓata hannu a cikin wanka guda ɗaya.
Ka bushe da tsabta ko kuma ka bar shi ya bushe a cikin yanayi.
Hannun da ke da danshi suna da saukin sake kamuwa da cuta. Yankunan da ba a wanke su ba sun hada da yatsun hannu, wuyan hannu, tsakanin yatsun hannu da kuma ƙusa.
Na'urar ƙusa da ƙusa mai ƙusa na iya zama mai cutarwa ga ƙwayoyin cuta.
Ana ba da shawarar man shafawa sau da yawa don hana bushewar hannu; bushewar fata na iya haifar da lalacewar fata, wanda zai iya ƙara haɗarin watsa kamuwa da cuta.
"Za'a iya amfani da zaɓuɓɓuka masu arha daban-daban idan ya cancanta a ƙasashe masu tasowa don sauƙaƙe wanke hannu inda babu ruwan famfo da/ko sabulu. Misali, zuba ruwa da/ko sabulu daga galon rataye ko bushewar takarda tare da ramuka masu dacewa da/ko amfani da toka. A cikin yanayin iyakancewar ban ruwa (kamar makarantu ko yankunan karkara a ƙasashe masu tasowa), akwai hanyoyin da za su iya rage yawan amfani da ruwa kamar ""tankunan ba tare da takalma ba"" da sauran zaɓuɓɓukan da ke da ƙarancin amfani. "
Tap-free tap, fasaha ce mai sauƙi wacce ke amfani da yanki wanda ke rataye ta igiya da kuma madaidaicin madaidaiciya don zuba ruwa mai yawa akan hannayenka da kuma sabulu.
Goge hannu da kyau wani muhimmin bangare ne na tsafta, amma akwai muhawara kan yadda za a bushe hannu a cikin gidajen wanka na jama'a.
Ƙarin bincike ya nuna cewa takarda na hannu sun fi lafiya fiye da na'urar bushewa ta lantarki da ake amfani da ita a yawancin gidajen wanka.
A shekarar 2008, an gudanar da wani bincike da Jami'ar Westminster da ke Landan da kuma Tissue Symposium na Turai, wanda ya samu tallafin masana'antar takarda, don kwatanta lafiyar da takarda, na'urar bushewa da kuma na'urar bushewa ta Airjet ke bayarwa.
Bayan wankewa da bushewa da bushewar hannu tare da na'urar bushewar iska, an gano cewa matsakaicin adadin kwayoyin cuta ya karu da kashi 194% a kan yatsan hannu da 254% a kan yatsan hannu.
Goge hannu da mai shayarwa ya haifar da matsakaicin ƙaruwar ƙwayoyin cuta a kan yatsan hannu zuwa 42% da kuma a kan hannu zuwa 15%.
Bayan wanke hannu da bushewa da takarda mai tsabta, adadin kwayoyin sun ragu da kashi 76% a kan yatsun hannu da kashi 77% a kan yatsun hannu. Masana kimiyya sun ci gaba da yin gwaje-gwaje don gano ko akwai yiwuwar kamuwa da juna tsakanin sauran masu amfani da gidan wanka da yanayin gidan wanka saboda amfani da kowane irin bushewa.
Mai bushe iska na Airjet, wanda ke fitar da iska daga motar a cikin saurin mita 180 a sakan daya (kilomita 650 a awa daya), yana iya fitar da kwayoyin halittu daga hannu da na'ura kuma yana iya gurɓata masu amfani da gidan wanka da kuma yanayin wanka har zuwa mita 2.
Amfani da na'urar bushewa mai zafi yana watsa kwayoyin halitta zuwa wani yanki na 0.25 m.
Takarda mai tsabtace hannu ba ta nuna cewa microorganisms sun bazu ba. A shekara ta 2005, wani bincike da TÜV Produkt und Umwelt ya gudanar ya bincika hanyoyin bushewa na hannu.
An lura da canje-canje masu zuwa a cikin adadin kwayoyin bayan bushewa:
Akwai kamfanoni daban-daban na masu yin bushe-bushe hannu, kuma an kwatanta masu bushe-bushe hannu da takarda.
Wanke hannu tare da tawul ɗin tsabtace hannu yayin tafiya zai iya zama madadin sabulu da ruwa.
Dole ne maganin kashe cututtukan barasa ya kasance aƙalla kashi 60 cikin ɗari na barasa.
Wanke hannu na likita ya zama tilas ne tun bayan da likitan Hungary Ignaz Semmelweis (a 1846) ya gano ingancinsa wajen hana kamuwa da cuta a cikin asibiti.
Akwai wasu na'urorin lantarki da ke tunatar da ma'aikatan kiwon lafiya da su wanke hannu da amfani da bayanan.
Wani bincike ya nuna cewa amfani da su ya rage yawan kamuwa da cuta.
Wanke hannu na likita, ta amfani da isasshen sabulu da ruwa ko mai wankewa, kuma wanke kowane ɓangare na hannu aƙalla na dakika 15.
Za a kulle hannayen hannu da yatsunsu.
Idan akwai ƙura da kuma zane a ƙarƙashin kusoshi, zai fi kyau a yi amfani da goga don tsabtace shi.
Tun da yake ƙwayoyin cuta suna zaune a cikin ruwa da kuma hannayen hannu, yana da muhimmanci a wanke su da kyau sannan a bushe su da tsabtace hannu.
Bayan bushewa, dole ne a yi amfani da takarda mai tsabta don rufe bututun ruwa (da kuma buɗe duk wani ƙofar da ake buƙata).
Wannan zai hana hannayen sake kamuwa da cutar ta hanyar irin wannan farfajiyar.
"Manufar wanke hannu a cibiyoyin kiwon lafiya shine kawar da kwayoyin cuta (""microbes"") da kuma hana yaduwar kwayar cutar".
Jaridar Kiwon Lafiya ta New England ta ruwaito cewa rashin wanke hannu a yawancin wuraren kiwon lafiya ya kai matakin da ba za a iya yarda da shi ba, tare da likitoci da ma'aikatan jinya da yawa da ke mantawa da wanke hannayensu a kai a kai kafin su sadu da marasa lafiya, wanda ke haifar da yaduwar kwayoyin cuta.
Wani bincike ya nuna cewa wanke hannu da kuma wasu ayyuka masu sauki na iya rage yawan kamuwa da cututtukan cututtukan jini ta hanyar catheter da kashi 66%. Hukumar Lafiya ta Duniya ta wallafa wata kasida da ke nuna yadda ake wanke hannu da kuma yadda ake wanke hannu a bangarorin kiwon lafiya.
Ka duba takardar jagorar kula da lafiyar hannu da hukumar lafiya ta fitar a shafin yanar gizon hukumar, wanda jama'a ke iya samunsa.
Wani binciken bita da ya danganci hakan ya yi ta hanyar Whitby da abokan aiki.
Idan ana buƙatar tabbatar da bin ƙa'idodi, na'urorin kasuwanci na iya auna da tabbatar da tsabtace hannu.
"Kungiyar Lafiya ta Duniya ta gabatar da ""yanayi biyar"" don wanke hannu:
Bayan sun yi hulɗa da jini/ruwa na jiki
Kafin a yi maganin rigakafi, da kuma
"Bayan kulawar mai haƙuri, ƙara sinadarai masu ƙoshin lafiya zuwa sabulu ("sabbin ""magani"" ko ""antibacterial"") yana taimakawa wajen kawar da ƙwayoyin cuta na kayan wanke hannu".
"Wannan matakin na kashewa zai iya zama mafi kyau kafin yin tiyata ko kuma a yanayin da kwayoyin da ke da juriya ga maganin rigakafi suka fi yawa. "Tsabtace" hannun mutum don tiyata yana buƙatar samun bututun ruwa wanda zai iya buɗewa da rufewa ba tare da taɓa hannu ba, mai wanke chlorohydrin ko iodine, kayan shafawa na hannu don bushe hannaye bayan wanka da goga mai tsabta don cirewa da kuma kayan shafawa don tsabtace ƙusa. "
Za a kawar da dukan kayan ado.
Wannan tsari ya ƙunshi wanke hannu da wuyan hannu har zuwa wuyan hannu na mintuna biyu zuwa shida.
Ba lallai ba ne a yi masa tsawa sosai (minti goma).
Idan ka wanke hannunka, kada ka sake wanke hannunka da ruwan da aka zuba a kan kwanon rufi.
Bayan an gama wanke hannayen, ana bushe hannayen tare da tsabtace tsabtace tsabta kuma an rufe suturar.
Don rage yaduwar ƙwayoyin cuta, yana da kyau a wanke hannu ko amfani da maganin kashe cuta kafin da kuma bayan kula da mai cutar.
Dangane da kula da kamuwa da cutar Staphylococcus a asibitoci, an tabbatar da cewa babban fa'idar wanke hannu yana zuwa ne kawai a cikin kashi 20% na farkon wankewar lokaci, tare da ci gaba da wankewa zuwa ƙarin kashi 35%, yana haifar da ƙarin fa'ida kaɗan.
Wanke hannu da sabulu mai sauƙi yana haifar da sau uku na kamuwa da cututtukan ƙwayoyin cuta idan aka kwatanta da wanke abinci da sabulu mai hana ƙwayoyin cuta. Kwatanta maganin shan giya da wanke hannu da sabulu mai hana ƙwayoyin cuta na matsakaicin lokaci na sakan 30 ya nuna cewa shan giya da hannu yana rage kamuwa da ƙwayoyin cuta da kashi 26 cikin ɗari fiye da sabulu mai hana ƙwayoyin cuta.
Amma sabulu da ruwa sun fi maganin kashe hannu na barasa tasiri wajen rage kwayar cutar A H1N1 da kuma cututtukan Clostridium difficile. Sauyawa don inganta tsabtar hannu a cibiyoyin kiwon lafiya na iya haɗawa da horar da ma'aikata kan yadda ake wanke hannu, haɓaka samun damar maganin kashe hannu na barasa da kuma tunatarwa ta rubutu da baki ga ma'aikata.
Ana buƙatar ƙarin bincike don gano wanne daga cikin waɗannan tsoma baki ne ya fi tasiri a cikin wuraren kiwon lafiya daban-daban.
A cikin ƙasashe masu tasowa, wanke hannu da sabulu ana ɗaukarsa a matsayin hanya mai arha kuma mai mahimmanci don cimma kyakkyawan tsabta da ma abinci mai gina jiki.
Koyaya, rashin wadatar ruwa, sabulu ko kayan wanke hannu masu aminci a gidajen mutane, makarantu da wuraren aiki yana haifar da ƙalubale don cimma ƙa'idodin wanke hannu na duniya.
Misali, a yankunan karkara na Afirka, akwai ƙananan wuraren wanke hannu kusa da gidajen wanka na sirri ko na jama'a, kodayake akwai zaɓuɓɓuka masu arha don gina wuraren wanke hannu.
Koyaya, ƙarancin yawan wanke hannu na iya zama sakamakon halaye na yau da kullun maimakon rashin sabulu ko ruwa.
Karfafawa da tallafawa wanke hannu da sabulu na iya tasiri kan yanke shawara, fadakar da jama'a game da fa'idodin wanke hannu, da kuma haifar da sauya halaye na dogon lokaci a cikin al'umma.
Don ingantaccen aiki, kulawa da kimantawa suna da mahimmanci.
"Binciken da aka yi na nazarin 70 ya nuna cewa hanyoyin da aka kafa al'umma sun yi tasiri wajen kara wanke hannu a cikin LMICs, yayin da kamfen na talla na zamantakewa ya yi tasiri. Misali na inganta wanke hannu a makarantu shine ""Tsarin taurari uku"" na UNICEF wanda ke karfafa makarantun su dauki matakai masu sauki da kuma saukin kudi, kamar tabbatar da cewa ban da bin sauran bukatun kiwon lafiya, dalibai suna wanke hannayensu da sabulu. "
Bayan samun mafi ƙarancin ƙimar, makarantu na iya samun ci gaba daga tauraro ɗaya zuwa ƙarshe zuwa tauraro uku.
Gina tashoshin wanke hannu na iya zama wani ɓangare na kamfen na talla na wanke hannu wanda ke da nufin rage cututtukan yara da mutuwar yara.
Ranar Wanke Hannun Duniya wani misali ne na kamfen wayar da kan jama'a wanda ke kokarin canza halayyar. A yayin annobar cutar coronavirus ta 2019-20, UNICEF ta inganta amfani da emojis na wanke hannu.
Karamin bincike ya yi la'akari da tasirin tasirin tasirin tsaftace hannu a cikin ƙasashe masu tasowa dangane da DALYs.
Koyaya, wani bincike ya nuna cewa inganta wanke hannu da sabulu ya fi sauran hanyoyin ruwa da tsaftacewa tsada.
"Mahimmancin wanke hannu ga lafiyar ɗan adam musamman ga mutane masu rauni kamar uwaye da suka haihu ko sojoji da suka ji rauni a asibitoci an fara gabatar da su ne a tsakiyar karni na 19 ta hanyar manyan malamai biyu na tsabtar hannu: Likita Ignaz Semmelweis na Hungary wanda ke aiki a Vienna a Austria da Florence Nightingale, ""mai kafa cibiyar kula da lafiya ta zamani"" a Ingila. "
A lokacin, yawancin mutane sun yi imanin cewa cututtukan cututtuka sun samo asali ne daga ƙanshin da ake kira miasmas.
A cikin shekarun 1980, yaduwar cututtukan da ke yaduwa ta hanyar abinci da cututtukan da ke da alaƙa da kiwon lafiya ya sa Cibiyoyin Kula da Cututtuka da Cututtuka na Amurka suka inganta tsabtace hannu a matsayin hanya mai mahimmanci don hana fara kamuwa da cuta.
Barkewar mura ta alade a shekarar 2009 da kuma annobar COVID-19 ta duniya a shekarar 2020 sun wayar da kan kasashe da dama game da muhimmancin wanke hannu wajen hana irin wannan kamuwa da cuta.
"Misali, an sanya hotunan hoto tare da rubutun ""daidaitaccen hanyoyin wanke hannu"" kusa da wanka a cikin wuraren wanka na jama'a da kuma a cikin gidan wanka na gine-ginen gwamnati da filayen jirgin saman Jamus. "
"Farin cikin ""yanke mutum daga"" wani abu, yana nufin sanar da rashin son ɗaukar nauyi ko shiga ciki. "
Ya samo asali ne daga wani sashi na Linjilar Matiyu inda Pontius Bilatus ya yanke shawarar gicciye Yesu Kristi, amma ya sami ƙarin amfani a wasu maganganun Ingilishi.
"A cikin Shakespeare ""McBeth"", Lady Macbeth ta sake yin amfani da hannayenta ba tare da saninta ba don share ƙazanta, wanda ke nuna lamirinta game da laifin da ta aikata wanda ya sa mijinta ya aikata laifin. ""
An kuma nuna cewa mutane suna wanke hannayensu fiye da sauran mutane bayan tunatarwa ko tunanin ayyukan lalata kuma suna mai da hankali kan kayan wanka da wanke hannu.
Bugu da ƙari, mutanen da aka ba su izinin wanke hannayensu bayan irin wannan kulawa ba su da wataƙila su shiga cikin sauran ayyukan tilasta yin "tsabtacewa", kamar ba da kai.
Addinai suna ba da shawarar wanke hannu don dalilai na tsabta da alama. Wanke hannu na alama, amfani da ruwa ba tare da sabulu ba don wanke hannu, wani ɓangare ne na wanke hannu na al'ada wanda aka nuna a cikin addinai da yawa, gami da Baha'i, Hindu, Taoism da Nitiyat na Yama a cikin Yahudanci, Lawubu a cikin Kiristanci da Wazo a cikin Musulunci. Addinai suna ba da shawarar wanke hannu da kyau, musamman bayan wasu ayyuka.
Addinin Hindu, Yahudanci da Musulunci sun bada shawarar wanke hannu bayan wanka.
Addinin Hindu, Buddha, Sikh, Yahudanci da Musulunci sun bada umarnin wanke hannu kafin da bayan kowane abinci.
Kula da haɗarin aiki don COVID-19
Gudanar da haɗarin aiki don COVID-19 yana nufin amfani da hanyoyin kiwon lafiya da aminci don sarrafa haɗari da hana barkewar cutar coronavirus 2019 (COVID-19).
Kula da haɗarin da ya dace a wurin aiki ya dogara da yanayin aiki da aikin da aka ɗauka kuma ya bambanta dangane da kimanta haɗarin tushen haɗuwa da cutar, tsananin cutar a cikin al'umma da abubuwan haɗarin kowane ma'aikaci wanda zai iya zama mai saukin kamuwa da COVID-19.
Bisa ga sanarwar Hukumar Kula da Lafiya da Tsaro ta Amurka (OSHA), ayyukan da ke da ƙananan haɗari suna da mafi ƙarancin haɗuwa da jama'a da sauran ma'aikata, ana ba da shawarar waɗannan ayyukan su ɗauki mafi ƙarancin matakan hana kamuwa da cuta, gami da wanke hannu, ƙarfafa ma'aikata su zauna a gida idan sun kamu da cuta, amfani da abin rufe fuska da tsabtace gida da kuma tsabtace yanayin aiki.
Ciki har da ayyukan da ke da matsakaicin haɗari waɗanda ba sa buƙatar haɗuwa da yawa ko kusa da waɗanda ake zargi ko waɗanda ke da COVID-19, amma suna iya haɗuwa saboda haɗuwa kai tsaye da jama'a ko tafiya ta ƙasa da ƙasa.
Wannan ya hada da ma'aikata da ke hulɗa da jama'a a wurare kamar makarantu, wuraren aiki da ke da yawan jama'a da kuma wasu manyan shagunan sayar da kayayyaki.
Kula da haɗarin ga wannan rukunin, ban da matakan rigakafin kamuwa da cuta na farko, ya haɗa da iska ta amfani da matattarar iska mai inganci, kariya daga tari da samun damar kayan kariya na mutum don fuskantar mutumin da ke da COVID-19.
OSHA ta ɗauki ma'aikatan kiwon lafiya da ke fuskantar hulɗa da mutanen da ake zargi da COVID-19 a matsayin masu haɗari a cikin ayyukan da ke da haɗari, wanda ya fi haɗari idan aka yi amfani da hanyoyin samar da iska ko ɗaukar samfura daga waɗanda ake zargi ko waɗanda ke da COVID-19.
Ya hada da kulawar hadarin aiki da ya dace da waɗannan ma'aikata, kamar su kulawar injiniya kamar ɗakunan iska mai matsin lamba da kayan kariya na mutum wanda ya dace da aikin.
Cutar COVID-19 na iya haifar da tasiri mai yawa a wuraren aiki.
Ma'aikata na iya zama a wurin aiki saboda rashin lafiya, bukatar kula da wasu, ko tsoron kamuwa da cutar.
Hanyoyin kasuwanci na iya canzawa, duka dangane da kayayyakin da ake buƙata da kuma hanyar samun waɗannan kayayyaki (kamar sayayya a cikin lokutan hutu ko ta hanyar isar da wuri ko sabis na hawa).
A ƙarshe, jigilar kayayyaki daga yankunan da COVID-19 ya yi tasiri sosai na iya zama matsala. Za a iya amfani da shirin shiri da amsa cutar mai yaduwa don jagorantar matakan kariya.
A cikin tsare-tsaren, ana la'akari da matakan haɗarin da ke tattare da wurare daban-daban na aiki da ayyukan aiki, gami da tushen haɗuwa da cuta, abubuwan haɗarin zamantakewa da na gida da abubuwan haɗarin kowane ma'aikaci daban, gami da rashin lafiya ko kamuwa da cuta mai tsanani.
Hakanan za a bayyana hanyoyin da suka dace na sarrafawa don hana waɗannan haɗarin da kuma wasu tsare-tsaren don yanayin da zai iya faruwa bayan barkewar cutar.
Shirye-shiryen cututtuka da amsawa na cututtuka na iya aiwatar da su ta hanyar la'akari da shawarwarin ƙasa ko na gida.
Manufofin magance barkewar cutar sun hada da rage yaduwar cutar tsakanin ma'aikata, kare mutanen da ke da babban hadari daga cututtukan da ke tattare da ita, kiyaye ayyukan kasuwanci da rage tasirin da ba daidai ba ga sauran kamfanoni a cikin sarkar samar da kayayyaki.
Matsayin cutar a cikin al'umma, inda kasuwancin ke, yana shafar amsoshin da aka karɓa.
Tsarin kula da haɗari tsari ne da aka yi amfani da shi sosai don kiyaye lafiya da aminci a wurin aiki don rarraba kula da haɗari bisa ga tasirin tasirin.
Inda ba zai yiwu a kawar da haɗarin COVID-19 ba, sarrafa injiniya sannan sarrafawar hukuma da ƙarshe kayan kariya na mutum sune mafi ingantattun hanyoyin sarrafawa.
Gudanar da injiniya shine cire ma'aikata daga haɗarin aiki ba tare da dogaro da halayyar ma'aikaci ba, wanda zai iya zama mafi kyawun mafita.
Kulawar gudanarwa shine canje-canje da aka bayar a cikin manufofin aiki ko hanyoyin aiki kuma ma'aikata ko ma'aikata zasu bi su.
Kayan kariya na mutum (PPE) ba su da tasiri sosai a kan sarrafawa da sarrafa injiniya amma suna iya hana wasu haɗari.
Duk nau'ikan PPE dole ne a zaɓi bisa ga haɗarin da suke da shi ga ma'aikata, a girka su yadda ya kamata (misali abin rufe fuska na likita), a yi amfani da su akai-akai, a bincika su, a gyara su, a maye gurbin su, kuma a buɗe su, a tsabtace su, a sake girka su idan ya cancanta, ko a jefa su don hana kamuwa da cuta.
Dangane da sanarwar Hukumar Kula da Lafiya da Tsaro ta Amurka (OSHA), ayyukan da ke da ƙarancin haɗari sune waɗanda ke da ƙarancin hulɗa da jama'a ko sauran abokan aiki.
Hanyoyin kariya na kamuwa da cuta da aka ba da shawarar ga mutane a duk wuraren aiki sun haɗa da wanke hannu akai-akai, ƙarfafa ma'aikata su kasance a gida idan sun kamu da cuta, amfani da abin rufe fuska, da rufe baki lokacin da suke tari ko tari, samun damar takarda da kwandon shara, shirya don sadarwa ta nesa ko lokutan aiki marasa tsari idan ya cancanta, ƙarfafa ma'aikata su yi amfani da sauran kayan aiki da kuma samun jadawalin tsabtace aiki na yau da kullun.
Ganowa da warewar mutane da ke iya kamuwa da cutar da sauri yana daya daga cikin muhimman matakai wajen kare ma'aikata, abokan ciniki, abokan ciniki da sauran mutane a wurin aiki.
Cibiyoyin Kula da Cututtuka da Rigakafin Cutar Amurka (CDC) sun ba da shawarar ma'aikata da ke da alamun cututtukan numfashi mai tsanani su zauna a gida har sai zazzabi, alamun zazzabi, da duk wasu alamun sun shuɗe, aƙalla awanni 24 bayan dakatar da shan maganin zazzabi ko mai sauya alamun cutar, da kuma samar da ƙa'idodin izinin magani masu sassauci don ba ma'aikata damar zama a gida don kula da dangin da ke fama da cutar, kuma duk ma'aikata sun san sabbin ƙa'idodin.
Bisa ga sanarwar OSHA, ayyukan da ke da matsakaicin haɗari sun haɗa da ayyukan da ke buƙatar haɗuwa da yawa da kuma nesa da wasu a cikin ƙafa shida (1.8 m) kuma ba a san ko masu amfani suna da cutar COVID-19 ba, amma suna iya kamuwa da SARS-CoV-2 saboda yawan shiga cikin al'umma ko tafiya ta ƙasa zuwa wurin da cutar ta COVID-19 ta ɓarke.
Wannan ya hada da ma'aikatan da ke hulɗa da jama'a, kamar waɗanda ke aiki a makarantu, wuraren aiki masu cunkoso da wasu manyan wuraren sayar da kayayyaki. Gudanar da aikin injiniya ga wannan rukunin da kuma rukunin da ke da mafi yawan haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin COVID-19, haɗakar da matakan haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin COVID-19, haɗakar da matakan haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin COVID-19, haɗakar da matakan haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin
Ma'aikatan wannan rukunin haɗarin ba sa buƙatar na'urar numfashi.
Idan mutum ya kamu da rashin lafiya a cikin jirgin sama, ana iya amfani da hanyoyin da suka dace don kare ma'aikata da sauran fasinjoji, tare da keɓewa daga harin da kuma kiyaye nesa da mutum mai rauni aƙalla ƙafa 6, sanya ma'aikatan da aka keɓe don mutumin da ke fama da cutar da kuma samar da abin rufe fuska ga mutumin da ke fama da cutar da kuma buƙatar su rufe baki da hanci da tawul lokacin da suke tari ko tari.
Ma'aikatan jirgin sama dole ne su sanya safofin hannu na sau ɗaya lokacin da suke kula da fasinjan da ke rashin lafiya ko taɓa abubuwan da ke cikin jiki ko wuraren da ke iya cutarwa kuma idan mai haƙuri yana da zazzabi, yawan tari ko ƙarancin numfashi, ya kamata su yi amfani da sauran kayan kariya na mutum, idan ya yiwu.
Ya kamata a zubar da safofin hannu da sauran kayan da ake amfani da su sau ɗaya a cikin jakar shara na asibiti, kuma a tsabtace wuraren da ke da cutar bayan aiki. Don jigilar kasuwanci, gami da jigilar jiragen ruwa da sauran jiragen ruwa, sarrafa haɗari ya haɗa da abubuwan kamar hana tafiya idan akwai cuta, keɓe kai da sanar da cibiyar kiwon lafiya ta jirgin idan aka lura da zazzabi ko wasu alamun bayyanar cututtuka yayin da yake cikin jirgin.
A mafi kyawun yanayi, ya kamata a bi magani a cikin keɓewar mutum. CDC tana ba da shawarar rufe makarantu da cibiyoyin kula da yara na ɗan lokaci don tsabtace da kuma tsabtace jiki, ba tare da la'akari da yadda cutar ta yadu a cikin al'umma ba, saboda mai yiwuwa mutum mai cutar ya kasance a cikin ginin makaranta.
Lokacin da yaduwar cutar ta kasance mai ƙaranci ko matsakaici, ana iya samun taimako ta hanyar dabarun nisantar jama'a kamar soke sansani, tarurruka da sauran tarurruka kamar koyarwar kai tsaye ko azuzuwan kiɗa ko cin abinci a cikin cafeteria, ƙara tazarar tebur, canza lokutan farawa da ƙare, iyakance halartar abokan cinikin da ba dole ba, da amfani da ofishin kiwon lafiya na musamman ga yara masu alamun cutar kama da mura.
Idan akwai yaduwar kamuwa da cuta a cikin al'umma, ban da dabarun nisantar zamantakewa, ya kamata a yi la'akari da hutun makarantu na dogon lokaci. CDC ta yi imanin cewa akwai ƙananan haɗarin lafiya kai tsaye ga ma'aikatan tilasta bin doka waɗanda ke gudanar da ayyukansu na yau da kullun.
Ana ba da shawarar jami'an tilasta bin doka waɗanda ke buƙatar tuntuɓar mutanen da ke da cutar ko ake zargi da COVID-19 su bi hanyoyin da suka dace da masu fasahar gaggawa na likita, gami da amfani da kayan kariya na mutum.
Idan har cutar ta faru a lokacin da ake tsoron kamuwa da cutar, ma'aikata su tsabtace belinsu da kayan aikin su kafin sake amfani da su ta hanyar fesawa ko tawul na gida da kuma bin ka'idodin aiki game da kiyayewa da zubar da kayan aikin PPE da aka yi amfani da su da kuma kiyayewa da wanke tufafi masu datti.
OSHA ta yi imanin cewa wasu ma'aikata a sashen kiwon lafiya da kuma na gidaje suna cikin ayyukan da ke da hadari ko kuma masu matukar hadari.
Ayyuka masu haɗari kamar su bayar da sabis na kiwon lafiya, tallafi, dakin gwaje-gwaje da ma'aikatan sufuri na likita waɗanda ke fuskantar marasa lafiya masu kamuwa ko waɗanda ake zargi da COVID-19.
Idan ma'aikata suna amfani da hanyoyin samar da aerosol, ko kuma suna karɓar da kuma ɗaukar samfura daga marasa lafiya da ake zargi ko waɗanda ke da COVID-19, waɗannan suna da haɗarin watsawa sosai.
Abubuwan da ke haifar da aerosol sun haɗa da tubing, matakan rage tari, bronchoscopy, wasu gwaje-gwaje da tiyata na haƙori ko ɗaukar samfurin kai tsaye.
Ayyukan da ke da haɗari sun haɗa da ayyukan da mutum zai yi bayan ya mutu don shirya gawawwakin waɗanda ake zargi ko suka kamu da COVID-19; idan aka yi wa gawawwakin, waɗannan ayyukan suna cikin rukunin ayyukan da ke da haɗari sosai. Dole ne a yi la'akari da ƙarin kulawar injiniya don waɗannan rukunin haɗarin, gami da ɗakunan keɓewa don marasa lafiya waɗanda ake zargi ko ke da COVID-19, musamman lokacin da ake aiwatar da hanyoyin samar da aerosol.
A wasu yanayi na kiwon lafiya da na gida, iska mai matsin lamba na musamman na iya zama mai dacewa.
Dole ne a kwashe samfurori tare da kiyaye matakan tsaro na matakin 3 na kare lafiyar.
Hukumar Lafiya ta Duniya (WHO) ta ba da shawarar cewa sabbin marasa lafiya su kasance a cikin wuraren jira na keɓewa dangane da ko suna da cutar COVID-19. OSHA ta ba da shawarar cewa waɗanda ke aiki a cikin nisan ƙafa shida daga marasa lafiya ko waɗanda ake zargi da SARS-CoV-2, da waɗanda ke aiwatar da hanyoyin samar da iska, su yi amfani da abin rufe fuska na likita, ban da sauran kayan kariya na mutum.
A cikin Amurka, a cikin tsarin ingantaccen shirin kare numfashi wanda ya hada da gwajin fuska, horo da kuma binciken likita, dole ne a yi amfani da abin rufe fuska na numfashi na N95 wanda ya sami amincewar NIOSH ko kuma samfura mafi kyau.
Sauran nau'ikan na'urorin numfashi na iya samar da ƙarin kariya da haɓaka jin daɗin ma'aikata. Hukumar Lafiya ta Duniya ba ta ba da shawarar yin amfani da ƙarin murfin ba, saboda COVID-19 cuta ce ta numfashi kuma ba a yadu ta hanyar ɓoyewar jiki.
Hukumar Lafiya ta Duniya ta ba da shawarar sanya abin rufe fuska na tiyata kawai ga ma'aikatan farawa.
Hukumar Lafiya ta Duniya (WHO) ta ba da shawarar cewa duk wanda ke karɓar, riƙewa, ko canja wurin samfuran numfashi da aka tattara daga marasa lafiya na COVID-19 ba tare da wani aikin samar da iska ba, ya yi amfani da abin rufe fuska, tabarau masu kariya, garkuwa da fuska, abin rufe fuska da safofin hannu.
Idan ana amfani da hanyar samar da iska, ana maye gurbin abin rufe fuska da abin rufe fuska na N95 ko FFP2.
Ganin cewa samar da PPE a duniya bai isa ba, WHO ta ba da shawarar rage buƙatar kayan kariya ta mutum ta hanyar waɗannan matakan: telemedicine (magani mai nisa), sanya shinge na jiki kamar su bayyanannun kwararrun, ba da izinin shiga dakin mai cutar COVID-19 kawai ga waɗanda ke cikin kulawa kai tsaye, amfani da PPE kawai don abubuwan da suka wajaba, amfani da abin rufe fuska na likita da rashin shi yayin kula da marasa lafiya da yawa waɗanda ke da cutar iri ɗaya, saka idanu kan sarkar PPE da daidaita shi, kuma a ƙarshe ƙarfafa mutanen da ba su da alamun cutar su yi amfani da abin rufe fuska na yau da kullun.
Daga: Katherine Maher, Shugaba na Gidauniyar Wikimedia
Zuwa: duk ma'aikatan Wikimedia Foundation
Rubutun: [Covid-19] Sauƙaƙa kaya da shirya don nan gaba
Ranar/lokacin aikawa: 14 ga Maris, 2020, 00:24 UTC
Ba da lasisi: CC0: wane haƙƙoƙi ba a kiyaye su ba
Muna ganin kanmu a cikin yanayi mai ban sha'awa a wannan watan.
Cutar COVID-19 ita ce abin da ke nuna alaƙar duniya da ke tsakanin mutane da kuma nauyinmu ga junanmu.
Wannan kalubale ne da ba a taba ganin irinsa ba, amma tabbas mun san cewa amsar da za mu iya bayarwa ita ce ta dogara ne da jin tausayi, hadin kai da kuma kula da al'umma wanda ke cikin zuciyar wannan kungiya.
Tausayi da kulawa da muka gani ta hanyar imel, kira da hira tsakanin dukkan abokan aikinmu ya nuna yadda muke farin cikin yin aiki tare da irin waɗannan mutane masu ban mamaki.
Ina godiya da alfahari da cewa ina da irin abokan aikina.
A makon da ya gabata, wani ya nuna godiya ga aikinmu.
Sun tunatar da ni yadda yake da mahimmanci ga duniya ta koma Wikipedia yanzu kuma yadda kasancewa kan layi da samun dama ga kowa alama ce mai ƙarfi ga waɗannan mahimman albarkatu.
Aikinku zai sa hakan ya yiwu, ko kuna taimakawa ci gaba da ayyukan yanar gizo ko ma'aikatanku suna samun hakkokinsu ko kuma kiyaye al'ummarmu lafiya.
Yanzu fiye da kowane lokaci, duniya tana buƙatar bayanan da Wikipedia ke bayarwa.
Yanzu ne lokacin da ba kawai abin da muke yi ba, amma yadda muke yi zai yi tasiri mai ma'ana a duniya.
Saboda mahimmancin wannan aikin da kuma rawar da kuke takawa a ciki, daga mako mai zuwa za a sami wasu canje-canje masu mahimmanci a yadda muke aiki tare.
Canjin aiki da kuma tsarinmu
Kamar yadda Robin ya ambata a baya, membobin Team C sun hadu a daren jiya don tattauna batun tsarinmu da kuma jadawalinmu na kwanaki da watanni masu zuwa.
A cikin wannan tattaunawar, mun yi la'akari da abin da muke tsammanin shine amsar da ta dace ga matsalar da muke fuskanta kuma shine mafi kyawun hanyar da za a kiyaye inganci da dorewar kamfanin.
Mun fi son mu rage tashin hankali da kuma tallafawa aikinmu na dogon lokaci.
Idan kana bukatar sake kira, babu matsala.
Ga dukkan ma'aikata, 'yan kwangila da ma'aikatan kwangila:
Har zuwa sanarwar na biyu, ana hasashen cewa za mu yi aiki na awa 4 a rana ko kuma awa 20 a mako.
Ba mu sanar da dokar hana fita ba - idan za ka iya yin karin sa'o'i kamar yadda ka saba, hukumar za ta iya amfana daga taimakonka.
Koyaya, duniya ba ta da tabbas a yanzu kuma ko kuna buƙatar kula da ƙaunatattunku da abinci ko kuma ku je wurin likita, lafiyarku tana da fifiko a gare mu.
Ba mu rubuta lokacinku ba.
Idan kana rashin lafiya, kada ka yi aiki.
Ba lallai ba ne a ambaci wannan, amma za mu sake ambaton shi.
Ba lallai ba ne a nemi izinin warkewa ko PTO - kawai gaya wa manajan ku kuma taimaka wa ƙungiyar ku ta sake nazarin kalandarku da kuma jadawalin lokaci don tabbatar da cewa an rufe mahimman wuraren aiki.
(Idan sakamakon gwajin ku na COVID-19 ya tabbata, don Allah a sanar da Brian a T&amp;C Ops don T&amp;C ta iya taimaka muku ta hanyar ba ku tallafi kuma tabbatar da cewa gudanarwar tana kula da yanayin ku sosai.)
Za a biya albashin mutanen da suke aiki a sa'o'i.
Mun riga mun yi alkawari kuma mun sake yin alkawarin girmama alkawuran da muka yi wa 'yan kwangilarmu da abokan aikinmu na lokaci.
Kowa ya kamata ya sami albashi bisa ga lokutan aiki na yau da kullun a cikin yanayi na yau da kullun.
Idan ba za ka iya yin aiki ba saboda rashin lafiya, wannan ya haɗa da kai.
Idan kana son yin aiki, za mu goyi bayan ka.
Mutane da yawa suna amfani da aiki a matsayin hanyar kalubalantar damuwarsu da duniya.
Abin da muke yi na iya zama mai matukar muhimmanci, musamman a lokutan da muke fuskantar hakan.
Muna sake tuna cewa wannan batun ya shafi kula da kanku ne.
Muna buƙatar ku tuntuɓi mai kula da ku, don mu san abin da za mu yi tsammani kuma mu iya daidaita kanmu bisa ga hakan.
Wasu ayyuka ana ɗaukarsu wajibi ne.
Waɗannan abubuwa ne da za a ci gaba da yi.
Kamfanonin SRE, HR Ops, Trust & Safety da ƙungiyoyin tara kuɗi (a tsakanin wasu) suna yin aiki mai mahimmanci wanda zai iya buƙatar ƙarin tallafi.
Za mu fara wani tsari a dukkan sassan don tantance manufofin yanzu da kuma mayar da hankali kan tallafawa duk abin da ya zama dole don aiwatar da wannan manufa.
Akwai aiki mai yawa da za a yi, za mu mai da hankali ne kawai ga ayyukan da suka fi muhimmanci.
Rage saurin aiki a yanzu ba zai haifar da lahani ba.
"Ba mu da niyyar "" ninka lokaci "" don biyan jinkiri lokacin da cutar ta ƙare. "
Ba za a sa ran ku yi aiki fiye da yadda ya kamata don ku cika kwanakin da aka ƙayyade ba, wanda yanzu ba shi da ma'ana.
Mun yarda cewa yanayi ya canza kuma za mu dauki matakai idan ya cancanta don kafa sababbin manufofi da jadawalin lokaci.
Me zai faru da APP?
Don dacewa da gaskiyar da tsammanin sabon zamanin aiki, muna shirin canza lokacin isar da shirinmu na shekara-shekara na 2020-2021.
Muna shirin fadada shirinmu na 2019-2020 don ba da karin lokaci da kasafin kudi da kuma baiwa ma'aikata damar fifita ayyuka na yau da kullun, kula da kansu da kuma kula da ƙaunatattun su, yayin da waɗanda suke buƙatar ko son yin aiki, suna da sauƙin aiki a cikin 'yan makonnin da ke zuwa.
Wannan tsawaita jadawalin zai rage matsin lamba na yanzu don tsarawa da matsin lamba akan ƙungiyar gaba ɗaya.
Za mu gabatar da shawararmu ga kwamitin a mako mai zuwa kuma za mu sanar da wakilai da ƙungiyoyi game da matakai na gaba da zarar an amince.
Muna godiya ga tawagar APP saboda jagorancin da suka bayar.
Yanayin aiki, haɗari da tsabta
A makon da ya gabata, mun gano cewa wani ma'aikacinmu da ke zaune a SF yana iya kamuwa da cutar COVID-19.
Koyaya, don kiyaye matakan tsaro, mun yi amfani da ƙungiyar masu tsabtace ƙwayoyin cuta don tsabtace dukkan fuska a ofishin San Francisco.
Sun yi amfani da maganin rigakafin cutar asibiti don kashe duk wani rufi da kuma lobby da ɗakunan da ke ƙare a bene.
Ginin yana aiwatar da tsarin kula da kansa ta hanyar amfani da kayayyakin da ke kare rigakafin mazaunanta.
Muna jin dadi cewa ofishin zai kasance a shirye don lokacin dawowarmu.
Ofishin DC ɗinmu yana kan WeWork, wanda ya raba yarjejeniyar COVID-19 tare da mu da duk ma'aikatan DC.
A makon da ya gabata, ofishin mu na DC ya canza zuwa cikakkiyar hanya kuma ya bi ka'idodin da aka raba tare da San Francisco.
Kamar yadda wasu abokanmu mazauna birnin New York City suka sani, muna tattaunawa kan yin hayar wani wuri a Brooklyn.
Tattaunawa na ci gaba amma yana iya jinkirta.
Wasu abokan aikinmu suna fuskantar aiki na nesa a karon farko.
Ya kamata abokan aikinmu na dogon lokaci su san cewa wasu canje-canje na iya faruwa kuma ina so in ba da wasu shawarwari:
Za a iyakance tsawon zaman zuwa awa daya ko biyu.
Idan kana bukatar karin tarurruka, ka yi tunanin raba tarurruka zuwa kwanaki da dama.
Bayyana taron a fili, shirya jadawalin taron, da kuma aika abubuwan da za a karanta a gaba.
Yi kiran bidiyo ta asali tare da kayan aiki kamar Google Docs da Zoom don sauƙaƙe haɗin kai da sadarwar kai tsaye.
A duk tarurruka, mai jagoranci yana da wanda zai kula da tattaunawar tambayoyin da kuma jerin masu magana, kuma yana da wanda zai ɗauki bayanin kula (ko kuma ya haɗa kai don ɗaukar bayanin kula).
Idan kana bukatar wani mai saukin kai, aika imel zuwa goyon bayan fasaha.
Ku yi amfani da kuɗin da kuka samu don ku sayi kayan abinci.
Shiga tashar #remoties a Slack kuma tattauna da abokan aikinka game da rarraba aiki
Ƙungiyar Ayyukan Human Resources za ta bincika jagororin ergonomics da kuma taron bita don tallafawa haɓaka rarraba aiki a duk faɗin tushe.
A makon da ya gabata, mun nemi duk masu karɓar tallafi na zamantakewa da su soke abubuwan da Wikimedia ke tallafawa, kamar su Edith Etan, har sai Hukumar Lafiya ta Duniya ta sanar da ƙarshen cutar.
Za mu sanar da su cewa mun fahimci cewa buƙatarku don sokewa da sauran ƙuntatawa na iya sa ba zai yiwu a kammala ayyukan bayarwa da aka yarda ba kuma ba za a hukunta kowa ba saboda jinkiri ko canza waɗannan manufofin.
A mako mai zuwa, za mu ba da ƙarin bayani game da Wikimania da sauran taron al'umma na gida da na kan layi.
Ya bayyana cewa jama'ar duniya sun damu da wannan katsewar amma suna jin daɗin kasancewa cikin gaskiya game da ayyukan su na zamantakewa, Wikimedia da sauran hanyoyin.
CRT yana ci gaba da aiki don ƙirƙirar shafi a kan Meta-Wiki don samar da sarari ga al'umma don saka idanu kan tasirin da kuma bin hanyarmu tare da su.
Ka kasance cikin yanayin COVID-19
Za mu aika da gayyatar don gudanar da taron musamman na ma'aikata a ranar Alhamis mai zuwa da karfe 14:00 tare da 07:00 PT.
Za mu yi amfani da wannan damar don raba ƙarin labarai, amsa tambayoyinku da kuma tuntuɓar juna.
Mun shiga cikin wannan halin tare kuma muna shirye mu taimaka ta kowace hanya.
A halin yanzu, zaku iya samun bayanai ta wannan imel ɗin kuma ku ziyarci Office Wiki don duk sauran mahimman bayanai game da COVID-19.
CRT yana taimakawa wajen sabunta waɗannan shafuka da kuma adana duk bayanan tare.
Muna yin iya kokarinmu don sadarwa a kai a kai tare da ma'aikatan da ke zaune a kasashen da suka fi fama da cutar.
Idan kuna da wata tambaya game da tafiye-tafiye, abubuwan da suka faru, babban aiki, ko ƙalubalen ɗaukar hoto ko duk wani batun da kuke buƙatar taimako don warwarewa, da fatan za a sanar da CRT da sauri kuma kuyi aiki tare da shi.
Muna shirye don taimakawa wajen samar da tallafi da sadarwa, idan ya cancanta.
Idan kana da wani abu mai mahimmanci ko mai mahimmanci, tuntuɓi Bryan Judan - Manajan Ayyuka na HR na Duniya.
Duk wani daga cikin waɗannan canje-canjen ba za a ɗauka cewa ya bar aiki da alkawuran ba.
Akasin haka, a yanzu suna nuna cewa aikinmu da alkawuranmu dole ne su dace da sabon yanayin da ba a taɓa gani ba.
Waɗannan matakai ne da muke ganin suna da mahimmanci don tallafawa juna don ci gaba da aiki, don ba da tallafin da ake buƙata ga motsinmu da kuma duniyar da ta dogara da ita.
Ayyukanmu suna jiran mu zuwa lokacin da ya dace.
Yanzu lokaci ya yi da za mu goyi bayan juna da kuma samar da sarari don muhimman ayyuka da za mu yi a makonni da watakila watanni masu zuwa.
Muna bukatar ku duka don yin wannan, kuma saboda haka muna rokon ku duka ku kula da kanku da iyalanku don ku kasance cikin mafi kyawun yanayin da zai yiwu a lokacin da ake buƙata.
Yanzu, don Allah -- wanke hannuwanku kuma kada ku taɓa fuskarku!
Katherine, sashen CRT (Amanda K, Amy V, Bryan J, Doreen D, Gregory V, Jaime V, Joel L, Lynette L, Ryan M, da Tony S) da sauran membobin ƙungiyar gudanarwa (Grant I, Heather W, Jaime V, Janeen U, Lisa S, Robyn A, Ryan M da Toby N).
Enzyme mai canza angiotensin 2B (ACE2) shine enzyme wanda ke haɗuwa da waje (ɓangaren ƙwayoyin cuta) na ƙwayoyin huhu, jijiyoyin jini, zuciya, ƙwayoyin cuta, da hanji.
ACE2 yana magance aikin enzyme mai canza angiotensin ta hanyar rage adadin angiotensin 2 da haɓaka angiotensin (1-7), yana mai da shi ingantaccen maƙasudin magani don magance cututtukan zuciya. ACE2 kuma yana aiki azaman ƙofar shiga cikin ƙwayoyin cuta ga wasu ƙwayoyin cuta.
An kira nau'in ɗan adam na enzyme hACE2.
Angiotensin-2 mai canza enzyme yana dauke da wani metallosamine mai dauke da sinadarin rhyo wanda yake a cikin kwayoyin intracellular da sauran kwayoyin.
Kwayar ACE2 tana dauke da yankin M2 na peptidase na n-terminal da kuma yankin amino acid mai dauke da c-terminal na cysteine.
ACE2 shine mai wucewa daya-mai wucewa wanda yake da aikin enzyme wanda yake a cikin kwayoyin halitta a cikin huhu da sauran kayan.
An cire yankin waje na ACE2 daga yankin membrane ta wani enzyme da ake kira shadase, kuma an saki furotin da aka samu a cikin jini kuma a ƙarshe an fitar da shi a cikin fitsari.
ACE2 yana cikin yawancin kwayoyin jiki: ACE2 yana haɗuwa da membrane na ƙwayoyin ƙwayoyin cuta, ƙwayoyin ƙwayoyin cuta na ƙananan hanji, ƙwayoyin intravascular da ƙwayoyin tsoka na jijiyoyin jini a yawancin kwayoyin.
Hakanan ana samun ACE2 mRNA a cikin kwakwalwar kwakwalwa, cortex, hypothalamus, da kuma kwakwalwar kwakwalwa.
Babban aikin ACE2 shine aiki azaman mai hana ACE.
ACE yana raba hormone angiotensin 1 zuwa angiotensin 2 wanda shine mai hana jijiyoyin jini.
ACE2 a madadin haka, yana raba phenylalanine amino acid carboxyl-terminal daga angiotensin-II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) kuma yana hydrolyze shi zuwa angiotensin mai fadada jijiya (1-7), (H-Asp-Arg-Val-Tyr-Ile-His-Pro-OH).
ACE2 na iya haifar da fashewar wasu peptides da suka hada da / ((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((
ACE2 kuma yana daidaita wucewar masu ɗaukar amino acid SLC6A19 daga membrane kuma yana da tasiri a cikin cutar Hartnap.
ACE2 a matsayin furotin na membrane, yana aiki a matsayin babban wurin shiga cikin kwayar halitta don wasu coronaviruses, gami da HCoV-NL63 (kwayar cutar da ke haifar da SARS) da SARS-CoV-2 (kwayar cutar da ke haifar da COVID-19).
Musamman, haɗuwa da furotin mai saurin S1 a cikin SARS-CoV da SARS-CoV2 tare da yankin enzymatic ACE2 a saman ƙwayoyin, yana haifar da endosytosis da watsawa na ƙwayoyin cuta da enzymes zuwa endosomes a cikin ƙwayoyin.
Wannan tsarin shigarwa ya kuma bukaci shirya furotin S ta hanyar kwayar cutar sirine ta TMPRSS2 mai masaukin baki, wanda aka bincika hana shi a matsayin magani mai yuwuwa. Wannan ya haifar da zaton cewa rage matakan ACE2 a cikin ƙwayoyin zai iya taimakawa wajen yaƙar kamuwa da cuta.
Koyaya, ƙungiyoyi da hukumomin kulawa da yawa sun ba da shawarar ci gaba da ƙididdigar hana ACE da maganin ARB.
"Binciken farko da meta-analysis da aka buga a ranar 11 ga Yuli, 2012 ya nuna cewa ""amfani da masu hana ACE yana da alaƙa da raguwar kashi 34 cikin ɗari na haɗarin ciwon huhu idan aka kwatanta da masu kula""".
"Bugu da kari, ""ya kuma rage haɗarin cututtukan kirji a cikin marasa lafiya da aka kula da su da masu hana enzyme mai canza siginar angiotensin, marasa lafiya da ke da haɗarin cututtukan kirji, musamman marasa lafiya da bugun jini da kuma rashin ƙarfi na zuciya. "
"Amfani da masu hana ACE kuma yana da alaƙa da rage mutuwar kirji, kodayake sakamakon ba shi da ƙarfi sosai game da haɗarin kirji gaba ɗaya. """
An gano cewa ACE2 na mutum (rhACE2), sabon magani ne don raunin huhu mai tsanani, wanda ya inganta haemodynamics na huhu da kuma iskar oxygen a cikin aladu da ke fama da cutar cutar dysentery mai saurin numfashi na lipopolysaccharide.
Rabin rayuwar rhACE2 a cikin mutane kusan awanni 10 ne, tare da farkon aiki na mintuna 30 da tsawon lokacin tasiri na awanni 24.
Bincike daban-daban ya nuna cewa rhACE2 na iya zama magani mai ban sha'awa ga waɗanda ke da juriya ga masu hana tsarin renin-angiotensin (RAS inhibitors) ko kuma a cikin marasa lafiya tare da dogon lokaci na angiotensin II. An bincika allurar rhACE2 a cikin nazarin asibiti don maganin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuk
"Tsarin COVID-19 B, aikace-aikacen software na wayar hannu ne da aka tsara don taimakawa wajen bin diddigin kira a cikin martani ga cutar COVID-19 ta 2019-20, wanda shine aiwatar da gano mutane (""Saduwa"") waɗanda zasu iya kasancewa cikin hulɗa da mutum mai cutar".
An gabatar da aikace-aikace da yawa ko kuma an haɓaka su tare da tallafin hukuma a wasu yankuna da yankuna.
An kirkiro wasu tsare-tsare don ƙirƙirar aikace-aikacen bin diddigin sadarwa.
An sami damuwa game da tsare sirri, musamman game da tsarin da ke aiki bisa bin diddigin yanayin yanayin masu amfani da aikace-aikacen wayar hannu.
Zaɓuɓɓukan da ba su da matsala sun haɗa da amfani da siginar Bluetooth don yin rikodin kusanci da mai amfani da sauran wayoyin hannu.
A ranar 10 ga Afrilu, 2020, Google da Apple sun sanar da cewa za su ba da damar tallafawa waɗannan aikace-aikacen da ke amfani da Bluetooth kai tsaye a cikin tsarin aiki na Android da iOS.
A China, gwamnatin kasar Sin, tare da hadin gwiwar Alipay, ta kaddamar da wani shiri wanda zai baiwa 'yan kasa damar duba ko sun taba hulda da mutanen da ke dauke da cutar COVID-19.
An yi amfani da shi a cikin birane fiye da 200 na kasar Sin. A Singapore, ana amfani da software mai suna Tris Togdhar.
"Kungiyar Kayan Fasahar Bayanai ta Yankin ta haɓaka wannan app, an buga shi a matsayin Open Text kuma ana ba da shi ga gwamnati. Arewacin Macedonia ta ƙaddamar da aikace-aikacen wayar hannu mai suna "" StopKorona! "", tushen Bluetooth don bin diddigin tuntuɓar mutane masu yuwuwar kamuwa da cuta, wanda ke ba da damar saurin amsawa ga hukumomin kiwon lafiya".
Ma'aikatar Sadarwa da Fasaha da Ma'aikatar Lafiya ne suka samar da wannan software.
Tun daga ranar 14 ga Afrilu, 2020, ana jiran amincewar Google Play da Apple App Store.
"A ranar 12 ga Afrilu, gwamnati ta bayyana cewa shirin bin diddigin mai magana yana kan wani mataki na ci gaba kuma zai kasance a shirye don turawa cikin 'yan makonni. An kuma shirya irin wannan shirin a Ireland da Faransa ("StopCovid"")".
Ostiraliya da New Zealand suna tunanin samar da software bisa ga software na Singapore na Tris Tugas da kuma yarjejeniyar Bluetooth. Rasha na shirin tsara software na geofencing don marasa lafiya waɗanda aka bayyana cewa suna da cutar COVID-19 kuma suna zaune a Moscow don tabbatar da cewa ba za su fita daga gida ba.
Ross Anderson, Farfesa a fannin Injiniyan Tsaro a Jami'ar Cambridge, ya lissafa wasu matsaloli masu yuwuwa a tsarin da ke kan aikace-aikace, gami da rashin inganci da rashin inganci idan aka yi amfani da aikace-aikacen ne kawai ga karamin ɓangaren jama'a.
"Apple, yana magance damuwa game da yaduwar aikace-aikacen ɓatarwa ko cutarwa na ""coronavirus"", ya sanya ƙuntatawa ga ƙungiyoyi waɗanda zasu iya ƙara aikace-aikacen da suka shafi cutar ta Coronavirus zuwa App Store, yana iyakance shi ga ƙungiyoyi "" hukuma "" ko masu izini.
Google da Amazon sun aiwatar da irin wannan takunkumin.
Masu fafutukar kare sirrin sun nuna damuwa game da amfani da sa ido na jama'a ta amfani da aikace-aikacen cutar ta COVID-19, musamman dangane da rushewar kayan aikin sa ido da aka kafa don magance cutar ta COVID-19 bayan an kawar da barazanar kwayar cutar.
Kungiyar Amnesty International da fiye da wasu kungiyoyi 100 sun fitar da wata sanarwa da ke kira da a takaita irin wannan sa ido.
Kungiyoyi sun bayyana sharudda 8 ga ayyukan gwamnati:
"Ya kamata sa ido ya zama ""doka, dole, da kuma dacewa""
Ya kamata a kawo karshen tarihin fadada sa ido da sa ido.
Dole ne a iyakance amfani da bayanai ga dalilan COVID-19.
Dole ne a kiyaye tsaro da kuma rashin sani, kuma dole ne a tabbatar da wannan kariya ta hanyar shaida.
Ba za a iya sanya saurin nuna bambanci da kuma nuna wariya ta hanyar sa ido ta hanyar dijital ba.
Duk wani raba bayanai da wasu mutane ya kamata a ayyana shi a cikin doka.
Dole ne a sami kariya daga cin zarafi da kuma hakkin ɗan ƙasa ya ɗauki alhakin cin zarafi;
"Za a buƙaci haɗin kai mai ma'ana daga duk ""masu ruwa da tsaki"" ciki har da masana kiwon lafiyar jama'a da ƙungiyoyin da aka yi watsi da su. Kungiyar Kwamfuta ta Jamus (CCC) da kuma Masu Ba da Labarai Ba tare da Kan iyakoki (ARASF) sun buga jerin bincike. "
Shirin da aka gabatar na Google/Apple yana nufin magance matsalar sa ido na yau da kullun ta hanyar cire tsarin bin diddigin daga tsarin aiki na na'urar su, lokacin da ba a buƙatar su.
Wasu ƙasashe suna amfani da hanyar gano wuri ta hanyar hanyar sadarwa maimakon aikace-aikace, suna kawar da buƙatar saukar da aikace-aikace da damar guje wa bin sawu.
An tabbatar da bin diddigin hanyar sadarwa a Isra'ila.
Hanyoyin sadarwa na hanyar sadarwa waɗanda ke samun damar yin amfani da bayanan wuri mai mahimmanci suna haifar da matsalolin sirri.
Duk da haka, ba duk tsarin da ke da sabobin cibiyar sadarwa ba ne ke buƙatar samun damar yin amfani da bayanan wuri na mutum. An kafa wasu tsarin tsare sirri wanda ke amfani da sabobin cibiyar sadarwa kawai don sadarwa ta hanyar sadarwa (duba sashe na gaba).
A Koriya ta Kudu, an yi amfani da tsarin da ba a haɗa shi da software don bin diddigin kira.
Maimakon amfani da aikace-aikacen keɓancewa, tsarin yana tattara bayanan bin diddigin daga tushe daban-daban, gami da bayanan bin diddigin wayar hannu da bayanan ma'amala da katin kuɗi, kuma yana haɗa waɗannan don samar da faɗakarwa ta hanyar saƙon rubutu ga waɗanda ake zargi da kamuwa da cuta.
Baya ga amfani da wannan bayanin don faɗakar da masu sauraro, gwamnati ta ba da damar samun damar jama'a, wanda aka ba da izini saboda canje-canje masu yawa a cikin dokokin sirri bayan barkewar cutar MERS a ƙasar.
Ana samun wannan bayanin a cikin aikace-aikace da kuma shafukan yanar gizo. Kasashe kamar Jamus sun yi la'akari da amfani da tsarin tsare sirri da kuma tsare sirri.
Har zuwa ranar 6 ga Afrilu, 2020, ba a riga an fitar da cikakkun bayanai ba.
Binciken sirri na kira shine ingantaccen ra'ayi wanda ya ba da damar bincike mai yawa tun daga 2013. Tun daga ranar 7 ga Afrilu, 2020, sama da ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwar
Koyaya, PEPP-PT ƙoƙari ne na daidaitawa wanda ya ƙunshi duka hanyoyin da aka mai da hankali da kuma mai rarrabewa, kuma ba yarjejeniya ɗaya ba. Yarjejeniyar da aka rarraba ta ƙunshi bin diddigin kewaye da tsare sirri (DP-PPT / DP-3T), lambar kiran TCN na wucin gadi), lambar taron kira (FKA, CEN), ladabi mai mahimmanci na tsare sirri da kuma hanyoyin bin diddigin wayar hannu (PACT), da sauransu.
A cikin waɗannan ladabi, bayanan da za a iya gano su ba sa barin motar kuma duk abubuwan da aka gano suna faruwa a cikin motar.
Ƙungiyar tsare sirri a MIT Media Lab tana haɓaka SafePaths, wani dandamali wanda ke amfani da fasahohin tsare sirri yayin tattarawa da amfani da bayanan wuri ko hanyar haɗuwa don bin hanyar yaduwar COVID-19.
"Wannan ya dogara ne akan bincike daga farar takarda ""Aikace-aikacen da suka tafi: Tsare Sirri a Lokacin Bala'i"" wanda aka buga a watan Maris na 2020. Wani irin wannan yunƙuri shine dandamali na SafeTrace na Enigma MPC, kamfanin da ke haɓaka fasahohin tsare sirri wanda aka fara kirkirar su a MIT Media Lab. "
SafeTrace ta amfani da fasahohin kayan aiki masu aminci yana ba masu amfani damar raba bayanai masu mahimmanci game da wurin su da amincin su tare da sauran masu amfani da hukumomi ba tare da haɗarin sirrin wannan bayanan ba.
A ranar 5 ga Afrilu, 2020, an kafa TCN Global Coalition ta ƙungiyoyi waɗanda ke kewaye da ainihin wannan tsarin da kuma ladabi tare da ƙarin haɗuwa, tare da manufar rage rikice-rikice da haɓaka haɗin gwiwar duniya a cikin sa ido da shirye-shiryen faɗakarwa - wanda shine mabuɗin don cimma karɓa mai yawa.
A ranar 9 ga Afrilu, 2020, gwamnatin Singapore ta sanar da cewa ta ba da damar buɗe tushen yarjejeniyar BlueTrace da ake amfani da ita a cikin software na gwamnati.
A ranar 10 ga Afrilu, 2020, Google da Apple, kamfanonin da ke sarrafa tsarin aiki na Android da iOS, sun sanar da sabon abu don bin diddigin mai magana wanda suka yi iƙirarin cewa yana kiyaye sirrin mutum, bisa ga haɗin fasahar Bluetooth mai ƙarancin makamashi da kuma ɓoye sirrin sirri.
Sun kuma wallafa bayanan fasahohin da aka yi amfani da su a cikin wannan tsarin.
A cewar Apple da Google, an tsara tsarin ne don a iya fadada shi a matakai uku:
Bayyana sabbin kayan aiki don ƙarfafa gwamnatoci don ƙirƙirar shirye-shiryen bin diddigin cutar ta COVID-19 tare da kiyaye sirrin sirri.
Haɗa kai tsaye zuwa iOS da Android; Google da Apple suna shirin rarraba tsarin da farko ta hanyar sabuntawar tsarin aiki sannan kuma cire shi ta hanyar da aka saba.
Sake amfani da magani (wanda kuma ake kira sake amfani da magani, sake tsarawa, sake amfani da shi ko kuma sake amfani da magani) shine sake amfani da magani da aka amince dashi don magance cuta ko cuta daban da abin da aka fara amfani da magani.
Wannan yanki ne na bincike na kimiyya wanda yanzu ake bi don haɓaka ingantaccen magani na COVID-19.
Sauran fannonin bincike sun hada da samar da allurar rigakafin COVID-19 da kuma allurar plasma ga mutanen da suka warke. SARS-CoV-2 yana da sunadarai 66 da ke da damar samar da magani, kowannensu yana da wurare masu haɗuwa da ligand.
Binciken waɗannan wuraren haɗin yana ba da kyakkyawan shiri don samar da maganin rigakafin cutar mai tasiri akan sunadarai na COVID-19.
Muhimman sunadarai da SARS-CoV-2 ke niyya sune protease mai kama da papayain, RNA mai dogara da RNA polymerase, helicase, protein S (S), da ribosphatease ADP.
Hussain AA da abokan aikinsa sun yi nazarin wasu samfura da yawa kuma sun inganta su don kamanceceniya da irin wannan magani tare da mafi girman matakin yarda da shi don hanzarta haɓaka maganin anti-SARS-CoV-2 a cikin binciken su na farko, wanda aka ba da shawarar a cikin ƙirar binciken asibiti.
Chloroquine magani ne na maganin zazzabin cizon sauro wanda ake amfani dashi wajen magance wasu cututtukan da ke warkarwa.
A ranar 18 ga watan Maris, Hukumar Lafiya ta Duniya ta sanar da cewa chloroquine da hydroxychloroquine suna cikin magungunan guda hudu da aka yi nazari a matsayin wani ɓangare na binciken asibiti na gama gari.
Gwamnan New York Andrew Cuomo ya sanar da cewa za a fara gwajin jihar New York akan chloroquine da hydroxychloroquine a ranar 24 ga Maris. A ranar 28 ga Maris, FDA ta ba da izinin amfani da hydroxychloroquine sulfate da chloroquine phosphate a ƙarƙashin izinin amfani na gaggawa (EUA).
Ba a amince da wannan magani ta hanyar binciken asibiti na FDA ba kuma ana ba da izini ne kawai azaman magani na gwaji don maganin gaggawa a cikin marasa lafiya da ke asibiti waɗanda ba za su iya karɓar magani a cikin binciken asibiti ba.
Cibiyar Kula da Cututtuka da Rigakafi ta ce "Ba a tabbatar da amfani da maganin hydroxychloroquine ba, a lokaci-lokaci ko a lokaci-lokaci, don rigakafi ko maganin kamuwa da cutar SARS-CoV-2".
Likitoci sun ce za su yi amfani da shi ne idan "babu wani zaɓi".
Kungiyar bincike ta Turkiyya a Vayettebol tana gudanar da bincike kan amfani da Chloroquine a hade tare da shinkafa, bitamin A, bitamin C da bitamin D.
Ana gudanar da bincike mai zurfi a Jami'ar Duke da Jami'ar Oxford.
Kwalejin Kiwon Lafiya ta NYU Langone tana gudanar da gwaji kan aminci da ingancin amfani da hydroxychloroquine a matsayin rigakafi.
"Nazarin asibiti na kasar Sin a Wuhan da Shenzhen sun yi ikirarin cewa Favivir yana da ""cikakken tasiri""".
A matsakaici na kwanaki 4, sakamakon gwajin marasa lafiya 35 a cikin shanun ya kasance mara kyau, yayin da tsawon lokacin cutar a cikin marasa lafiya 45 waɗanda ba su karɓa ba ya kasance kwanaki 11.
A cikin wani bincike da aka yi a Wuhan kan marasa lafiya 240 da ke fama da cutar kirji, rabin su sun sha maganin Favipiruvir da kuma rabin Ominepuvir.
Hukumar Magunguna ta Italiya ta tunatar da jama'a cewa hujjojin da ke goyon bayan maganin ba su da yawa kuma na farko ne.
A ranar 2 ga Afrilu, Jamus ta sanar da cewa za ta sayi maganin daga Japan don adanawa kuma za ta sami taimako daga sojojin don isar da maganin zuwa asibitocin jami'a inda za a yi amfani da maganin don kula da marasa lafiya na COVID-19.
"A cewar South China Morning Post, Shinzo Abe ya ba da shawarar gwamnatin Trump ta sayi maganin. Wannan magani na iya zama mai tasiri a cikin mawuyacin yanayi inda cutar ta riga ta ninka.
Ba zai zama mai lafiya ba don amfani da mata masu juna biyu ko mutanen da ke ƙoƙarin haihuwa.
"Binciken da aka yi kan lupinavir/ritonavir (Caltra), hadewar maganin rigakafin cutar lupinavir da ritonavir, ya kammala da cewa ""ba a ga wani amfani ba""".
An tsara wadannan magungunan ne domin hana kwayar cutar HIV ta hanyar hada shi da sinadarin protease.
Wata tawagar masu bincike daga Jami'ar Colorado na kokarin gyara maganin da kuma samar da wani abu da zai hada da kwayar cutar SARS-CoV-2. Akwai sukar a cikin al'ummar kimiyya game da tura albarkatu zuwa amfani da maganin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutut
Hukumar Lafiya ta Duniya ta hada da maganin Lupinavir/Ritonavir a cikin gwajin hadin gwiwa na kasa da kasa.
Gilead Sciences ce ta kirkiro da kuma bunkasa Remdesivir a matsayin maganin cutar Ebola da kuma kamuwa da cutar Marburg. Daga baya Gilead Sciences ta gano cewa Remdesivir yana da aikin rigakafin kwayar cutar a cikin yanayin kashe-kashe kan cututtukan cutar filayo, Nomo, Paramix, da Corona.
Wata matsala game da maganin antiviral shine ƙirƙirar juriya ta hanyar maye gurbi wanda zai iya haifar da cutar da kuma watsa nau'in cutar.
Wasu binciken farko na gwaji sun nuna cewa, cutar ta Remdesivir na iya samun babbar takunkumi ta kwayoyin halitta. Akwai wasu gwaje-gwaje na asibiti da ke gudana, ciki har da guda biyu da asibitocin Jami'ar Cleveland suka gudanar, daya a kan mutane masu saurin kamuwa da cutar, daya kuma a kan wadanda suka kamu da cutar mai tsanani.
Nazarin asibiti guda uku na allurar bitamin C ga waɗanda ke asibiti da marasa lafiya masu tsanani saboda COVID-19 suna gudana; gwaji biyu tare da sarrafa placebo (China, Kanada) da gwaji ɗaya ba tare da sarrafawa ba (Italiya).
Jihar New York ta fara gwajin maganin rigakafin azithromycin a ranar 24 ga Maris, 2020.
Cibiyar Lafiya ta Duniya ta Japan (NCGM) tana shirin yin nazarin asibiti don Alucotigine (Cyclosonide), corticosteroid mai numfashi don asma, don magance marasa lafiya masu alamun cutar coronavirus.
Wani nau'in enzyme mai canzawa na angiotensin 2 yana gudana a matsayin gwaji na mataki na 2 tare da marasa lafiya 200 da aka zaɓa daga mawuyacin hali a Denmark, Jamus da Austria, don tantance tasirin magani.
Masu bincike a Cibiyar Karin Jiki ta Montreal a Kanada a halin yanzu suna nazarin rawar da Cholchisine ke takawa wajen rage kumburi da matsalolin huhu a cikin marasa lafiya da ke fama da alamun COVID-19 masu sauƙi.
Wannan binciken, wanda ake kira COLCORONA, ya shafi mutane 6,000 masu shekaru 40 zuwa sama waɗanda aka gano suna da COVID-19 amma suna fuskantar ƙananan alamun cutar da ba sa buƙatar kwanciyar hankali.
Mata masu juna biyu ko masu shayarwa ko kuma waɗanda ba sa amfani da ingantaccen tsarin hana haihuwa ba su cancanci shiga.
An gwada wasu magungunan hana kumburi a Italiya.
Ana amfani da heparin sosai don kula da marasa lafiya saboda ƙarancin nauyin kwayoyin, wanda ya sa Hukumar Kula da Magunguna ta Italiya ta ba da shawarar amfani da shi.
An sanar da wani bincike mai yawa na marasa lafiya 300 kan amfani da sinadarin enoxaparin a cikin maganin rigakafi da magani a ranar 14 ga Afrilu a Italiya.
Saboda SARS-CoV-2 kwayar cuta ce, an mai da hankali sosai kan amfani da maganin rigakafin kwayar cuta da aka tabbatar da cutar kamar su MERS, SARS da West Nile.
Ribavirin: Rabovirine ya ba da shawarar bisa ga bugu na bakwai na jagororin kasar Sin don maganin COVID-19.
Ominefenovir: An bada shawarar Ominefenovir don maganin COVID-19 bisa ga gyare-gyare na bakwai na ka'idojin kasar Sin
Wasu maganin rigakafi da ake ganin za a iya amfani da su wajen maganin COVID-19 sun hada da:
Tuselizomb (mai karɓar IL-6): An amince da shi daga China.
An kuma gudanar da gwaji a Italiya da China, kuma za ku iya ganin tosilezomab #COVID-19.
Allurar COVID-19 allurar rigakafi ce mai ka'ida akan cutar coronavirus 2019 (COVID-19).
Kodayake babu wani allurar rigakafin da ya kammala karatun asibiti, ana kokarin yin irin wannan.
A ƙarshen Fabrairu 2020, Hukumar Lafiya ta Duniya (WHO) ta sanar da cewa ba ta tsammanin za a sami allurar rigakafin cutar SARS-CoV-2 a ƙasa da watanni 18.
An gabatar da alluran rigakafi guda biyar a cikin binciken rigakafin mataki na farko a watan Afrilu.
An gano COVID-19 a watan Disamba na 2019.
Wani babban fashewa a duniya a shekarar 2020, wanda ya haifar da saka hannun jari da bincike mai yawa don samar da allurar rigakafi.
Kungiyoyi da dama suna amfani da kwayoyin halittar da aka buga don haɓaka yiwuwar allurar rigakafin cutar SARS-CoV-2.
Kamar yadda aka bayyana a watan Afrilu, jagororin shirin CEPI don haɓaka allurar rigakafi sune: saurin, ƙarfin samarwa, faɗaɗa sikelin da samun damar duniya.
A watan Afrilu, masana kimiyya na CEPI sun ba da rahoton cewa ana gudanar da bincike da haɓaka dandamali daban-daban na fasaha 10 a farkon 2020 don ƙirƙirar ingantaccen allurar rigakafin COVID-19.
Babban manufofin dandalin, wanda ya ci gaba a cikin farkon binciken rigakafi, sun haɗa da:
nucleic acid (DNA da RNA) (mai haɓaka mataki na ɗaya da ɗan takarar allurar rigakafi: Moderna, mRNA-1273)
Mai ɗaukar hoto na kwayar cuta (mataki na 1 mai haɓakawa da allurar rigakafi: CanSino Biologics, mai ɗaukar hoto na adenovirus nau'in 5)
A cikin watan Afrilu, masana kimiyya na Coalition for Epidemic Preparedness Innovations (CEPI) sun ba da rahoton cewa, a cikin jimillar alluran rigakafi 115, 78 an tabbatar da su a matsayin ayyukan aiki (79, a cewar Cibiyar Milken), da kuma sauran alluran rigakafi 37, amma akwai karancin bayanai a bayyane (ana ɗauka cewa suna cikin tsari ko ƙirar ƙira).
Gwajin Phase I-II yana gwada rigakafin farko da ci gaban rigakafi kuma galibi ana yin sa ne ba tare da izini ba kuma ana sarrafa shi ta hanyar placebo kuma ana gudanar da shi a wurare da yawa, yayin da ake tantance mafi inganci da madaidaicin sashi.
Gwaje-gwajen Phase 3 yawanci suna haɗuwa da ƙarin mahalarta, gami da ƙungiyar kulawa da gwajin rigakafin rigakafi don rigakafin cutar da kuma kula da abubuwan da ke tattare da su a mafi kyawun kashi.
"Daga cikin alluran rigakafi 79 da ake ba da shawarar a cikin ci gaba mai gudana (wanda aka amince da shi a farkon Afrilu 2020), 74 ba su kai matakin kimantawa a cikin mutane ba (har yanzu suna cikin binciken ""preclinical"")".
A ranar 24 ga Janairu, 2020, a Ostiraliya, Jami'ar Queensland ta sanar da cewa tana nazarin yiwuwar allurar rigakafin kwayar cutar Clamp wacce ke canza kwayar cutar kwayar cutar ta hanyar kwayoyin halitta don tayar da martani na rigakafi.
A ranar 24 ga Janairu, 2020, Cibiyar Alurar riga kafi ta Duniya (VIDO-InterVac) a Jami'ar Saskatchewan a Kanada ta sanar da fara aikin kan allurar rigakafi, wanda aka shirya fara gwajin ɗan adam a cikin 2021.
An sanar da ayyukan samar da allurar rigakafi a Cibiyar Kula da Cututtuka da Rigakafin cutar ta China a ranar 26 ga Janairu, 2020 da Jami'ar Hong Kong a ranar 28 ga Janairu, 2020.
A ranar 29 ga Janairu, 2020, Kamfanin Johnson Pharmaceutical, karkashin jagorancin Hank Schwimmer, ya sanar da cewa sun fara aikin samar da allurar rigakafi.
Janssen tana haɗin gwiwa kan samar da allurar rigakafin da za a iya sha tare da abokin aikinta na fasahar kere-kere, Vaxart.
A ranar 18 ga Maris, 2020, BioSolutions Emergent ta sanar da haɗin gwiwar samarwa tare da Vaxart don samar da allurar rigakafin.
A ranar 8 ga Fabrairu, 2020, Incogene Laboratory a Romania ta buga wata kasida game da tsara allurar rigakafi tare da fasahar da ta yi kama da na maganin cutar kansa, ta hanyar yin allurar rigakafin sabon kwayar cutar.
A ranar 25 ga watan Maris, shugaban cibiyar ya sanar da cewa sun kammala hada allurar rigakafin kuma sun fara gwaji.
A ranar 27 ga Fabrairu, 2020, daya daga cikin kamfanonin Generex, NuGenerex Immuno-Oncology, ya sanar da cewa sun fara aikin samar da allurar rigakafi don samar da maganin peptides na Ii-Key da ke yaki da COVID-19.
"Suna son samar da shawarar rigakafin da za a iya gwadawa a kan mutane cikin ""kwanaki 90".
A ranar 5 ga Maris, 2020, Jami'ar Washington da ke St. Louis ta sanar da shirin samar da allurar rigakafi.
A ranar 5 ga Maris, 2020, Cibiyar Bincike da Kayan Aikin Sojojin Amurka a Fort Detrick da Cibiyar Bincike ta Sojoji ta Walter Reed a Silver Spring, dukansu biyu a Yammacin Maryland, sun ba da sanarwar cewa suna aiki kan allurar rigakafi.
A ranar 10 ga Maris, 2020, Emergent Biosolutions ya sanar da cewa yana aiki tare da Novavax.
A cikin samar da allurar rigakafi.
Abokan hulɗa sun sanar da ci gaba da shirye-shirye don gwajin farko na asibiti da gwajin asibiti na lokaci ɗaya har zuwa Yuli 2020.
A ranar 12 ga Maris, 2020, Ma'aikatar Lafiya ta Indiya ta sanar da cewa sun yi aiki kan nau'ikan 11 na keɓancewa kuma har ma da saurin aiwatar da hanyoyin, samar da allurar rigakafin zai ɗauki aƙalla kimanin shekara ɗaya da rabi zuwa biyu.
A ranar 12 ga Maris, 2020, Medicago, wani kamfanin kere-kere na kere-kere da ke Quebec City, ya sanar da cewa zai samar da kwayar cutar coronavirus-kamar ta hanyar kashe wani bangare na kudade daga cibiyoyin kiwon lafiya na Kanada.
Wannan samfurin rigakafin yana cikin binciken dakin gwaje-gwaje kuma an shirya gwajinsa akan mutane a watan Yuli ko Agusta 2020.
A farkon wannan makon, jaridar Guardian ta ruwaito cewa shugaban Amurka Donald Trump ya ba da "wadataccen kuɗi don samun damar yin rigakafin COVID-19" ga CureVac, kuma ya fuskanci adawa daga gwamnatin Jamus.
A ranar 17 ga Maris, 2020, kamfanin magunguna na Amurka Pfizer ya sanar da haɗin gwiwa tare da kamfanin BioNTech na Jamus don haɓaka allurar rigakafi mai tushen mRNA.
Ana sa ran fara allurar rigakafin mai son rai bisa mRNA, wanda ake kira BNT162, wanda a halin yanzu yana cikin matakin farko na gwajin asibiti, a watan Afrilu 2020.
A Italiya a ranar 17 ga Maris, 2020, Takis Biotech, wani kamfanin fasahar kere-kere na Italiya ya sanar da cewa za su sami sakamakon gwajin rigakafin a watan Afrilu na 2020, kuma za a iya gwada samfurin rigakafin su na ƙarshe a kan mutum.
A Faransa, a ranar 19 ga Maris, 2020, Coalition for Epidemic Preparedness Innovations (CEPI) ta ba da dala miliyan 4.9 ga ƙungiyar bincike kan allurar rigakafin COVID-19, wanda ya haɗa da Cibiyar Pasteur, Thames Biosciences (Austria), da Jami'ar Pittsburgh, wanda ya kai dala miliyan 29 a cikin haɗin gwiwa don samar da allurar rigakafin COVID-19.
Sauran abokan haɗin CEPI don samar da allurar rigakafin COVID-19 sun haɗa da: Moderna, Curevac, Inovio, Novavax, Jami'ar Hong Kong, Jami'ar Oxford da Jami'ar Queensland.
Hukumomin kiwon lafiya na Rasha sun sanar a ranar 20 ga Maris, 2020 cewa masana kimiyya sun fara gwajin kan alluran rigakafi daban-daban guda shida.
Masu bincike a Kwalejin Imperial na London sun sanar a ranar 20 ga Maris, 2020 cewa suna kan aikin samar da allurar rigakafin RNA mai karfafa kanta don COVID-19.
An samar da samfurin allurar rigakafin cikin kwanaki 14 da samun kwayar cutar daga China.
A ƙarshen Maris, Gwamnatin Kanada ta sanar da cewa ta ba da tallafin dala miliyan 275 na Kanada don gudanar da bincike 96 kan matakan magance COVID-19, gami da manyan ayyukan allurar rigakafi a kamfanoni da jami'o'in Kanada kamar su Medicago da Jami'ar Saskatchewan.
"A lokaci guda, Gwamnatin Kanada ta sanar da ware dala miliyan 192 musamman don samar da allurar rigakafin COVID-19 tare da shirye-shiryen ƙirƙirar ""Bankin allurar rigakafin ƙasa"" tare da sabbin alluran rigakafi da za a iya amfani da su yayin barkewar wasu ƙwayoyin cuta na COVID-19.
"A ranar 2 ga Afrilu, 2020, masu bincike a Jami'ar Kiwon Lafiya ta Pittsburgh sun sanar da gwajin PittCoVacc, wanda zai iya zama allurar rigakafin COVID-19 a cikin beraye, suna mai cewa ""MNAs da aka karɓa na allurar rigakafin SARS-CoV-2 S1 sun haifar da amsawar rigakafin antigen mai ƙarfi [a cikin beraye] wanda ya bayyana makonni 2 bayan rigakafin. ""
A ranar 16 ga Afrilu, 2020, Jami'ar Magunguna ta Waterloo ta bayyana samfurin rigakafin DNA a matsayin yiwuwar fesa hanci.
Ta amfani da bacteriophages, an tsara DNA don yin kwafi a cikin kwayoyin halittar mutum don samar da kwayoyin cutar-kamar marasa cutarwa, wanda zai iya motsa tsarin rigakafi don samar da ƙwayoyin cuta ga SARS-CoV-2.
A watan Maris na shekarar 2020, gwamnati, masana'antu da jami'o'i uku na Amurka sun ba da damar samun damar shiga kwamfutocin IBM, tare da albarkatun girgije daga Holt Packard, Amazon, Microsoft da Google.
Wasu alluran rigakafi suna da tasirin da ba na musamman ba, wanda ake kira tasirin da ba na musamman ba.
Wannan yana nufin cewa suna iya samun fa'idodi fiye da rigakafin cutar.
Wani gwaji na bazuwar a Ostiraliya yana neman yin rajistar ma'aikatan kiwon lafiya 4,170.
Akwai yiwuwar cewa alluran rigakafin da ake ci gaba ba su da lafiya ko kuma ba su da tasiri.
Bincike na farko don kimanta ingancin allurar rigakafin COVID-19 ta amfani da samfuran dabbobi na musamman, watau mice transgenic-ACE2, sauran dabbobin dakin gwaje-gwaje, da dabbobi masu shayarwa marasa ɗan adam, har yanzu suna nuna buƙatar matakan tsaro na matakin- 3 don sarrafa ƙwayoyin cuta masu rai da haɗin kai na duniya don tabbatar da daidaitattun hanyoyin aminci.
An gwada allurar rigakafin SARS da MERS a kan dabbobi.
Har zuwa shekarar 2020, babu wani magani ko rigakafin kariya ga SARS da aka nuna cewa yana da aminci da tasiri a cikin mutane.
Dangane da takardun da aka buga a cikin 2005 ko 2006, gabatar da ci gaba da sabbin alluran rigakafi da magunguna don maganin SARS sun kasance fifiko ga gwamnatoci da hukumomin kiwon lafiyar jama'a a duk duniya. Har ila yau, babu wani rigakafin da aka amince da shi game da MERS.
Lokacin da cutar ta MERS ta zama sananne, an yi imanin cewa binciken da ake yi a kan SARS na iya samar da wani tsari mai amfani don samar da allurar rigakafi da kuma maganin kamuwa da cutar MERS-CoV.
Ya zuwa Maris 2020, akwai allurar rigakafin MERS (DNA-based) da ta kammala gwajin asibiti na mataki na farko, kuma akwai wasu uku da ke gudana, duk alluran rigakafin mai ɗaukar hoto, biyu masu ɗaukar hoto (ChAdOx1-MERS, BVRS-GamVac) da kuma mai ɗaukar hoto na MVA (MVA-MERS-S).
Shafukan sada zumunta sun inganta ka'idar makirci da ke da'awar cewa an san kwayar cutar COVID-19 kuma akwai riga-kafi.
Takaddun shaida da aka ambata ta hanyar kafofin watsa labarun daban-daban suna magana ne game da takaddun shaida na yanzu don jerin kwayoyin halitta da kuma alluran rigakafi don wasu nau'ikan coronavirus kamar SARS.
Cutar kwayar cuta ta 2019 (COVID-19) cuta ce mai yaduwa wacce cutar coronavirus mai saurin numfashi mai saurin kamuwa da cuta 2 (SARS-CoV-2) ta haifar.
Alamun da aka saba da su sun hada da zazzabi, tari da kuma wahalar numfashi.
Sauran alamun na iya haɗawa da gajiya, ciwon tsoka, zawo, ciwon hanci, rashin jin ƙanshi da ciwon ciki.
Lokaci daga lokacin da aka kamu da kwayar cutar zuwa lokacin bayyanar cututtuka yawanci yakan ɗauki kimanin kwanaki 5, amma yana iya bambanta daga kwana biyu zuwa goma sha huɗu.
Kodayake yawancin mutane suna da ƙananan alamun bayyanar cututtuka, wasu suna fama da cutar sankara da kuma rashin aiki da yawa.
Ya zuwa ranar 17 ga Afrilu, 2020, an samu sama da mutane miliyan 2.24 da suka kamu da cutar a kasashe 210 da yankuna, wanda ya yi sanadiyar mutuwar mutane sama da 153,000.
An samu karin mutane 568,000 da suka warke. An fara yada kwayar cutar ta hanyar hulda kai tsaye, yawanci ta hanyar saukad da daga tari, tari ko kuma yin hancin.
Lokacin da aka samar da waɗannan ɗigon a lokacin da ake yin burodi, yawanci suna manne da ƙasa ko saman maimakon su yi tafiya mai nisa.
Mutane na iya kamuwa da cutar ta hanyar taɓa wani abu sannan su taɓa idanunsu, hanci, ko baki.
Kwayar cutar na iya rayuwa sama da awanni 72 a kan saman.
Cutar ta fi yaduwa a cikin kwanaki uku na farko bayan bayyanar cututtuka, kodayake ana iya samun yaduwa kafin bayyanar cututtuka da kuma a cikin matakan cutar. Hanyar ganewar asali ta hanyar polymerase chain reaction reverse transcription (rRT-PCR) daga substrate na hanawa.
Ana ba da shawarar sanya abin rufe fuska ga mutanen da ake zargin suna da kwayar cutar da masu kula da su.
Shawarwari sun bambanta game da amfani da abin rufe fuska ga jama'a, tare da wasu hukumomi suna adawa da amfani da abin rufe fuska, wasu suna ba da shawarar shi, wasu kuma sun sanya shi tilas.
A halin yanzu, babu wani rigakafi ko takamaiman maganin rigakafin cutar COVID-19.
An samu yaduwar cutar a cikin kasashe da dama a duk yankuna shida na WHO.
Mutanen da suka kamu da kwayar cutar na iya zama ba su da alamun cutar ko kuma suna iya nuna alamun cutar kamar mura kamar zazzabi, tari, gajiya, ko kuma numfashi mai wuya.
Alamun gaggawa sun haɗa da wahalar numfashi, ciwon kirji ko matsi mai ɗorewa, rikicewa, wahalar farkawa da launin ruwan kasa na fuska ko lebe; idan akwai alamun, ana ba da shawarar neman magani nan da nan.
Wani lokaci, ana iya ganin alamun tsarin numfashi na sama kamar tari, hanci ko ciwon makogwaro.
An lura da alamun cututtukan narkewa kamar tari, amai da kuma zawo a cikin kashi daban-daban.
Wasu masu kamuwa da cutar a China sun sami tsananin bugun zuciya da kuma rashin nutsuwa.
A wasu mutane, cutar na iya haifar da cututtukan kirji, rashin aiki da kuma mutuwa.
Ana kiran wannan lokacin lokacin rufi.
Lokacin ɓoyewa don COVID-19 yawanci kwanaki biyar zuwa shida ne amma zangon juyin halitta na iya bambanta tsakanin kwana biyu zuwa 14.
Kashi 97.5 na mutane suna nuna alamun cutar har zuwa kwanaki 11.5 bayan kamuwa da cutar. Rahotanni sun nuna cewa ba duk masu kamuwa da cutar ba ne ke nuna alamun cutar.
Har yanzu ba a san matsayin wadannan masu dauke da cutar ba a yaduwar cutar ba, kodayake shaidar farko ta nuna cewa suna iya taka rawa wajen yaduwar cutar.
Rashin bayyanar cututtukan da ba su nuna alamun ba a halin yanzu ba a sani ba kuma ana nazarin su, a cewar Cibiyoyin Kula da Cututtuka da Cututtuka na Koriya (KCDC), kashi 20 cikin dari na dukkan wadanda aka tabbatar ba su nuna alamun ba yayin da suke asibiti.
Hukumar Lafiya ta kasa ta kasar Sin ta fara hada wadanda ba su da alamun cutar a cikin kididdigar cutar ta yau da kullun daga ranar 1 ga Afrilu. Daga cikin mutane 166 da suka kamu da cutar a wannan ranar, mutane 130 (78%) ba su da alamun cutar a lokacin gwajin.
Tsotsewa da kuma zubar da hanci suna da babban adadin mai cutar.
Magana da ƙarfi yana fitar da ƙananan ƙananan abubuwa idan aka kwatanta da magana ta al'ada.
Wani bincike a Singapore ya nuna cewa tari ba tare da kariya ba na iya haifar da zubar da ɗigon numfashi na tsawon mita 4.5 (ƙafa 15).
Kodayake kwayar cutar ba ta yawan zama a cikin iska, National Academy of Sciences ta ce ana iya watsa ta wannan hanyar kuma samfurori daga iska a waje na mutane sun sami tabbataccen samfurin RNA na kwayar cutar.
Wasu hanyoyin kiwon lafiya kamar su tubalisation da kuma CPR na iya haifar da watsawa na numfashi a cikin iska kuma hakan na haifar da fitar iska.
Ko da yake akwai damuwa cewa cutar za ta iya yaduwa ta hanyar kwayar cuta, amma rashin yiwuwar hakan yana da ƙarancin gaske. Mafi yawan cutar shine lokacin da mutum ke da alamun, kodayake yana iya yaduwa kafin bayyanar alamun.
Cibiyar Kula da Cututtuka da Cututtuka a Turai ta ce yayin da ba a bayyana yadda cutar ke yaduwa ba, mutum ɗaya yana iya kamuwa da mutane biyu zuwa uku. Kwayar cutar tana iya zama a kan fuska na tsawon sa'o'i.
Musamman, an ga cewa cutar tana iya ganowa har zuwa kwana ɗaya akan takalma, fiye da kwana uku akan filastik (polypropylene) da bakin karfe (AISI 304) da sama da awanni huɗu akan jan ƙarfe.
Koyaya, wannan ya dogara da yanayin zafi da zafin jiki.
Sabulu da mai tsabtace jiki suna da amfani idan aka yi amfani da su yadda ya kamata: kayayyakin sabulu suna kawar da kuma kashe murfin kariya na kwayar cutar, kuma suna ware kwayar cutar daga fata da sauran wurare.
Sauran hanyoyin kamar su benzalkonium chloride da chloroxydine glucant (mai kashe cututtukan tiyata) ba su da tasiri sosai. A cikin binciken da aka yi a Hong Kong, an ɗauki samfuran sallama a matsakaiciyar tazara kwana biyu bayan asibiti.
A cikin marasa lafiya 5 cikin 6, na farko ya nuna mafi girman kwayar cutar, kuma mai haƙuri na shida ya nuna mafi girman kwayar cutar a rana ta biyu.
Kwayar cuta mai saurin numfashi ta coronavirus 2 (SARS-CoV-2) sabuwar kwayar cuta ce ta numfashi da aka fara ganowa a cikin mutane uku da ke fama da cutar kirji da kuma na hanci a Wuhan wadanda ke fama da matsalar rashin isashshen iskar oxygen da kuma matsalar numfashi.
Dukkanin halayen sabon SARS-CoV-2 suna bayyana a cikin coronaviruses dangi a yanayi.
A waje da jikin mutum, ana kashe kwayar cutar ta hanyar sabulu na yau da kullun, wanda ke lalata kumfa mai riƙe da shi a cikin bene da aka samar. COVID-19 yana da kusanci da SARS-CoV-2.
huhu ne mafiya saukin kamuwa da cutar COVID-19, saboda kwayar cutar tana shiga cikin kwayoyin da ke karbar bakuncin ta hanyar enzyme mai sauya angiotensin 2 (ACE2), mai karba wanda ya fi yawa a cikin kwayoyin alveolar na huhu biyu.
"Virus yana amfani da takamaiman glycoprotein (peplomer) wanda ake kira ""spike"" don haɗawa da ACE2 da shiga cikin kwayar mai masaukin baki".
Kashi 12% na masu kula da asibiti a Wuhan, China, sun sami rauni na zuciya mai tsanani, wanda yafi faruwa a cikin mummunan cuta.
Yawan cututtukan zuciya da jijiyoyin jini suna da yawa saboda amsawar kumburi da kuma rikicewar tsarin rigakafi yayin ci gaban cutar, amma lalacewar tsokoki na zuciya na iya kasancewa da alaƙa da masu karɓar ACE2 a cikin zuciya.
Ana bayyana masu karɓar ACE2 sosai a cikin zuciya kuma suna da alaƙa da aikin zuciya.
An lura da yawan kamuwa da cutar thrombosis (31%) da kuma thrombo-embolism na jijiya (25%) a cikin marasa lafiya na ICU da ke dauke da COVID-19 kuma hakan na iya danganta da rashin ingantaccen yanayin cutar. Autopsies na mutanen da suka mutu saboda COVID-19 sun nuna lalataccen ƙwayar alveoli (DAD) da kuma tarin kumburi wanda ya ƙunshi lymphocytes a cikin huhu.
Kodayake SARS-CoV-2 yana da sha'awar ƙwayoyin mucous waɗanda ke bayyana ACE2, marasa lafiya da ke da COVID-19 suna nuna alamun bayyanar cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut
Musamman, an nuna cewa kwayoyin T masu cutarwa masu fitar da GM-CM suna da alaƙa da haɓakar ƙwayar IL-6 mai ɓoye kumburi da kuma cututtukan huhu masu tsanani a tsakanin marasa lafiya na COVID-19.
An kuma bayar da rahoton cutar lymphocytic a autopsy.
Hukumar Lafiya ta Duniya (WHO) ta wallafa wasu ka'idojin gwaji na cutar.
Hanyar gwajin shine rRT-PCR (polymerase chain reaction).
Ana yin gwajin ne a kan samfurin numfashi da aka samo daga ƙuƙwalwar hanci; duk da haka, ana iya amfani da ƙuƙwalwar hanci ko samfurin ƙuƙwalwa.
Sakamakon yawanci yana samuwa cikin 'yan sa'o'i zuwa kwana biyu.
Ana iya yin gwajin jini, amma ana buƙatar samfuran jini guda biyu da aka ɗauka a tsakanin makonni biyu kuma sakamakon yana da ƙarancin ƙimar lokaci.
Masana kimiyya na kasar Sin sun iya ware wani nau'in kwayar cutar ta COVID-19 da kuma bayyana tsarin kwayoyinta, don haka dakunan gwaje-gwaje a duk duniya zasu iya samar da tsarin polymerase chain reaction (PCR) da kansu don gano kamuwa da cutar bisa kwayar cutar.
Ya zuwa ranar 4 ga Afrilu, 2020, ana ci gaba da gwajin rigakafi (wanda zai iya gano kamuwa da cuta mai aiki da kuma ko mutum ya kamu da cutar a baya), amma har yanzu ba a yi amfani da shi sosai ba.
Kwarewar Sin ta nuna cewa gwajin ya kasance daidai da kashi 60 zuwa 70 cikin dari.
Hukumar Abinci da Magunguna ta Amurka ta amince da gwajin farko na kulawar a ranar 21 ga Maris, 2020, don amfani a ƙarshen wannan watan. Hanyar bincike da asibitin Zongnan na Jami'ar Wuhan ya fitar, ya ba da shawarar hanyoyin gano kamuwa da cuta bisa ga alamun asibiti da cututtukan cututtuka.
Cuttings na gilashin gilashi masu yawa masu rarraba biyu tare da rarrabawar kewaye, asymmetrical da baya suna da yawa a cikin kamuwa da cutar da wuri.
Cikewar huhu, tsarin da ba a saba gani ba (kauriwar wuyan lobby da cikawar aljihunan iska) da kuma yawan kumburi sune alamun ci gaban cutar.
Akwai bayanai kaɗan game da lalacewar microscopy da kuma pathophysiology na COVID-19.
Babban binciken pathology na autopsy ya hada da:
Microscopy: Pluriety, exocardial sclerosis, ƙwayoyin cuta da kuma ƙwayar huhu
Akwai nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan.
Cutar kirji mai laushi: ciwon huhu, hyperplasia na pneumocytes, manyan pneumocytes na atypical, cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cut
Cutar huhu mai tsanani: Cutar Alveolar Damage (DAD) tare da fitowar alveolar.
DAD yana haifar da cututtukan cututtukan numfashi mai tsanani (ARDS) da kuma raguwar yawan iskar oxygen a cikin jini.
Jiyya na kirji da kuma hanci: daidaitawar sallama a cikin cavities na airbags da fibrosis tsakanin huhu
Jini: Tsuntsu cikin babban jijiya (DIC); halayen leucorethroblastic
Matakan kariya don rage haɗarin kamuwa da cuta sun haɗa da zama a gida, guje wa zuwa wuraren da mutane ke yawan zuwa, wanke hannuwanka a kai a kai da sabulu da ruwa na aƙalla sakan 20, kiyaye tsaftace numfashi mai kyau da kuma guje wa taɓa idanu, hanci ko baki da hannayenka.
CDC (Cibiyar Kula da Cututtuka) ta ba da shawarar rufe baki da hanci tare da tawul lokacin da kake tari ko tari kuma idan babu wani tawul, tofa ko tari a cikin wuyanka.
Ana ba da shawarar kiyaye tsabtace hannu bayan tari ko tari.
Don rage yaduwar cutar ta hanyar masu dauke da cutar marasa alamun cutar, CDC ta ba da shawarar yin amfani da abin rufe fuska a wuraren taruwa. Dabarun nisantar jama'a suna nufin rage hulɗa da jama'a ta hanyar rufe makarantu da wuraren aiki, ƙuntata tafiye-tafiye da soke manyan tarurrukan jama'a.
Tsarin nesa ya kuma hada da mutane su nisanta akalla ƙafa 6 (mita 1.8).
"Babu wani magani da aka sani da zai iya hana kamuwa da COVID-19. Saboda mafi ƙarancin lokacin da zai yiwu don samun allurar rigakafi ba zai kasance ba kafin 2021, babban batun da ke faruwa a cikin kula da COVID-19 shine ƙoƙarin rage ƙaruwar cutar, ko kuma abin da ake kira ""sarrafa layin"".
CDC ta kuma shawarci mutane su wanke hannayensu na tsawon dakika 20, musamman bayan sun je gidan wanka ko kuma idan hannayensu sun kasance masu datti, kafin cin abinci ko bayan sun goge hanci, bayan yin tari da tari.
Bugu da ƙari, ana ba da shawarar masu amfani da su sha giya tare da aƙalla kashi 60 cikin ɗari na giya, amma kawai idan sabulu da ruwa ba su da sauƙi. WHO ta ba da shawarwari biyu don samar da gida a yankunan da ba a samun sauƙin samun kayan aikin kashe wutan hannu na kasuwanci.
A cikin wannan tsari, aikin antimicrobial ya samo asali ne daga ethanol ko isopropanol.
"Ana amfani da hydrogen peroxide don taimakawa wajen kawar da ƙwayoyin cuta a cikin giya. "" Ba abu ne mai aiki na maganin shafawa na hannu ba"" .
An kara glycerol a matsayin mai shafar danshi.
Ana kula da mutane tare da kulawa mai tallafi wanda zai iya haɗawa da maganin ruwa, ƙarin oxygen da tallafi ga sauran gabobin rayuwa.
CDC ta ba da shawarar cewa mutanen da ake zargin suna da masu watsawa su yi amfani da abin rufe fuska mai sauƙi.
An yi amfani da iskar oxygen na membrane na waje (ECMO) don magance matsalar rashin numfashi, amma har yanzu ana nazarin amfanin sa.
An ba da shawarar kiyaye tsabtar mutum da salon rayuwa mai kyau da cin abinci mai gina jiki don inganta tsarin rigakafi.
Magungunan tallafi na iya zama mai tasiri ga mutanen da ke da alamun rashin lafiya da kuma farkon kamuwa da cutar. Hukumar Lafiya ta Duniya (WHO) da Hukumar Lafiya ta Kasa ta China (Chinese National Health Commission) sun fitar da shawarwari don kula da mutanen da ke asibiti saboda COVID-19.
Kwararrun masu kula da kulawa ta musamman da masu ilimin huhu a Amurka sun tattara shawarwarin magani daga hukumomi daban-daban a cikin tushen kyauta, IBCC.
Har zuwa watan Afrilu 2020, babu wani takamaiman magani don COVID-19.
Wasu likitocin sun fi son yin amfani da paracetamol don sauƙaƙe bayyanar cututtuka fiye da ibuprofen don maganin farko.
Don rage haɗarin kamuwa da kwayar cutar, dole ne a yi taka tsantsan, musamman a cikin yanayin magani inda ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin.
Ga masu kula da lafiyar da ke kula da mutanen da ke da COVID-19, CDC ta ba da shawarar sanya mutum a cikin ɗakin keɓewar cututtukan iska (AIIR) ban da amfani da daidaitattun matakan kariya, kulawa ta tuntuɓar, da kula da kamuwa da cuta ta iska. CDC ta bayyana hanyoyin amfani da kayan kariya na mutum (PPE) yayin annobar.
Kayan da aka ba da shawarar sun haɗa da: PPE, tsarin numfashi ko abin rufe fuska, kariya ga idanu da safofin hannu na likita. Idan akwai, ana son kayan numfashi (maimakon abin rufe fuska).
An amince da matattarar numfashi ta N95 don wuraren masana'antu, amma FDA ta ba da izinin amfani da waɗannan masks ɗin kawai don yanayin da aka amince da amfani da gaggawa (EUA).
An tsara su ne don kare ƙwayoyin da ke cikin iska kamar ƙura, amma ba a tabbatar da ingancinsu a kan takamaiman mai amfani da kwayoyin halitta don amfanin da ba a ambata a kan lakabin ba.
CDC ta ba da shawarar yin amfani da kariya ta fuska, ko kuma a matsayin na ƙarshe, abin rufe fuska na gida lokacin da ba a samun abin rufe fuska.
Yawancin cututtukan COVID-19 ba su da tsanani har su buƙaci aikin numfashi na inji ko makamancin haka, amma kashi ɗaya cikin ɗari na waɗanda ke da cutar suna buƙatar wannan.
Ana nazarin nau'in taimakon numfashi da marasa lafiya ke buƙata tare da rashin ƙarfi na numfashi wanda ya haifar da COVID-19 a halin yanzu a kan mutane a asibitoci, kuma hujjoji sun nuna cewa ana iya hana intussation ko tubing a cikin tsarin numfashi ta amfani da bututun mai matsin lamba ko matsin lamba na iska.
Ba a san ko wanne ne zai haifar da fa'ida iri ɗaya ga waɗanda ke da mummunan cuta ba.
Wasu likitoci sun fi son ci gaba da amfani da na'urar motsa jiki ta hanyar iska a lokacin da ake samun damar, saboda wannan fasaha tana iyakance yaduwar aerosol fiye da maganin iskar oxygen na dogon lokaci. Abubuwan da suka fi faruwa a cikin tsofaffi (mutane sama da shekaru 60 da kuma musamman ma waɗanda suka wuce shekaru 80).
Yawancin ƙasashe masu tasowa ba su da isassun asibitoci, wanda ke iyakance ƙarfin tsarin kiwon lafiya don magance hauhawar ba zato ba tsammani na COVID-19 da ke buƙatar asibiti.
Wani bincike a China ya nuna cewa kashi 5% sun shiga sashen kula da gaggawa, kashi 2.3% sun bukaci taimakon na'urar numfashi ta wucin gadi, kuma kashi 1.4% sun mutu.
A China, kusan kashi 30% na mutanen da aka kwantar a asibiti saboda COVID-19 an kai su ICU.
Yanayin iska yana da rikitarwa yayin da cutar ta COVID-19 ta ci gaba da ci gaba da cutar ta ARDS kuma isar da iskar oxygen na ƙara zama da wahala.
Ana amfani da masu sanyaya iska, gami da yanayin sarrafa matsin lamba da PEEP mai tsayi, don haɓaka isar da iskar oxygen yayin rage haɗarin lalacewar huhu da ke da alaƙa da tsarin numfashi da pneumothorax.
Za a iya samun ƙananan PEEPs a cikin tsofaffin na'urorin iska.
Bincike kan yiwuwar maganin ya fara a watan Janairun 2020, kuma ana ganin magungunan antiviral da yawa a cikin nazarin asibiti.
Rameswar ya kasance mafi tasiri har zuwa yanzu.
Kodayake zai iya ɗaukar lokaci kafin 2021 don ƙirƙirar sabon magani, yawancin magungunan gwaji sun riga sun tabbatar da wasu amfani ko an riga an tabbatar da su a cikin gwaji na ci gaba.
Ana iya gwada maganin antiviral akan mutanen da ke da mummunan cuta.
Hukumar Lafiya ta Duniya ta ba da shawarar masu sa kai su shiga gwajin don tantance inganci da rigakafin magani. Hukumar Abinci da Magunguna ta Amurka ta ba da izinin ɗan lokaci don amfani da plasma na mutane masu warkewa a matsayin magani na gwaji a cikin yanayin da rayuwar mutum ke cikin haɗari ko kai tsaye.
Ba a gudanar da binciken asibiti da ake buƙata don nuna rigakafi da inganci ga cutar ba.
A watan Fabrairun 2020, kasar Sin ta gabatar da wani software na wayar hannu don magance barkewar cutar.
Ana buƙatar masu amfani su shigar da sunansu da lambar gano su.
"Wannan shirin yana iya gano ""kusa da kusanci"" kuma sakamakon haka yana iya haifar da haɗarin kamuwa da cuta ta amfani da bayanan sa ido".
Kowane mai amfani zai iya bincika matsayin sauran masu amfani uku.
Idan aka gano wata barazana, shirin ba wai kawai yana ba da shawarar keɓe kai ba, amma kuma yana sanar da haɗarin ga hukumomin kiwon lafiya na gida. Ana amfani da babban bayanan bincike na wayar salula, fasahar gano fuska, bin diddigin wayar salula da kuma ilimin kere kere don gano abubuwan da suka shafi kamuwa da cutar da mutanen da suka yi hulɗa da Koriya ta Kudu, Taiwan da Singapore.
A watan Maris na shekarar 2020, gwamnatin Isra'ila ta kunna hukumomin tsaro don bin diddigin bayanan wayar mutane da ake zargin suna da cutar coronavirus.
Wannan ya faru ne don keɓewa da kuma kare mutanen da ke iya hulɗa da mutanen da ke dauke da cutar.
Har ila yau, a watan Maris na 2020, Deutsche Telekom ta raba bayanan wuri tare da hukumar gwamnatin tarayya ta Jamus, Cibiyar Robert Koch don bincike da hana yaduwar cutar.
Rasha ta aiwatar da fasahar gano fuska don gano masu keta dokar keɓewa.
"Julio Galera, memba na Hukumar Lafiya ta Yammacin Italiya, ya ce ta hanyar masu sadarwar wayar hannu an sanar da cewa ""40% na mutane suna tafiya zuwa wannan ko wancan hanyar".
Gwamnatin Jamus ta gudanar da wani taron shakatawa na tsawon sa'o'i 48 da ya gabata tare da sama da mutane 42,000 da suka halarci taron.
Shugaban Estonia, Kersti Kaljulaid, ya kuma yi kira ga duniya da ta samar da hanyoyin magance cutar coronavirus.
Mutanen da ke keɓewa na iya fuskantar damuwa, ƙuntatawa na tafiya, rikicewar magani, ko tsoron kamuwa da cuta.
"BBC ta nakalto Rory O'Connor ta ce: ""Ƙarin rashin jin daɗin zamantakewa, kadaici, damuwa game da lafiya, damuwa da matsalar tattalin arziki sun zama guguwa a duk ma'anar cutar da lafiyar mutum da lafiyar mutum""".
Cutar na iya zama mai sauƙin bayyanar cututtuka ko ma ba tare da bayyanar ba, kuma yana kama da cututtuka tare da matsalolin numfashi na yau da kullun kamar na yau da kullun.
Yanayin na sauƙaƙe yawanci yana faruwa a cikin makonni biyu, yayin da a cikin mutane masu tsanani, zai iya ɗaukar makonni uku zuwa shida don warkewa.
Bisa ga bayanan da aka samu daga wasu ƙwayoyin cuta masu kama da SARS da MERS, mata masu juna biyu na iya zama masu haɗarin kamuwa da COVID-19, amma ba a sami bayanan COVID-19 a halin yanzu. A cikin wasu mutane, COVID-19 na iya shafar huhu da kuma haifar da ciwon kirji.
A cikin mutanen da ke kamuwa da COVID-19, zai iya hanzarta ci gaba zuwa ciwon rashin ƙarfi na numfashi (ards) wanda ke haifar da rashin ƙarfi na numfashi, girgizar sararin samaniya ko rashin ƙarfi na gabobin jiki.
Matsalar COVID-19 ta haɗa da ciwon sukari, ƙoshin lafiya da lalacewar zuciya, ƙwayoyin cuta da hanta.
An lura da rikicewar hawan jini, ko kuma a takaice, karuwar lokacin prothrombin, a cikin kashi 6 cikin ɗari na waɗanda aka shigar da su asibiti tare da COVID-19, yayin da aka lura da rashin aikin al'ada na al'ada a cikin kashi 4 cikin ɗari na wannan rukunin.
A kusan kashi 20 zuwa 30% na mutanen da ke da COVID-19, suna da enzymes na hanta (transaminases).
A cewar wannan rahoton, matsakaicin lokacin tsakanin bayyanar cututtuka da mutuwa ya kasance kwanaki goma, wanda biyar daga cikinsu sun kasance a cikin yanayin asibiti.
Koyaya, a cikin marasa lafiya da aka shigar da su ICU, matsakaicin lokaci tsakanin lokacin asibiti da lokacin mutuwa ya kasance kwanaki 7.
A cikin binciken farko, matsakaicin lokacin daga lokacin bayyanar cututtuka zuwa mutuwa ya kasance kwanaki 14, tare da kewayon yanayin juyin halitta daga kwanaki 6 zuwa 41.
A wani bincike da hukumar lafiya ta kasar Sin (NHC) ta gudanar, maza sun samu kashi 2.8 cikin 100 na mace-mace, yayin da mata suka samu kashi 1.7 cikin 100.
Binciken kwayoyin halitta na kwayoyin bayan mutuwa ya nuna lalacewar alveolar da aka rarraba tare da fibromycin oxide na salula a cikin kwayoyin biyu.
An lura da sauye-sauyen kwayar cutar kwayar cuta a cikin pennucytes.
Hoton na huhu ya yi kama da cututtukan cututtukan numfashi (ARDS).
A cikin kashi 11.8 na mutuwar da Hukumar Lafiya ta China ta ruwaito, cutar zuciya ta haifar da yawan troponin ko kuma rashin ciwon zuciya.
A Amurka, kashi 89% na mutanen da ke asibiti suna da cututtukan da ke tattare da su, a cewar Maris. Samun damar samar da magunguna da tattalin arzikin yankin ba su kasance marasa tasiri ba a kan yawan mutuwa.
Kimanin yawan mutuwar da ake samu daga wannan yanayin ya bambanta saboda bambance-bambance na yanki da kuma matsalolin da ake fuskanta na hanyoyin.
Ƙananan ƙididdigar ƙananan ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar.
Koyaya, gaskiyar cewa mutuwar ta samo asali ne daga abubuwan da aka kamu da su a baya na iya nufin cewa ba a kimanta yawan mutuwar a halin yanzu ba.
Masu shan sigari sun fi sau 1.4 nuna alamun cutar COVID-19 kuma kusan sau 2.4 suna buƙatar kulawa ta musamman idan aka kwatanta da waɗanda ba sa shan sigari. An sami damuwa game da ciwon na dogon lokaci.
Jami'an asibitin Hong Kong sun gano raguwar kashi 20% zuwa 30% a cikin karfin huhu a cikin adadin mutanen da suka warke daga cutar, kuma hotunan huhu sun nuna lalacewar gabobin.
Hakanan yana iya haifar da ciwon bayan kulawa ta musamman.
Har zuwa Maris 2020, ba a san ko kamuwa da cutar a baya a cikin mutanen da suka warke daga cutar zai haifar da ingantaccen rigakafi na dogon lokaci ba.
Tsaron rayuka na mutane yana da kyau dangane da halayyar sauran kwayar cutar, amma an bayar da rahoton cewa mutanen da suka sami cikakkiyar lafiya bayan kamuwa da COVID-19 sun sake kamuwa da cutar.
An yi imanin cewa waɗannan lokuta suna ƙara cutar da ke ci gaba maimakon sake kamuwa da cuta.
Ana ganin cewa kwayar cutar ta kasance ta halitta kuma ta samo asali ne daga dabbobi ta hanyar kamuwa da cuta.
Ba a san ainihin asalin ba, amma yaduwar kamuwa da cuta ta hanyar hanyar mutum zuwa mutum ya kasance har zuwa Disamba 2019.
Nazarin 41 na farko da aka tabbatar da cutar COVID-19, wanda aka buga a cikin Janairu 2020 a cikin The Lancet, ya ba da sanarwar ranar farko ta bayyanar cututtuka a ranar 1 ga Disamba, 2019.
Bayanan hukuma na WHO sun ba da rahoton cewa alamun farko na cutar sun kasance a ranar 8 ga Disamba, 2019.
Yawancin lokaci ana amfani da ma'auni da yawa don ƙididdige ƙimar mutuwa.
Wadannan adadi sun bambanta dangane da yanki da tsawon lokaci kuma sun bambanta dangane da yawan gwajin, ingancin tsarin kiwon lafiya, zaɓuɓɓukan magani, lokacin da aka kashe tun farkon barkewar cutar da kuma yanayin alƙaluma kamar shekaru, jinsi da lafiyar gaba ɗaya.
A ƙarshen 2019, Hukumar Lafiya ta Duniya (ICD-10) ta ba da lambar cutar gaggawa ta U07.1 ga waɗanda suka mutu waɗanda ke da cutar SARS-CoV-2 da aka tabbatar da su a cikin dakin gwaje-gwaje, da kuma lambar U07.2 ga marasa lafiya da suka mutu waɗanda ke da cutar COVID-19 ta asibiti ko ta annoba ba tare da kamuwa da cutar SARS-CoV-2 da aka tabbatar da su a cikin dakin gwaje-gwaje ba.
A cewar Jami'ar Johns Hopkins, yawan mutuwar duniya a ranar 17 ga Afrilu, 2020 ya kai kashi 6.9% (153822/22401191).
Ƙididdigar sun bambanta dangane da yanki. Sauran ma'auni sun haɗa da yawan mutuwar (CFR), wanda ke nuna mutanen da suka kamu da cutar kuma suka mutu, da kuma yawan mutuwar kamuwa da cuta (IFR), wanda ke nuna yawan masu kamuwa da cuta (wanda aka gano ko ba a gano ba) waɗanda suka mutu daga cutar.
Waɗannan ƙididdigar ba su da iyakance ga lokaci kuma suna bin takamaiman yawan jama'a daga kamuwa da cuta zuwa warwarewa.
Kodayake ba duk marasa lafiya bane ke samar da kwayar cutar, kasancewar wadannan kwayar cutar a cikin mutane na nuna yawan wadanda suka kamu.
A tsakiyar cutar a Italiya, a cikin ƙaramin ƙauyen Castiglione d'Adda, 80 (kashi 1.7) daga cikin mutane 4,600 suka mutu.
A Ganglet, cutar ta bazu ta hanyar bukukuwan Carnival kuma ta yadu tsakanin matasa, wanda hakan ya rage yawan mutuwar. Koyaya, ba duk mutuwar COVID-19 bane.
Bugu da kari, tsarin kiwon lafiya na Jamus bai yi nasara ba wajen karbar marasa lafiya da kuma kula da su.
A Netherlands, kimanin kashi 3% na masu ba da jini na iya samun rigakafi.
69 (0.004% na yawan jama'a) sun rasa rayukansu saboda COVID-19.
Tasirin cutar pandemic da kuma yawan mace-mace da ke tattare da ita sun bambanta ga maza da mata.
Yawan mutuwar maza ya fi yawa a cikin binciken da aka yi a China da Italiya.
Mafi girman haɗarin yana ga maza a cikin shekarunsu na 50, kuma rata tsakanin maza da mata kawai a cikin kashi 90 ne.
A kasar Sin, yawan mace-macen da aka samu ya kai kashi 8.2 cikin 100 na maza da kuma kashi 7.1 cikin 100 na mata.
Ba a san ainihin dalilin da ya sa bambancin jinsi yake ba, amma halayyar hali da kwayoyin halitta na iya zama dalili.
Bambance-bambance na rigakafi bisa jinsi, ƙarancin shan sigari a cikin mata da kuma kamuwa da cututtukan da ke tattare da su, kamar hawan jini a cikin ƙarami fiye da mata, na iya ba da gudummawa ga mutuwar maza.
A Turai, 57% na waɗanda suka kamu da cutar maza ne, kuma maza sun kai kashi 72% na waɗanda suka mutu sakamakon COVID-19.
Tun daga watan Afrilu na 2020, gwamnatin Amurka ba ta bin diddigin bayanan kamuwa da cutar COVID-19 ta hanyar jima'i.
Bincike ya nuna cewa cututtukan da ke haifar da kwayar cuta kamar Ebola, cutar kanjamau, mura da SARS suna da tasiri daban-daban a kan mata da maza.
Mafi yawan ma'aikatan kiwon lafiya, musamman ma ma'aikatan jinya, mata ne, wadanda ke da damar kamuwa da cutar.
Hukumar Lafiya ta Duniya (WHO) ta sanar a ranar 11 ga Fabrairu, 2020 cewa sunan cutar a hukumance shine "COVID-19".
Shugaban Hukumar Lafiya ta Duniya Tedros Adhanom Ghebreyesus ya bayyana cewa CO shine asalin kalmar coronavirus, VI shine asalin kalmar kwayar cutar kuma D shine asalin kalmar cutar a cikin Turanci, kuma lambar 19 tana nuna lokacin da aka fara ganin cutar ta farko: 31 ga Disamba, 2019.
An zaɓi sunan ne bisa ga jagororin sunayen duniya don hana ɓarna, tare da la'akari da rashin nuna takamaiman yanki na ƙasa (misali China), ko takamaiman nau'in dabbobi ko rukuni na mutane. An kira kwayar cutar da ke haifar da COVID-19 SARS-CoV-2.
"Har ila yau, WHO tana amfani da kalmar ""COVID-19 virus"" ko ""COVID-19 virus"" a cikin sanarwar jama'a".
"A yadda aka saba, ""coronavirus"" tana nufin cutar da cuta.
"A lokacin da cutar ta fara bulla a Wuhan na kasar Sin, an san cutar da cutar tare da sunayen ""coronavirus"" da ""Wuhan coronavirus"".
A watan Janairun 2020, Hukumar Lafiya ta Duniya ta sanya sunan cutar 2019-nCoV da kuma cutar numfashi mai tsanani 2019-nCoV, bisa ga takardun da aka fitar a shekarar 2015 don samar da cutar da kwayar cutar ta wucin gadi bisa ga wurin da ake.
An fitar da sunayen COVID-19 da SARS-CoV-2 a ranar 11 ga Fabrairu, 2020.
Saboda iyakancewar iyawa a cikin sarkar samar da sabis na yau da kullun, wasu masana'antun dijital suna samar da kayayyakin kiwon lafiya kamar su masu amfani da hanci ko kayan aikin iska.
Misali, lokacin da asibiti a Italiya ke buƙatar bawul ɗin iska da sauri kuma mai ba da sabis ɗin ba zai iya ba da shi ba, wani farawa na gida wanda aka tsara shi ya samar da bawul 100 a cikin dare ɗaya.
Bayan barkewar cutar COVID-19, ka'idojin maƙarƙashiya, da bayanai marasa kyau game da asalin, girman, rigakafi, magani, da sauran fannoni na cutar sun bayyana kuma an buga su cikin sauri a Intanet.
An gano cewa mutane na iya yada kwayar cutar zuwa wasu dabbobi.
Binciken ya gaza wajen gano hujjojin kwayar cutar a aladu, ducks da kuma fararen dabbobin.
Babu wani magani ko allurar rigakafi da aka amince da shi don maganin cutar.
Ana gudanar da bincike na duniya kan allurar rigakafi da magunguna don COVID-19 ta hukumomin gwamnati, kungiyoyin kimiyya da masu bincike na masana'antu.
"A watan Maris, WHO ta ƙaddamar da ""Solidarity Trial"" don kimanta tasirin maganin maganin ƙwayoyin cuta huɗu da ke akwai waɗanda ke da babban fata na tasiri".
Babu allurar rigakafi, amma cibiyoyi daban-daban suna aiki sosai kan samar da samfurin rigakafi.
Saboda SARS-CoV da SARS-CoV-2 duk suna amfani da mai karɓar ACE2 don shiga cikin ƙwayoyin ɗan adam, binciken da aka yi a baya akan SARS-CoV yana da amfani.
An bincika dabarun allurar rigakafi guda uku a cikin wannan mahallin.
Da farko, masu binciken sun yi niyyar samar da rigakafin cutar mai kara kuzari.
Amfani da irin wannan kwayar cutar, ko dai mai kashewa ko mai mutuwa, shine don haifar da saurin amsawar garkuwar jikin mutum ga sabon kamuwa da COVID-19.
Dabara ta biyu, allurar rigakafi, tana da nufin samar da rigakafi wanda zai sa tsarin garkuwar jikin mutum ya zama mai saukin kamuwa da takamaiman kwayoyin cutar.
Game da kwayar SARS-CoV-2, bincike ya mayar da hankali kan furotin S-spike wanda ke taimakawa kwayar cutar ta haɗa kanta da mai karɓar enzyme ACE2.
Dabara ta uku ita ce allurar rigakafin nucleic acid (RNA ko DNA, sabuwar fasaha don inganta allurar rigakafi).
Dole ne a gwada allurar rigakafin gwaji na kowane ɗayan waɗannan dabarun don rigakafi da tasiri. A ranar 16 ga Maris, 2020, an fara gwajin asibiti na farko na allurar rigakafi tare da masu ba da gudummawa huɗu a Seattle.
Allurar rigakafin ta ƙunshi kwayar halitta mara lahani da aka kwafa daga kwayar cutar da ke haifar da cutar. An ba da shawarar ingantaccen rigakafin antibody a matsayin wata babbar ƙalubale don samar da allurar rigakafin SARS-COV-2, amma wannan batun yana da rikici.
Fiye da nazarin asibiti 300 suna gudana a watan Afrilu 2020.
A halin yanzu ana nazarin gwaji bakwai don maganin zazzabin cizon sauro, gami da karatu huɗu akan hydroxychloroquine ko chloroquine.
Anin-anti-viral na sabon aiki yana da babban ɓangare na binciken Sin, tare da gwajin gwaji na kashi uku na 9 akan Remdesivir a ƙasashe daban-daban a ƙarshen Afrilu.
Tun daga watan Afrilu na shekarar 2020, ana gudanar da aikin gwaji mai karfi don samar da allurar rigakafin COVID-19 tare da magungunan da aka zaba. Ana nazarin magungunan rigakafin cutar da yawa don maganin COVID-19, gami da Redmecivir, chloroquine da hydroxychloroquine, lupinavir/ritonavir, da lupinavir/ritonavir tare da interferon beta.
Ya zuwa Maris 2020, akwai shaidar gwaji game da tasirin Remdesivir.
An ga ci gaba a asibiti a cikin marasa lafiya da ke shan magani tare da amfani da Remdesivir.
Ana gudanar da gwajin gwaji na kashi na uku a Amurka, China da Italiya. An yi nazarin chloroquine, wanda aka yi amfani da shi a baya don magance zazzabin cizon sauro, tare da sakamakon farko a watan Fabrairun 2020.
Koyaya, akwai kira don sake nazarin binciken da sauran masu bincike suka yi.
Hukumomin kiwon lafiya na Koriya da China sun ba da shawarar yin amfani da chloroquine.
Koyaya, Cibiyar Kwayar cutar Wuhan, yayin da take ba da shawarar kashi ɗaya a kowace rana, ta nuna cewa ninki biyu na wannan adadin yana da haɗari sosai kuma yana iya zama mai mutuwa.
A ranar 28 ga Maris, 2020, FDA ta ba da izinin gaggawa na hydroxychloroquine da chloroquine don kula da mutanen da ke da COVID-19. Tsarin na 7 na kasar Sin ya hada da interferon, ribavirin ko umifenovir don amfani da su a kan COVID-19.
Bayanai na farko sun nuna cewa ana buƙatar babban allurai na ribavirin don hana SARS-CoV-2 a cikin yanayin dakin gwaje-gwaje.
Bayan nuna cewa yana hana SARS-CoV-2 ƙananan taro, an ba da shawarar nitasoxanide don ƙarin nazarin cikin jiki. Nazarin ya nuna cewa haɗuwa da farko na furotin spike tare da sirine mai gina jiki tsakanin membrane 2 (TMPRSS2) yana da mahimmanci don shigar da SARS-CoV-2 ta hanyar hulɗa tare da mai karɓar ACE2.
Karin binciken da aka yi kan chloroquine da hydroxychloroquine tare da ko ba tare da azithromycin ba yana da matukar iyakancewa wanda ke hana al'umma ta likita yarda da gwajin waɗannan hanyoyin magani ba tare da ƙarin nazarin ba. Seltamivir ba ya hana SARS-CoV-2 a cikin yanayin dakin gwaje-gwaje kuma ba shi da wani tasiri a cikin maganin COVID-19.
Guguwar Sitokin na iya zama matsala a cikin matakan COVID-19 na gaba.
Akwai shaidar cewa hydroxychloroquine na iya samun tasirin anti-cytocin storm.Tucylisumab an saka shi cikin umarnin magani bayan kammala wani ɗan gajeren bincike da Hukumar Lafiya ta China ta yi.
Bayan nuna sakamako mai kyau a cikin mutane masu cutar mai tsanani, yana ƙarƙashin gwajin gwaji na Phase 2 a matakin ƙasa na Italiya.
Ana amfani da gwajin jini tare da gwajin serum ferritin don gano yanayin guguwar cytokine, don magance irin wannan ci gaban cututtukan da ake cewa shine dalilin mutuwar mutane da yawa da suka kamu da cutar.
An amince da maganin mai karɓar mai karɓar interleukin 6 ta FDA a cikin 2017 bisa ga nazarin yanayin da aka yi don maganin cutar cutar cytokine mai hana steroid wanda ya haifar da wani dalili daban, maganin CAR T-cell.
Ya zuwa yanzu, babu wata hujja ta bazuwar ko ta sarrafawa cewa tosilezomab magani ne mai tasiri ga CRS.
Ana nazarin watsa kwayoyin cutar da aka tace da kuma kwayoyin cutar da aka tattara daga tsarin rigakafin mutane da suka warke daga COVID-19 zuwa masu kamuwa da cutar a halin yanzu a matsayin hanyar da ba a yi rigakafi ba.
An gwada wannan dabarar don SARS ba tare da tabbataccen sakamako ba.
Rashin amfani da kwayar cutar shine tsarin aiki wanda a ciki maganin rigakafin da ba shi da tasiri zai iya haifar da wani abu mai kariya ga SARS-CoV-2.
Koyaya, wasu hanyoyin kamar su cytotoxicity da / ko maganin rigakafi na rigakafi na ƙwayoyin cuta na iya faruwa.
Ana ci gaba da wasu nau'ikan maganin rigakafin da ba su da aiki, misali, amfani da rigakafin monoclonal na wucin gadi.
Samfurin maganin magani daga mutanen da suka warke, wanda ya ƙunshi ɓangaren ruwa na jini daga marasa lafiya da suka warke, wanda ya ƙunshi ƙwayoyin cuta na musamman na kwayar cutar, na iya ƙaruwa don saurin amfani.
Cutar cutar coronavirus, rukuni ne na cututtukan da ke da alaƙa da juna.
Li Wenliang, likita a asibitin Wuhan, wanda daga baya ya kamu da cutar kuma ya mutu bayan ya san cewa cutar ta bazu.
